
<html lang="en"     class="pb-page"  data-request-id="1bf795dd-1303-4917-9580-52950578511a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.8b01530;issue:issue:10.1021/jmcmar.2019.62.issue-9"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer’s Disease" /></meta><meta name="dc.Creator" content="Ahmed  Morsy" /></meta><meta name="dc.Creator" content="Paul C.  Trippier" /></meta><meta name="dc.Description" content="Alzheimer’s disease (AD) is the most common dementia. No cure exists, and current treatment only manages early symptoms. Mitochondrial dysfunction is a hallmark of amyloid-β (Aβ) neurotoxicity, the..." /></meta><meta name="Description" content="Alzheimer’s disease (AD) is the most common dementia. No cure exists, and current treatment only manages early symptoms. Mitochondrial dysfunction is a hallmark of amyloid-β (Aβ) neurotoxicity, the..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 16, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01530" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01530" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01530" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01530" /></link>
        
    
    

<title>Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer’s Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01530" /></meta><meta property="og:title" content="Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer’s Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0007.jpeg" /></meta><meta property="og:description" content="Alzheimer’s disease (AD) is the most common dementia. No cure exists, and current treatment only manages early symptoms. Mitochondrial dysfunction is a hallmark of amyloid-β (Aβ) neurotoxicity, the pathogenic protein implicated in AD. This is due in part to the interaction between Aβ and amyloid-binding alcohol dehydrogenase (ABAD). This mitochondrial protein is a vital energy regulator that, following Aβ binding, activates signaling cascades that lead to neuronal death. One of the most significant roles of ABAD is to maintain the balance of estradiol/estrone in neurons. However, the Aβ–ABAD interaction disrupts this balance and leads to a reduction in levels of estradiol, thus leading to an increase in reactive oxygen species levels and to apoptosis. Two additional proteins, peroxiredoxin-2 and endophilin-1, are implicated in Aβ–ABAD complex-mediated toxicity. Targeting the Aβ–ABAD interaction has emerged as a novel therapeutic strategy for AD. Herein, we review the chemistry and pharmacology of reported ABAD inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01530"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01530">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01530&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01530&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01530&amp;href=/doi/10.1021/acs.jmedchem.8b01530" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 4252-4264</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01469" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b01610" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer’s Disease</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ahmed Morsy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ahmed Morsy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ahmed++Morsy">Ahmed Morsy</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor">Paul C. Trippier</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul C. Trippier</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, United States</div><div class="loa-info-affiliations-info">Center for Chemical Biology, Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#e595849089cb91978c95958c8097a59191908d9686cb808190"><span class="__cf_email__" data-cfemail="215140544d0f5553485151484453615555544952420f444554">[email protected]</span></a>. Phone: +1-806-414-9245.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul+C.++Trippier">Paul C. Trippier</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4947-5782" title="Orcid link">http://orcid.org/0000-0002-4947-5782</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01530&amp;href=/doi/10.1021%2Facs.jmedchem.8b01530" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 4252–4264</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 16, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 October 2018</li><li><span class="item_label"><b>Published</b> online</span>16 November 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 May 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01530" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01530</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4252%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAhmed%2BMorsy%252C%2BPaul%2BC.%2BTrippier%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D9%26contentID%3Dacs.jmedchem.8b01530%26title%3DAmyloid-Binding%2BAlcohol%2BDehydrogenase%2B%2528ABAD%2529%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BAlzheimer%25E2%2580%2599s%2BDisease%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4264%26publicationDate%3DMay%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01530"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2814</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01530" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer’s Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ahmed&quot;,&quot;last_name&quot;:&quot;Morsy&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;C. Trippier&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;4252-4264&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01530&quot;},&quot;abstract&quot;:&quot;Alzheimer’s disease (AD) is the most common dementia. No cure exists, and current treatment only manages early symptoms. Mitochondrial dysfunction is a hallmark of amyloid-β (Aβ) neurotoxicity, the pathogenic protein implicated in AD. This is due in part to the interaction between Aβ and amyloid-binding alcohol dehydrogenase (ABAD). This mitochondrial protein is a vital energy regulator that, following Aβ binding, activates signaling cascades that lead to neuronal death. One of the most significant roles of ABAD is to maintain the balance of estradiol/estrone in neurons. However, the Aβ–ABAD interaction disrupts this balance and leads to a reduction in levels of estradiol, thus leading to an increase in reactive oxygen species levels and to apoptosis. Two additional proteins, peroxiredoxin-2 and endophilin-1, are implicated in Aβ–ABAD complex-mediated toxicity. Targeting the Aβ–ABAD interaction has emerged as a novel therapeutic strategy for AD. Herein, we review the chemistry and pharmacology of reported ABA&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01530&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01530" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01530&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01530" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01530&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01530" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01530&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01530&amp;href=/doi/10.1021/acs.jmedchem.8b01530" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01530" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01530" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01530%26sid%3Dliteratum%253Aachs%26pmid%3D30444369%26genre%3Darticle%26aulast%3DMorsy%26date%3D2019%26atitle%3DAmyloid-Binding%2BAlcohol%2BDehydrogenase%2B%2528ABAD%2529%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BAlzheimer%25E2%2580%2599s%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D9%26spage%3D4252%26epage%3D4264%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/jmcmar.2019.62.issue-9/20190509/jmcmar.2019.62.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01530&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Alzheimer’s disease (AD) is the most common dementia. No cure exists, and current treatment only manages early symptoms. Mitochondrial dysfunction is a hallmark of amyloid-β (Aβ) neurotoxicity, the pathogenic protein implicated in AD. This is due in part to the interaction between Aβ and amyloid-binding alcohol dehydrogenase (ABAD). This mitochondrial protein is a vital energy regulator that, following Aβ binding, activates signaling cascades that lead to neuronal death. One of the most significant roles of ABAD is to maintain the balance of estradiol/estrone in neurons. However, the Aβ–ABAD interaction disrupts this balance and leads to a reduction in levels of estradiol, thus leading to an increase in reactive oxygen species levels and to apoptosis. Two additional proteins, peroxiredoxin-2 and endophilin-1, are implicated in Aβ–ABAD complex-mediated toxicity. Targeting the Aβ–ABAD interaction has emerged as a novel therapeutic strategy for AD. Herein, we review the chemistry and pharmacology of reported ABAD inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01456" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01456" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the most common form of dementia affecting millions of people worldwide. Clinically, AD is characterized by loss of cognitive function including memory, language, and motor skills.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The main pathological hallmarks of the AD brain are the presence of extracellular senile plaques of amyloid-β (Aβ) peptides, neurofibrillary tangles and loss of neuronal cells, particularly cholinergic neurons.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> The leading molecular theory of the early stages of AD is the amyloid cascade hypothesis;<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> an imbalance in the production or clearance of the Aβ peptide results in accumulation of Aβ and initiation of a cascade of events that lead to neurodegeneration and dementia.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> However, the druggability of the amyloid cascade hypothesis is in doubt following several phase III clinical trial failures of beta-site amyloid precursor protein cleaving enzyme (BACE) inhibitors and antibodies.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Amyloid then aggregates to form oligomers that are neurotoxic.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> The oligomers accumulate in the mitochondria of neurons leading to a series of slow and separate mechanistic neurodegenerative events that eventually lead to neurotoxicity and synaptic dysfunction.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> This accumulation also leads, through an as yet unknown process, to the formation of hyperphosphorylated tau protein, part of an overall neurodegenerative mechanism that is deemed to be toxic to neurons and leads to neuroinflammation. Loss of synaptic function and mitochondrial abnormalities are associated with early stages of AD which directly relate to the process of toxicity caused by amyloid and contribute to the neurodegeneration which ultimately leads to brain atrophy and patient death.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a></div><div class="NLM_p">Currently, there are no disease-modifying therapies for the treatment of AD.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Only five drugs (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) have been approved by the U.S. Food and Drug Administration (FDA), four of which are cholinesterase inhibitors (tacrine,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> donepezil,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> rivastigmine,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and galantamine<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a>) and one of which is a <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate (NMDA) receptor antagonist (memantine<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a>). These pharmacological agents have had limited effect in improving the cognitive function of AD patients and do not slow the progression of the disease. Clinical studies have shown that these agents temporarily stabilize cognitive impairment and help to maintain global function, delaying the need for patient palliative care by only a few months.<a onclick="showRef(event, 'ref18 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref20 ref21">(18,20,21)</a> Clearly, the development of novel treatment options capable of modifying the underlying pathophysiology of AD is an unmet clinical need that results in significant morbidity and mortality.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of clinically approved drugs for the treatment of Alzheimer’s disease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01530&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Treating AD has proven highly challenging with all completed clinical trials failing to achieve a positive clinical effect, highlighting that a clear understanding of AD pathology is still unclear. A relatively large number of chemically diverse secretase inhibitors (both β and γ) that target the formation of Aβ have failed clinical trials, showing no benefit in slowing the progression of the disease. Kumar et al. recently summarized the use of secretase inhibitors, γ-secretase modulators, and α-secretase enhancers in clinical trials, and the reader is directed to this review and included references for more in depth analysis.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Trials of agents that work to target the clearance of Aβ have also failed. Antibodies that bind Aβ and reduce its accumulation in the brain or initiate an immune response have proven unsuccessful in offering an effective treatment, with several high profile clinical trial failures.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> Panzaa et al. highlighted the use of amyloid-based immunotherapy for Alzheimer’s disease as still questionable.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Hence, the ongoing clinical trials using amyloid-based immunotherapy (ClinicalTrials.gov identifiers NCT01127633, NCT01900665, NCT01760005) are cast into doubt. Perhaps the continuing failures of these clinical trials targeting Aβ are due to approaching protein aggregation at too late a stage of disease progression. The accumulation of Aβ has been shown to begin in the brain before signs of cognitive decline become apparent.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26−28)</a> Since Aβ is formed intracellularly,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> accumulating evidence suggests that early Aβ toxicity may be initiated from its binding to intracellular targets resulting in disruption of cellular biochemistry that leads to cell death. The identification and pharmacological modulation of cellular targets that bind Aβ may enable therapeutic intervention at earlier stages of AD progression, with the caveat that biomarkers for early stage AD are currently lacking and are urgently needed.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> Due to the role of mitochondrial dysfunction and oxidative stress in the early pathology of AD, mitochondrial targets have promising potenial.<a onclick="showRef(event, 'ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35">(32−35)</a></div><div class="NLM_p last">Genetics have a role to play within AD; patients with a mutation in amyloid precursor protein (APP), which results in overproduction of Aβ, will experience early onset AD.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Patients with a mutation in apolipoprotein E4 (APOE4), which affects the clearance of Aβ, will experience late onset AD.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In addition, several other gene mutations have been discovered such as presenilin-1 and presenilin-2 mutations, which increase the risk for developing AD.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> However, the majority of AD patients have no known genetic mutation, thus supporting the amyloid cascade hypothesis as the underlying pathophysiology resulting in disease onset.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Mitochondrial Dysfunction in Alzheimer’s Disease</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84854" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84854" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The amyloid cascade hypothesis has gained traction over the past decades and is now the most widely accepted theory as to the cause of AD.<a onclick="showRef(event, 'ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41">(39−41)</a> Recent studies indicate that the soluble oligomeric form of Aβ is the most toxic species of amyloid and correlates well with the severity of the disease.<a onclick="showRef(event, 'ref9 ref42'); return false;" href="javascript:void(0);" class="ref ref9 ref42">(9,42)</a> Alzheimer’s disease pathology is believed to start 15–20 years before manifestation of symptoms, which presents a general hypothesis of a slow neurodegenerative mechanism caused by amyloid aggregation. The exact mechanism of amyloid toxicity remains unknown despite extensive research in the past several decades. Numerous studies indicate the presence of amyloid protein intracellularly which led to the modification of the original amyloid cascade hypothesis to identify the intracellular oligomers as the neurotoxic form of Aβ.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> The formation of Aβ starts by a transmembrane protein, APP (695–770 amino acids in length), which is sequentially cleaved by the aspartate proteases β- and γ-secretase, that leads to the formation of Aβ peptide (1–42) and a degenerated C-terminus. Amyloid then aggregates to form dimers, tetramers, and oligomers.<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45−47)</a> Extracellularly, Aβ can have different molecular conformations, from dimers, tetramers, and oligomers, forming highly aggregated fibers that are the major component of amyloid plaques.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a> The presence of Aβ intracellularly causes toxicity through different mechanisms. Mitochondrial dysfunction is the hallmark of Aβ-induced toxicity.<a onclick="showRef(event, 'ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52">(50−52)</a> The presence of Aβ in the mitochondria is implicated in the free radical generation and resultant oxidative damage seen in AD.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Decrease in glucose utilization in neurons of AD patients further suggests mitochondrial defects. Recent studies revealed that cognitively normal patients with the APOE4 allele have abnormal glucose metabolism, suggesting that mitochondrial dysfunction is an early stage of AD progression.<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53,54)</a> Further, in in vitro assays testing for Krebs cycle enzymes using cells obtained from the autopsy of AD patient brains, mitochondrial enzymes have been shown to be significantly decreased, including critical enzymes in the mitochondrial respiratory chain; pyruvate dehydrogenase, ketoglutarate dehydrogenase, and isocitrate dehydrogenase.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Several studies have shown that Aβ toxicity in neurons could directly damage mitochondrial respiration and associated enzyme activity.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> Accumulation of Aβ has also been associated with a decrease in the activity of cytochrome <i>c</i> oxidase, the terminal enzyme in the electron transport chain. These findings suggest the involvement of mitochondria in Aβ toxicity and impairment of glucose metabolism due to dysfunction of mitochondrial respiratory function. Therefore, mitochondrial proteins have gained much attention as possible mechanisms by which Aβ causes its toxicity, leading in turn to suggest these enzymes as possible pharmacological targets for the treatment of AD.</div><div class="NLM_p last">Mitochondrial dysfunction is associated with synaptic dysfunction in the early pathological features of AD.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Binding of Aβ to proteins in the mitochondria results in synaptic dysfunction, impaired mitochondrial respiration, ATP depletion, and production of reactive oxygen species (ROS).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Multiple reports have studied the effect of incubating Aβ with isolated mitochondria which resulted in reduction of mitochondrial complex IV activity, as well as the formation of the mitochondrial permeability transition pore (mPTP) which leads to apoptosis.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> Two mitochondrial targets in particular have become the center of interest; amyloid binding alcohol dehydrogenase (ABAD) and cyclophilin D (CypD). The two proteins have been heavily implicated in mitochondrial toxicity. Binding of Aβ, in its oligomeric form, to ABAD has been shown to inhibit enzyme activity in the micromolar range.<a onclick="showRef(event, 'ref45 ref61'); return false;" href="javascript:void(0);" class="ref ref45 ref61">(45,61)</a> Due to its essential physiological role in the mitochondria, human ABAD acts as a cofactor to Aβ-induced cellular stress.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Several other mitochondrial targets of Aβ are being investigated beyond ABAD, and for further information on this emerging area the reader is directed to excellent reviews on the subject.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62,63)</a></div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Amyloid Binding Alcohol Dehydrogenase</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73210" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73210" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">First identified by a yeast two-hybrid screen for Aβ binding molecules,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> ABAD is also known as 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10), endoplasmic reticulum-associated amyloid β-peptide-binding protein (ERAB), and short-chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD). The enzyme is a homotetramer protein complex with a molecular mass of 108 kDa, consisting of 261 amino acids, that is encoded by the gene HSD17B10 located at chromosome Xp11.2.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Binding of Aβ to ABAD has been implicated in the development of AD; recent studies detected elevated ABAD levels in the regions of the hippocampus and cerebral cortex which are generally affected by AD pathology.<a onclick="showRef(event, 'ref64 ref66 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref64 ref66 ref67 ref68">(64,66−68)</a> Binding of Aβ was found to be to nanomolar affinity (40–70 nM),<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> but it is not until the micromolar ranges where ABAD activity is compromised.<a onclick="showRef(event, 'ref45 ref61 ref66'); return false;" href="javascript:void(0);" class="ref ref45 ref61 ref66">(45,61,66)</a> This suggests that a higher concentration of Aβ, likely in its oligomeric form, is required to occupy the binding site and induce the observed conformation changes in the enzyme.</div><div class="NLM_p">The mitochondrial enzyme ABAD is a multifunctional protein, fulfilling several metabolic roles. The enzyme plays a role in the β-oxidation cycle, oxidizing 3-hydroxyacyl-CoAs.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The enzyme functions as a vital energy regulator within the mitochondria, containing a Rossman fold that acts to oxidize alcohols and reduce aldehydes and ketones on a variety of substrates with a nicotinamide adenine dinucleotide (NAD<sup>+</sup>) molecule as a cofactor.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> The enzyme is also required for the catabolism of isoleucine, in which it catalyzes the conversion of 2-methyl-3-hydroxybutyryl-CoA (MHB) to 2-methylacetoacetyl-CoA.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Wide substrate specificity exists including steroids, simple alcohols, fatty acid metabolites, and amino acid metabolites.<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a> The enzyme catalyzes the third step of mitochondrial oxidation, converting <span class="smallcaps smallerCapital">l</span>-3-hydroxyacyl-CoA in the presence of NAD<sup>+</sup> to 3-ketoacyl-CoA, NADH, and H<sup>+</sup>. The enzyme has a role in sex steroid and neurosteroid metabolism due to its 3α- and 17β-hydroxysteroid dehydrogenase activity.<a onclick="showRef(event, 'ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref75 ref76">(75,76)</a> The oxidation of 3α-adiol to 5α-dihydrotestosterone in androgen metabolism is catalyzed by ABAD, and it converts 17β-estradiol to estrone in estrogen metabolism. A broad range of substrates can be controlled by ABAD,<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> although recent studies reveal a greater specificity for neurosteroids. It was recently determined that ABAD activity in neurosteroid metabolism of estrogens is a unidirectional process breaking down estradiol to estrone.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><div class="NLM_p">Several essential functions in the brain are controlled by ABAD. Reports indicate that ABAD is one of the protein constituents of postsynaptic density, a complex of proteins that maintains the integrity and structures of the synapse and also mediates responses from the presynaptic axon terminals.<a onclick="showRef(event, 'ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref78 ref79">(78,79)</a> Moreover, function of ABAD has also been associated with GABA<sub>A</sub> receptors, as it catalyzes the oxidation of the neurosteroids allopregnanolone and allotetrahydrodeoxycorticosterone, both of which are positive modulators of GABA<sub>A</sub> receptors in the brain.<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80,81)</a> After oxidation, these substrates increase receptor opening frequency and duration.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div><div class="NLM_p">The protective effects of ABAD have been shown in cases of ischemia and Parkinson’s disease.<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83,84)</a> Overexpression of ABAD in neuroblastoma cells, however, enhances the cytotoxic effects of Aβ.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The enzyme’s activity in the wild type form, but not the mutant form, has been linked to mitochondrial and oxidative stress in vitro<a onclick="showRef(event, 'ref64 ref66'); return false;" href="javascript:void(0);" class="ref ref64 ref66">(64,66)</a> and in vivo.<a onclick="showRef(event, 'ref58 ref66'); return false;" href="javascript:void(0);" class="ref ref58 ref66">(58,66)</a> Binding of Aβ to ABAD has been shown to cause disruption in enzyme activity toward specific substrates. Such substrates are known to possess neuroprotective effects in processes directly related to AD pathology. For example, estradiol can reduce the generation of Aβ by altering the metabolism of APP and disrupting its trafficking.<a onclick="showRef(event, 'ref85 ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref85 ref86 ref87">(85−87)</a> Moreover, estradiol has been shown to inhibit tau hyperphosphorylation and can also modulate glycogen synthase kinase-3β (GSK-3β) activity, a kinase that is involved in tau phosphorylation. Estradiol deactivates GSK-3β by inducing its phosphorylation, thereafter reducing tau phosphorylation.<a onclick="showRef(event, 'ref88 ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref88 ref89 ref90">(88−90)</a></div><div class="NLM_p">The presence of Aβ in the mitochondria triggers a cascade of events that leads to apoptosis.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> In vitro binding studies determined Aβ (1–20), Aβ (1–40), and Aβ (1–42) to be toxic in a dose-dependent manner when bound to ABAD. However, Aβ (25–35) showed no binding to ABAD, indicating that only specific forms of Aβ bind to a specific site within ABAD, forming a complex in the mitochondrial matrix.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Methylene blue, an FDA approved drug used to treat methemoglobinemia and cyanide poisoning, became a drug of interest for the treatment of AD. The molecule is currently in phase III clinical trials under the name of Rember (ClinicalTrials.gov identifier NCT03539380) to assess its effect in improving cognitive function. Preliminary trials resulted in an 81% decrease in the rate of mental decline compared to patients taking placebo.<a onclick="showRef(event, 'ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref91 ref92">(91,92)</a> In mechanistic studies, it was proposed that methylene blue inhibits the Aβ–ABAD interaction and decreases mitochondrial dysfunction by decreasing the expression of ABAD levels, in addition to decreasing Aβ levels.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a></div><div class="NLM_p last">The Aβ–ABAD complex has been studied extensively using different techniques. An enzyme-linked immunosorbent assay (ELISA) showed dose-dependent binding of ABAD to Aβ.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Surface plasmon resonance (SPR) and nuclear magnetic resonance (NMR) studies revealed that Aβ binding to ABAD induces conformational changes in the enzyme structure, thereby inactivating normal enzymatic turnover and ultimately resulting in neuronal apoptosis.<a onclick="showRef(event, 'ref66 ref95 ref96'); return false;" href="javascript:void(0);" class="ref ref66 ref95 ref96">(66,95,96)</a> X-ray crystal structure studies of the Aβ–ABAD complex revealed that protein–protein interaction has a direct link to Aβ toxicity.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Coimmunoprecipitation followed by immunoblotting analysis detected Aβ–ABAD complex in the AD brain.<a onclick="showRef(event, 'ref64 ref97'); return false;" href="javascript:void(0);" class="ref ref64 ref97">(64,97)</a> Crystal structures of the interaction of ABAD with its substrates (fatty acids and hydroxysteroids) support the proposed physiological and pathological relevance to AD progression.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Confocal microscopy studies were also performed to confirm the mitochondrial colocalization and interaction of ABAD with Aβ in both AD patients and transgenic mice overexpressing ABAD and mutant APP (Tg mAPP/ABAD).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Neurons from these animals exhibited increased oxidative stress, increased generation of ROS, DNA fragmentation, neuronal apoptosis, and impairment in learning compared to single-transgenic mAPP mice.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> In another study, neurons from Tg mAPP/ABAD mice were shown to exhibit decreased activity of cyclooxygenase (COX) enzyme, spontaneous release of ROS, loss of mitochondrial membrane potential, a decrease in ATP production, and release of cytochrome <i>c</i> from mitochondria with subsequent induction of caspase-3-like activity followed by apoptotic cell death.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> These findings overwhelmingly confirmed the Aβ–ABAD interaction as crucial to elicit Aβ toxicity and that the binding causes a cascade of events that eventually lead to neuronal damage. Thereafter, studies focused on identifying inhibitors for this interaction in order to further study the enzyme and to potentially improve cognitive health. The search for inhibitors started with a decoy peptide, synthesized to encompass the L<sub>D</sub> loop, the region in the enzyme that is crucial for Aβ binding. By use of SPR, the peptide was shown to prevent binding of Aβ, confirming the L<sub>D</sub> loop of the enzyme to be an ideal target for molecular modeling to identify small molecules that can inhibit the interaction.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Moreover, in vivo inhibition of the Aβ–ABAD interaction using the decoy peptide reduces Aβ accumulation and improves mitochondrial function in a mouse model of AD.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Aβ–ABAD Toxicity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The mechanism by which the Aβ–ABAD complex elicits, or potentiates, toxicity is still unclear. However, it is well established that Aβ binding to ABAD induces a conformational change in the enzyme that prevents the binding of NAD<sup>+</sup>, preventing the enzyme performing its role in the oxidation of substrates, leading to changes in mitochondrial membrane permeability, which in turn has deleterious effects on mitochondrial enzymes.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Another consideration is that formation of the protein–protein interaction prevents ABAD from carrying out its function to remove toxic aldehydes.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> The enzyme functions as a modulator for several different substrates that have been implicated in Aβ–ABAD complex toxicity resulting in a cascade of toxic events that follow Aβ–ABAD binding (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref100 ref101 ref102'); return false;" href="javascript:void(0);" class="ref ref100 ref101 ref102">(100−102)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Diagram illustrating Aβ–ABAD complex induced toxicity. (1) Upregulation of endophilin-1 (Ep-1) by ABAD activates the JNK pathway which leads to cytotoxicity. (2) Upregulation of peroxiredoxin-2 (Prdx-2), which is responsible for degradation of peroxides, by ABAD. However, due to elevated levels of CdK5, elevated Prdx-2 is deactivated which leads to peroxide accumulation. (3) Conversion of estradiol to estrone is upregulated with complex interaction leading to reduced levels of estradiol in the mitochondria. Estradiol has remarkable effects in neuron protection (a–i). (a) Deactivation of estradiol leads to the inability of the mitochondria to sequestrate Ca<sup>2+</sup> ions from the cytosol. This effect is induced by Aβ leading to accumulation of Ca<sup>2+</sup> ions in the cytosol which results in Cdk5 activation. The accumulation of Ca<sup>2+</sup> ions in the cytosol also leads to ROS generation. (b) Estradiol increases the production of antioxidants by increasing glutathione levels, decreasing oxidative DNA damage in the mitochondria. (c) Estradiol reduces amyloid precursor protein (APP) processing, decreasing Aβ levels and concomitantly its aggregation into plaques. (d) Estradiol induces the phosphorylation of glycogen synthase kinase-3β (GSK-3β) which inactivates the enzyme and reduces tau phosphorylation. (e, f) Estradiol functions to enhance the downregulation of proapoptotic proteins (e.g., Bim) and the expression of antiapoptotic proteins (e.g., Bcl-2 and Bcl-xL). (g, i) Estradiol exerts an effect on the electron transport chain by increasing the expression of some complexes in the mitochondrial respiratory chain, including complex I (CI) and complex IV (CIV). (h) Estradiol has been shown to prevent mitochondrial release of cytochrome <i>c</i>, which activates the caspase cascade in the cytoplasm leading to apoptosis. (4) Participation of ABAD in the final degradation steps of the amino acid isoleucine is inhibited by Aβ binding, which leads to the accumulation of 2-methyl-3-hydroxybutyrate. The latter has toxic effects in inhibiting Krebs cycle enzymes and complex IV activity. (5) Toxic aldehydes that accumulate in the mitochondria are degraded by ABAD. This degradation is inhibited by Aβ binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01530&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Physiological levels of estradiol in the mitochondria play a vital role as both antioxidants and as calcium regulators and as such are an essential determinant of neuronal survival.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Higher prevalence and incidence of AD are encountered in women, with two-thirds of AD patients being female.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Studies show that women exhibit greater senile plaque deposition than men.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Estradiol binds to the nuclear estrogen receptors α and β and acts as a transcription factor. It enhances the expression of antiapoptotic proteins, such as Bcl-2 and Bcl-xL, and downregulates the expression of Bim, a proapoptotic factor, preventing programmed cell death.<a onclick="showRef(event, 'ref90 ref100'); return false;" href="javascript:void(0);" class="ref ref90 ref100">(90,100)</a> Estradiol also activates antioxidant systems to protect neuronal cells from apoptosis by upregulating the expression of manganese superoxide dismutase and glutathione peroxidase.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> In a study employing ovariectomized female rats, estradiol showed direct effects as an antioxidant and subsequently decreased oxidative DNA damage in the mitochondria.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> One of the most significant roles of ABAD is to maintain the balance of estradiol/estrone in neurons. However, Aβ–ABAD interaction disrupts this balance and leads to a reduction in levels of estradiol, thus leading to an increase in ROS levels, DNA fragmentation, and apoptosis.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></div><div class="NLM_p">Two other ABAD-related proteins have been identified to date that are elevated subsequent to Aβ–ABAD interaction. The first, peroxiredoxin-2 (Prdx-2), functions as an antioxidant and has been shown to be inactivated in AD.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> In transgenic AD mice and the post-mortem human brain of AD patients, the expression of Prdx-2 is shown to be elevated due to the attempted protection of neurons from Aβ-induced toxicity.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Inactivation of Prdx-2 is controlled by a kinase that has been shown to be elevated in AD, CDK5,<a onclick="showRef(event, 'ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref107 ref108">(107,108)</a> which phosphorylates Thr<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> and results in deactivation of Prdx-2.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></div><div class="NLM_p last">The second ABAD-related protein, endophilin-1 (Ep-1), is a member of a family of proteins that are responsible for synaptic vesicle endocytosis, mitochondrial function, and receptor trafficking.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> This family of proteins has been implicated in a number of neurodegenerative diseases,<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> including in AD where it is overexpressed.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> The activity of stress kinase c-Jun N-terminal kinase (JNK) has been shown to be linked to Ep-1 in primary cortical neurons and HEK-293 cells.<a onclick="showRef(event, 'ref112 ref113'); return false;" href="javascript:void(0);" class="ref ref112 ref113">(112,113)</a> Through a germinal center-like kinase (GLK)-mediated pathway, Ep-1 binds to GLK by its C-terminal domain affecting lipid membrane curvature for synaptic vesicle formation.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> This results in the activation of mitogen-activated protein kinase kinase kinase 1 (MAP3K1),<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> which then activates a cascade of kinases that eventually leads to the translocation of JNK to the nucleus or other target sites to phosphorylate downstream effectors, thereby affecting significant aspects of neuronal function such as neurite outgrowth, mitochondrial function, synaptic plasticity, and apoptosis.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> These consequences of ABAD-related protein activity highlight a wider role of ABAD in healthy neuronal function. Thus, Aβ binding to ABAD does not just inhibit enzyme activity; it manipulates its activity toward specific substrates and proteins. Production or inhibition of these substrates is implicit in the complex mechanisms of toxicity induced by Aβ–ABAD interaction.</div></div><div id="sec1_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Imaging</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66216" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66216" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The development of a labeled or fluorogenic ligand which can be used in brain imaging techniques such as positron emission tomography (PET), single photon emission computed tomography (SPECT), or magnetic resonance imaging (MRI) would provide a useful tool for studying ongoing processes in the brain and may assist in the identification of biomarkers to monitor AD progression.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Cyclohexenylaminonaphthalene alcohol (CHANA) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) is a fluorogenic probe developed for imaging ABAD activity.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> The probe is structurally similar to estradiol, a known substrate for ABAD, and through fluorescent microscopy the fluorogenic probe enables noninvasive and continuous measurement of ABAD activity in cells. The CHANA probe exhibits very low fluorescence, whereas the corresponding ketone product, cyclohexenylaminonaphthalene ketone (CHANK), is highly fluorescent.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> This property allows active monitoring of ABAD activity by measuring the intensity of accumulated CHANK. A specific enantiomer of CHANA has been speculated to be a selective substrate for ABAD;<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> (−)–CHANA showed specific binding to ABAD and can be utilized both in in vitro enzyme assays or for fluorescence microscopy studies to evaluate ABAD activity. The probe was used to evaluate the change in enzyme activity following Aβ binding in the living cell and demonstrated that the enzyme activity is reduced following Aβ binding.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> A variety of benzothiazole chemotypes are being employed for imaging purposes, and for further information regarding their use the reader is directed to an excellent review that discusses the use of benzothiazole scaffold in the CNS.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Using NAD<sup>+</sup> as a Cofactor, ABAD Catalyzes the Oxidation of CHANA to the Ketone CHANK<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01530&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Assay Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A number of assay protocols have been developed to test the activity of small molecule ABAD inhibitors. A high-throughput screen (HTS) was developed that employed binding of 5 μg of Aβ to a 2.5 μM concentration of isolated biotin-labeled ABAD, which ultimately identified frentizole, a known bioactive compound, as an Aβ–ABAD interaction inhibitor.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></div><div class="NLM_p">Estradiol has long been used as an indicator of assay readout results, and kits are commercially available to quantify the amount of estradiol produced by measurement of absorbance at 412 nm. The level of estradiol present in SH-SY5Y cells treated with 0.5 μM concentration of Aβ and incubated with derivatives that function as ABAD inhibitors can therefore be determined as directly proportional to the potency of the inhibitor allowing direct comparison of the small molecules tested.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> This assay has the advantage of determining the activity of the tested compounds in an intact cell in the presence of Aβ.</div><div class="NLM_p">An in vitro assay and HTS platform have been used for identification of small molecules that can modulate ABAD activity in the presence of NADH.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> The assay tested 6759 compounds for activity to inhibit ABAD, identifying 16 hits. Acetoacetyl-CoA was considered to be the best substrate for ABAD as it provides a balanced chance of finding competitive, noncompetitive, or uncompetitive inhibitors. In the presence of NADH, acetoacetyl-CoA, and isolated ABAD enzyme, the potency of the tested compounds can be determined by the change of NADH absorbance. The concentrations needed to produce a functional signal are 2.5 nM ABAD, 117 μM acetoacetyl-CoA, and 100 μM NADH.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> This enzyme assay directly tested potency of compounds toward inhibiting enzyme activity in the presence of acetoacetyl-CoA, assessing the reduction activity of the enzyme. This version of the ABAD enzyme assay was used to identify virtually all of the known ABAD inhibitors, with few exceptions.</div><div class="NLM_p">An alternative assay employs HEK-293 cells, which only express low levels of steroidogenic enzymes, transfected with the ABAD enzyme and utilizing radiolabeled estradiol at a concentration of 1 μM. The radioactivity associated with the estradiol substrate and its metabolite is quantified to determine the percentage of transformation and thereby the percentage of inhibition.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> This enzyme assay offers the advantage of testing the steroidal activity of ABAD in the presence of inhibitors while minimizing the effect of any other steroidal enzyme in an intact cell to avoid false positives.</div><div class="NLM_p last">More recently, two biological assays have been reported that measure the inhibition of steroidal derivative transformation by ABAD. These assays use isolated ABAD enzyme with either radiolabeled allopregnanolone or estradiol as steroidal substrates for ABAD. The assays were optimized to have a fixed concentration of 1 μM for allopregnanolone or estradiol, 400 ng/mL for ABAD, and 1 mM for the NAD<sup>+</sup> cofactor. The inhibition activity of tested compounds was measured by quantifying the transformation of radiolabeled allopregnanolone or estradiol to their metabolites after separation using thin layer chromatography plates. This enzyme assay measures the oxidation activity of the enzyme through allopregnanolone and estradiol, substrates normally oxidized by ABAD in the presence of NAD<sup>+</sup>.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></div></div><div id="sec1_6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">ABAD Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84412" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84412" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The search for small molecule inhibitors of the Aβ–ABAD interaction has been challenging. While the decoy peptide mentioned above does inhibit the interaction, peptide-based compounds encounter significant limitations in progressing to a clinical therapeutic.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0008.gif" alt="" id="GRAPHIC-d7e670-autogenerated" /></img><div class="NLM_p">Currently, only a limited number of small molecule ABAD inhibitors are known. Fused pyrazole compounds have been extensively studied for their ability to inhibit ABAD.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> A potent ABAD inhibitor, AG18051 (<b>1</b>), containing a pyrazolo[3,4-<i>d</i>]pyrimidine-4(1<i>H</i>)-thione backbone (IC<sub>50</sub> = 92 nM) has been reported. By use of the evolutionary programming for molecular replacement (EPMR) structure-based drug design program, the inhibitor was identified and cocrystallized with human ABAD in the presence of NAD<sup>+</sup> cofactor. Compound <b>1</b> is the most potent ABAD inhibitor known to date that has AD-related biological activity in intact cells. The inhibitor occupies the substrate binding pocket and forms a covalent adduct with the NAD<sup>+</sup> cofactor within the active site of ABAD (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Compound <b>1</b> has been used to test the relevance of Aβ–ABAD in AD pathology in vitro.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Moreover, it has been shown to ameliorate Aβ-induced toxicity at the cellular level.<a onclick="showRef(event, 'ref71 ref120'); return false;" href="javascript:void(0);" class="ref ref71 ref120">(71,120)</a></div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Map of interactions between an inhibitor and the ABAD enzyme. Compound <b>1</b> (red) interacts with ABAD amino acid residues (black) and the cofactor NAD<sup>+</sup> (blue), forming a covalent adduct between the N2 atom of <b>1</b> and the C4 atom of NAD<sup>+</sup>. Shown are hydrophobic interactions (black wavy lines), hydrogen bonding (black dashed lines), and π–π interactions (green wavy lines), Protein Data Bank code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1U7T">1U7T</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01530&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further molecular dynamics studies on <b>1</b> highlighted that the relative conformation of the azepane and phenyl rings of <b>1</b> appears to be related to the flexibility of the substrate binding loop of ABAD. During simulation of the <b>1</b>–ABAD complex the substrate binding loop moves to a more open conformation which in turn leads to the weakening, or loss, of hydrophobic interactions with the azepane and phenyl rings of <b>1</b>. However, due to conformational flux between the azepane and the phenyl rings, these rings may sample many conformations and the phenyl ring tends to reconfigure inside the more spacious binding cavity in order to keep the hydrophobic interactions with the loop, thereby hindering its open conformation. Thus, the conformation of these two rings is of importance to the inhibition of enzyme activity.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Further SAR studies on <b>1</b> identified six inhibitors with nanomolar ABAD inhibition activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> The resulting most potent inhibitor (<b>2</b>) features the addition of a hydroxy group in position 3 of the phenyl ring, which possessed an ABAD IC<sub>50</sub> of 51 nM. Other modifications that resulted in nanomolar inhibition activity included substitution of the azepane ring, and compound <b>3</b>, containing a 4-butylpiperidin-4-ol moiety, possessed an IC<sub>50</sub> of 71 nM. Substitution of the azepane heterocycle with 4-phenylpiperidin-4-ol (<b>4</b>) or 4-(4-bromophenyl)piperidin-4-ol (<b>5</b>) resulted in inhibitors with IC<sub>50</sub> values of 81 nM and 82 nM, respectively. Rupture of the azepane ring to introduce a diethylamine moiety (<b>6</b>) or ring expansion to an azocane ring (<b>7</b>) resulted in inhibitors with equipotent activity to <b>1</b>, possessing IC<sub>50</sub> values of 93 nM and 96 nM, respectively, indicating that hydrophobicity at this position of the scaffold does not correlate to inhibition activity. These nanomolar analogues have not been tested further in an in vitro setting, and some may be expected to suffer from limiting solubility issues based on work conducted in our laboratory.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Derivatives of AG18051 with Nanomolar ABAD Inhibition Activity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0006.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p last">A computational optimization study was performed to predict analogues of <b>1</b> with higher potency.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Using molecular mechanics Poisson–Boltzmann surface area methodology, prediction of the relative free energy of differently modified inhibitor–NAD enzyme complexes was calculated. Simple modifications were evaluated with the aim of keeping the overall structure of <b>1</b> to preserve favorable absorption distribution metabolism and excretion (ADME) properties.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> The study identified 15 inhibitors that showed a decrease in binding free energy up to −6.97 kcal/mol. These inhibitors are in the same range of molecular weight and hydrogen bond donor/acceptor count as the parent compound and are not predicted to adversely affect the ADME profile. Substitutions deemed favorable for stronger binding were located on the phenyl and azepane ring moieties. The introduction of a methoxy group to the seven-membered ring in position 1, or a methyl group in position 7 or 9, resulted in predicted formation of a strong hydrogen bond and therefore higher binding affinity. The purine ring, given its importance in adduct formation and consequent enzyme inhibition, was not subjected to chemical modification.</div></div><div id="sec1_7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Steroidal Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Interestingly, during the search for inhibitors of 17β-HSD isoforms for the treatment of estrogen-related diseases,<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Ayan et al. identified the steroidal compound RM-532-46 (<b>8</b>) as a reversible ABAD inhibitor (IC<sub>50</sub> = 0.55 μM).<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Note that the assay used in this study was to evaluate the inhibitory potency of the steroidal analogues in the transformation of estradiol into estrone by ABAD which was transfected in intact HEK-293 cells. However, most recently further SAR studies on compound <b>8</b> and its analogues were performed using the two new developed assays mentioned above (radiolabeled allopregnanolone and estradiol enzyme inhibition assays). Compound <b>8</b> at 100 μM showed 14.7% inhibition of ABAD activity in the allopregnanolone assay and at 300 μM showed 30% inhibition of ABAD activity in the estradiol assay. The minor modification of changing the ketone group in position 17 with an α-OH resulted in increased activity with inhibition of 41.7% of ABAD activity in the allopregnanolone assay at 100 μM concentration and a similar inhibition to compound <b>8</b> in the estradiol assay at 300 μM concentration. Calculated IC<sub>50</sub> for compound <b>8</b> was determined in the allopregnanolone assay to be 985 μM and in the estradiol assay to be 710 μM despite possessing IC<sub>50</sub> of 0.55 μM in HEK-293 cells transfected by ABAD. This raises an important issue as to the reproducibility of inhibition activity between different assay types and makes the direct comparison of inhibitors identified in different assays challenging. The α-OH substituted compound showed an IC<sub>50</sub> of 235 μM in the allopregnanolone assay and 610 μM in the estradiol assay.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Further modification (<b>9</b>) resulted in 58.8% inhibition of ABAD activity at 300 μM in the estradiol assay. However, in the allopregnanolone assay at 100 μM concentration, <b>9</b> showed only 8% inhibition of ABAD activity.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0009.gif" alt="" id="GRAPHIC-d7e861-autogenerated" /></img></div><div id="sec1_8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Frentizole Analogues</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Frentizole, an FDA approved immunosuppressant drug, was identified as an Aβ–ABAD interaction inhibitor (IC<sub>50</sub> = 200 μM) using an ELISA-based screening assay.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Structure–activity relationship studies performed on the benzothiazole moiety, encompassing a library of 45 analogues, identified the urea moiety as pharmacophoric. The benzothiazole ring SAR identified that a halogen electron-withdrawing group (EWG), such as chlorine (<b>10</b>) or fluorine (<b>11</b>), enhances activity. Exploration of the SAR of the terminal phenyl ring revealed appendage of functionality with increased polarity around all substituent positions enhanced ABAD inhibition activity. Further increase in activity was achieved with a <i>para</i>-substituted hydroxy group, with further enhancement of activity achieved when a methyl ester was introduced <i>ortho</i> to the hydroxy. Two active benzothiazole-based inhibitors, compounds <b>10</b> and <b>11</b>, were identified to inhibit Aβ–ABAD interaction with IC<sub>50</sub> values of 6.46 μM and 6.56 μM, respectively, when halogen, <i>para</i>-hydroxy, and methyl ester functionalities were combined.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> However, the activity of these compounds to inhibit Aβ-induced cytotoxicity in vitro or in vivo has not been determined. Further SAR studies for the benzothiazoleurea phenyl scaffold retained the <i>para</i>-hydroxy group and included an <i>ortho</i>-chlorine on the terminal phenyl ring combined with an EWG group on the benzothiazole ring.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Compound <b>12</b> at 25 μM concentration resulted in 80% inhibition of ABAD activity in which acetoacetyl-CoA was used as a substrate in the assay. Another compound with the benzothiazoleurea phenyl backbone (<b>15</b>) bearing a 3,5-dichloro-4-hydroxyphenyl scaffold showed similar ABAD inhibition activity to compound <b>12</b>.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Interestingly, compounds <b>10</b> and <b>11</b>, when tested in the assay used to identify <b>15</b>, showed almost no inhibition activity at 25 μM concentration (4% and 3% inhibition, respectively) despite being the most potent inhibitors in the Aβ–ABAD interaction assay. This again makes the direct comparison of inhibitors identified in different assays challenging.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0010.gif" alt="" id="GRAPHIC-d7e929-autogenerated" /></img><div class="NLM_p">In the search for dual-acting molecules that can inhibit mitochondrial-induced toxicity by acting on two distinct pathological processes, another study developed inhibitors of casein kinase 1 (CK1) activity that were also capable of inhibiting ABAD. Isoforms of CK1 are responsible for tau phosphorylation.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> The enzyme can modulate the activity of γ-secretase and consequently the production of Aβ.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Screening previously synthesized frentizole derivatives for their efficiency to inhibit CK1 activity as well as ABAD identified compound <b>13</b> which possessed an ABAD IC<sub>50</sub> = 1.67 μM, the most potent inhibitor of this chemotype identified to date.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> The compound combines the pharmacophoric features of the benzothiazole urea derivatives, a chlorine substituted benzothiazole ring, the urea linker, and a <i>para</i>-hydroxy moiety on the terminal phenyl ring, with an adjacent chlorine. Direct substitution of the chlorine of <b>13</b> with a more electron-withdrawing fluorine atom (<b>14</b>) resulted in similar activity with ABAD IC<sub>50</sub> = 1.89 μM.</div><div class="NLM_p last">In summary, the presence of the hydroxy group attached to the <i>para</i> position of the phenylurea ring is shown to be essential for its ability to inhibit ABAD and the addition of an adjacent EWG (such as chlorine or an ester) greatly increases this activity. These modifications are combined with the pharmacophoric role of an EWG on the benzothiazole ring.</div></div><div id="sec1_9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Benzothiazole Linker Analogues</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Further studies on the frentizole chemotype aimed at changes in the linker moiety identified a benzothiazoleamino phosphonate analogue that possessed moderate affinity for binding ABAD. Conversion of the benzothiazole urea linker to a benzothiazole aminomethyl phosphonate linker (<b>16</b>) results in reduced inhibition activity (IC<sub>50</sub> = 52.7 μM) but a somewhat improved pharmacokinetic profile.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Analyzing the SAR of this inhibitor showed similar results to the initial SAR performed on the parent.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> As anticipated, a hydroxy group on the terminal phenyl ring at the <i>para</i>-position is essential for ABAD inhibition.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> In vitro studies of compound <b>16</b> showed a reduction in calcium-induced mPTP, decreased Aβ-induced mitochondrial dysfunction, and increased ATP levels.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Blood–brain barrier (BBB) permeability is obviously crucial for a CNS drug.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Compound <b>16</b> achieved somewhat limited penetration, yielding 4–50 ng/mL peak brain concentration and 2 μg/mL peak plasma concentration from a 10 mg/kg dose in male and female C57BL/6 mice.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> However, the achieved <i>C</i><sub>max</sub> in the brain (4.8 ng/mL) from a 10 mg/kg dose prohibits the exposure of an IC<sub>50</sub> amount of compound. Thus, therapeutically effective target engagement would not be possible. The scaffold serves as a novel chemotype for inhibiting ABAD that requires further optimization to achieve submicromolar inhibition activity and BBB penetration. However, the BBB penetration of this scaffold may be an unsurmountable roadblock. The limited chemical space available around the aminophosphonate moiety and the limitations imposed by the known pharmacophore may prohibit coexistence of both potent activity and BBB penetration. These results spurred the investigation of modified-linker analogues to adjust the pharmacophoric features of the parent compound by substituting the urea linker with guanidine or the addition of a methoxy group at the <i>para</i>-position of the phenylurea. This library identified compound <b>17</b>, possessing ABAD IC<sub>50</sub> = 3.06 μM. The compound showed satisfactory physicochemical properties, presenting a novel lead structure for inhibition of the Aβ–ABAD interaction that may penetrate the BBB.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0011.gif" alt="" id="GRAPHIC-d7e1015-autogenerated" /></img></div><div id="sec1_10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Combination ABAD/MAOI Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The frentizole scaffold has been combined with the known monoamine oxidase inhibitor (MAOI) ladostigil to identify a molecule that has a dual effect: inhibiting both ABAD and MAO. A library of synthesized derivatives demonstrated that the most potent inhibitor for MAO (IC<sub>50</sub> = 6.34 μM) lacked ABAD inhibition activity. However, the study did identify that a moderately potent ABAD inhibitor, compound <b>18</b>, at 100 μM concentration possessed approximately 60% inhibition of ABAD activity.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0012.gif" alt="" id="GRAPHIC-d7e1028-autogenerated" /></img></div><div id="sec1_11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Targeting Loop D</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58724" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58724" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The recently obtained X-ray structure of human ABAD in complex with the Aβ protein strongly substantiated the conjecture that Aβ binding to ABAD distorts the native conformation and normal function of the enzyme.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> However, poor election density prevents the visualization of Aβ in crystal form. The region of ABAD comprising amino acid residues 95–113, termed loop D (L<sub>D</sub>), becomes highly disordered following Aβ binding. Thus, the L<sub>D</sub> area of ABAD was subjected to docking studies to identify potential inhibitors. Receptor-based pharmacophore modeling, as well as a virtual screening of the Asinex and Chemdiv chemical databases, identified 20 hits, two of which, compounds <b>19</b> and <b>20</b>, possessed ABAD inhibition activity, with IC<sub>50</sub> values of 4.4 and 9.6 μM, respectively. These compounds were evaluated for their ability to ameliorate Aβ-induced mitochondrial dysfunction in HT-22 cells, resulting in reduction of cell toxicity and Aβ-induced ATP depletion.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0013.gif" alt="" id="GRAPHIC-d7e1054-autogenerated" /></img></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04356" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04356" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this review we have cemented the Aβ–ABAD interaction as a crucial modulator of the magnitude of Aβ-induced neurotoxicity. Inhibition of this interaction may provide candidate therapeutics for AD that can conceivably act in a disease-modifying manner. Medicinal chemistry to engage this novel target is in its infancy as only moderately potent inhibitors (IC<sub>50</sub> values of 53–1.5 μM) have yet been identified, most of which occupy only limited chemical space, with the frentizole chemotype dominating. Only one chemotype (<b>1</b>) possesses submicromolar activity to date, and this has resulted in just seven compounds with such activity. Continued development of pharmacophore mapping and extensive structure–activity relationship studies being conducted in our laboratory and others are anticipated to provide access to potent and “drug-like” ABAD inhibitors. Such compounds will be employed for lead discovery and as chemical probes to identify the significance of inhibiting the Aβ–ABAD protein–protein interaction on the integrity of the cell in terms of protein expression, mitochondrial function, and cell viability.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01530" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70781" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70781" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul C. Trippier</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Chemical Biology, Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4947-5782" title="Orcid link">http://orcid.org/0000-0002-4947-5782</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b8c8d9cdd496cccad1c8c8d1ddcaf8cccccdd0cbdb96dddccd"><span class="__cf_email__" data-cfemail="1a6a7b6f76346e68736a6a737f685a6e6e6f726979347f7e6f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ahmed Morsy</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Ahmed Morsy</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01530&amp;id=BIO-d7e1068-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ahmed Morsy</b> completed his Bachelor of Science degree in Pharmacy and Biotechnology from the German University, Cairo, Egypt, in 2012. He then obtained his Master degree in Pharmaceutical Science from the University of Florida in 2016. He joined the Graduate Program in Pharmaceutical Sciences of Texas Tech University Health Sciences Center as a Ph.D. student in the fall of 2016 and is presently working in the laboratory of Dr. Paul Trippier.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Paul C. Trippier</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01530&amp;id=BIO-d7e1073-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Paul C. Trippier</b> received a D.Phil. in Synthetic Organic Chemistry from the University of Oxford under the guidance of Prof. Mark Moloney and completed postdoctoral work in medicinal chemistry at Cardiff University with Prof. Chris McGuigan and in chemical biology at Northwestern University with Prof. Richard B. Silverman. Paul is currently an Assistant Professor in the School of Pharmacy at Texas Tech University Health Sciences Center where he directs a group focused on early stage drug discovery and target identification for a number of indications including neurodegenerative diseases, stroke, and cancer.</p></figure></div><div class="ack" id="ACK-d7e1408-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54384" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54384" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to the Texas Alzheimer’s Research and Care Consortium for an award under the Investigator Grant Program (TARCC-IGP, Grant 3523313) to P.C.T. for support of our Alzheimer’s disease drug discovery program.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">17β-HSD10</td><td class="NLM_def"><p class="first last">17β-hydroxysteroid dehydrogenase type 10</p></td></tr><tr><td class="NLM_term">ABAD</td><td class="NLM_def"><p class="first last">amyloid-binding alcohol dehydrogenase</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">APOE4</td><td class="NLM_def"><p class="first last">apolipoprotein E4</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β</p></td></tr><tr><td class="NLM_term">BACE</td><td class="NLM_def"><p class="first last">beta-site amyloid precursor protein cleaving enzyme</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CI</td><td class="NLM_def"><p class="first last">complex I</p></td></tr><tr><td class="NLM_term">CII</td><td class="NLM_def"><p class="first last">complex II</p></td></tr><tr><td class="NLM_term">CIII</td><td class="NLM_def"><p class="first last">complex III</p></td></tr><tr><td class="NLM_term">CIV</td><td class="NLM_def"><p class="first last">complex IV</p></td></tr><tr><td class="NLM_term">Cytc</td><td class="NLM_def"><p class="first last">cytochromes complex</p></td></tr><tr><td class="NLM_term">CHANA</td><td class="NLM_def"><p class="first last">cyclohexenylaminonaphthalene alcohol</p></td></tr><tr><td class="NLM_term">CHANK</td><td class="NLM_def"><p class="first last">cyclohexenylaminonaphthalene ketone</p></td></tr><tr><td class="NLM_term">CK1</td><td class="NLM_def"><p class="first last">casein kinase 1</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum concentration</p></td></tr><tr><td class="NLM_term">COX</td><td class="NLM_def"><p class="first last">cyclooxygenase enzyme</p></td></tr><tr><td class="NLM_term">CypD</td><td class="NLM_def"><p class="first last">cyclophilin D</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">Ep-1</td><td class="NLM_def"><p class="first last">endophilin-1</p></td></tr><tr><td class="NLM_term">EPMR</td><td class="NLM_def"><p class="first last">evolutionary programming for molecular replacement</p></td></tr><tr><td class="NLM_term">ERAB</td><td class="NLM_def"><p class="first last">endoplasmic reticulum-associated amyloid β-peptide-binding protein</p></td></tr><tr><td class="NLM_term">EWG</td><td class="NLM_def"><p class="first last">electron-withdrawing group</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">GLK</td><td class="NLM_def"><p class="first last">germinal center-like kinase</p></td></tr><tr><td class="NLM_term">GSK-3β</td><td class="NLM_def"><p class="first last">glycogen synthase kinase 3β</p></td></tr><tr><td class="NLM_term">HADH2</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">l</span>-3-hydroxyacyl-coenzyme A dehydrogenase type II</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening assay</p></td></tr><tr><td class="NLM_term">IIe</td><td class="NLM_def"><p class="first last">isoleucine</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">L<sub>D</sub></td><td class="NLM_def"><p class="first last">loop D</p></td></tr><tr><td class="NLM_term">MRI</td><td class="NLM_def"><p class="first last">magnetic resonance imaging</p></td></tr><tr><td class="NLM_term">MAA-CoA</td><td class="NLM_def"><p class="first last">2-methylacetoacetyl-coenzyme A</p></td></tr><tr><td class="NLM_term">MAOI</td><td class="NLM_def"><p class="first last">monoamine oxidase inhibitor</p></td></tr><tr><td class="NLM_term">MAP3K1</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase kinase kinase 1</p></td></tr><tr><td class="NLM_term">MHB</td><td class="NLM_def"><p class="first last">2-methyl-3-hydroxybutyrate</p></td></tr><tr><td class="NLM_term">MHB-CoA</td><td class="NLM_def"><p class="first last">2-methyl-3-hydroxybutyryl-coenzyme A</p></td></tr><tr><td class="NLM_term">mPTP</td><td class="NLM_def"><p class="first last">mitochondrial permeability transition pore</p></td></tr><tr><td class="NLM_term">NAD<sup>+</sup></td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">Prdx-2</td><td class="NLM_def"><p class="first last">peroxiredoxin-2</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SCHAD</td><td class="NLM_def"><p class="first last">short-chain 3-hydroxyacyl-CoA dehydrogenase</p></td></tr><tr><td class="NLM_term">SPECT</td><td class="NLM_def"><p class="first last">single photon emission computed tomography</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">Tg mAPP/ABAD</td><td class="NLM_def"><p class="first last">transgenic mice overexpressing ABAD and mutant APP.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30850" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30850" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 137 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albert, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeKosky, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagust, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thies, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelps, C. H.</span></span> <span> </span><span class="NLM_article-title">The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease</span>. <i>Alzheimer's Dementia</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">270</span>– <span class="NLM_lpage">279</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2011.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.jalz.2011.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=21514249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BC3MrhsFaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=270-279&author=M.+S.+Albertauthor=S.+T.+DeKoskyauthor=D.+Dicksonauthor=B.+Duboisauthor=H.+H.+Feldmanauthor=N.+C.+Foxauthor=A.+Gamstauthor=D.+M.+Holtzmanauthor=W.+J.+Jagustauthor=R.+C.+Petersenauthor=P.+J.+Snyderauthor=M.+C.+Carrilloauthor=B.+Thiesauthor=C.+H.+Phelps&title=The+diagnosis+of+mild+cognitive+impairment+due+to+Alzheimer%E2%80%99s+disease%3A+recommendations+from+the+national+institute+on+aging-Alzheimer%E2%80%99s+association+workgroups+on+diagnostic+guidelines+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.jalz.2011.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</span></div><div class="casAuthors">Albert Marilyn S; DeKosky Steven T; Dickson Dennis; Dubois Bruno; Feldman Howard H; Fox Nick C; Gamst Anthony; Holtzman David M; Jagust William J; Petersen Ronald C; Snyder Peter J; Carrillo Maria C; Thies Bill; Phelps Creighton H</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">270-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of developing criteria for the symptomatic predementia phase of Alzheimer's disease (AD), referred to in this article as mild cognitive impairment due to AD.  The workgroup developed the following two sets of criteria: (1) core clinical criteria that could be used by healthcare providers without access to advanced imaging techniques or cerebrospinal fluid analysis, and (2) research criteria that could be used in clinical research settings, including clinical trials.  The second set of criteria incorporate the use of biomarkers based on imaging and cerebrospinal fluid measures.  The final set of criteria for mild cognitive impairment due to AD has four levels of certainty, depending on the presence and nature of the biomarker findings.  Considerable work is needed to validate the criteria that use biomarkers and to standardize biomarker analysis for use in community settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQog-HW7g5tSOqrn-c4Of3KfW6udTcc2ebhzHxz4C7rFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrhsFaktA%253D%253D&md5=609df181936d75a42ae8db4826713f85</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2011.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2011.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DM.%2BS.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DDickson%26aufirst%3DD.%26aulast%3DDubois%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DH.%2BH.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DGamst%26aufirst%3DA.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DSnyder%26aufirst%3DP.%2BJ.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DThies%26aufirst%3DB.%26aulast%3DPhelps%26aufirst%3DC.%2BH.%26atitle%3DThe%2520diagnosis%2520of%2520mild%2520cognitive%2520impairment%2520due%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520recommendations%2520from%2520the%2520national%2520institute%2520on%2520aging-Alzheimer%25E2%2580%2599s%2520association%2520workgroups%2520on%2520diagnostic%2520guidelines%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2011%26volume%3D7%26spage%3D270%26epage%3D279%26doi%3D10.1016%2Fj.jalz.2011.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisodia, S. S.</span></span> <span> </span><span class="NLM_article-title">Mutant genes in familial Alzheimer’s disease and transgenic models</span>. <i>Annu. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">505</span>, <span class="refDoi"> DOI: 10.1146/annurev.neuro.21.1.479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1146%2Fannurev.neuro.21.1.479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=9530504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK1cXhsFyhtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=479-505&author=D.+L.+Priceauthor=S.+S.+Sisodia&title=Mutant+genes+in+familial+Alzheimer%E2%80%99s+disease+and+transgenic+models&doi=10.1146%2Fannurev.neuro.21.1.479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant genes in familial Alzheimer's disease and transgenic models</span></div><div class="casAuthors">Price, Donald L.; Sisodia, Sangram S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">479-505</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with 163 refs.  The most common cause of dementia occurring in mid- to late-life is Alzheimer's disease (AD).  Some cases of AD, particularly those of early onset, are familial and inherited as autosomal dominant disorders linked to the presence of mutant genes that encode the amyloid precursor protein (APP) or the presenilins (PS1 or PS2).  These mutant gene products cause dysfunction/death of vulnerable populations of nerve cells important in memory, higher cognitive processes, and behavior.  AD affects 7-10% of individuals >65 yr of age and perhaps 40% of individuals >80 yr of age.  For the late-onset cases, the principal risk factors are age and apolipoprotein (apoE) allele type, with apoE4 allele being a susceptibility factor.  In this review, we briefly discuss the clin. syndrome of AD and the neurobiol./neuropathol. of the disease and then focus attention on mutant genes linked to autosomal dominant familial AD (FAD), the biol. of the proteins encoded by these genes, and the recent exciting progress in investigations of genetically engineered animal models that express these mutant genes and develop some features of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowUt4ulmJ7ErVg90H21EOLACvtfcHk0lgyYhPtSMzrMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsFyhtLY%253D&md5=fa1bf9dbad95faabcd6854eca46bad83</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.21.1.479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.21.1.479%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26atitle%3DMutant%2520genes%2520in%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520transgenic%2520models%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1998%26volume%3D21%26spage%3D479%26epage%3D505%26doi%3D10.1146%2Fannurev.neuro.21.1.479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Translating cell biology into therapeutic advances in Alzheimer’s disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>399</i></span>,  <span class="NLM_fpage">A23</span>– <span class="NLM_lpage">A31</span>, <span class="refDoi"> DOI: 10.1038/399a023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1038%2F399a023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10392577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK1MXktlejsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=A23-A31&author=D.+J.+Selkoe&title=Translating+cell+biology+into+therapeutic+advances+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2F399a023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Translating cell biology into therapeutic advances in Alzheimer's disease</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">399</span>
        (<span class="NLM_cas:issue">6738, Suppl.</span>),
    <span class="NLM_cas:pages">A23-A31</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">A review, with 100 refs.  Studies of the mol. basis of Alzheimer's disease exemplify the increasingly blurred distinction between basic and applied biomedical research.  The four genes so far implicated in familial Alzheimer's disease have each been shown to elevate brain levels of the self-aggregating amyloid-β protein, leading gradually to profound neuronal and glial alteration, synaptic loss, and dementia.  Progress in understanding this cascade has helped to identify specific therapeutic targets and provides a model for elucidating other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmIBdNyGPXN7Vg90H21EOLACvtfcHk0lhWS3pOWDLNYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktlejsLg%253D&md5=617535c8a17e13091e330acb6bfcf8b2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F399a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F399a023%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DTranslating%2520cell%2520biology%2520into%2520therapeutic%2520advances%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D1999%26volume%3D399%26spage%3DA23%26epage%3DA31%26doi%3D10.1038%2F399a023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease at 25 years</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.15252/emmm.201606210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.15252%2Femmm.201606210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=27025652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=595-608&author=D.+J.+Selkoeauthor=J.+Hardy&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease+at+25+years&doi=10.15252%2Femmm.201606210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease at 25 years</span></div><div class="casAuthors">Selkoe, Dennis J.; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">595-608</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Despite continuing debate about the amyloid β-protein or Aβ hypothesis, new lines of evidence from labs. and clinics worldwide support the concept that an imbalance between prodn. and clearance of Aβ42 and related Aβ peptides is a very early, often initiating factor in Alzheimer's disease AD.  Confirmation that presenilin is the catalytic site of γ-secretase has provided a linchpin: all dominant mutations causing early-onset AD occur either in the substrate amyloid precursor protein, APP or the protease presenilin of the reaction that generates Aβ.  Duplication of the wild-type APP gene in Down's syndrome leads to Aβ deposits in the teens, followed by microgliosis, astrocytosis, and neurofibrillary tangles typical of AD.  Apolipoprotein E4, which predisposes to AD in > 40% of cases, has been found to impair Aβ clearance from the brain.  Sol. oligomers of Aβ42 isolated from AD patients' brains can decrease synapse no., inhibit long-term potentiation, and enhance long-term synaptic depression in rodent hippocampus, and injecting them into healthy rats impairs memory.  The human oligomers also induce hyperphosphorylation of tau at AD-relevant epitopes and cause neuritic dystrophy in cultured neurons.  Crossing human APP with human tau transgenic mice enhances tau-pos. neurotoxicity.  In humans, new studies show that low cerebrospinal fluid CSF Aβ42 and amyloid-PET positivity precede other AD manifestations by many years.  Most importantly, recent trials of three different Aβ antibodies solanezumab, crenezumab, and aducanumab have suggested a slowing of cognitive decline in post hoc analyses of mild AD subjects.  Although many factors contribute to AD pathogenesis, Aβ dyshomeostasis has emerged as the most extensively validated and compelling therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGo1qmyvVtbVg90H21EOLACvtfcHk0lhWS3pOWDLNYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D&md5=b7a2003ba5d341f5eef5c7e9454235ce</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.15252%2Femmm.201606210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201606210%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520at%252025%2520years%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D595%26epage%3D608%26doi%3D10.15252%2Femmm.201606210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenk, D.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: molecular understanding predicts amyloid-based therapeutics</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1146/annurev.pharmtox.43.100901.140248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1146%2Fannurev.pharmtox.43.100901.140248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12415125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFWqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2003&pages=545-584&author=D.+J.+Selkoeauthor=D.+Schenk&title=Alzheimer%E2%80%99s+disease%3A+molecular+understanding+predicts+amyloid-based+therapeutics&doi=10.1146%2Fannurev.pharmtox.43.100901.140248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: Molecular understanding predicts amyloid-based therapeutics</span></div><div class="casAuthors">Selkoe, Dennis J.; Schenk, Dale</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">545-584</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Degenerative diseases of the brain were long considered among the most obscure and intractable of human maladies.  However, recent advances in understanding their mechanisms have brought us to the verge of potential disease-modifying agents.  This progress is perhaps best exemplified by the case of Alzheimer's disease.  The application of mol. pathol. and genetics has led to the recognition that the 4 genes implicated to date in familial Alzheimer's disease all chronically elevate cerebral levels of the amyloid β-protein (Aβ).  Accordingly, small mol. inhibitors of the β- and γ-secretases, the proteases that generate Aβ from its precursor, are under active development, and some have shown in vivo efficacy in mouse models.  An alternative approach, active or passive immunization against Aβ, has received extensive pre-clin. validation in mice, but an effective prepn. free of significant side effects in humans is still awaited.  Several other potential therapies are also reviewed here.  If one or more of these varied approaches is ultimately proven to slow or prevent dementia, Alzheimer's disease will become a salient example of the successful application of reductionist biol. to the most complex of organs, the human cerebral cortex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJVtpoYKa-LVg90H21EOLACvtfcHk0ljKATYqCDAOSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFWqt74%253D&md5=5298d8939885e0b94bf43472721f0455</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.43.100901.140248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.43.100901.140248%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DSchenk%26aufirst%3DD.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520molecular%2520understanding%2520predicts%2520amyloid-based%2520therapeutics%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2003%26volume%3D43%26spage%3D545%26epage%3D584%26doi%3D10.1146%2Fannurev.pharmtox.43.100901.140248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J.</span></span> <span> </span><span class="NLM_article-title">Lessons learned from Alzheimer disease: clinical trials with negative outcomes</span>. <i>Clin. Transl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1111/cts.12491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1111%2Fcts.12491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=28767185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BC1cfjsVyqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=147-152&author=J.+Cummings&title=Lessons+learned+from+Alzheimer+disease%3A+clinical+trials+with+negative+outcomes&doi=10.1111%2Fcts.12491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes</span></div><div class="casAuthors">Cummings Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and translational science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-152</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4EcVa2l0ofS86Js-BCLiifW6udTcc2eZ-2CNzLftERLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfjsVyqtA%253D%253D&md5=6318eac19ef6e09ab99933284f55bf96</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fcts.12491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcts.12491%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%26atitle%3DLessons%2520learned%2520from%2520Alzheimer%2520disease%253A%2520clinical%2520trials%2520with%2520negative%2520outcomes%26jtitle%3DClin.%2520Transl.%2520Sci.%26date%3D2018%26volume%3D11%26spage%3D147%26epage%3D152%26doi%3D10.1111%2Fcts.12491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbagh, M.</span></span> <span> </span><span class="NLM_article-title">Why do trials for Alzheimer’s disease drugs keep failing? a discontinued drug perspective for 2010–2015</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1080/13543784.2017.1323868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1080%2F13543784.2017.1323868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=28460541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2sXot1Shu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=735-739&author=D.+Mehtaauthor=R.+Jacksonauthor=G.+Paulauthor=J.+Shiauthor=M.+Sabbagh&title=Why+do+trials+for+Alzheimer%E2%80%99s+disease+drugs+keep+failing%3F+a+discontinued+drug+perspective+for+2010%E2%80%932015&doi=10.1080%2F13543784.2017.1323868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015</span></div><div class="casAuthors">Mehta, Dev; Jackson, Robert; Paul, Gaurav; Shi, Jiong; Sabbagh, Marwan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">735-739</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: There are dozens of drugs in development for AD with billions of dollars invested.  Despite the massive investment in AD drugs and a burgeoning pipeline, there have been more setbacks and failures than treatment successes.: The classes of drugs that have failed to date include the monoclonal antibodies, the gamma secretase inhibitors, dimebon, neurochem. enhancers, and one tau drug.  Data for these compds. were sought through a PubMed search and a clin. trials.gov search.: The obvious question to be posed is: Why are they failing.  Is the treatment of symptomatic dementia too late.  Are the therapeutic targets incorrect.  Are the clin. methodologies imprecise, misleading, or inaccurate.  This review summarizes the drugs that have failed during 2010-2015 and offers possible theories as to why they have failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphTh-OjoTzgbVg90H21EOLACvtfcHk0lg7_UKqUwJ3fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXot1Shu7Y%253D&md5=efa88fffd86b5674b1b3f19342947933</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1080%2F13543784.2017.1323868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543784.2017.1323868%26sid%3Dliteratum%253Aachs%26aulast%3DMehta%26aufirst%3DD.%26aulast%3DJackson%26aufirst%3DR.%26aulast%3DPaul%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DSabbagh%26aufirst%3DM.%26atitle%3DWhy%2520do%2520trials%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520drugs%2520keep%2520failing%253F%2520a%2520discontinued%2520drug%2520perspective%2520for%25202010%25E2%2580%25932015%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2017%26volume%3D26%26spage%3D735%26epage%3D739%26doi%3D10.1080%2F13543784.2017.1323868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Small, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, C. A.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease and the amyloid β protein: what is the role of amyloid?</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1999.0730443.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1046%2Fj.1471-4159.1999.0730443.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10428038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK1MXkslOqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1999&pages=443-449&author=D.+H.+Smallauthor=C.+A.+McLean&title=Alzheimer%E2%80%99s+disease+and+the+amyloid+%CE%B2+protein%3A+what+is+the+role+of+amyloid%3F&doi=10.1046%2Fj.1471-4159.1999.0730443.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease and the amyloid β protein: what is the role of amyloid?</span></div><div class="casAuthors">Small, David H.; McLean, Catriona A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">443-449</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 96 refs.  Topics include: amyloid protein and amyloid precursor protein; role of amyloid β in Alzheimer's disease pathogenesis; amyloid precursor protein transgenic mice; amyloid toxicity in vitro; apolipoprotein E and amyloid β toxicity; is sol. amyloid β important in Alzheimer's pathogenesis; a novel variant of Alzheimer's disease; is amyloid β1-42/43 the only toxic form of amyloid β.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAFMWJKeKhjLVg90H21EOLACvtfcHk0lg7_UKqUwJ3fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkslOqsr4%253D&md5=af8c07e499b2f64f4d0a38d35afce700</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1999.0730443.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1999.0730443.x%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DD.%2BH.%26aulast%3DMcLean%26aufirst%3DC.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520and%2520the%2520amyloid%2520%25CE%25B2%2520protein%253A%2520what%2520is%2520the%2520role%2520of%2520amyloid%253F%26jtitle%3DJ.%2520Neurochem.%26date%3D1999%26volume%3D73%26spage%3D443%26epage%3D449%26doi%3D10.1046%2Fj.1471-4159.1999.0730443.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cleary, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmeister, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuskowski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashe, K. H.</span></span> <span> </span><span class="NLM_article-title">Natural oligomers of the amyloid-β protein specifically disrupt cognitive function</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1038/nn1372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1038%2Fnn1372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15608634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD2cnksFeqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=79-84&author=J.+P.+Clearyauthor=D.+M.+Walshauthor=J.+J.+Hofmeisterauthor=G.+M.+Shankarauthor=M.+A.+Kuskowskiauthor=D.+J.+Selkoeauthor=K.+H.+Ashe&title=Natural+oligomers+of+the+amyloid-%CE%B2+protein+specifically+disrupt+cognitive+function&doi=10.1038%2Fnn1372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function</span></div><div class="casAuthors">Cleary James P; Walsh Dominic M; Hofmeister Jacki J; Shankar Ganesh M; Kuskowski Michael A; Selkoe Dennis J; Ashe Karen H</div><div class="citationInfo"><span class="NLM_cas:title">Nature neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-84</span>
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    </div><div class="casAbstract">A central unresolved problem in research on Alzheimer disease is the nature of the molecular entity causing dementia.  Here we provide the first direct experimental evidence that a defined molecular species of the amyloid-beta protein interferes with cognitive function.  Soluble oligomeric forms of amyloid-beta, including trimers and dimers, were both necessary and sufficient to disrupt learned behavior in a manner that was rapid, potent and transient; they produced impaired cognitive function without inducing permanent neurological deficits.  Although beta-amyloidosis has long been hypothesized to affect cognition, the abnormally folded protein species associated with this or any other neurodegenerative disease has not previously been isolated, defined biochemically and then specifically characterized with regard to its effects on cognitive function.  The biochemical isolation of discrete amyloid-beta moieties with pathophysiological properties sets the stage for a new approach to studying the molecular mechanisms of cognitive impairment in Alzheimer disease and related neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxJ50jZifCN56KlWarZTAzfW6udTcc2ebBLF3rFhx4GLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cnksFeqsQ%253D%253D&md5=538ad375375c965463e33ae791da930d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnn1372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1372%26sid%3Dliteratum%253Aachs%26aulast%3DCleary%26aufirst%3DJ.%2BP.%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DHofmeister%26aufirst%3DJ.%2BJ.%26aulast%3DShankar%26aufirst%3DG.%2BM.%26aulast%3DKuskowski%26aufirst%3DM.%2BA.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DAshe%26aufirst%3DK.%2BH.%26atitle%3DNatural%2520oligomers%2520of%2520the%2520amyloid-%25CE%25B2%2520protein%2520specifically%2520disrupt%2520cognitive%2520function%26jtitle%3DNat.%2520Neurosci.%26date%3D2005%26volume%3D8%26spage%3D79%26epage%3D84%26doi%3D10.1038%2Fnn1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manczak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anekonda, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. H.</span></span> <span> </span><span class="NLM_article-title">Mitochondria are a direct site of Aβ accumulation in Alzheimer’s disease neurons: implications for free radical generation and oxidative damage in disease progression</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1437</span>– <span class="NLM_lpage">1449</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddl066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1093%2Fhmg%2Fddl066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=16551656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslGhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=1437-1449&author=M.+Manczakauthor=T.+S.+Anekondaauthor=E.+Hensonauthor=B.+S.+Parkauthor=J.+Quinnauthor=P.+H.+Reddy&title=Mitochondria+are+a+direct+site+of+A%CE%B2+accumulation+in+Alzheimer%E2%80%99s+disease+neurons%3A+implications+for+free+radical+generation+and+oxidative+damage+in+disease+progression&doi=10.1093%2Fhmg%2Fddl066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression</span></div><div class="casAuthors">Manczak, Maria; Anekonda, Thimmappa S.; Henson, Edward; Park, Byung S.; Quinn, Joseph; Reddy, P. Hemachandra</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1437-1449</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a complex, neurodegenerative disease characterized by the impairment of cognitive function in elderly individuals.  In a recent global gene expression study of APP transgenic mice, we found elevated expression of mitochondrial genes, which we hypothesize represents a compensatory response because of mitochondrial oxidative damage caused by the over-expression of mutant APP and/or amyloid beta (Aβ).  We investigated this hypothesis in a series of expts. examg. what forms of APP and Aβ localize to the mitochondria, and whether the presence of these species is assocd. with mitochondrial dysfunction and oxidative damage.  Using immunoblotting, digitonin fractionation, immunofluorescence, and electron microscopy techniques, we found a relationship between mutant APP derivs. and mitochondria in brain slices from Tg2576 mice and in mouse neuroblastoma cells expressing mutant human APP.  Further, to det. the functional relationship between mutant APP/Aβ and oxidative damage, we quantified Aβ levels, hydrogen peroxide prodn., cytochrome oxidase activity and carbonyl proteins in Tg2576 mice and age-matched wild-type (WT) littermates.  Hydrogen peroxide levels were found to be significantly increased in Tg2576 mice when compared with age-matched WT littermates and directly correlated with levels of sol. Aβ in Tg2576 mice, suggesting that sol. Aβ may be responsible for the prodn. of hydrogen peroxide in AD progression in Tg2576 mice.  Cytochrome c oxidase activity was found to be decreased in Tg2576 mice when compared with age-matched WT littermates, suggesting that mutant APP and sol. Aβ impair mitochondrial metab. in AD development and progression.  An increase in hydrogen peroxide and a decrease in cytochrome oxidase activity were found in young Tg2576 mice, prior to the appearance of Aβ plaques.  These findings suggest that early mitochondrially targeted therapeutic interventions may be effective in delaying AD progression in elderly individuals and in treating AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN8u5Rx5XNe7Vg90H21EOLACvtfcHk0lg2RKnG0CloKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslGhsLs%253D&md5=c2f689e07c3b0b7950d1758684c263f7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddl066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddl066%26sid%3Dliteratum%253Aachs%26aulast%3DManczak%26aufirst%3DM.%26aulast%3DAnekonda%26aufirst%3DT.%2BS.%26aulast%3DHenson%26aufirst%3DE.%26aulast%3DPark%26aufirst%3DB.%2BS.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DP.%2BH.%26atitle%3DMitochondria%2520are%2520a%2520direct%2520site%2520of%2520A%25CE%25B2%2520accumulation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520neurons%253A%2520implications%2520for%2520free%2520radical%2520generation%2520and%2520oxidative%2520damage%2520in%2520disease%2520progression%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2006%26volume%3D15%26spage%3D1437%26epage%3D1449%26doi%3D10.1093%2Fhmg%2Fddl066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacques, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdoch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whetsell,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manczak, M.</span></span> <span> </span><span class="NLM_article-title">Differential loss of synaptic proteins in Alzheimer’s disease: implications for synaptic dysfunction</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.3233/JAD-2005-7203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-2005-7203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15851848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsVSjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=103-117&author=P.+H.+Reddyauthor=G.+Maniauthor=B.+S.+Parkauthor=J.+Jacquesauthor=G.+Murdochauthor=+Whetsellauthor=J.+Kayeauthor=M.+Manczak&title=Differential+loss+of+synaptic+proteins+in+Alzheimer%E2%80%99s+disease%3A+implications+for+synaptic+dysfunction&doi=10.3233%2FJAD-2005-7203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction</span></div><div class="casAuthors">Reddy, P. Hemachandra; Mani, Geethalakshmi; Park, Byung S.; Jacques, Joline; Murdoch, Geoffrey; Whetsell, William, Jr.; Kaye, Jeffrey; Manczak, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">103-117</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The objective of our research was to det. synaptic protein levels in brain specimens from AD subjects and age-matched control subjects.  Further, to det. whether presynaptic or postsynaptic compartments of neurons are preferentially affected in AD patients, we studied 3 presynaptic vesicle proteins (synaptotagmin, synaptophysin, and Rab 3A), 2 synaptic membrane proteins (Gap 43 and synaptobrevin), and 2 postsynaptic proteins (neurogranin and synaptopodin) in specimens from AD and age-matched control brains.  Two brain regions - the frontal and parietal cortices - were assessed for protein levels by immunoblotting anal.  We found a loss of both presynaptic vesicle proteins and postsynaptic proteins in all brain specimens from AD patients compared to those from age-matched control subjects.  Further, we found that the loss of synaptic proteins was more severe in the frontal cortex brain specimens than in the parietal cortex brain specimens from the AD subjects compared to those from the control subjects, suggesting that the frontal brain may be crit. for synaptic function in AD.  Using immunohistochem. techniques, we also detd. the distribution pattern of all synaptic proteins in both the frontal and parietal cortices brain specimens from control subjects.  Of the 7 synaptic proteins studied, the presynaptic proteins synaptophysin and rab 3A and the postsynaptic protein synaptopodin were the most down-regulated.  Our study suggests that postsynaptic proteins and presynaptic proteins are important for synaptic function and may be related to cognitive impairments in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriUMUM1XJKZ7Vg90H21EOLACvtfcHk0lg2RKnG0CloKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsVSjs70%253D&md5=5de577ab06fd74e163f4f264d11a9843</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3233%2FJAD-2005-7203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2005-7203%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DP.%2BH.%26aulast%3DMani%26aufirst%3DG.%26aulast%3DPark%26aufirst%3DB.%2BS.%26aulast%3DJacques%26aufirst%3DJ.%26aulast%3DMurdoch%26aufirst%3DG.%26aulast%3DWhetsell%26aulast%3DKaye%26aufirst%3DJ.%26aulast%3DManczak%26aufirst%3DM.%26atitle%3DDifferential%2520loss%2520of%2520synaptic%2520proteins%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520synaptic%2520dysfunction%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2005%26volume%3D7%26spage%3D103%26epage%3D117%26doi%3D10.3233%2FJAD-2005-7203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWeeney, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manczak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutala, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partovi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searles, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J.</span></span> <span> </span><span class="NLM_article-title">Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer’s disease</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1240</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddh140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1093%2Fhmg%2Fddh140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15115763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktF2qtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=1225-1240&author=P.+H.+Reddyauthor=S.+McWeeneyauthor=B.+S.+Parkauthor=M.+Manczakauthor=R.+V.+Gutalaauthor=D.+Partoviauthor=Y.+Jungauthor=V.+Yauauthor=R.+Searlesauthor=M.+Moriauthor=J.+Quinn&title=Gene+expression+profiles+of+transcripts+in+amyloid+precursor+protein+transgenic+mice%3A+up-regulation+of+mitochondrial+metabolism+and+apoptotic+genes+is+an+early+cellular+change+in+Alzheimer%E2%80%99s+disease&doi=10.1093%2Fhmg%2Fddh140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease</span></div><div class="casAuthors">Reddy, P. Hemachandra; McWeeney, Shannon; Park, Byung S.; Manczak, Maria; Gutala, Ramana V.; Partovi, Dara; Jung, Youngsin; Yau, Vincent; Searles, Robert; Mori, Motomi; Quinn, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1225-1240</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by the impairment of cognitive functions and by beta amyloid (Aβ) plaques in the cerebral cortex and the hippocampus.  Our objective was to det. genes that are crit. for cellular changes in AD progression, with particular emphasis on changes early in disease progression.  We investigated an established amyloid precursor protein (APP) transgenic mouse model (the Tg2576 mouse model) for gene expression profiles at three stages of disease progression: long before (2 mo of age), immediately before (5 mo) and after (18 mo) the appearance of Aβ plaques.  Using cDNA microarray techniques, we measured mRNA levels in 11 283 cDNA clones from the cerebral cortex of Tg2576 mice and age-matched wild-type (WT) mice at each of the three time points.  This gene expression anal. revealed that the genes related to mitochondrial energy metab. and apoptosis were up-regulated in 2-mo-old Tg2576 mice and that the same genes were up-regulated at 5 and 18 mo of age.  These microarray results were confirmed using northern blot anal.  Results from in situ hybridization of mitochondrial genes-ATPase-6, heat-shock protein 86 and programmed cell death gene 8-suggest that the granule cells of the hippocampal dentate gyrus and the pyramidal neurons in the hippocampus and the cerebral cortex are up-regulated in Tg2576 mice compared with WT mice.  Results from double-labeling in situ hybridization suggest that in Tg2576 mice only selective, over-expressed neurons with the mitochondrial gene ATPase-6 undergo oxidative damage.  These results, therefore, suggest that mitochondrial energy metab. is impaired by the expression of mutant APP and/or Aβ, and that the up-regulation of mitochondrial genes is a compensatory response.  These findings have important implications for understanding the mechanism of Aβ toxicity in AD and for developing therapeutic strategies for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRxZE0Angzw7Vg90H21EOLACvtfcHk0lh1zeTSxL0JGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktF2qtLg%253D&md5=4ab7f2b86af2799003dda9676ff64dac</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddh140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddh140%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DP.%2BH.%26aulast%3DMcWeeney%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DB.%2BS.%26aulast%3DManczak%26aufirst%3DM.%26aulast%3DGutala%26aufirst%3DR.%2BV.%26aulast%3DPartovi%26aufirst%3DD.%26aulast%3DJung%26aufirst%3DY.%26aulast%3DYau%26aufirst%3DV.%26aulast%3DSearles%26aufirst%3DR.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DJ.%26atitle%3DGene%2520expression%2520profiles%2520of%2520transcripts%2520in%2520amyloid%2520precursor%2520protein%2520transgenic%2520mice%253A%2520up-regulation%2520of%2520mitochondrial%2520metabolism%2520and%2520apoptotic%2520genes%2520is%2520an%2520early%2520cellular%2520change%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2004%26volume%3D13%26spage%3D1225%26epage%3D1240%26doi%3D10.1093%2Fhmg%2Fddh140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, M. F.</span></span> <span> </span><span class="NLM_article-title">Are mitochondria critical in the pathogenesis of Alzheimer’s disease?</span>. <i>Brain Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">618</span>– <span class="NLM_lpage">632</span>, <span class="refDoi"> DOI: 10.1016/j.brainresrev.2005.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.brainresrev.2005.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=16269322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFOhsbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=618-632&author=P.+H.+Reddyauthor=M.+F.+Beal&title=Are+mitochondria+critical+in+the+pathogenesis+of+Alzheimer%E2%80%99s+disease%3F&doi=10.1016%2Fj.brainresrev.2005.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Are mitochondria critical in the pathogenesis of Alzheimer's disease?</span></div><div class="casAuthors">Reddy, P. Hemachandra; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">618-632</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review summarizes recent findings that suggest a causal connection between mitochondrial abnormalities and sporadic Alzheimer's disease (AD).  Genetic causes of AD are known only for a small proportion of familial AD patients, but for a majority of sporadic AD patients, genetic causal factors are still unknown.  Currently, there are no early detectable biomarkers for sporadic AD, and there is a lack of understanding of the pathophysiol. of the disease.  Findings from recent genetic studies of AD pathogenesis suggest that mitochondrial defects may play an important role in sporadic AD progression, and that mitochondrial abnormalities and oxidative damage may play a significant role in the progression of familial AD.  Findings from biochem. studies, in vitro studies, gene expression studies, and animal model studies of AD are reviewed, and the possible contribution of mitochondrial mutations to late-onset sporadic AD is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplwJeNzXHyqrVg90H21EOLACvtfcHk0lh1zeTSxL0JGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFOhsbrL&md5=eb375220b5f5eccb90b2b119f97f3377</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresrev.2005.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresrev.2005.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DP.%2BH.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DAre%2520mitochondria%2520critical%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2005%26volume%3D49%26spage%3D618%26epage%3D632%26doi%3D10.1016%2Fj.brainresrev.2005.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trippier, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen Labby, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawker, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mataka, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <span> </span><span class="NLM_article-title">Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3121</span>– <span class="NLM_lpage">3147</span>, <span class="refDoi"> DOI: 10.1021/jm3015926</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3015926" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFeju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3121-3147&author=P.+C.+Trippierauthor=K.+Jansen+Labbyauthor=D.+D.+Hawkerauthor=J.+J.+Matakaauthor=R.+B.+Silverman&title=Target-+and+mechanism-based+therapeutics+for+neurodegenerative+diseases%3A+strength+in+numbers&doi=10.1021%2Fjm3015926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers</span></div><div class="casAuthors">Trippier, Paul C.; Jansen Labby, Kristin; Hawker, Dustin D.; Mataka, Jan J.; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3121-3147</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of new therapeutics for the treatment of neurodegenerative pathophysiologies currently stands at a crossroads.  This presents an opportunity to transition future drug discovery efforts to target disease modification, an area in which much still remains unknown.  In this Perspective we examine recent progress in the areas of neurodegenerative drug discovery, focusing on some of the most common targets and mechanisms: N-methyl-d-aspartic acid (NMDA) receptors, voltage gated calcium channels (VGCCs), neuronal nitric oxide synthase (nNOS), oxidative stress from reactive oxygen species, and protein aggregation.  These represent the key players identified in neurodegeneration and are part of a complex, intertwined signaling cascade.  The synergistic delivery of two or more compds. directed against these targets, along with the design of small mols. with multiple modes of action, should be explored in pursuit of more effective clin. treatments for neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjl83DGjxqKrVg90H21EOLACvtfcHk0lh1zeTSxL0JGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFeju78%253D&md5=a8ea6d8cf4f9d3bba76d40ceacc9c26d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm3015926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3015926%26sid%3Dliteratum%253Aachs%26aulast%3DTrippier%26aufirst%3DP.%2BC.%26aulast%3DJansen%2BLabby%26aufirst%3DK.%26aulast%3DHawker%26aufirst%3DD.%2BD.%26aulast%3DMataka%26aufirst%3DJ.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DTarget-%2520and%2520mechanism-based%2520therapeutics%2520for%2520neurodegenerative%2520diseases%253A%2520strength%2520in%2520numbers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3121%26epage%3D3147%26doi%3D10.1021%2Fjm3015926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sameem, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeedi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahdavi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafiee, A.</span></span> <span> </span><span class="NLM_article-title">A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.10.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.ejmech.2016.10.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=27876467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFait77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2017&pages=332-345&author=B.+Sameemauthor=M.+Saeediauthor=M.+Mahdaviauthor=A.+Shafiee&title=A+review+on+tacrine-based+scaffolds+as+multi-target+drugs+%28MTDLs%29+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2016.10.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease</span></div><div class="casAuthors">Sameem, Bilqees; Saeedi, Mina; Mahdavi, Mohammad; Shafiee, Abbas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">332-345</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a multifactorial neurol. disorder among elderly people and combinatorial factors such as genetic, lifestyle, and environmental are involved in onset and disease progression.  It has been demonstrated that loss of cholinergic transmission is one of the most significant causes of AD.  One strategy currently being investigated for the development of new therapeutics relates to the enhancement of cholinergic system through several ways.  At this juncture, anticholinesterase inhibitors have absorbed lots of attention and different marketed drugs such as donepezil, rivastigmine, tacrine, and galantamine have been developed. 9-Amino-1,2,3,4-tetrahydroacridine known as tacrine was introduced in 1945 as an efficient anticholinesterase agent.  The mechanism of action of tacrine was proved to inhibit the metab. of acetylcholine and therefore extending its activity and raising levels in the cerebral cortex.  However, extensive use of tacrine was limited since it showed various side effects and toxicity.  Thus, lots of efforts were carried out to prep. tacrine analogs to overcome the related adverse effects.  This review describes differently synthesized tacrine-based scaffolds as cholinesterase inhibitors to manage Alzheimer's disease (AD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrURdMfJvk17bVg90H21EOLACvtfcHk0lgRP5mAJUOsyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFait77F&md5=2462b18c5601b6491dfe553452268f40</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.10.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.10.060%26sid%3Dliteratum%253Aachs%26aulast%3DSameem%26aufirst%3DB.%26aulast%3DSaeedi%26aufirst%3DM.%26aulast%3DMahdavi%26aufirst%3DM.%26aulast%3DShafiee%26aufirst%3DA.%26atitle%3DA%2520review%2520on%2520tacrine-based%2520scaffolds%2520as%2520multi-target%2520drugs%2520%2528MTDLs%2529%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D128%26spage%3D332%26epage%3D345%26doi%3D10.1016%2Fj.ejmech.2016.10.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farlow, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doody, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedhoff, L. T.</span></span> <span> </span><span class="NLM_article-title">A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1212/WNL.50.1.136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1212%2FWNL.50.1.136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=9443470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK1cXotVKjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=136-145&author=S.+L.+Rogersauthor=M.+R.+Farlowauthor=R.+S.+Doodyauthor=R.+Mohsauthor=L.+T.+Friedhoff&title=A+24-week%2C+double-blind%2C+placebo-controlled+trial+of+donepezil+in+patients+with+Alzheimer%E2%80%99s+disease&doi=10.1212%2FWNL.50.1.136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease</span></div><div class="casAuthors">Rogers, S. L.; Farlow, M. R.; Doody, R. S.; Mohs, R.; Friedhoff, L. T.; Donepezil Study Group</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">136-145</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">The efficacy and safety of donepezil as a treatment for patients with mild to moderate Alzheimer's disease (AD) was investigated in a multicenter, double-blind study.  Patients were randomly assigned to treatment with placebo, 5 mg/d donepezil, or 10 mg/d donepezil for 24 wk followed by a 6-wk, single-blind placebo washout.  The primary efficacy measures were the cognitive portion of the Alzheimer's Disease Assessment Scale (ADAS-cog) and the Clinician's Interview Based Assessment of Change-Plus (CIBIC plus), with the Mini-Mental State Examn. (MMSE), Clin. Dementia Rating Scale-Sum of the Boxes (CDR-SB), and patient rated Quality of Life (QoL) used as secondary measures.  Cognitive function, as measured by the ADAS-cog, was improved in the 5- and 10-mg/d donepezil groups as compared with the placebo group at weeks 12, 18, and 24.  Clinician's global ratings on the CIBIC plus also improved in both the 5- and 10-mg/d donepezil groups relative to placebo.  At the end of the 6-wk placebo washout phase, ADAS-cog scores and CIBIC plus ratings were not different for the three groups.  Significant treatment benefits were also obsd. consistently in both the 5- and 10-mg/d groups on the MMSE and the CDR-SB, but there was no consistent effect on the patient-rated QoL.  Cholinergic side effects (primarily diarrhea, nausea, and vomiting) were reported more often in the 10-mg/d group than either the 5-mg/d or placebo groups.  Side effects were transient and generally mild in severity.  Thus, that donepezil is a well-tolerated drug that improves cognition and global function in patients with mild to moderate AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhyp_qMswETbVg90H21EOLACvtfcHk0lgRP5mAJUOsyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVKjsA%253D%253D&md5=b6a9326804fdeb58d057ce2f35771455</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1212%2FWNL.50.1.136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.50.1.136%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DS.%2BL.%26aulast%3DFarlow%26aufirst%3DM.%2BR.%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DMohs%26aufirst%3DR.%26aulast%3DFriedhoff%26aufirst%3DL.%2BT.%26atitle%3DA%252024-week%252C%2520double-blind%252C%2520placebo-controlled%2520trial%2520of%2520donepezil%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1998%26volume%3D50%26spage%3D136%26epage%3D145%26doi%3D10.1212%2FWNL.50.1.136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rösler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicin-Sain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agid, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal-Bianco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stähelin, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharabawi, M.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomised controlled trial</span>. <i>BMJ</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>318</i></span>,  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1136/bmj.318.7184.633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1136%2Fbmj.318.7184.633" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=1999&pages=633-640&author=M.+R%C3%B6slerauthor=R.+Anandauthor=A.+Cicin-Sainauthor=S.+Gauthierauthor=Y.+Agidauthor=P.+Dal-Biancoauthor=H.+B.+St%C3%A4helinauthor=R.+Hartmanauthor=M.+Gharabawi&title=Efficacy+and+safety+of+rivastigmine+in+patients+with+Alzheimer%E2%80%99s+disease%3A+international+randomised+controlled+trial&doi=10.1136%2Fbmj.318.7184.633"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1136%2Fbmj.318.7184.633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.318.7184.633%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25B6sler%26aufirst%3DM.%26aulast%3DAnand%26aufirst%3DR.%26aulast%3DCicin-Sain%26aufirst%3DA.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DAgid%26aufirst%3DY.%26aulast%3DDal-Bianco%26aufirst%3DP.%26aulast%3DSt%25C3%25A4helin%26aufirst%3DH.%2BB.%26aulast%3DHartman%26aufirst%3DR.%26aulast%3DGharabawi%26aufirst%3DM.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520rivastigmine%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520international%2520randomised%2520controlled%2520trial%26jtitle%3DBMJ%26date%3D1999%26volume%3D318%26spage%3D633%26epage%3D640%26doi%3D10.1136%2Fbmj.318.7184.633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kershaw, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilienfeld, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span> <span> </span><span class="NLM_article-title">A 5-month, randomized, placebo-controlled trial of galantamine in AD</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2269</span>– <span class="NLM_lpage">2276</span>, <span class="refDoi"> DOI: 10.1212/WNL.54.12.2269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1212%2FWNL.54.12.2269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10881251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFSmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2000&pages=2269-2276&author=P.+N.+Tariotauthor=P.+R.+Solomonauthor=J.+C.+Morrisauthor=P.+Kershawauthor=S.+Lilienfeldauthor=C.+Ding&title=A+5-month%2C+randomized%2C+placebo-controlled+trial+of+galantamine+in+AD&doi=10.1212%2FWNL.54.12.2269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A 5-month, randomized, placebo-controlled trial of galantamine in AD</span></div><div class="casAuthors">Tariot, P. N.; Solomon, P. R.; Morris, J. C.; Kershaw, P.; Lilienfeld, S.; Ding, C.; Ahern, G.; Aronson, S.; Brenner, R.; Burke, W.; Cochran, J.; Cohen, S.; Cummins, H.; Drachman, D.; Duboff, E.; Farlow, M.; Ferris, S.; Forchetti, C.; Frey, J.; Grossberg, G.; Harrell, L.; Hoffstetter, M.; Holub, R.; Kaye, J.; Landbloom, R.; Levin, K.; Lindahl, L.; Londborg, P.; Lyketsos, C.; Maguire, G.; Mallya, G.; Merideth, C.; Mintzer, J.; Morris, J.; Newhouse, P.; Ng, K.; Plopper, M.; Porteinsson, A.; Probst, T.; Raskind, M.; Reichman, W.; Richardson, B.; Richter, R.; Ross, J.; Sadowsky, C.; Saur, D.; Sauter, M.; Scharre, D.; Schindler, R.; Schneider, L.; Scinto, L.; Siegal, A.; Smith, W.; Solomon, P.; Steinberg, A.; Stone, W.; Tariot, P. N.; Thein, S.; Van Dyck, C.; Visser, J.; Walshe, T., III; Weiner, M.; West, S.</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2269-2276</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The efficacy and tolerability of galantamine, using a slow dose escalation schedule of up to 8 wk, were evaluated in 978 patients with mild to moderate AD.  The study consisted of a 5-mo multicenter, placebo-controlled, double-blind trial.  Following a 4-wk placebo run-in, patients were randomized to one of four treatment arms: placebo or galantamine escalated to final maintenance doses of 8, 16, or 24 mg/day.  Outcome measures included the cognitive subscale of the AD Assessment Scale (ADAS-cog), the Clinician's Interview-Based Impression of Change plus Caregiver Input (CIBIC-plus), the AD Cooperative Study Activities of Daily Living inventory, and the Neuropsychiatric Inventory.  Std. safety evaluations and adverse event monitoring were carried out.  After 5 mo, the galantamine-placebo differences on ADAS-cog were 3.3 points for the 16 mg/day group and 3.6 points for the 24 mg/day group (p < 0.001 vs. placebo, both doses).  Compared with placebo, the galantamine 16- and 24-mg/day groups also had a significantly better outcome on CIBIC-plus, activities of daily living, and behavioral symptoms.  Treatment discontinuations due to adverse events were low in all galantamine groups (6 to 10%) and comparable with the discontinuation rate in the placebo group (7%).  The incidence of adverse events in the galantamine groups, notably gastrointestinal symptoms, was low and most adverse events were mild.  Galantamine 16 and 24 mg/day significantly benefits the cognitive, functional, and behavioral symptoms of AD as compared with placebo.  Slow dose escalation appears to enhance the tolerability of galantamine, minimizing the incidence and severity of adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn9bdC2XgNr7Vg90H21EOLACvtfcHk0lhK34FT6wi-gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFSmsL8%253D&md5=1833030f74b7331699a45fbe3f750dcb</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1212%2FWNL.54.12.2269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.54.12.2269%26sid%3Dliteratum%253Aachs%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DSolomon%26aufirst%3DP.%2BR.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DKershaw%26aufirst%3DP.%26aulast%3DLilienfeld%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DC.%26atitle%3DA%25205-month%252C%2520randomized%252C%2520placebo-controlled%2520trial%2520of%2520galantamine%2520in%2520AD%26jtitle%3DNeurology%26date%3D2000%26volume%3D54%26spage%3D2269%26epage%3D2276%26doi%3D10.1212%2FWNL.54.12.2269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, N.</span></span> <span> </span><span class="NLM_article-title">Memantine monotherapy for Alzheimer’s disease: a systematic review and meta-analysis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0123289</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0123289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1371%2Fjournal.pone.0123289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=25860130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOjsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0123289&author=S.+Matsunagaauthor=T.+Kishiauthor=N.+Iwata&title=Memantine+monotherapy+for+Alzheimer%E2%80%99s+disease%3A+a+systematic+review+and+meta-analysis&doi=10.1371%2Fjournal.pone.0123289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis</span></div><div class="casAuthors">Matsunaga, Shinji; Kishi, Taro; Iwata, Nakao</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0123289/1-e0123289/16</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">We performed an updated meta-anal. of randomized placebo-controlled trials testing memantine monotherapy for patients with Alzheimer's disease (AD).  The meta-anal. included randomized controlled trials of memantine monotherapy for AD, omitting those in which patients were also administered a cholinesterase inhibitor.  Cognitive function, activities of daily living, behavioral disturbances, global function, stage of dementia, drug discontinuation rate, and individual side effects were compared between memantine monotherapy and placebo groups.  The primary outcomes were cognitive function and behavioral disturbances; the others were secondary outcomes.  Nine studies including 2433 patients that met the study's inclusion criteria were identified.Memantine monotherapy significantly improved cognitive function [standardized mean difference(SMD) =-0.27, 95% confidence interval (CI) =-0.39 to-0.14, p = 0.0001], behavioral disturbances (SMD =-0.12, 95% CI =-0.22 to-0.01, p = 0.03), activities of daily living(SMD =-0.09, 95% CI =-0.19 to-0.00, p = 0.05), global function assessment (SMD =-0.18,95% CI =-0.27 to-0.09, p = 0.0001), and stage of dementia (SMD =-0.23, 95% CI =-0.33 to -0.12, p = 0.0001) scores.  Memantine was superior to placebo in terms of discontinuation because of inefficacy [risk ratio (RR) = 0.36, 95% CI = 0.17 - to 0.74, p = 0.006, no. needed to harm (NNH)=non significant].  Moreover, memantine was assocd. with less agitation compared with placebo (RR=0.68, 95% CI = 0.49 to 0.94, p = 0.02, NNH=non significant).  There were no significant differences in the rate of discontinuation because of all causes, all adverse events, and individual side effects other than agitation between the memantine monotherapy and placebo groups.  Memantine monotherapy improved cognition, behavior, activities of daily living, global function, and stage of dementia and was well-tolerated by AD patients.  However, the effect size in terms of efficacy outcomes was small and thus there is limited evidence of clin. benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxxAhpchXSEbVg90H21EOLACvtfcHk0lhK34FT6wi-gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOjsrbN&md5=258bbdd8ceaa9f456ac6406b3788a7df</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0123289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0123289%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DIwata%26aufirst%3DN.%26atitle%3DMemantine%2520monotherapy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0123289%26doi%3D10.1371%2Fjournal.pone.0123289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J. L.</span></span> <span> </span><span class="NLM_article-title">Cholinesterase inhibitors: a new class of psychotropic compounds</span>. <i>Am. J. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1176/ajp.157.1.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1176%2Fajp.157.1.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10618007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD3c%252FosVyisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2000&pages=4-15&author=J.+L.+Cummings&title=Cholinesterase+inhibitors%3A+a+new+class+of+psychotropic+compounds&doi=10.1176%2Fajp.157.1.4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cholinesterase inhibitors: A new class of psychotropic compounds</span></div><div class="casAuthors">Cummings J L</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-15</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  This article reviews evidence indicating that acetylcholinesterase inhibitors have psychotropic properties.  METHOD:  The author reviewed the English-language literature pertinent to the response of neuropsychiatric symptoms in Alzheimer's disease and related conditions to cholinergic agents.  RESULTS:  The cholinergic system originates in the basal forebrain and projects diffusely to the cerebral cortex; the limbic and paralimbic regions receive the most abundant cholinergic projections.  The basal forebrain nuclei are positioned at the interface of the limbic system and cerebral cortex, where they play a role in mediating emotional responses.  The basal forebrain nuclei are atrophic in Alzheimer's disease, leading to a widespread cholinergic deficit.  The cholinergic disturbance may contribute to neuropsychiatric manifestations of the disease.  The treatment of patients with Alzheimer's disease with acetylcholinesterase inhibitors reduces neuropsychiatric symptoms, particularly apathy and visual hallucinations.  In some studies, a variety of other neuropsychiatric symptoms have been reported to respond to treatment with acetylcholinesterase inhibitors.  Response profiles vary among acetylcholinesterase inhibitors.  CONCLUSIONS:  Acetylcholinesterase inhibitors have psychotropic effects and may play an important role in controlling neuropsychiatric and behavioral disturbances in patients with Alzheimer's disease.  These agents also may contribute to the management of other disorders with cholinergic system abnormalities and neuropsychiatric symptoms.  The beneficial response is most likely mediated through limbic cholinergic structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBmZ73YslrSXwOGIfWJ7-GfW6udTcc2eZKq0RJ0AFxXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c%252FosVyisw%253D%253D&md5=ecdf0b8be61b64add937ec55b3820997</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1176%2Fajp.157.1.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fajp.157.1.4%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DCholinesterase%2520inhibitors%253A%2520a%2520new%2520class%2520of%2520psychotropic%2520compounds%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2000%26volume%3D157%26spage%3D4%26epage%3D15%26doi%3D10.1176%2Fajp.157.1.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geldmacher, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provenzano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McRae, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastey, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ieni, J. R.</span></span> <span> </span><span class="NLM_article-title">Donepezil is associated with delayed nursing home placement in patients with Alzheimer’s disease</span>. <i>J. Am. Geriatr. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">937</span>– <span class="NLM_lpage">944</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2389.2003.51306.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1046%2Fj.1365-2389.2003.51306.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12834513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD3sznsFyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=937-944&author=D.+S.+Geldmacherauthor=G.+Provenzanoauthor=T.+McRaeauthor=V.+Masteyauthor=J.+R.+Ieni&title=Donepezil+is+associated+with+delayed+nursing+home+placement+in+patients+with+Alzheimer%E2%80%99s+disease&doi=10.1046%2Fj.1365-2389.2003.51306.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease</span></div><div class="casAuthors">Geldmacher David S; Provenzano George; McRae Thomas; Mastey Vera; Ieni John R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Geriatrics Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">937-44</span>
        ISSN:<span class="NLM_cas:issn">0002-8614</span>.
    </div><div class="casAbstract">OBJECTIVES:  To assess the relationship between donepezil treatment and time to nursing home placement (NHP) for patients with Alzheimer's disease (AD).  DESIGN:  Observational follow-up of patient NHP and vital status.  SETTING:  Community.  PARTICIPANTS:  Patients previously enrolled in one of three randomized, double-blind, placebo-controlled clinical trials of donepezil and two subsequent open-label studies (total N = 1,115); 671 patients provided complete data for analysis.  MEASUREMENTS:  Data were obtained through follow-up interviews with caregivers and chart reviews of patients with AD.  Comparison groups were defined by whether patients received an effective dose of donepezil (>/=5 mg/d; >/=80% compliance) for specific numbers of weeks during the double-blind or open-label trial phase, in both phases, or in neither.  Cox proportional hazards models were used to estimate risk ratios for NHP and survival curves from which median times to NHP were estimated for first dementia-related placement of longer than 2 weeks and permanent placement.  The models were adjusted for age, sex, baseline Mini-Mental State Examination score, whether the caregiver was a spouse, caregiver continuity, and use of other cholinesterase inhibitors after the clinical trials.  RESULTS:  Use of donepezil of 5 mg/d or more was associated with significant delays in NHP.  A cumulative dose-response relationship was observed between longer-term sustained donepezil use and delay of NHP.  When donepezil was taken at an effective dose for at least 9 to 12 months, conservative estimates of the time gained before NHP were 21.4 months for first dementia-related NHP and 17.5 months for permanent NHP.  CONCLUSION:  Use of donepezil by AD patients resulted in significant delays in NHP.  Long-term use of donepezil may help AD patients live longer in community settings, with consequent personal, social, and economic benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXmoyhFZauwfcsfMJQC1ZdfW6udTcc2eZKq0RJ0AFxXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sznsFyrsw%253D%253D&md5=ba06fb717bec801eb57215ea4d53185e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2389.2003.51306.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2389.2003.51306.x%26sid%3Dliteratum%253Aachs%26aulast%3DGeldmacher%26aufirst%3DD.%2BS.%26aulast%3DProvenzano%26aufirst%3DG.%26aulast%3DMcRae%26aufirst%3DT.%26aulast%3DMastey%26aufirst%3DV.%26aulast%3DIeni%26aufirst%3DJ.%2BR.%26atitle%3DDonepezil%2520is%2520associated%2520with%2520delayed%2520nursing%2520home%2520placement%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Am.%2520Geriatr.%2520Soc.%26date%3D2003%26volume%3D51%26spage%3D937%26epage%3D944%26doi%3D10.1046%2Fj.1365-2389.2003.51306.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganeshpurkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span> <span> </span><span class="NLM_article-title">Secretase inhibitors for the treatment of Alzheimer’s disease: long road ahead</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">436</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.ejmech.2018.02.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2018&pages=436-452&author=D.+Kumarauthor=A.+Ganeshpurkarauthor=D.+Kumarauthor=G.+Modiauthor=S.+K.+Guptaauthor=S.+K.+Singh&title=Secretase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+long+road+ahead&doi=10.1016%2Fj.ejmech.2018.02.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DGaneshpurkar%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DModi%26aufirst%3DG.%26aulast%3DGupta%26aufirst%3DS.%2BK.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26atitle%3DSecretase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520long%2520road%2520ahead%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D148%26spage%3D436%26epage%3D452%26doi%3D10.1016%2Fj.ejmech.2018.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. S.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of anti-amyloid-β immunotherapy for Alzheimer’s disease: a systematic review and network meta-analysis</span>. <i>Ann. Clin. Transl. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">931</span>– <span class="NLM_lpage">942</span>, <span class="refDoi"> DOI: 10.1002/acn3.469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1002%2Facn3.469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=29296624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1aisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2017&pages=931-942&author=J.+J.+Moauthor=J.+Y.+Liauthor=Z.+Yangauthor=Z.+Liuauthor=J.+S.+Feng&title=Efficacy+and+safety+of+anti-amyloid-%CE%B2+immunotherapy+for+Alzheimer%E2%80%99s+disease%3A+a+systematic+review+and+network+meta-analysis&doi=10.1002%2Facn3.469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of anti-amyloid-β immunotherapy for Alzheimer's disease: a systematic review and network meta-analysis</span></div><div class="casAuthors">Mo, Jia-Jie; Li, Jin-yu; Yang, Zheng; Liu, Zhou; Feng, Jin-Shan</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Clinical and Translational Neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">931-942</span>CODEN:
                <span class="NLM_cas:coden">ACTNCG</span>;
        ISSN:<span class="NLM_cas:issn">2328-9503</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To review the optimality and safety of different anti-Amyloid-β(Aβ) immunotherapies for Alzheimer's disease (AD).  Published randomized controlled trials were comprehensively reviewed from electronic databases (Cochrane library, Embase, Pubmed, and Google scholar).  Pooled outcomes as mean difference or odds ratio values with 95% confidence interval were reported.  The network ests. with confidence and predictive intervals for all pairwise relative effects was evaluated.  Optimal intervention was ranked by benefit-risk ratio based on the surface under the cumulative ranking curve.  Eleven eligible RCTs from 9 literatures, including 5141 patients and 5 interventions were included.  The quality of evidence was rated low in comparisons.  For efficacy, in terms of Mini-Mental State Examn., aducanumab and solanezumab are significantly effective than placebo.  For safety, in terms of Amyloid-Related Imaging Abnormalities (ARIA), bapineuzumab and aducanumab are significantly worse than placebo.  There were no significant differences in outcomes of Alzheimer's disease Assessment Scale-Cognitive subscale, Disability Assessment for Dementia, Adverse Events, and mortality.  Given the clin. therapeutic effects of anti-Aβ immunotherapies for AD, aducanumab and solanezumab improve the cognitive function, while aducanumab and bapineuzumab may increase the risks of ARIA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn_fg1tzcXi7Vg90H21EOLACvtfcHk0lg1Bi2SnXuFwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1aisw%253D%253D&md5=a0a2234699269313e850fb54e7e90bcd</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Facn3.469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Facn3.469%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DJ.%2BJ.%26aulast%3DLi%26aufirst%3DJ.%2BY.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DFeng%26aufirst%3DJ.%2BS.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520anti-amyloid-%25CE%25B2%2520immunotherapy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520systematic%2520review%2520and%2520network%2520meta-analysis%26jtitle%3DAnn.%2520Clin.%2520Transl.%2520Neurol.%26date%3D2017%26volume%3D4%26spage%3D931%26epage%3D942%26doi%3D10.1002%2Facn3.469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gold, M.</span></span> <span> </span><span class="NLM_article-title">Phase II clinical trials of anti-amyloid β antibodies: when is enough, enough?</span>. <i>Alzheimers Dement.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2017.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.trci.2017.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BC1M7kt1ahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=402-409&author=M.+Gold&title=Phase+II+clinical+trials+of+anti-amyloid+%CE%B2+antibodies%3A+when+is+enough%2C+enough%3F&doi=10.1016%2Fj.trci.2017.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II clinical trials of anti-amyloid β antibodies: When is enough, enough?</span></div><div class="casAuthors">Gold Michael</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">402-409</span>
        ISSN:<span class="NLM_cas:issn">2352-8737</span>.
    </div><div class="casAbstract">Efforts to develop new therapies to combat Alzheimer's disease suffer from extraordinarily high failure rates that make it difficult to justify continued investment in the field.  Although there are a number of plausible explanations for this extremely high attrition rate, one of the explanations that has received little attention is the lack of compelling data from Phase II studies for compounds that have been pushed into Phase III trials and then have failed.  An analysis of publicly available data from the Phase II studies for bapineuzumab and solanezumab indicates that neither compound produced compelling evidence of drug-like behavior that would justify their progression into pivotal trials.  The published data suggest that sponsors took decisions to move these compounds into Phase III on the basis of vastly limited data that were rife with type I error and probably driven by commercial concerns.  The continued push to move compounds that are not likely to succeed in later stage clinical trials threatens to erode trust in the clinical research enterprise making it much harder to properly test truly promising compounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRC88SOrTJcQHp3bfzSLaX5fW6udTcc2eYUphDBVOp6a7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7kt1ahsQ%253D%253D&md5=50060bb8c54f52030c388b88d0c4904a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2017.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2017.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DGold%26aufirst%3DM.%26atitle%3DPhase%2520II%2520clinical%2520trials%2520of%2520anti-amyloid%2520%25CE%25B2%2520antibodies%253A%2520when%2520is%2520enough%252C%2520enough%253F%26jtitle%3DAlzheimers%2520Dement.%26date%3D2017%26volume%3D3%26spage%3D402%26epage%3D409%26doi%3D10.1016%2Fj.trci.2017.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panza, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logroscino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbimbo, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solfrizzi, V.</span></span> <span> </span><span class="NLM_article-title">Is there still any hope for amyloid-based immunotherapy for Alzheimer’s disease?</span>. <i>Curr. Opin. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1097/YCO.0000000000000041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1097%2FYCO.0000000000000041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=24445401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BC2czntVOmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=128-137&author=F.+Panzaauthor=G.+Logroscinoauthor=B.+P.+Imbimboauthor=V.+Solfrizzi&title=Is+there+still+any+hope+for+amyloid-based+immunotherapy+for+Alzheimer%E2%80%99s+disease%3F&doi=10.1097%2FYCO.0000000000000041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?</span></div><div class="casAuthors">Panza Francesco; Logroscino Giancarlo; Imbimbo Bruno P; Solfrizzi Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">128-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  We reviewed clinical trials on active and passive anti-β-amyloid (Aβ) immunotherapy for the treatment of Alzheimer's disease with a particular focus on monoclonal antibodies against Aβ.  RECENT FINDINGS:  Studies on anti-Alzheimer's disease immunotherapy published in the period from January 2012 to October 2013 were reviewed.  SUMMARY:  Both active and passive anti-Aβ immunotherapies were shown to clear brain Aβ deposits.  However, an active anti-Aβ vaccine (AN1792) has been discontinued because it caused meningoencephalitis in 6% of Alzheimer's disease patients treated.  Among passive immunotherapeutics, two Phase III clinical trials in mild-to-moderate Alzheimer's disease patients with bapineuzumab, a humanized monoclonal antibody directed at the N-terminal sequence of Aβ, were disappointing.  Another antibody, solanezumab, directed at the mid-region of Aβ, failed in two Phase III clinical trials in mild-to-moderate Alzheimer's disease patients.  A third Phase III study with solanezumab is ongoing in mildly affected Alzheimer's disease patients based on encouraging results in this subgroup of patients.  Second-generation active Aβ vaccines (ACC-001, CAD106, and Affitope AD02) and new passive anti-Aβ immunotherapies (gantenerumab and crenezumab) are being tested in prodromal Alzheimer's disease patients, in presymptomatic individuals with Alzheimer's disease-related mutations, or in asymptomatic individuals at risk of developing Alzheimer's disease to definitely test the Aβ cascade hypothesis of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3vSyGxuaMyax48Rj5GnGofW6udTcc2eYUphDBVOp6a7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czntVOmuw%253D%253D&md5=f03e24b748ee62cae91aec8786629f17</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1097%2FYCO.0000000000000041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FYCO.0000000000000041%26sid%3Dliteratum%253Aachs%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DLogroscino%26aufirst%3DG.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DSolfrizzi%26aufirst%3DV.%26atitle%3DIs%2520there%2520still%2520any%2520hope%2520for%2520amyloid-based%2520immunotherapy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DCurr.%2520Opin.%2520Psychiatry%26date%3D2014%26volume%3D27%26spage%3D128%26epage%3D137%26doi%3D10.1097%2FYCO.0000000000000041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, C. S.</span></span> <span> </span><span class="NLM_article-title">Cognitive decline in preclinical Alzheimer’s disease: amyloid-beta versus tauopathy</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.3233/JAD-170490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-170490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=29154274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWhsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=265-281&author=C.+M.+Huberauthor=C.+Yeeauthor=T.+Mayauthor=A.+Dhanalaauthor=C.+S.+Mitchell&title=Cognitive+decline+in+preclinical+Alzheimer%E2%80%99s+disease%3A+amyloid-beta+versus+tauopathy&doi=10.3233%2FJAD-170490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy</span></div><div class="casAuthors">Huber, Colin M.; Yee, Connor; May, Taylor; Dhanala, Apoorva; Mitchell, Cassie S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">265-281</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">We perform a large-scale meta-anal. of 51 peer-reviewed 3xTg-AD mouse publications to compare Alzheimer's disease (AD) quant. clin. outcome measures, including amyloid-β (Aβ), total tau, and phosphorylated tau (pTau), with cognitive performance in Morris water maze (MWM) and Novel Object Recognition (NOR).  "High" levels of Aβ (Aβ40, Aβ42) showed significant but weak trends with cognitive decline (MWM: slope=0.336, R2=0.149, n=259, p<0.001; NOR: slope=0.156, R2=0.064, n=116, p<0.05); only sol. Aβ or directly measured Aβ meaningfully contribute.  Tau expression in 3xTg-AD mice was within 10-20% of wild type and not assocd. with cognitive decline.  In contrast, increased pTau is directly and significantly correlated with cognitive decline in MWM (slope=0.408, R2=0.275, n=371, p< <0.01) and NOR (slope=0.319, R2=0.176, n=113, p<0.05).  While a variety of pTau epitopes (AT8, AT270, AT180, PHF-1) were examd., AT8 correlated most strongly with cognition (slope=0.586, R2=0.521, n=185, p< <0.001).  Multiple linear regression confirmed pTau is a stronger predictor of MWM performance than Aβ.  Despite pTau's lower phys. concn. than Aβ, pTau levels more directly and quant. correlate with 3xTg-AD cognitive decline. pTau's contribution to neurofibrillary tangles well after Aβ levels plateau makes pTau a viable treatment target even in late-stage clin. AD.  Principal component anal., which included hyperphosphorylation induced by kinases (pGSK3β, GSK3β, CDK5), identified phosphorylated ser9 GSK3β as the primary contributor to MWM variance.  In summary, meta-anal. of cognitive decline in preclin. AD finds tauopathy more impactful than Aβ.  Nonetheless, complex AD interactions dictate successful therapeutics harness synergy between Aβ and pTau, possibly through the GSK3 pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm4_iPfdFiMbVg90H21EOLACvtfcHk0licaXQBtZVMdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWhsbnN&md5=ae00c194a044b3ee5ddaf5097c2f592f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3233%2FJAD-170490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-170490%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DC.%2BM.%26aulast%3DYee%26aufirst%3DC.%26aulast%3DMay%26aufirst%3DT.%26aulast%3DDhanala%26aufirst%3DA.%26aulast%3DMitchell%26aufirst%3DC.%2BS.%26atitle%3DCognitive%2520decline%2520in%2520preclinical%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520amyloid-beta%2520versus%2520tauopathy%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2018%26volume%3D61%26spage%3D265%26epage%3D281%26doi%3D10.3233%2FJAD-170490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wekstein, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashford, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markesbery, W. R.</span></span> <span> </span><span class="NLM_article-title">“Preclinical” AD revisited: neuropathology of cognitively normal older adults</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.1212/WNL.55.3.370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1212%2FWNL.55.3.370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10932270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD3cvgs1Gjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2000&pages=370-376&author=F.+A.+Schmittauthor=D.+G.+Davisauthor=D.+R.+Weksteinauthor=C.+D.+Smithauthor=J.+W.+Ashfordauthor=W.+R.+Markesbery&title=%E2%80%9CPreclinical%E2%80%9D+AD+revisited%3A+neuropathology+of+cognitively+normal+older+adults&doi=10.1212%2FWNL.55.3.370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">"Preclinical" AD revisited: neuropathology of cognitively normal older adults</span></div><div class="casAuthors">Schmitt F A; Davis D G; Wekstein D R; Smith C D; Ashford J W; Markesbery W R</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">370-6</span>
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    </div><div class="casAbstract">OBJECTIVE:  To classify neuropathologic alterations in the brains of nondemented older adults using current sets of criteria for AD.  BACKGROUND:  AD neuropathologic alterations are found in the brains of some nondemented elderly subjects and suggest the possibility of presymptomatic AD.  Three sets of guidelines have been developed to classify AD using senile plaques, neuritic plaques, and neurofibrillary tangles (NFT).  METHODS:  Neuropathologic changes in 59 older adults followed longitudinally with a standard battery of mental status measures were investigated using Khachaturian, Consortium to Establish a Registry for Alzheimer's Disease (CERAD), and National Institute on Aging-Reagan Institute (NIA-RI) guidelines.  AD neuropathologic markers were evaluated in neocortical and allocortical regions.  Cases were categorized as neuropathologically "normal" or "AD-like" and compared for possible mental status differences.  RESULTS:  Between 11 and 49% of cases met one or more of the three classifications of AD.  With adjustments for multiple comparisons, only NFT in hippocampal CA1 region were associated with autopsy age, suggesting that this may represent a pathologic process associated with normal brain aging.  Using the NIA-RI guidelines, subjects in the AD-like group performed less well on the immediate paragraph recall and word-list delayed recall than their counterparts who did not meet these guidelines.  CONCLUSIONS:  These data indicate that the prevalence of "preclinical" AD in our population is relatively low based on the NIA-RI classification.  Although many subjects had AD-like changes based on CERAD and Khachaturian guidelines, they exhibited no differences in mental performance, suggesting that the aging brain may be able to withstand such structural changes without meaningful impact on mental functioning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtwE-qlOsc2bGbPKh4T9eAfW6udTcc2eZBf_cry25Nu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3cvgs1Gjsg%253D%253D&md5=694e3894918918a091a82e935212d401</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1212%2FWNL.55.3.370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.55.3.370%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DF.%2BA.%26aulast%3DDavis%26aufirst%3DD.%2BG.%26aulast%3DWekstein%26aufirst%3DD.%2BR.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26aulast%3DAshford%26aufirst%3DJ.%2BW.%26aulast%3DMarkesbery%26aufirst%3DW.%2BR.%26atitle%3D%25E2%2580%259CPreclinical%25E2%2580%259D%2520AD%2520revisited%253A%2520neuropathology%2520of%2520cognitively%2520normal%2520older%2520adults%26jtitle%3DNeurology%26date%3D2000%26volume%3D55%26spage%3D370%26epage%3D376%26doi%3D10.1212%2FWNL.55.3.370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storandt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKeel, D. W.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, L.</span></span> <span> </span><span class="NLM_article-title">Cerebral amyloid deposition and diffuse plaques in “normal” aging: evidence for presymptomatic and very mild Alzheimer’s disease</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">707</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1212/WNL.46.3.707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1212%2FWNL.46.3.707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=8618671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADyaK287ntlKrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1996&pages=707-719&author=J.+C.+Morrisauthor=M.+Storandtauthor=D.+W.+McKeelauthor=E.+H.+Rubinauthor=J.+L.+Priceauthor=E.+A.+Grantauthor=L.+Berg&title=Cerebral+amyloid+deposition+and+diffuse+plaques+in+%E2%80%9Cnormal%E2%80%9D+aging%3A+evidence+for+presymptomatic+and+very+mild+Alzheimer%E2%80%99s+disease&doi=10.1212%2FWNL.46.3.707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease</span></div><div class="casAuthors">Morris J C; Storandt M; McKeel D W Jr; Rubin E H; Price J L; Grant E A; Berg L</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">707-19</span>
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    </div><div class="casAbstract">The presence of senile plaques in the neocortex of apparently nondemented elderly persons often is accepted as part of "normal" aging.  Alternatively, because cerebral deposition of beta-amyloid may be a key mechanism in the development of Alzheimer's disease (AD), the presence of beta-amyloid-containing plaques may represent very early AD.  To examine the relationships of cognitively normal aging, very mild dementia of the Alzheimer type, and the presence of neocortical senile plaques, we performed clinicopathologic correlation in 21 longitudinally studied healthy elderly subjects (84.5 +/- 6.6 years old at death).  Nine subjects had strikingly high plaque densities in the neocortex; two of these subjects died of head injury before which there was no evidence of cognitive impairment.  The other seven subjects with high plaque densities had clinical evidence for very mild cognitive impairment (Clinical Dementia Rating score of 0.5) at some time during their course and mildly impaired psychometric performance at last assessment before death.  The remaining 12 subjects had no clinical or psychometric impairment and had few or no neocortical AD lesions.  These results suggest that senile plaques may not be part of normal aging but instead represent presymptomatic or unrecognized early symptomatic AD.  The high density of senile plaques (predominately of the diffuse subtype) in the cortex of subjects just at the threshold of detectable dementia is consistent with the hypothesis that beta-amyloid deposition is an initial pathogenetic event in the development of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS7hpkD840LCEodMGTatQ7LfW6udTcc2eZBf_cry25Nu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK287ntlKrsg%253D%253D&md5=074f0b988d557ba2704057bf7dea22aa</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1212%2FWNL.46.3.707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.46.3.707%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DStorandt%26aufirst%3DM.%26aulast%3DMcKeel%26aufirst%3DD.%2BW.%26aulast%3DRubin%26aufirst%3DE.%2BH.%26aulast%3DPrice%26aufirst%3DJ.%2BL.%26aulast%3DGrant%26aufirst%3DE.%2BA.%26aulast%3DBerg%26aufirst%3DL.%26atitle%3DCerebral%2520amyloid%2520deposition%2520and%2520diffuse%2520plaques%2520in%2520%25E2%2580%259Cnormal%25E2%2580%259D%2520aging%253A%2520evidence%2520for%2520presymptomatic%2520and%2520very%2520mild%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1996%26volume%3D46%26spage%3D707%26epage%3D719%26doi%3D10.1212%2FWNL.46.3.707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tepper, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronicke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soom, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaether, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrich, M.</span></span> <span> </span><span class="NLM_article-title">Mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1942</span>– <span class="NLM_lpage">1947</span>, <span class="refDoi"> DOI: 10.1073/pnas.0904532106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1073%2Fpnas.0904532106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=1942-1947&author=R.+P.+Friedrichauthor=K.+Tepperauthor=R.+Ronickeauthor=M.+Soomauthor=M.+Westermannauthor=K.+Reymannauthor=C.+Kaetherauthor=M.+Fandrich&title=Mechanism+of+amyloid+plaque+formation+suggests+an+intracellular+basis+of+A%CE%B2+pathogenicity&doi=10.1073%2Fpnas.0904532106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0904532106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0904532106%26sid%3Dliteratum%253Aachs%26aulast%3DFriedrich%26aufirst%3DR.%2BP.%26aulast%3DTepper%26aufirst%3DK.%26aulast%3DRonicke%26aufirst%3DR.%26aulast%3DSoom%26aufirst%3DM.%26aulast%3DWestermann%26aufirst%3DM.%26aulast%3DReymann%26aufirst%3DK.%26aulast%3DKaether%26aufirst%3DC.%26aulast%3DFandrich%26aufirst%3DM.%26atitle%3DMechanism%2520of%2520amyloid%2520plaque%2520formation%2520suggests%2520an%2520intracellular%2520basis%2520of%2520A%25CE%25B2%2520pathogenicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D1942%26epage%3D1947%26doi%3D10.1073%2Fpnas.0904532106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mantzavinos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexiou, A.</span></span> <span> </span><span class="NLM_article-title">Biomarkers for Alzheimer’s disease diagnosis</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.2174/1567205014666170203125942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F1567205014666170203125942" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=28164766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KgsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=1149-1154&author=V.+Mantzavinosauthor=A.+Alexiou&title=Biomarkers+for+Alzheimer%E2%80%99s+disease+diagnosis&doi=10.2174%2F1567205014666170203125942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Biomarkers for Alzheimer's Disease Diagnosis</span></div><div class="casAuthors">Mantzavinos, Vasileios; Alexiou, Athanasios</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1149-1154</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Objective: The dramatic increase in the population with dementia expected in the next decades is accompanied by the establishment of novel and innovated methods that will offer accurate and efficient detection of the disease in its early stages.  While Alzheimer's disease is the most common cause of dementia, by the time it is typically diagnosed, substantial neuronal loss and neuropathol. lesions can damage many brain regions.  The aim of this study is to investigate the main risk factors that affect and increase Alzheimer's disease progression over time even in cases with no significant memory impairment present.  Several potential markers are discussed such as oxidative stress, metal ions, vascular disorders, protein dysfunctions and alterations in the mitochondrial populations.  Conclusion: A multiparametric model of Alzheimer's biomarkers is presented according to the latest classification of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN6gse_lUKI7Vg90H21EOLACvtfcHk0ljxsHlEF0a_9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KgsLvP&md5=c50ce37874def79fb57d88790bd7346e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F1567205014666170203125942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205014666170203125942%26sid%3Dliteratum%253Aachs%26aulast%3DMantzavinos%26aufirst%3DV.%26aulast%3DAlexiou%26aufirst%3DA.%26atitle%3DBiomarkers%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520diagnosis%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2017%26volume%3D14%26spage%3D1149%26epage%3D1154%26doi%3D10.2174%2F1567205014666170203125942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frisoni, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boccardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barkhof, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blennow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiotis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Démonet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garibotto, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gietl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herholz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jack, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nobili, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ten Kate, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albanese, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossuyt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerami, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacobini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lönneborg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovblad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattsson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinuevo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monsch, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosimann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padovani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porteri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratib, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Aubert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scerri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheltens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schott, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonni, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teipel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vineis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visser, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winblad, B.</span></span> <span> </span><span class="NLM_article-title">Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(17)30159-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS1474-4422%2817%2930159-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=28721928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BC1cjovFyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=661-676&author=G.+B.+Frisoniauthor=M.+Boccardiauthor=F.+Barkhofauthor=K.+Blennowauthor=S.+Cappaauthor=K.+Chiotisauthor=J.+D%C3%A9monetauthor=V.+Garibottoauthor=P.+Giannakopoulosauthor=A.+Gietlauthor=O.+Hanssonauthor=K.+Herholzauthor=C.+R.+Jackauthor=F.+Nobiliauthor=A.+Nordbergauthor=H.+M.+Snyderauthor=M.+Ten+Kateauthor=A.+Varroneauthor=E.+Albaneseauthor=S.+Beckerauthor=P.+Bossuytauthor=M.+C.+Carrilloauthor=C.+Ceramiauthor=B.+Duboisauthor=V.+Galloauthor=E.+Giacobiniauthor=G.+Goldauthor=S.+Hurstauthor=A.+L%C3%B6nneborgauthor=K.+Lovbladauthor=N.+Mattssonauthor=J.+Molinuevoauthor=A.+U.+Monschauthor=U.+Mosimannauthor=A.+Padovaniauthor=A.+Piccoauthor=C.+Porteriauthor=O.+Ratibauthor=L.+Saint-Aubertauthor=C.+Scerriauthor=P.+Scheltensauthor=J.+M.+Schottauthor=I.+Sonniauthor=S.+Teipelauthor=P.+Vineisauthor=P.+J.+Visserauthor=Y.+Yasuiauthor=B.+Winblad&title=Strategic+roadmap+for+an+early+diagnosis+of+Alzheimer%E2%80%99s+disease+based+on+biomarkers&doi=10.1016%2FS1474-4422%2817%2930159-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers</span></div><div class="casAuthors">Frisoni Giovanni B; Boccardi Marina; Barkhof Frederik; Blennow Kaj; Cappa Stefano; Chiotis Konstantinos; Saint-Aubert Laure; Demonet Jean-Francois; Garibotto Valentina; Giannakopoulos Panteleimon; Albanese Emiliano; Gietl Anton; Hansson Oskar; Herholz Karl; Jack Clifford R Jr; Nobili Flavio; Nordberg Agneta; Snyder Heather M; Carrillo Maria C; Ten Kate Mara; Scheltens Philip; Varrone Andrea; Becker Stefanie; Bossuyt Patrick; Cerami Chiara; Dubois Bruno; Gallo Valentina; Giacobini Ezio; Gold Gabriel; Hurst Samia; Lonneborg Anders; Lovblad Karl-Olof; Mattsson Niklas; Molinuevo Jose-Luis; Monsch Andreas U; Mosimann Urs; Padovani Alessandro; Picco Agnese; Porteri Corinna; Ratib Osman; Scerri Charles; Schott Jonathan M; Sonni Ida; Teipel Stefan; Vineis Paolo; Visser Pieter Jelle; Yasui Yutaka; Winblad Bengt</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">661-676</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The diagnosis of Alzheimer's disease can be improved by the use of biological measures.  Biomarkers of functional impairment, neuronal loss, and protein deposition that can be assessed by neuroimaging (ie, MRI and PET) or CSF analysis are increasingly being used to diagnose Alzheimer's disease in research studies and specialist clinical settings.  However, the validation of the clinical usefulness of these biomarkers is incomplete, and that is hampering reimbursement for these tests by health insurance providers, their widespread clinical implementation, and improvements in quality of health care.  We have developed a strategic five-phase roadmap to foster the clinical validation of biomarkers in Alzheimer's disease, adapted from the approach for cancer biomarkers.  Sufficient evidence of analytical validity (phase 1 of a structured framework adapted from oncology) is available for all biomarkers, but their clinical validity (phases 2 and 3) and clinical utility (phases 4 and 5) are incomplete.  To complete these phases, research priorities include the standardisation of the readout of these assays and thresholds for normality, the evaluation of their performance in detecting early disease, the development of diagnostic algorithms comprising combinations of biomarkers, and the development of clinical guidelines for the use of biomarkers in qualified memory clinics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQQsaQSaJb_kCXXDYhVZBdlfW6udTcc2ea4edKyo48b27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjovFyrsw%253D%253D&md5=a274f11320b0bbcd56943e5e3f709c21</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2817%2930159-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252817%252930159-X%26sid%3Dliteratum%253Aachs%26aulast%3DFrisoni%26aufirst%3DG.%2BB.%26aulast%3DBoccardi%26aufirst%3DM.%26aulast%3DBarkhof%26aufirst%3DF.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DCappa%26aufirst%3DS.%26aulast%3DChiotis%26aufirst%3DK.%26aulast%3DD%25C3%25A9monet%26aufirst%3DJ.%26aulast%3DGaribotto%26aufirst%3DV.%26aulast%3DGiannakopoulos%26aufirst%3DP.%26aulast%3DGietl%26aufirst%3DA.%26aulast%3DHansson%26aufirst%3DO.%26aulast%3DHerholz%26aufirst%3DK.%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DNobili%26aufirst%3DF.%26aulast%3DNordberg%26aufirst%3DA.%26aulast%3DSnyder%26aufirst%3DH.%2BM.%26aulast%3DTen%2BKate%26aufirst%3DM.%26aulast%3DVarrone%26aufirst%3DA.%26aulast%3DAlbanese%26aufirst%3DE.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DBossuyt%26aufirst%3DP.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DCerami%26aufirst%3DC.%26aulast%3DDubois%26aufirst%3DB.%26aulast%3DGallo%26aufirst%3DV.%26aulast%3DGiacobini%26aufirst%3DE.%26aulast%3DGold%26aufirst%3DG.%26aulast%3DHurst%26aufirst%3DS.%26aulast%3DL%25C3%25B6nneborg%26aufirst%3DA.%26aulast%3DLovblad%26aufirst%3DK.%26aulast%3DMattsson%26aufirst%3DN.%26aulast%3DMolinuevo%26aufirst%3DJ.%26aulast%3DMonsch%26aufirst%3DA.%2BU.%26aulast%3DMosimann%26aufirst%3DU.%26aulast%3DPadovani%26aufirst%3DA.%26aulast%3DPicco%26aufirst%3DA.%26aulast%3DPorteri%26aufirst%3DC.%26aulast%3DRatib%26aufirst%3DO.%26aulast%3DSaint-Aubert%26aufirst%3DL.%26aulast%3DScerri%26aufirst%3DC.%26aulast%3DScheltens%26aufirst%3DP.%26aulast%3DSchott%26aufirst%3DJ.%2BM.%26aulast%3DSonni%26aufirst%3DI.%26aulast%3DTeipel%26aufirst%3DS.%26aulast%3DVineis%26aufirst%3DP.%26aulast%3DVisser%26aufirst%3DP.%2BJ.%26aulast%3DYasui%26aufirst%3DY.%26aulast%3DWinblad%26aufirst%3DB.%26atitle%3DStrategic%2520roadmap%2520for%2520an%2520early%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520based%2520on%2520biomarkers%26jtitle%3DLancet%2520Neurol.%26date%3D2017%26volume%3D16%26spage%3D661%26epage%3D676%26doi%3D10.1016%2FS1474-4422%2817%2930159-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C. R.</span></span> <span> </span><span class="NLM_article-title">The key role of mitochondria in Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.3233/JAD-2006-9202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-2006-9202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=16873957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFWksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=101-110&author=P.+I.+Moreiraauthor=S.+M.+Cardosoauthor=M.+S.+Santosauthor=C.+R.+Oliveira&title=The+key+role+of+mitochondria+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2006-9202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The key role of mitochondria in Alzheimer's disease</span></div><div class="casAuthors">Moreira, Paula I.; Oliveira, Catarina; Moreira, P. I.; Cardoso, S. M.; Santos, M. S.; Oliveira, C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-110</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Mitochondria are uniquely poised to play a pivotal role in neuronal cell survival or death because they are regulators of both energy metab. and apoptotic pathways.  This review is mainly focused in the discussion of evidence suggesting a clear assocn. between amyloid-β toxicity, mitochondrial dysfunction, oxidative stress and neuronal damage/death in Alzheimer's disease pathophysiol.  The knowledge that mitochondrial dysfunction has a preponderant role in Alzheimer's disease opened a window for new therapeutic strategies aimed to preserve/ameliorate mitochondrial function.  Based on recent developments in mitochondrial research, increased pharmacol. and pharmaceutical efforts have lead to the emergence of 'Mitochondrial Medicine' as a whole new field of biomedical research being this topic discussed in the last section of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzsD89dmGMrLVg90H21EOLACvtfcHk0li6VvkE_UhF4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFWksbc%253D&md5=1fbca5d81ff757752825d3ad2a68b95f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3233%2FJAD-2006-9202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2006-9202%26sid%3Dliteratum%253Aachs%26aulast%3DMoreira%26aufirst%3DP.%2BI.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DSantos%26aufirst%3DM.%2BS.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26atitle%3DThe%2520key%2520role%2520of%2520mitochondria%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2006%26volume%3D9%26spage%3D101%26epage%3D110%26doi%3D10.3233%2FJAD-2006-9202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C. R.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: a lesson from mitochondrial dysfunction</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1621</span>– <span class="NLM_lpage">1630</span>, <span class="refDoi"> DOI: 10.1089/ars.2007.1703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1089%2Fars.2007.1703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17678440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqs7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=1621-1630&author=P.+I.+Moreiraauthor=M.+S.+Santosauthor=C.+R.+Oliveira&title=Alzheimer%E2%80%99s+disease%3A+a+lesson+from+mitochondrial+dysfunction&doi=10.1089%2Fars.2007.1703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: a lesson from mitochondrial dysfunction</span></div><div class="casAuthors">Moreira, Paula I.; Santos, Maria S.; Oliveira, Catarina R.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1621-1630</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Extensive literature exists supporting a role for mitochondrial dysfunction and oxidative damage in the pathogenesis of Alzheimer's disease.  Mitochondria are a major source of intracellular reactive oxygen species and are particularly vulnerable to oxidative stress.  This review discusses evidence supporting the notion that mitochondrial dysfunction is intimately assocd. with Alzheimer's disease pathogenesis.  Furthermore, the potential connection between mitochondrial dysfunction/oxidative stress and autophagy in Alzheimer's disease is also discussed.  As a result of insufficient digestion of oxidatively damaged macromols. and organelles by autophagy, neurons progressively accumulate lipofuscin (biol. garbage) that could exacerbate neuronal dysfunction.  The knowledge that mitochondrial dysfunction has a preponderant role in several pathol. conditions instigated the development of mitochondrial antioxidant therapies.  Mitochondria-targeted antioxidant treatments are briefly discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0S9m8V-vH2bVg90H21EOLACvtfcHk0li6VvkE_UhF4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqs7bK&md5=3b730dafa94880be4dfd3a671c7c72a8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1089%2Fars.2007.1703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2007.1703%26sid%3Dliteratum%253Aachs%26aulast%3DMoreira%26aufirst%3DP.%2BI.%26aulast%3DSantos%26aufirst%3DM.%2BS.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520lesson%2520from%2520mitochondrial%2520dysfunction%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2007%26volume%3D9%26spage%3D1621%26epage%3D1630%26doi%3D10.1089%2Fars.2007.1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunomura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress signaling in Alzheimer’s disease</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">532</span>, <span class="refDoi"> DOI: 10.2174/156720508786898451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F156720508786898451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=19075578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKgsbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=525-532&author=B.+Suauthor=X.+Wangauthor=A.+Nunomuraauthor=P.+Moreiraauthor=H.+Leeauthor=G.+Perryauthor=M.+Smithauthor=X.+Zhu&title=Oxidative+stress+signaling+in+Alzheimer%E2%80%99s+disease&doi=10.2174%2F156720508786898451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress signaling in Alzheimer's disease</span></div><div class="casAuthors">Su, B.; Wang, X.; Nunomura, A.; Moreira, P. I.; Lee, H.-gon; Perry, G.; Smith, M. A.; Zhu, X.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">525-532</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Multiple lines of evidence demonstrate that oxidative stress is an early event in Alzheimer's disease (AD), occurring prior to cytopathol., and therefore may play a key pathogenic role in AD.  Oxidative stress not only temporally precedes the pathol. lesions of the disease but also activates cell signaling pathways, which, in turn, contribute to lesion formation and, at the same time, provoke cellular responses such as compensatory upregulation of antioxidant enzymes found in vulnerable neurons in AD.  In this review, we provide an overview of the evidence of oxidative stress and compensatory responses that occur in AD, particularly focused on potential sources of oxidative stress and the roles and mechanism of activation of stress-activated protein kinase pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNWDrffmgJnbVg90H21EOLACvtfcHk0lgfOSqwr70GxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKgsbzK&md5=824f978a3325a0d6901f9c56c39f599c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F156720508786898451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720508786898451%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DNunomura%26aufirst%3DA.%26aulast%3DMoreira%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DOxidative%2520stress%2520signaling%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2008%26volume%3D5%26spage%3D525%26epage%3D532%26doi%3D10.2174%2F156720508786898451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rego, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C. R.</span></span> <span> </span><span class="NLM_article-title">An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">741</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.3233/JAD-2009-0972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-2009-0972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=19387110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVansbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=741-761&author=P.+I.+Moreiraauthor=A.+I.+Duarteauthor=M.+S.+Santosauthor=A.+C.+Regoauthor=C.+R.+Oliveira&title=An+integrative+view+of+the+role+of+oxidative+stress%2C+mitochondria+and+insulin+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2009-0972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">An Integrative View of the Role of Oxidative Stress, Mitochondria and Insulin in Alzheimer's Disease</span></div><div class="casAuthors">Bierhaus, Angelika; Moreira, Paula I.; Duarte, Ana I.; Santos, Maria S.; Rego, A. Cristina; Oliveira, Catarina R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">741-761</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  The processes underlying the pathogenesis of Alzheimer's disease involve several factors including impaired glucose/energy metab., mitochondrial dysfunction, oxidative stress and altered insulin-signaling pathways.  This review is mainly devoted to discuss evidence supporting the notion that mitochondrial dysfunction and oxidative stress are interconnected and intimately assocd. with the development and progression of Alzheimer's disease.  Furthermore, the review explores the role of insulin signaling in the pathophysiol. of the disease.  Indeed, several studies have begun to find links between insulin and mechanisms with clear pathogenic implications for this disorder.  Understanding the key mechanisms involved in the etiopathogenesis of Alzheimer's disease may provide opportunities for the design of efficacious preventive and therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrLUlhiU4CjbVg90H21EOLACvtfcHk0lgfOSqwr70GxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVansbs%253D&md5=960303a887281e0297b84c025c5f6933</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3233%2FJAD-2009-0972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2009-0972%26sid%3Dliteratum%253Aachs%26aulast%3DMoreira%26aufirst%3DP.%2BI.%26aulast%3DDuarte%26aufirst%3DA.%2BI.%26aulast%3DSantos%26aufirst%3DM.%2BS.%26aulast%3DRego%26aufirst%3DA.%2BC.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26atitle%3DAn%2520integrative%2520view%2520of%2520the%2520role%2520of%2520oxidative%2520stress%252C%2520mitochondria%2520and%2520insulin%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2009%26volume%3D16%26spage%3D741%26epage%3D761%26doi%3D10.3233%2FJAD-2009-0972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rovelet-Lecrux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannequin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Meur, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laquerriere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vital, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumanchin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuillette, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brice, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vercelletto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frebourg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campion, D.</span></span> <span> </span><span class="NLM_article-title">APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1038/ng1718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1038%2Fng1718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=16369530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCmtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=24-26&author=A.+Rovelet-Lecruxauthor=D.+Hannequinauthor=G.+Rauxauthor=N.+Le+Meurauthor=A.+Laquerriereauthor=A.+Vitalauthor=C.+Dumanchinauthor=S.+Feuilletteauthor=A.+Briceauthor=M.+Vercellettoauthor=F.+Dubasauthor=T.+Frebourgauthor=D.+Campion&title=APP+locus+duplication+causes+autosomal+dominant+early-onset+Alzheimer+disease+with+cerebral+amyloid+angiopathy&doi=10.1038%2Fng1718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy</span></div><div class="casAuthors">Rovelet-Lecrux, Anne; Hannequin, Didier; Raux, Gregory; Le Meur, Nathalie; Laquerriere, Annie; Vital, Anne; Dumanchin, Cecile; Feuillette, Sebastien; Brice, Alexis; Vercelletto, Martine; Dubas, Frederic; Frebourg, Thierry; Campion, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-26</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report duplication of the APP locus on chromosome 21 in five families with autosomal dominant early-onset Alzheimer disease (ADEOAD) and cerebral amyloid angiopathy (CAA).  Among these families, the duplicated segments had a minimal size ranging from 0.58 to 6.37 Mb.  Brains from individuals with APP duplication showed abundant parenchymal and vascular deposits of amyloid-β peptides.  Duplication of the APP locus, resulting in accumulation of amyloid-β peptides, causes ADEOAD with CAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6mApoy_JS5bVg90H21EOLACvtfcHk0lgcvI5uA51iMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCmtrzO&md5=0752ab2fe84de169286b75e9d01f457e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fng1718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1718%26sid%3Dliteratum%253Aachs%26aulast%3DRovelet-Lecrux%26aufirst%3DA.%26aulast%3DHannequin%26aufirst%3DD.%26aulast%3DRaux%26aufirst%3DG.%26aulast%3DLe%2BMeur%26aufirst%3DN.%26aulast%3DLaquerriere%26aufirst%3DA.%26aulast%3DVital%26aufirst%3DA.%26aulast%3DDumanchin%26aufirst%3DC.%26aulast%3DFeuillette%26aufirst%3DS.%26aulast%3DBrice%26aufirst%3DA.%26aulast%3DVercelletto%26aufirst%3DM.%26aulast%3DDubas%26aufirst%3DF.%26aulast%3DFrebourg%26aufirst%3DT.%26aulast%3DCampion%26aufirst%3DD.%26atitle%3DAPP%2520locus%2520duplication%2520causes%2520autosomal%2520dominant%2520early-onset%2520Alzheimer%2520disease%2520with%2520cerebral%2520amyloid%2520angiopathy%26jtitle%3DNat.%2520Genet.%26date%3D2006%26volume%3D38%26spage%3D24%26epage%3D26%26doi%3D10.1038%2Fng1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strittmatter, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmechel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. George-Hyslop, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pericak-Vance, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joo, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosi, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gusella, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crapper-MacLachlan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crain, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldgaber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roses, A. D.</span></span> <span> </span><span class="NLM_article-title">Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1467</span>– <span class="NLM_lpage">1472</span>, <span class="refDoi"> DOI: 10.1212/WNL.43.8.1467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1212%2FWNL.43.8.1467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=8350998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK2cXhvVyksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1993&pages=1467-1472&author=A.+M.+Saundersauthor=W.+J.+Strittmatterauthor=D.+Schmechelauthor=P.+H.+St.+George-Hyslopauthor=M.+A.+Pericak-Vanceauthor=S.+H.+Jooauthor=B.+L.+Rosiauthor=J.+F.+Gusellaauthor=D.+R.+Crapper-MacLachlanauthor=M.+J.+Albertsauthor=C.+Huletteauthor=B.+Crainauthor=D.+Goldgaberauthor=A.+D.+Roses&title=Association+of+apolipoprotein+E+allele+epsilon+4+with+late-onset+familial+and+sporadic+Alzheimer%E2%80%99s+disease&doi=10.1212%2FWNL.43.8.1467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease</span></div><div class="casAuthors">Saunders, A.M.; Strittmatter, W.J.; Schmechel, D.; St. George-Hyslop, P.H.; Pericak-Vance, M.A.; Joo, S.H.; Rosi, B.L.; Gusella, J.F.; Crapper-MacLachlan, D.R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1467-72</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    </div><div class="casAbstract">Apolipoprotein E, type ε4 allele (APOE ε4), is assocd. with late-onset familial Alzheimer's disease (AD).  There is high avidity and specific binding of amyloid β-peptide with the protein ApoE.  To test the hypothesis that late-onset familial AD may represent the clustering of sporadic AD in families large enough to be studied, the authors extended the analyses of APOE alleles to several series of sporadic AD patients.  APOE ε4 is significantly assocd. with a series of probable sporadic AD patients.  Spouse controls did not differ from CEPH grandparent controls from the Center d'Etude du Polymorphisme Humain (CEPH) or from literature controls.  A large combined series of autopsy-documented sporadic AD patients also demonstrated highly significant assocn. with the APOE ε4 allele.  These data support the involvement of ApoE ε4 in the pathogenesis of late-onset familial and sporadic AD.  ApoE isoforms may play an important role in the metab. of β-peptide, and APOE ε4 may operate as a susceptibility gene (risk factor) for the clin. expression of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0dhnjdKkrybVg90H21EOLACvtfcHk0lgcvI5uA51iMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhvVyksbc%253D&md5=f4430df7ead1b04c44ccc1e7bd25648d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1212%2FWNL.43.8.1467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.43.8.1467%26sid%3Dliteratum%253Aachs%26aulast%3DSaunders%26aufirst%3DA.%2BM.%26aulast%3DStrittmatter%26aufirst%3DW.%2BJ.%26aulast%3DSchmechel%26aufirst%3DD.%26aulast%3DSt.%2BGeorge-Hyslop%26aufirst%3DP.%2BH.%26aulast%3DPericak-Vance%26aufirst%3DM.%2BA.%26aulast%3DJoo%26aufirst%3DS.%2BH.%26aulast%3DRosi%26aufirst%3DB.%2BL.%26aulast%3DGusella%26aufirst%3DJ.%2BF.%26aulast%3DCrapper-MacLachlan%26aufirst%3DD.%2BR.%26aulast%3DAlberts%26aufirst%3DM.%2BJ.%26aulast%3DHulette%26aufirst%3DC.%26aulast%3DCrain%26aufirst%3DB.%26aulast%3DGoldgaber%26aufirst%3DD.%26aulast%3DRoses%26aufirst%3DA.%2BD.%26atitle%3DAssociation%2520of%2520apolipoprotein%2520E%2520allele%2520epsilon%25204%2520with%2520late-onset%2520familial%2520and%2520sporadic%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1993%26volume%3D43%26spage%3D1467%26epage%3D1472%26doi%3D10.1212%2FWNL.43.8.1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">Amyloid, the presenilins and Alzheimer’s disease</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">154</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/S0166-2236(96)01030-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS0166-2236%2896%2901030-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=9106355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK2sXitVKnt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1997&pages=154-159&author=J.+Hardy&title=Amyloid%2C+the+presenilins+and+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0166-2236%2896%2901030-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid, the presenilins and Alzheimer's disease</span></div><div class="casAuthors">Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">154-159</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 53 refs.  Various mutations in the amyloid protein precursor and presenilin genes can lead to early onset, autosomal Alzheimer's disease.  A series of mis-sense mutations (with one exception) in each of these genes has been shown to cause disease in a fully penetrant fashion.  It has recently been shown, both in vivo and in model systems, that tissues expressing these mutations have increased prodn. of amyloid (Aβ) ending at residue 42.  It has also recently been shown that this form of Aβ is deposited early and selectively in the disease process and is more fibrillogenic in vitro.  It is argued that these genetic and mol. biol. data provide strong support for the veracity of the 'amyloid cascade hypothesis' for disease pathogenesis, and that this hypothesis offers a coherent framework for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5cIu4TWX4f7Vg90H21EOLACvtfcHk0lg2fTgxPeixlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitVKnt7Y%253D&md5=e79e6df0cf82f21a9b7d7738193b3830</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0166-2236%2896%2901030-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-2236%252896%252901030-2%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DAmyloid%252C%2520the%2520presenilins%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Neurosci.%26date%3D1997%26volume%3D20%26spage%3D154%26epage%3D159%26doi%3D10.1016%2FS0166-2236%2896%2901030-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glenner, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. W.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">885</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(84)80190-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS0006-291X%2884%2980190-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=6375662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaL2cXitVOntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1984&pages=885-890&author=G.+G.+Glennerauthor=C.+W.+Wong&title=Alzheimer%E2%80%99s+disease%3A+initial+report+of+the+purification+and+characterization+of+a+novel+cerebrovascular+amyloid+protein&doi=10.1016%2FS0006-291X%2884%2980190-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  initial report of the purification and characterization of a novel cerebrovascular amyloid protein</span></div><div class="casAuthors">Glenner, George G.; Wong, Caine W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">885-90</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">A purified protein derived from the twisted β-pleated sheet fibrils in cerebrovascular amyloidosis assocd. with Alzheimer's disease was isolated by Sephadex G-100 column chromatog. with 5 M guanidine-HCl in 1 N acetic acid and by HPLC.  Partial amino acid sequence anal. and a computer search reveals this protein to have nohomol. with any protein sequenced thus far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqimb5yE9JMLrVg90H21EOLACvtfcHk0lg2fTgxPeixlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXitVOntLw%253D&md5=e30caf2b0d9c41ee223b53ffe7a690dd</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2884%2980190-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252884%252980190-4%26sid%3Dliteratum%253Aachs%26aulast%3DGlenner%26aufirst%3DG.%2BG.%26aulast%3DWong%26aufirst%3DC.%2BW.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520initial%2520report%2520of%2520the%2520purification%2520and%2520characterization%2520of%2520a%2520novel%2520cerebrovascular%2520amyloid%2520protein%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1984%26volume%3D120%26spage%3D885%26epage%3D890%26doi%3D10.1016%2FS0006-291X%2884%2980190-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reiman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1073/pnas.2635903100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1073%2Fpnas.2635903100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=14688411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvFamtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=284-289&author=E.+M.+Reimanauthor=K.+Chenauthor=G.+E.+Alexanderauthor=R.+J.+Caselliauthor=D.+Bandyauthor=D.+Osborneauthor=A.+M.+Saundersauthor=J.+Hardy&title=Functional+brain+abnormalities+in+young+adults+at+genetic+risk+for+late-onset+Alzheimer%E2%80%99s+dementia&doi=10.1073%2Fpnas.2635903100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia</span></div><div class="casAuthors">Reiman, Eric M.; Chen, Kewei; Alexander, Gene E.; Caselli, Richard J.; Bandy, Daniel; Osborne, David; Saunders, Ann M.; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">284-289</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fluorodeoxyglucose positron emission tomog. (PET) studies have found that patients with Alzheimer's dementia (AD) have abnormally low rates of cerebral glucose metab. in posterior cingulate, parietal, temporal, and prefrontal cortex.  We previously found that cognitively normal, late-middle-aged carriers of the apolipoprotein E ε4 allele, a common susceptibility gene for late-onset Alzheimer's dementia, have abnormally low rates of glucose metab. in the same brain regions as patients with probable AD.  We now consider whether ε4 carriers have these regional brain abnormalities as relatively young adults.  Apolipoprotein E genotypes were established in normal volunteers 20-39 yr of age.  Clin. ratings, neuro-psychol. tests, magnetic resonance imaging, and PET were performed in 12 ε4 heterozygotes, all with the ε3/ε4 genotype, and 15 non-carriers of the ε4 allele, 12 of whom were individually matched for sex, age, and educational level.  An automated algorithm was used to generate an aggregate surface-projection map that compared regional PET measurements in the two groups.  The young adult ε4 carriers and non-carriers did not differ significantly in their sex, age, educational level, clin. ratings, or neuro-psychol. test scores.  Like previously studied patients with probable AD and late-middle-aged ε4 carriers, the young ε4 carriers had abnormally low rates of glucose metab. bilaterally in the posterior cingulate, parietal, temporal, and prefrontal cortex.  Carriers of a common Alzheimer's susceptibility gene have functional brain abnormalities in young adulthood, several decades before the possible onset of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKUTJEVcwSX7Vg90H21EOLACvtfcHk0lg2fTgxPeixlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvFamtg%253D%253D&md5=7bf636ff7cc591b9757bf86cfb8099ff</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2635903100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2635903100%26sid%3Dliteratum%253Aachs%26aulast%3DReiman%26aufirst%3DE.%2BM.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DAlexander%26aufirst%3DG.%2BE.%26aulast%3DCaselli%26aufirst%3DR.%2BJ.%26aulast%3DBandy%26aufirst%3DD.%26aulast%3DOsborne%26aufirst%3DD.%26aulast%3DSaunders%26aufirst%3DA.%2BM.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DFunctional%2520brain%2520abnormalities%2520in%2520young%2520adults%2520at%2520genetic%2520risk%2520for%2520late-onset%2520Alzheimer%25E2%2580%2599s%2520dementia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D284%26epage%3D289%26doi%3D10.1073%2Fpnas.2635903100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span> <span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1038/nrd3505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1038%2Fnrd3505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=21852788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics&doi=10.1038%2Fnrd3505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics</span></div><div class="casAuthors">Karran, Eric; Mercken, Marc; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">698-712</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The amyloid cascade hypothesis, which posits that the deposition of the amyloid-β peptide in the brain is a central event in Alzheimer's disease pathol., has dominated research for the past twenty years.  Several therapeutics that were purported to reduce amyloid-β prodn. or aggregation have failed in Phase III clin. testing, and many others are in various stages of development.  Therefore, it is timely to review the science underpinning the amyloid cascade hypothesis, consider what type of clin. trials will constitute a valid test of this hypothesis and explore whether amyloid-β-directed therapeutics will provide the medicines that are urgently needed by society for treating this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-zjcfHaQ87Vg90H21EOLACvtfcHk0lj19y9CBsMEQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L&md5=cf2824a56a4c3df6e265d8788970729d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnrd3505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3505%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712%26doi%3D10.1038%2Fnrd3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manelli, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stine, W. B.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krafft, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaDu, M. J.</span></span> <span> </span><span class="NLM_article-title">Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">32046</span>– <span class="NLM_lpage">32053</span>, <span class="refDoi"> DOI: 10.1074/jbc.M201750200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1074%2Fjbc.M201750200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12058030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD38XmslOqu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=32046-32053&author=K.+N.+Dahlgrenauthor=A.+M.+Manelliauthor=W.+B.+Stineauthor=L.+K.+Bakerauthor=G.+A.+Krafftauthor=M.+J.+LaDu&title=Oligomeric+and+fibrillar+species+of+amyloid-%CE%B2+peptides+differentially+affect+neuronal+viability&doi=10.1074%2Fjbc.M201750200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability</span></div><div class="casAuthors">Dahlgren, Karie N.; Manelli, Arlene M.; Stine, W. Blaine, Jr.; Baker, Lorinda K.; Krafft, Grant A.; LaDu, Mary Jo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">32046-32053</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Genetic evidence predicts a causative role for amyloid-β (Aβ) in Alzheimer's disease.  Recent debate has focused on whether fibrils (amyloid) or sol. oligomers of Aβ are the active species that contribute to neurodegeneration and dementia.  We developed two aggregation protocols for the consistent prodn. of stable oligomeric or fibrillar prepns. of Aβ-(1-42).  Here we report that oligomers inhibit neuronal viability 10-fold more than fibrils and ∼40-fold more than unaggregated peptide, with oligomeric Aβ-(1-42)-induced inhibition significant at 10 nM.  Under Aβ-(1-42) oligomer- and fibril-forming conditions, Aβ-(1-40) remains predominantly as unassembled monomer and had significantly less effect on neuronal viability than prepns. of Aβ-(1-42).  We applied the aggregation protocols developed for wild type Aβ-(1-42) to Aβ-(1-42) with the Dutch (E22Q) or Arctic (E22G) mutations.  Oligomeric prepns. of the mutations exhibited extensive protofibril and fibril formation, resp., but were not consistently different from wild type Aβ-(1-42) in terms of inhibition of neuronal viability.  However, fibrillar prepns. of the mutants appeared larger and induced significantly more inhibition of neuronal viability than wild type Aβ-(1-42) fibril prepns.  These data demonstrate that protocols developed to produce oligomeric and fibrillar Aβ-(1-42) are useful in distinguishing the structural and functional differences between Aβ-(1-42) and Aβ-(1-40) and genetic mutations of Aβ-(1-42).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm0s9ysdX6drVg90H21EOLACvtfcHk0lj19y9CBsMEQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmslOqu7Y%253D&md5=1e31e90f856d7c6f881686839a383f37</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M201750200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M201750200%26sid%3Dliteratum%253Aachs%26aulast%3DDahlgren%26aufirst%3DK.%2BN.%26aulast%3DManelli%26aufirst%3DA.%2BM.%26aulast%3DStine%26aufirst%3DW.%2BB.%26aulast%3DBaker%26aufirst%3DL.%2BK.%26aulast%3DKrafft%26aufirst%3DG.%2BA.%26aulast%3DLaDu%26aufirst%3DM.%2BJ.%26atitle%3DOligomeric%2520and%2520fibrillar%2520species%2520of%2520amyloid-%25CE%25B2%2520peptides%2520differentially%2520affect%2520neuronal%2520viability%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D32046%26epage%3D32053%26doi%3D10.1074%2Fjbc.M201750200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Multhaup, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">A modified β-amyloid hypothesis: intraneuronal accumulation of the β-amyloid peptide – the first step of a fatal cascade</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">520</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2004.02737.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1111%2Fj.1471-4159.2004.02737.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15485483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsFelsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2004&pages=513-520&author=O.+Wirthsauthor=G.+Multhaupauthor=T.+A.+Bayer&title=A+modified+%CE%B2-amyloid+hypothesis%3A+intraneuronal+accumulation+of+the+%CE%B2-amyloid+peptide+%E2%80%93+the+first+step+of+a+fatal+cascade&doi=10.1111%2Fj.1471-4159.2004.02737.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A modified β-amyloid hypothesis: Intraneuronal accumulation of the β-amyloid peptide - the first step of a fatal cascade</span></div><div class="casAuthors">Wirths, Oliver; Multhaup, Gerd; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">513-520</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Accumulating evidence points to an important role of intraneuronal Aβ as a trigger of the pathol. cascade of events leading to neurodegeneration and eventually to Alzheimer's disease (AD) with its typical clin. symptoms, like memory impairment and change in personality.  In the present article, the authors review recent findings on intracellular monomeric and oligomeric β-amyloid (Aβ) generation and its pathol. function in cell culture, transgenic AD mouse models and post mortem brain tissue of AD and Down syndrome patients, as well as its interaction with oxidative stress and its relevance in apoptotic cell death.  Based on these results, a modified Aβ hypothesis is formulated, that integrates biochem., neuropathol. and genetic observations with AD-typical neuron loss and plaque formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpXHxnoi6kZbVg90H21EOLACvtfcHk0ljDRTK7RvvKtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsFelsLw%253D&md5=e3db96ce783f5601f419017611f353a7</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2004.02737.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2004.02737.x%26sid%3Dliteratum%253Aachs%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DMulthaup%26aufirst%3DG.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DA%2520modified%2520%25CE%25B2-amyloid%2520hypothesis%253A%2520intraneuronal%2520accumulation%2520of%2520the%2520%25CE%25B2-amyloid%2520peptide%2520%25E2%2580%2593%2520the%2520first%2520step%2520of%2520a%2520fatal%2520cascade%26jtitle%3DJ.%2520Neurochem.%26date%3D2004%26volume%3D91%26spage%3D513%26epage%3D520%26doi%3D10.1111%2Fj.1471-4159.2004.02737.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostinho, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C. R.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease-associated neurotoxic mechanisms and neuroprotective strategies</span>. <i>Curr. Drug Targets: CNS Neurol. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.2174/1568007054546117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F1568007054546117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=16101556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVyktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=383-403&author=C.+Pereiraauthor=P.+Agostinhoauthor=P.+I.+Moreiraauthor=S.+M.+Cardosoauthor=C.+R.+Oliveira&title=Alzheimer%E2%80%99s+disease-associated+neurotoxic+mechanisms+and+neuroprotective+strategies&doi=10.2174%2F1568007054546117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies</span></div><div class="casAuthors">Pereira, C.; Agostinho, P.; Moreira, P. I.; Cardoso, S. M.; Oliveira, C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-403</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The characteristic hallmarks of Alzheimer's disease (AD), the most common form of dementia in the elderly, include senile plaques, mainly composed of beta-amyloid (Aβ) peptide, neurofibrillary tangles and selective synaptic and neuronal loss in brain regions involved in learning and memory.  Genetic studies, together with the demonstration of Aβ neurotoxicity, led to the development of the amyloid cascade hypothesis to explain the AD-assocd. neurodegenerative process.  However, a modified version of this hypothesis has emerged, the Aβ cascade hypothesis, which takes into account the fact that sol. oligomeric forms and protofibrils of Aβ and its intraneuronal accumulation also play a key role in the pathogenesis of the disease.  Recent evidence posit that synaptic dysfunction triggered by non fibrillar Aβ species is an early event involved in memory decline in AD.  The current understanding of the mol. mechanisms responsible for impaired synaptic function and cognitive deficits is outlined in this review, focusing on oxidative stress and disturbed metal ion homeostasis, Ca2+ dysregulation, mitochondria and endoplasmic reticulum dysfunction, cholesterol dyshomeostasis and impaired neurotransmission.  The activation of apoptotic cell death as a mechanism of neuronal loss in AD, and the prominent role of neuroinflammation in this neurodegenerative disorder, are also reviewed herein.  Furthermore, we will focus on the more relevant therapeutical strategies currently used, namely those involving antioxidants, drugs for neurotransmission improvement, hormonal replacement, γ- and β- secretase inhibitors, Aβ clearance agents (Aβ immunization, disruption of Aβ fibrils, modulation of the cholesterol-mediated Aβ transport), non-steroidal anti-inflammatory drugs (NSAIDs), microtubules stabilizing drugs and kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd7Y_ekx0ttrVg90H21EOLACvtfcHk0ljDRTK7RvvKtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVyktL8%253D&md5=bf7c8fe2bfa5e81dd6d0975edfd745a9</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2174%2F1568007054546117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007054546117%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DC.%26aulast%3DAgostinho%26aufirst%3DP.%26aulast%3DMoreira%26aufirst%3DP.%2BI.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease-associated%2520neurotoxic%2520mechanisms%2520and%2520neuroprotective%2520strategies%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2005%26volume%3D4%26spage%3D383%26epage%3D403%26doi%3D10.2174%2F1568007054546117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Mohanna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D. M.</span></span> <span> </span><span class="NLM_article-title">Role of ERAB/<span class="smallcaps smallerCapital">l</span>-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Aβ-induced cytotoxicity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">2145</span>– <span class="NLM_lpage">2156</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.4.2145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1074%2Fjbc.274.4.2145" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=2145-2156&author=S.+D.+Yanauthor=Y.+Shiauthor=A.+Zhuauthor=J.+Fuauthor=H.+Zhuauthor=Y.+Zhuauthor=L.+Gibsonauthor=E.+Sternauthor=K.+Collisonauthor=F.+Al-Mohannaauthor=S.+Ogawaauthor=A.+Roherauthor=S.+G.+Clarkeauthor=D.+M.+Stern&title=Role+of+ERAB%2Fl-3-hydroxyacyl-coenzyme+A+dehydrogenase+type+II+activity+in+A%CE%B2-induced+cytotoxicity&doi=10.1074%2Fjbc.274.4.2145"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.4.2145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.4.2145%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DA.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DGibson%26aufirst%3DL.%26aulast%3DStern%26aufirst%3DE.%26aulast%3DCollison%26aufirst%3DK.%26aulast%3DAl-Mohanna%26aufirst%3DF.%26aulast%3DOgawa%26aufirst%3DS.%26aulast%3DRoher%26aufirst%3DA.%26aulast%3DClarke%26aufirst%3DS.%2BG.%26aulast%3DStern%26aufirst%3DD.%2BM.%26atitle%3DRole%2520of%2520ERAB%252Fl-3-hydroxyacyl-coenzyme%2520A%2520dehydrogenase%2520type%2520II%2520activity%2520in%2520A%25CE%25B2-induced%2520cytotoxicity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D2145%26epage%3D2156%26doi%3D10.1074%2Fjbc.274.4.2145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu-Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendiaz, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teplow, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amarante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeloff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edenson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lile, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biere, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span> <span> </span><span class="NLM_article-title">β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=%CE%B2-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0lgpTkFKuq9D9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3D%25CE%25B2-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saftig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craessaerts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderstichele, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guhde, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annaert, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Figura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Leuven, F.</span></span> <span> </span><span class="NLM_article-title">Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>391</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1038/34910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1038%2F34910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=9450754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK1cXot1GrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=1998&pages=387-390&author=B.+De%0AStrooperauthor=P.+Saftigauthor=K.+Craessaertsauthor=H.+Vandersticheleauthor=G.+Guhdeauthor=W.+Annaertauthor=K.+Von+Figuraauthor=F.+Van+Leuven&title=Deficiency+of+presenilin-1+inhibits+the+normal+cleavage+of+amyloid+precursor+protein&doi=10.1038%2F34910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein</span></div><div class="casAuthors">De Strooper, Bart; Saftig, Paul; Craessaerts, Katleen; Vanderstichele, Hugo; Guhde, Gundula; Annaert, Wim; Von Figura, Kurt; Van Leuven, Fred</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">391</span>
        (<span class="NLM_cas:issue">6665</span>),
    <span class="NLM_cas:pages">387-390</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Point mutations in the presenilin-1 gene (PS1) are a major cause of familial Alzheimer's disease.  They result in a selective increase in the prodn. of the amyloidogenic peptide amyloid-β (1-42) by proteolytic processing of the amyloid precursor protein (APP).  Here the authors investigate whether PS1 is also involved in normal APP processing in neuronal cultures derived from PS1-deficient mouse embryos.  Cleavage by α- and β-secretase of the extracellular domain of APP was not affected by the absence of PS1, whereas cleavage by γ-secretase of the transmembrane domain of APP was prevented, causing carboxyl-terminal fragments of APP to accumulate and a fivefold drop in the prodn. of amyloid peptide.  Pulse-chase expts. indicated that PS1 deficiency specifically decreased the turnover of the membrane-assocd. fragments of APP.  As in the regulation of cholesterol metab. by proteolysis of a membrane-bound transcription factor, PS1 appears to facilitate a proteolytic activity that cleaves the integral membrane domain of APP.  The results indicate that mutations in PS1 that manifest clin. cause a gain of function and that inhibition of PS1 activity is a potential target for anti-amyloidogenic therapy in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_3BuiX5XxmLVg90H21EOLACvtfcHk0lgpTkFKuq9D9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXot1GrtQ%253D%253D&md5=4327e88b436a201cd4c01938ae01e9f0</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2F34910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F34910%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DCraessaerts%26aufirst%3DK.%26aulast%3DVanderstichele%26aufirst%3DH.%26aulast%3DGuhde%26aufirst%3DG.%26aulast%3DAnnaert%26aufirst%3DW.%26aulast%3DVon%2BFigura%26aufirst%3DK.%26aulast%3DVan%2BLeuven%26aufirst%3DF.%26atitle%3DDeficiency%2520of%2520presenilin-1%2520inhibits%2520the%2520normal%2520cleavage%2520of%2520amyloid%2520precursor%2520protein%26jtitle%3DNature%26date%3D1998%26volume%3D391%26spage%3D387%26epage%3D390%26doi%3D10.1038%2F34910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, G.</span></span> <span> </span><span class="NLM_article-title">Toward a rational design to regulate β-amyloid fibrillation for Alzheimer’s disease treatment</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00477</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00477" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFyhsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=198-210&author=X.+Hanauthor=G.+He&title=Toward+a+rational+design+to+regulate+%CE%B2-amyloid+fibrillation+for+Alzheimer%E2%80%99s+disease+treatment&doi=10.1021%2Facschemneuro.7b00477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Toward a Rational Design to Regulate β-Amyloid Fibrillation for Alzheimer's Disease Treatment</span></div><div class="casAuthors">Han, Xu; He, Gefei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">198-210</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The last decades have witnessed a growing global burden of Alzheimer's disease (AD).  Evidence indicates that the onset and progression of AD is assocd. with β-amyloid (Aβ) peptide fibrillation.  As such, there is a strong passion with discovering potent Aβ fibrillation inhibitors that can be developed into anti-amyloidogenic agents for AD treatment.  Current challenges that have arisen with this development involve with Aβ oligomer toxicity suppression and Blood Brain Barrier penetration capability.  Considering most natural or biol. events, one would observe that there is usually a "seed" to direct natural materials to assemble in response to a certain stimulation.  Inspired by this, several materials or compds., including nanoparticle, peptide or peptide mimics, and org. mols., have been designed for the purpose of redirecting or impeding Aβ aggregation.  Achieving these tasks requires comprehensive understanding on initial Aβ assembly into insol. deposits, main concerns with fibrillation inhibition, and current major methodologies to disrupt the aggregation.  Herein, the objective of this review is to address these three areas, and enable the pathway for a promising therapeutic agent design for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlO7qg2ReQI7Vg90H21EOLACvtfcHk0lhegcsg4SysDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFyhsL%252FP&md5=f9331d8eed6fa7d057c78d9234ac2d6c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00477%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DG.%26atitle%3DToward%2520a%2520rational%2520design%2520to%2520regulate%2520%25CE%25B2-amyloid%2520fibrillation%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D198%26epage%3D210%26doi%3D10.1021%2Facschemneuro.7b00477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokce, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luthi-Carter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lashuel, H. A.</span></span> <span> </span><span class="NLM_article-title">The ratio of monomeric to aggregated forms of Aβ40 and Aβ42 Is an important determinant of amyloid-β aggregation, fibrillogenesis, and toxicity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">28176</span>– <span class="NLM_lpage">28189</span>, <span class="refDoi"> DOI: 10.1074/jbc.M803159200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1074%2Fjbc.M803159200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=28176-28189&author=A.+Janauthor=O.+Gokceauthor=R.+Luthi-Carterauthor=H.+A.+Lashuel&title=The+ratio+of+monomeric+to+aggregated+forms+of+A%CE%B240+and+A%CE%B242+Is+an+important+determinant+of+amyloid-%CE%B2+aggregation%2C+fibrillogenesis%2C+and+toxicity&doi=10.1074%2Fjbc.M803159200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M803159200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M803159200%26sid%3Dliteratum%253Aachs%26aulast%3DJan%26aufirst%3DA.%26aulast%3DGokce%26aufirst%3DO.%26aulast%3DLuthi-Carter%26aufirst%3DR.%26aulast%3DLashuel%26aufirst%3DH.%2BA.%26atitle%3DThe%2520ratio%2520of%2520monomeric%2520to%2520aggregated%2520forms%2520of%2520A%25CE%25B240%2520and%2520A%25CE%25B242%2520Is%2520an%2520important%2520determinant%2520of%2520amyloid-%25CE%25B2%2520aggregation%252C%2520fibrillogenesis%252C%2520and%2520toxicity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D28176%26epage%3D28189%26doi%3D10.1074%2Fjbc.M803159200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span> <span> </span><span class="NLM_article-title">Amyloid-β-induced mitochondrial dysfunction</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.3233/JAD-2007-12208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-2007-12208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17917162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtV2isrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=177-184&author=J.+X.+Chenauthor=S.+D.+Yan&title=Amyloid-%CE%B2-induced+mitochondrial+dysfunction&doi=10.3233%2FJAD-2007-12208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β-induced mitochondrial dysfunction</span></div><div class="casAuthors">Chen, John Xi; Yan, Shi Du</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-184</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  As an important mol. in the pathogenesis of Alzheimer's disease (AD), amyloid-β (Aβ) interferes with multiple aspects of mitochondrial function, including energy metab. failure, prodn. of reactive oxygen species (ROS) and permeability transition pore formation.  Recent studies have demonstrated that Aβ progressively accumulates within mitochondrial matrix, providing a direct link to mitochondrial toxicity.  Aβ-binding alc. dehydrogenase (ABAD) is localized to the mitochondrial matrix and binds to mitochondrial Aβ.  Interaction of ABAD with Aβ exaggerates Aβ-mediated mitochondrial and neuronal perturbation, leading to impaired synaptic function, and dysfunctional spatial learning/memory.  Thus, blockade of ABAD/Aβ interaction may be a potential therapeutic strategy for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD6drXohcejrVg90H21EOLACvtfcHk0lhegcsg4SysDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtV2isrnJ&md5=5e242b0989da66c0178c3cbc45877d04</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.3233%2FJAD-2007-12208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2007-12208%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BX.%26aulast%3DYan%26aufirst%3DS.%2BD.%26atitle%3DAmyloid-%25CE%25B2-induced%2520mitochondrial%2520dysfunction%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2007%26volume%3D12%26spage%3D177%26epage%3D184%26doi%3D10.3233%2FJAD-2007-12208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manczak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calkins, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirendeb, U.</span></span> <span> </span><span class="NLM_article-title">Amyloid-beta and mitochondria in aging and Alzheimer’s disease: implications for synaptic damage and cognitive decline</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.3233/JAD-2010-100504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-2010-100504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnt12gs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=499-512&author=P.+H.+Reddyauthor=M.+Manczakauthor=P.+Maoauthor=M.+J.+Calkinsauthor=A.+P.+Reddyauthor=U.+Shirendeb&title=Amyloid-beta+and+mitochondria+in+aging+and+Alzheimer%E2%80%99s+disease%3A+implications+for+synaptic+damage+and+cognitive+decline&doi=10.3233%2FJAD-2010-100504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β and Mitochondria in Aging and Alzheimer's Disease: Implications for Synaptic Damage and Cognitive Decline</span></div><div class="casAuthors">Zhu, Xiongwei; Beal, M. Flint; Wang, Xinglong; Perry, George; Smith, Mark A.; Reddy, P. Hemachandra; Manczak, Maria; Mao, Peizhong; Calkins, Marcus J.; Reddy, Arubala P.; Shirendeb, Ulziibat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">S499-S512</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  This article reviews the role of amyloid-β (Aβ) and mitochondria in synaptic damage and cognitive decline found in patients with Alzheimer's disease (AD).  Recent mol., cellular, animal model, and postmortem brain studies have revealed that Aβ and mitochondrial abnormalities are key factors that cause synaptic damage and cognitive decline in AD.  Aβ is reported to accumulate in subcellular compartments and to impair the normal function of neurons in AD patients.  Further, recent studies using biochem. methods and electron microscopy have revealed that the accumulation of Aβ at nerve terminals affect synaptic activities, including the release of neurotransmitters and synaptic vesicles.  Recent studies of the relationship between mitochondria and Aβ in AD patients suggest that in mitochondria, structural changes caused by Aβ result in increased mitochondrial fragmentation, decreased mitochondrial fusion, mitochondrial dysfunction, and synaptic damage.  This paper discusses the latest research on Aβ, mitochondria, age-dependent factors of AD in the brain, and synaptic damage in AD.  This paper also briefly discusses potential mitochondrial therapeutics in the treatment of patients with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_CuDhga_-PLVg90H21EOLACvtfcHk0lhegcsg4SysDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnt12gs7Y%253D&md5=e9c3b35d27164661ee6a242112d004b8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3233%2FJAD-2010-100504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2010-100504%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DP.%2BH.%26aulast%3DManczak%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DP.%26aulast%3DCalkins%26aufirst%3DM.%2BJ.%26aulast%3DReddy%26aufirst%3DA.%2BP.%26aulast%3DShirendeb%26aufirst%3DU.%26atitle%3DAmyloid-beta%2520and%2520mitochondria%2520in%2520aging%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520synaptic%2520damage%2520and%2520cognitive%2520decline%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2010%26volume%3D20%26spage%3D499%26epage%3D512%26doi%3D10.3233%2FJAD-2010-100504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casley, C.</span></span> <span> </span><span class="NLM_article-title">β-Amyloid fragment 25–35 causes mitochondrial dysfunction in primary cortical neurons</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">258</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1006/nbdi.2002.0516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1006%2Fnbdi.2002.0516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12270688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvFais7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=258-267&author=C.+Casley&title=%CE%B2-Amyloid+fragment+25%E2%80%9335+causes+mitochondrial+dysfunction+in+primary+cortical+neurons&doi=10.1006%2Fnbdi.2002.0516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid Fragment 25-35 Causes Mitochondrial Dysfunction in Primary Cortical Neurons</span></div><div class="casAuthors">Casley, C. S.; Land, J. M.; Sharpe, M. A.; Clark, J. B.; Duchen, M. R.; Canevari, L.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">258-267</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">β-Amyloid deposition and compromised energy metab. both occur in vulnerable brain regions in Alzheimer's disease.  It is not known whether β-amyloid is the cause of impairment of energy metab., nor whether impaired energy metab. is specific to neurons.  The authors' results, using primary neuronal cultures, show that 24-h incubation with Aβ25-35 caused a generalized decrease in the specific activity of mitochondrial enzymes per mg of cellular protein, induced mitochondrial swelling, and decreased total mitochondrial no.  Incubation with Aβ25-35 decreased ATP concn. to 58% of control in neurons and 71% of control in astrocytes.  Levels of reduced glutathione were also lowered by Aβ25-35 in both neurons (from 5.1 to 2.9 nmol/mg protein) and astrocytes (from 25.2 to 14.9 nmol/mg protein).  The authors conclude that 24-h treatment with extracellular Aβ25-35 causes mitochondrial dysfunction in both astrocytes and neurons, the latter being more seriously affected.  In astrocytes mitochondrial impairment was confined to complex I inhibition, whereas in neurons a generalized loss of mitochondria was seen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkuf21I9zDr7Vg90H21EOLACvtfcHk0liI-LcutEsWHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvFais7c%253D&md5=6d8941571c2441dd70de6554ccdc98c4</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1006%2Fnbdi.2002.0516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnbdi.2002.0516%26sid%3Dliteratum%253Aachs%26aulast%3DCasley%26aufirst%3DC.%26atitle%3D%25CE%25B2-Amyloid%2520fragment%252025%25E2%2580%259335%2520causes%2520mitochondrial%2520dysfunction%2520in%2520primary%2520cortical%2520neurons%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2002%26volume%3D10%26spage%3D258%26epage%3D267%26doi%3D10.1006%2Fnbdi.2002.0516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mosconi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorbi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacmias, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cristofaro, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fayyaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracco, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herholz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pupi, A.</span></span> <span> </span><span class="NLM_article-title">Age and ApoE genotype interaction in Alzheimer’s disease: an FDG-PET study</span>. <i>Psychiatry Res., Neuroimaging</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1016/j.pscychresns.2003.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.pscychresns.2003.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15033184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVGisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2004&pages=141-151&author=L.+Mosconiauthor=S.+Sorbiauthor=B.+Nacmiasauthor=M.+T.+De+Cristofaroauthor=M.+Fayyazauthor=L.+Braccoauthor=K.+Herholzauthor=A.+Pupi&title=Age+and+ApoE+genotype+interaction+in+Alzheimer%E2%80%99s+disease%3A+an+FDG-PET+study&doi=10.1016%2Fj.pscychresns.2003.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study</span></div><div class="casAuthors">Mosconi, Lisa; Sorbi, Sandro; Nacmias, Benedetta; de Cristofaro, Maria Teresa R.; Fayyaz, Mozhgan; Bracco, Laura; Herholz, Karl; Pupi, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Psychiatry Research, Neuroimaging</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-151</span>CODEN:
                <span class="NLM_cas:coden">PSREEK</span>;
        ISSN:<span class="NLM_cas:issn">0925-4927</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Previous positron emission tomog. (PET) studies with fluorodeoxyglucose (FDG) as tracer in healthy elders showed that the epsilon4 allele of the apolipoprotein E (ApoE) gene is disruptive to cerebral glucose metab. (rCMRglu), possibly through the interaction with the aging process.  The present study was aimed at assessing whether this interaction occurs in patients with Alzheimer's disease (AD).  Eight-six AD patients, including 40 ApoE4 carriers and 46 non-carriers, underwent 18F-FDG PET scanning at rest.  ApoE groups were comparable for age, gender, age at onset and disease duration.  SPM'99 was used to assess rCMRGlu correlations with age, differences between ApoE groups and ApoE by age interaction, correcting for disease severity.  Results were reported at P < 0.001, uncorrected.  Correlations between age and rCMRGlu confirmed the well-known neg. relationship for both groups.  Lower rCMRGlu was found within the frontal and cingulate areas for ApoE4 carriers as compared with the non-carriers.  Addnl., a significant ApoE by age interaction was detected in the frontal and anterior cingulate cortex, with the ApoE4 carriers having a steeper regression slope with respect to the non-carriers.  These results indicate that age-related regional rCMRglu decreases within the frontal and anterior cingulate areas may be more severe in AD patients carrying the ApoE4 allele.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Hqozg80eWLVg90H21EOLACvtfcHk0liI-LcutEsWHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVGisL8%253D&md5=47fda669ddfa15ae92f49b49a21ab453</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.pscychresns.2003.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pscychresns.2003.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DMosconi%26aufirst%3DL.%26aulast%3DSorbi%26aufirst%3DS.%26aulast%3DNacmias%26aufirst%3DB.%26aulast%3DDe%2BCristofaro%26aufirst%3DM.%2BT.%26aulast%3DFayyaz%26aufirst%3DM.%26aulast%3DBracco%26aufirst%3DL.%26aulast%3DHerholz%26aufirst%3DK.%26aulast%3DPupi%26aufirst%3DA.%26atitle%3DAge%2520and%2520ApoE%2520genotype%2520interaction%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520FDG-PET%2520study%26jtitle%3DPsychiatry%2520Res.%252C%2520Neuroimaging%26date%3D2004%26volume%3D130%26spage%3D141%26epage%3D151%26doi%3D10.1016%2Fj.pscychresns.2003.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mosconi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacmias, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorbi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cristofaro, M. T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fayazz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracco, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herholz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pupi, A.</span></span> <span> </span><span class="NLM_article-title">Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer’s disease</span>. <i>J. Neurol., Neurosurg. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.1136/jnnp.2003.014993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1136%2Fjnnp.2003.014993" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=14966149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD2c7isVSmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2004&pages=370-376&author=L.+Mosconiauthor=B.+Nacmiasauthor=S.+Sorbiauthor=M.+T.+R.+De+Cristofaroauthor=M.+Fayazzauthor=A.+Teddeauthor=L.+Braccoauthor=K.+Herholzauthor=A.+Pupi&title=Brain+metabolic+decreases+related+to+the+dose+of+the+ApoE+e4+allele+in+Alzheimer%E2%80%99s+disease&doi=10.1136%2Fjnnp.2003.014993"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease</span></div><div class="casAuthors">Mosconi L; Nacmias B; Sorbi S; De Cristofaro M T R; Fayazz M; Tedde A; Bracco L; Herholz K; Pupi A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">370-6</span>
        ISSN:<span class="NLM_cas:issn">0022-3050</span>.
    </div><div class="casAbstract">OBJECTIVES:  Declines in brain glucose metabolism have been described early in Alzheimer's disease (AD), and there is evidence that a genetic predisposition to AD contributes to accelerate this process.  The epsilon 4 (e4) allele of the apolipoprotein E (ApoE) gene has been implicated as a major risk factor in this process.  The aim of this FDG-PET study was to assess the ApoE e4 dose related effect on regional cerebral glucose metabolism (METglc) in clinical AD patients, with statistical voxel based methods.  METHODS:  Eighty six consecutive mild to moderate AD patients included in the Network for Efficiency and Standardisation of Dementia Diagnosis database underwent FDG-PET scans at rest.  PCR was used to determine the ApoE genotype.  Patients were grouped as e4 non-carriers (n = 46), e3/e4 (n = 27) and e4/e4 (n = 13) carriers.  A voxel-based mapping program was used to compare each AD subgroup with a database of 35 sex and age matched controls (p<0.001, corrected for cluster extent) and also to compare between the subgroups (p<0.001, uncorrected).  RESULTS:  No difference was found as to age at examination, age at onset, sex, disease duration, educational level, or severity of dementia between AD subgroups.  Compared with controls, all AD subgroups had equivalent METglc reductions in the precuneus, posterior cingulate, parietotemporal, and frontal regions.  Direct comparisons between AD subgroups indicated that patients with at least one e4 allele had METglc reductions within additional associative and limbic areas compared with e4 non-carriers.  CONCLUSIONS:  The present FDG-PET study showed different metabolic phenotypes related to the ApoE genotype in clinical AD patients, as revealed with voxel based statistical methods.  The results suggest a generalised disorder in e4 carriers impairing metabolism globally, in addition to the more localised changes typical of AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKuIltGlqwETMsgLhIoICsfW6udTcc2ebVanwnCGHrVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7isVSmtg%253D%253D&md5=089ae01afa58e9e10e299a82585fd078</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.2003.014993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.2003.014993%26sid%3Dliteratum%253Aachs%26aulast%3DMosconi%26aufirst%3DL.%26aulast%3DNacmias%26aufirst%3DB.%26aulast%3DSorbi%26aufirst%3DS.%26aulast%3DDe%2BCristofaro%26aufirst%3DM.%2BT.%2BR.%26aulast%3DFayazz%26aufirst%3DM.%26aulast%3DTedde%26aufirst%3DA.%26aulast%3DBracco%26aufirst%3DL.%26aulast%3DHerholz%26aufirst%3DK.%26aulast%3DPupi%26aufirst%3DA.%26atitle%3DBrain%2520metabolic%2520decreases%2520related%2520to%2520the%2520dose%2520of%2520the%2520ApoE%2520e4%2520allele%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2004%26volume%3D75%26spage%3D370%26epage%3D376%26doi%3D10.1136%2Fjnnp.2003.014993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bubber, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haroutunian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blass, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, G. E.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial abnormalities in Alzheimer brain: mechanistic implications</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">703</span>, <span class="refDoi"> DOI: 10.1002/ana.20474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1002%2Fana.20474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15852400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFykt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=695-703&author=P.+Bubberauthor=V.+Haroutunianauthor=G.+Fischauthor=J.+P.+Blassauthor=G.+E.+Gibson&title=Mitochondrial+abnormalities+in+Alzheimer+brain%3A+mechanistic+implications&doi=10.1002%2Fana.20474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial abnormalities in Alzheimer brain: mechanistic implications</span></div><div class="casAuthors">Bubber, Parvesh; Haroutunian, Vahram; Fisch, Gene; Blass, John P.; Gibson, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">695-703</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Redns. in cerebral metab. sufficient to impair cognition in normal individuals also occur in Alzheimer's disease (AD).  The degree of clin. disability in AD correlates closely to the magnitude of the redn. in brain metab.  Therefore, we tested whether impairments in tricarboxylic acid (TCA) cycle enzymes of mitochondria correlate with disability.  Brains were from patients with autopsy-confirmed AD and clin. dementia ratings (CDRs) before death.  Significant (p < 0.01) decreases occurred in the activities of the pyruvate dehydrogenase complex (-41%), isocitrate dehydrogenase (-27%), and the α-ketoglutarate dehydrogenase complex (-57%).  Activities of succinate dehydrogenase (complex II) (+44%) and malate dehydrogenase (+54%) were increased (p < 0.01).  Activities of the other four TCA cycle enzymes were unchanged.  All of the changes in TCA cycle activities correlated with the clin. state (p < 0.01), suggesting a coordinated mitochondrial alteration.  The highest correlation was with pyruvate dehydrogenase complex (r = 0.77, r2 = 0.59).  Measures to improve TCA cycle metab. might benefit AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLpCZoHPwibbVg90H21EOLACvtfcHk0lijUDBwa-chhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFykt70%253D&md5=64bd54a9e0e3a95f1466504235cce613</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fana.20474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20474%26sid%3Dliteratum%253Aachs%26aulast%3DBubber%26aufirst%3DP.%26aulast%3DHaroutunian%26aufirst%3DV.%26aulast%3DFisch%26aufirst%3DG.%26aulast%3DBlass%26aufirst%3DJ.%2BP.%26aulast%3DGibson%26aufirst%3DG.%2BE.%26atitle%3DMitochondrial%2520abnormalities%2520in%2520Alzheimer%2520brain%253A%2520mechanistic%2520implications%26jtitle%3DAnn.%2520Neurol.%26date%3D2005%26volume%3D57%26spage%3D695%26epage%3D703%26doi%3D10.1002%2Fana.20474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casley, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Land, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, M. A.</span></span> <span> </span><span class="NLM_article-title">β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1046/j.0022-3042.2001.00681.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1046%2Fj.0022-3042.2001.00681.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=11796747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1ajsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2002&pages=91-100&author=C.+S.+Casleyauthor=L.+Canevariauthor=J.+M.+Landauthor=J.+B.+Clarkauthor=M.+A.+Sharpe&title=%CE%B2-Amyloid+inhibits+integrated+mitochondrial+respiration+and+key+enzyme+activities&doi=10.1046%2Fj.0022-3042.2001.00681.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities</span></div><div class="casAuthors">Casley, C. S.; Canevari, L.; Land, J. M.; Clark, J. B.; Sharpe, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-100</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Disrupted energy metab., in particular reduced activity of cytochrome oxidase (EC 1.9.3.1), α-ketoglutarate dehydrogenase (EC 1.2.4.2) and pyruvate dehydrogenase (EC 1.2.4.1) have been reported in post-mortem Alzheimer's disease brain.  β-Amyloid is strongly implicated in Alzheimer's pathol. and can be formed intracellularly in neurons.  The authors have investigated the possibility that β-amyloid itself disrupts mitochondrial function.  Isolated rat brain mitochondria have been incubated with the β-amyloid alone or together with nitric oxide, which is known to be elevated in Alzheimer's brain.  Mitochondrial respiration, electron transport chain complex activities, α-ketoglutarate dehydrogenase activity and pyruvate dehydrogenase activity have been measured.  β-Amyloid caused a significant redn. in state 3 and state 4 mitochondrial respiration that was further diminished by the addn. of nitric oxide.  Cytochrome oxidase, α-ketoglutarate dehydrogenase and pyruvate dehydrogenase activities were inhibited by β-amyloid.  The Km of cytochrome oxidase for reduced cytochrome c was raised by β-amyloid.  The authors conclude that β-amyloid can directly disrupt mitochondrial function, inhibits key enzymes and may contribute to the deficiency of energy metab. seen in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoibWtfeyLcTbVg90H21EOLACvtfcHk0lijUDBwa-chhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1ajsQ%253D%253D&md5=f957475eedd775a66bef955818edf3a9</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1046%2Fj.0022-3042.2001.00681.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0022-3042.2001.00681.x%26sid%3Dliteratum%253Aachs%26aulast%3DCasley%26aufirst%3DC.%2BS.%26aulast%3DCanevari%26aufirst%3DL.%26aulast%3DLand%26aufirst%3DJ.%2BM.%26aulast%3DClark%26aufirst%3DJ.%2BB.%26aulast%3DSharpe%26aufirst%3DM.%2BA.%26atitle%3D%25CE%25B2-Amyloid%2520inhibits%2520integrated%2520mitochondrial%2520respiration%2520and%2520key%2520enzyme%2520activities%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D80%26spage%3D91%26epage%3D100%26doi%3D10.1046%2Fj.0022-3042.2001.00681.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreiro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resende de Oliveira, C.</span></span> <span> </span><span class="NLM_article-title">Cell degeneration induced by amyloid-β peptides</span>. <i>J. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1385/JMN:23:1-2:097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1385%2FJMN%3A23%3A1-2%3A097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15126695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks12jsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=97-104&author=C.+Pereiraauthor=E.+Ferreiroauthor=S.+M.+Cardosoauthor=C.+Resende+de+Oliveira&title=Cell+degeneration+induced+by+amyloid-%CE%B2+peptides&doi=10.1385%2FJMN%3A23%3A1-2%3A097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Cell degeneration induced by amyloid-β peptides. Implications for Alzheimer's disease</span></div><div class="casAuthors">Pereira, Claudia; Ferreiro, Elisabete; Cardoso, Sandra Morais; De Oliveira, Catarina Resende</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">97-104</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Extracellular accumulation of amyloid-β (Aβ) peptide and death of neurons in brain regions involved in learning and memory, particularly the cortex and the hippocampus, are central features of Alzheimer's disease (AD).  Neuronal Ca2+ overload and apoptosis are known to occur in AD.  Aβ might play a role in disrupting Ca2+ homeostasis, and this AD-assocd. amyloidogenic peptide has been reported to induce apoptotic death in cultured cells.  However, the specific intracellular signaling pathways by which Aβ triggers cell death are not yet well defined.  This article provides evidence for the involvement of mitochondrial dysfunction in Aβ-induced toxicity and for the role of mitochondria in apoptosis triggered by Aβ.  In addn., the endoplasmic reticulum (ER) seems to play a role in Aβ-induced apoptotic neuronal death, the ER stress being mediated by the perturbation of ER Ca2+ homeostasis.  It is likely that a better understanding of how Aβ induces neuronal apoptosis will lead to the identification of potential mol. targets for the development of therapies for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq_FVF_epParVg90H21EOLACvtfcHk0lijUDBwa-chhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks12jsbc%253D&md5=2d77e6efd27d7dac2166ecb0beae6e42</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1385%2FJMN%3A23%3A1-2%3A097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FJMN%253A23%253A1-2%253A097%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DC.%26aulast%3DFerreiro%26aufirst%3DE.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DResende%2Bde%2BOliveira%26aufirst%3DC.%26atitle%3DCell%2520degeneration%2520induced%2520by%2520amyloid-%25CE%25B2%2520peptides%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2004%26volume%3D23%26spage%3D97%26epage%3D104%26doi%3D10.1385%2FJMN%3A23%3A1-2%3A097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trillat, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. S.</span></span> <span> </span><span class="NLM_article-title">ABAD enhances Aβ-induced cell stress via mitochondrial dysfunction</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">598</span>, <span class="refDoi"> DOI: 10.1096/fj.04-2582fje</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1096%2Ffj.04-2582fje" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=597-598&author=K.+Takumaauthor=J.+Yaoauthor=J.+Huangauthor=H.+Xuauthor=X.+Chenauthor=J.+Luddyauthor=A.+C.+Trillatauthor=D.+M.+Sternauthor=O.+Arancioauthor=S.+S.+Yan&title=ABAD+enhances+A%CE%B2-induced+cell+stress+via+mitochondrial+dysfunction&doi=10.1096%2Ffj.04-2582fje"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1096%2Ffj.04-2582fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.04-2582fje%26sid%3Dliteratum%253Aachs%26aulast%3DTakuma%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLuddy%26aufirst%3DJ.%26aulast%3DTrillat%26aufirst%3DA.%2BC.%26aulast%3DStern%26aufirst%3DD.%2BM.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DYan%26aufirst%3DS.%2BS.%26atitle%3DABAD%2520enhances%2520A%25CE%25B2-induced%2520cell%2520stress%2520via%2520mitochondrial%2520dysfunction%26jtitle%3DFASEB%2520J.%26date%3D2005%26volume%3D19%26spage%3D597%26epage%3D598%26doi%3D10.1096%2Ffj.04-2582fje" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosunov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKhann, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molkentin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vonsattel, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer’s disease</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1097</span>– <span class="NLM_lpage">1105</span>, <span class="refDoi"> DOI: 10.1038/nm.1868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1038%2Fnm.1868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=18806802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1097-1105&author=H.+Duauthor=L.+Guoauthor=F.+Fangauthor=D.+Chenauthor=A.+A.+Sosunovauthor=G.+M.+McKhannauthor=Y.+Yanauthor=C.+Wangauthor=H.+Zhangauthor=J.+D.+Molkentinauthor=F.+J.+Gunn-Mooreauthor=J.+P.+Vonsattelauthor=O.+Arancioauthor=J.+X.+Chenauthor=S.+D.+Yan&title=Cyclophilin+D+deficiency+attenuates+mitochondrial+and+neuronal+perturbation+and+ameliorates+learning+and+memory+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnm.1868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease</span></div><div class="casAuthors">Du, Heng; Guo, Lan; Fang, Fang; Chen, Doris; Sosunov, Alexander A.; McKhann, Guy M.; Yan, Yilin; Wang, Chunyu; Zhang, Hong; Molkentin, Jeffery D.; Gunn-Moore, Frank J.; Vonsattel, Jean Paul; Arancio, Ottavio; Chen, John Xi; Yan, Shi Du</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1097-1105</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cyclophilin D (CypD, encoded by Ppif) is an integral part of the mitochondrial permeability transition pore, whose opening leads to cell death.  Here we show that interaction of CypD with mitochondrial amyloid-β protein (Aβ) potentiates mitochondrial, neuronal and synaptic stress.  The CypD-deficient cortical mitochondria are resistant to Aβ- and Ca2+-induced mitochondrial swelling and permeability transition.  Addnl., they have an increased calcium buffering capacity and generate fewer mitochondrial reactive oxygen species.  Furthermore, the absence of CypD protects neurons from Aβ- and oxidative stress-induced cell death.  Notably, CypD deficiency substantially improves learning and memory and synaptic function in an Alzheimer's disease mouse model and alleviates Aβ-mediated redn. of long-term potentiation.  Thus, the CypD-mediated mitochondrial permeability transition pore is directly linked to the cellular and synaptic perturbations obsd. in the pathogenesis of Alzheimer's disease.  Blockade of CypD may be a therapeutic strategy in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIHTwc-GU4IbVg90H21EOLACvtfcHk0lj9253c3K7EeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7vJ&md5=0105abbf8a32cc0638ddde7223df1966</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fnm.1868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1868%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DSosunov%26aufirst%3DA.%2BA.%26aulast%3DMcKhann%26aufirst%3DG.%2BM.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMolkentin%26aufirst%3DJ.%2BD.%26aulast%3DGunn-Moore%26aufirst%3DF.%2BJ.%26aulast%3DVonsattel%26aufirst%3DJ.%2BP.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DJ.%2BX.%26aulast%3DYan%26aufirst%3DS.%2BD.%26atitle%3DCyclophilin%2520D%2520deficiency%2520attenuates%2520mitochondrial%2520and%2520neuronal%2520perturbation%2520and%2520ameliorates%2520learning%2520and%2520memory%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D1097%26epage%3D1105%26doi%3D10.1038%2Fnm.1868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bobba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amadoro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lassandro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atlante, A.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial respiratory chain complexes I and IV are impaired by β-amyloid via direct interaction and through complex I-dependent ROS production, respectively</span>. <i>Mitochondrion</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">298</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1016/j.mito.2013.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.mito.2013.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=23562762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVGnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=298-311&author=A.+Bobbaauthor=G.+Amadoroauthor=D.+Valentiauthor=V.+Corsettiauthor=R.+Lassandroauthor=A.+Atlante&title=Mitochondrial+respiratory+chain+complexes+I+and+IV+are+impaired+by+%CE%B2-amyloid+via+direct+interaction+and+through+complex+I-dependent+ROS+production%2C+respectively&doi=10.1016%2Fj.mito.2013.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial respiratory chain Complexes I and IV are impaired by β-amyloid via direct interaction and through Complex I-dependent ROS production, respectively</span></div><div class="casAuthors">Bobba, A.; Amadoro, G.; Valenti, D.; Corsetti, V.; Lassandro, R.; Atlante, A.</div><div class="citationInfo"><span class="NLM_cas:title">Mitochondrion</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">298-311</span>CODEN:
                <span class="NLM_cas:coden">MITOCN</span>;
        ISSN:<span class="NLM_cas:issn">1567-7249</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here we investigate the effect of β-amyloid on mitochondrial respiratory function, i.e. mitochondrial oxygen consumption and membrane potential generation as well as the individual activities of both the mitochondrial Complexes I-IV, that compose mitochondrial electron transport chain, and the ATP synthase, by using homogenate from cerebellar granule cells, treated with low concns. of β-amyloid, and Alzheimer synaptic-enriched brain samples.  We found that β-amyloid caused both a selective defect in Complex I activity assocd. with an increase (5 fold) of intracellular reactive oxygen species and an impairment of Complex IV likely due to membrane lipid peroxidn.  In addn., a 130% increase of the GSSG/GSH ratio was measured in Alzheimer brains with respect to age-matched controls.  Knowing the mechanisms of action of β-amyloid could allow to mitigate or even to interrupt the toxic cascade that leads a cell to death.  The results of this study represent an important innovation because they offer the possibility to act at mitochondrial level and on specific sites to protect cells, for example by preventing the interaction of β-amyloid with the identified targets, by stabilizing or by restoring mitochondrial function or by interfering with the energy metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5gnysjBl9MLVg90H21EOLACvtfcHk0lj9253c3K7EeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVGnt74%253D&md5=da94e05feb9bb4a635a75c6eff140d26</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.mito.2013.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mito.2013.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DBobba%26aufirst%3DA.%26aulast%3DAmadoro%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DD.%26aulast%3DCorsetti%26aufirst%3DV.%26aulast%3DLassandro%26aufirst%3DR.%26aulast%3DAtlante%26aufirst%3DA.%26atitle%3DMitochondrial%2520respiratory%2520chain%2520complexes%2520I%2520and%2520IV%2520are%2520impaired%2520by%2520%25CE%25B2-amyloid%2520via%2520direct%2520interaction%2520and%2520through%2520complex%2520I-dependent%2520ROS%2520production%252C%2520respectively%26jtitle%3DMitochondrion%26date%3D2013%26volume%3D13%26spage%3D298%26epage%3D311%26doi%3D10.1016%2Fj.mito.2013.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oppermann, U. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjernberg, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terenius, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jornvall, H.</span></span> <span> </span><span class="NLM_article-title">Binding of amyloid β-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer’s disease</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>451</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(99)00586-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS0014-5793%2899%2900586-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=451&publication_year=1999&pages=238-242&author=U.+C.+Oppermannauthor=S.+Salimauthor=L.+O.+Tjernbergauthor=L.+Tereniusauthor=H.+Jornvall&title=Binding+of+amyloid+%CE%B2-peptide+to+mitochondrial+hydroxyacyl-CoA+dehydrogenase+%28ERAB%29%3A+regulation+of+an+SDR+enzyme+activity+with+implications+for+apoptosis+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0014-5793%2899%2900586-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2899%2900586-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252899%252900586-4%26sid%3Dliteratum%253Aachs%26aulast%3DOppermann%26aufirst%3DU.%2BC.%26aulast%3DSalim%26aufirst%3DS.%26aulast%3DTjernberg%26aufirst%3DL.%2BO.%26aulast%3DTerenius%26aufirst%3DL.%26aulast%3DJornvall%26aufirst%3DH.%26atitle%3DBinding%2520of%2520amyloid%2520%25CE%25B2-peptide%2520to%2520mitochondrial%2520hydroxyacyl-CoA%2520dehydrogenase%2520%2528ERAB%2529%253A%2520regulation%2520of%2520an%2520SDR%2520enzyme%2520activity%2520with%2520implications%2520for%2520apoptosis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFEBS%2520Lett.%26date%3D1999%26volume%3D451%26spage%3D238%26epage%3D242%26doi%3D10.1016%2FS0014-5793%2899%2900586-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hroch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musilek, K.</span></span> <span> </span><span class="NLM_article-title">A direct interaction between mitochondrial proteins and amyloid-β peptide and its significance for the progression and treatment of Alzheimer’s disease</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1056</span>– <span class="NLM_lpage">1085</span>, <span class="refDoi"> DOI: 10.2174/0929867322666150114163051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F0929867322666150114163051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=25620098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1ynsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=1056-1085&author=O.+Benekauthor=L.+Aitkenauthor=L.+Hrochauthor=K.+Kucaauthor=F.+Gunn-Mooreauthor=K.+Musilek&title=A+direct+interaction+between+mitochondrial+proteins+and+amyloid-%CE%B2+peptide+and+its+significance+for+the+progression+and+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F0929867322666150114163051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Benek, O.; Aitken, L.; Hroch, L.; Kuca, K.; Gunn-Moore, F.; Musilek, K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1056-1085</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The amyloid-β peptide (Aβ) has been assocd. with Alzheimer's disease (AD) for decades.  The original amyloid cascade hypothesis declared that the insol. extracellular plaques were responsible for Aβ toxicity.  Later, this hypothesis has been updated and sol. intracellular Aβ forms and their effects within the cell have come into focus.  Mitochondrial dysfunction plays an important role in the pathophysiol. of AD.  Aβ was detected inside mitochondria and several mitochondrial proteins were found to interact directly with Aβ.  Such interactions can affect a protein's function and cause damage to the mitochondria and finally to the whole cell.  This review summarizes the current knowledge of mitochondrial proteins directly interacting with A and discusses their significance for the development of therapeutics in the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwmL6_sO-FArVg90H21EOLACvtfcHk0lgWwCIUJd0JWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1ynsrc%253D&md5=889326c4c39e7e84adf9ad2117f37f6d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150114163051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150114163051%26sid%3Dliteratum%253Aachs%26aulast%3DBenek%26aufirst%3DO.%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DHroch%26aufirst%3DL.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DMusilek%26aufirst%3DK.%26atitle%3DA%2520direct%2520interaction%2520between%2520mitochondrial%2520proteins%2520and%2520amyloid-%25CE%25B2%2520peptide%2520and%2520its%2520significance%2520for%2520the%2520progression%2520and%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D1056%26epage%3D1085%26doi%3D10.2174%2F0929867322666150114163051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muirhead, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F. J.</span></span> <span> </span><span class="NLM_article-title">The consequences of mitochondrial amyloid β-peptide in Alzheimer’s disease</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>426</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1042/BJ20091941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1042%2FBJ20091941" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=20175748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlKiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2010&pages=255-270&author=K.+E.+Muirheadauthor=E.+Borgerauthor=L.+Aitkenauthor=S.+J.+Conwayauthor=F.+J.+Gunn-Moore&title=The+consequences+of+mitochondrial+amyloid+%CE%B2-peptide+in+Alzheimer%E2%80%99s+disease&doi=10.1042%2FBJ20091941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The consequences of mitochondrial amyloid β-peptide in Alzheimer's disease</span></div><div class="casAuthors">Muirhead, Kirsty E. A.; Borger, Eva; Aitken, Laura; Conway, Stuart J.; Gunn-Moore, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-270</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The Aβ (amyloid-β peptide) has long been assocd. with Alzheimer's disease, originally in the form of extracellular plaques.  However, in the present paper we review the growing evidence for the role of sol. intracellular Aβ in the disease progression, with particular ref. to Aβ found within the mitochondria.  Once inside the cell, Aβ is able to interact with a no. of targets, including the mitochondrial proteins ABAD (amyloid-binding alc. dehydrogenase) and CypD (cyclophilin D), which is a component of the mitochondrial permeability transition pore.  Interference with the normal functions of these proteins results in disruption of cell homeostasis and ultimately cell death.  The present review explores the possible mechanisms by which cell death occurs, considering the evidence presented on a mol., cellular and in vivo level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8b1oOK_xbzLVg90H21EOLACvtfcHk0lgWwCIUJd0JWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlKiu74%253D&md5=680a8762fe166e0602221e75e64f5aac</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1042%2FBJ20091941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20091941%26sid%3Dliteratum%253Aachs%26aulast%3DMuirhead%26aufirst%3DK.%2BE.%26aulast%3DBorger%26aufirst%3DE.%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DGunn-Moore%26aufirst%3DF.%2BJ.%26atitle%3DThe%2520consequences%2520of%2520mitochondrial%2520amyloid%2520%25CE%25B2-peptide%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D426%26spage%3D255%26epage%3D270%26doi%3D10.1042%2FBJ20091941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Mohanna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tohyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roherk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D.</span></span> <span> </span><span class="NLM_article-title">An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer’s disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>389</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1038/39522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1038%2F39522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=9338779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVSjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=1997&pages=689-695&author=S.+D.+Yanauthor=J.+Fuauthor=C.+Sotoauthor=X.+Chenauthor=H.+Zhuauthor=F.+Al-Mohannaauthor=K.+Collisonauthor=A.+Zhuauthor=E.+Sternauthor=T.+Saidoauthor=M.+Tohyamaauthor=S.+Ogawaauthor=A.+Roherkauthor=D.+Stern&title=An+intracellular+protein+that+binds+amyloid-%CE%B2+peptide+and+mediates+neurotoxicity+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2F39522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease</span></div><div class="casAuthors">Yan, Shi Du; Fu, Jin; Soto, Claudio; Chen, Xi; Zhu, Huaijie; Al-Mohanna, Futwan; Collison, Kate; Zhu, Aiping; Stern, Eric; Saido, Takaomi; Tohyama, Masaya; Ogawa, Satoshi; Roher, Alex; Stern, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">6652</span>),
    <span class="NLM_cas:pages">689-695</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Amyloid-β is a neurotoxic peptide which is implicated in the pathogenesis of Alzheimer's disease.  It binds an intracellular polypeptide known as ERAB, thought to be a hydroxysteroid dehydrogenase enzyme, which is expressed in normal tissues, but is overexpressed in neurons affected in Alzheimer's disease.  ERAB immunoppts. with amyloid-β, and when cell cultures are exposed to amyloid-β, ERAB inside the cell is rapidly redistributed to the plasma membrane.  The toxic effect of amyloid-β on these cells is prevented by blocking ERAB and is enhanced by overexpression of ERAB.  By interacting with intracellular amyloid-β, ERAB may therefore contribute to the neuronal dysfunction assocd. with Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4z15QNwg_QbVg90H21EOLACvtfcHk0lgWwCIUJd0JWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVSjtLc%253D&md5=b47b453a269f371e976486ee8c68cf6a</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2F39522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F39522%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DAl-Mohanna%26aufirst%3DF.%26aulast%3DCollison%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DA.%26aulast%3DStern%26aufirst%3DE.%26aulast%3DSaido%26aufirst%3DT.%26aulast%3DTohyama%26aufirst%3DM.%26aulast%3DOgawa%26aufirst%3DS.%26aulast%3DRoherk%26aufirst%3DA.%26aulast%3DStern%26aufirst%3DD.%26atitle%3DAn%2520intracellular%2520protein%2520that%2520binds%2520amyloid-%25CE%25B2%2520peptide%2520and%2520mediates%2520neurotoxicity%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D1997%26volume%3D389%26spage%3D689%26epage%3D695%26doi%3D10.1038%2F39522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Aβ: a potential cause of metabolic dysfunction in Alzheimer’s disease</span>. <i>IUBMB Life</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">686</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1080/15216540601047767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1080%2F15216540601047767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17424907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=686-694&author=X.+Chenauthor=S.+D.+Yan&title=Mitochondrial+A%CE%B2%3A+a+potential+cause+of+metabolic+dysfunction+in+Alzheimer%E2%80%99s+disease&doi=10.1080%2F15216540601047767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Aβ: a potential cause of metabolic dysfunction in Alzheimer's disease</span></div><div class="casAuthors">Chen, Xi; Yan, Shi Du</div><div class="citationInfo"><span class="NLM_cas:title">IUBMB Life</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">686-694</span>CODEN:
                <span class="NLM_cas:coden">IULIF8</span>;
        ISSN:<span class="NLM_cas:issn">1521-6543</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Deficits in mitochondrial function are a characteristic finding in Alzheimer's disease (AD), though the mechanism remains to be clarified.  Recent studies revealed that amyloid β peptide (Aβ) gains access into mitochondrial matrix, which was much more pronounced in both AD brain and transgenic mutant APP mice than in normal controls.  Aβ progressively accumulates in mitochondria and mediates mitochondrial toxicity.  Interaction of mitochondrial Aβ with mitochondrial enzymes such as amyloid β binding alc. dehydrogenase (ABAD) exaggerates mitochondrial stress by inhibiting the enzyme activity, releasing reactive oxygen species (ROS), and affecting glycolytic, Krebs cycle and/or the respiratory chain pathways through the accumulation of deleterious intermediate metabolites.  The pathways proposed may play a key role in the pathogenesis of this devastating neurodegenerative disorder, Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_CF2SM-eg7bVg90H21EOLACvtfcHk0lgTfS8hio176g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWjtbg%253D&md5=6d59ff700fa63d14c2e871a0f8e6cbcf</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1080%2F15216540601047767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15216540601047767%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DS.%2BD.%26atitle%3DMitochondrial%2520A%25CE%25B2%253A%2520a%2520potential%2520cause%2520of%2520metabolic%2520dysfunction%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DIUBMB%2520Life%26date%3D2006%26volume%3D58%26spage%3D686%26epage%3D694%26doi%3D10.1080%2F15216540601047767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lustbader, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirilli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspersen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinchese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lue, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zewier, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">H, W.</span></span> <span> </span><span class="NLM_article-title">ABAD directly links Aβ to mitochondrial toxicity in Alzheimer’s disease</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>304</i></span>,  <span class="NLM_fpage">448</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1126/science.1091230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1126%2Fscience.1091230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15087549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVWksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=448-452&author=J.+W.+Lustbaderauthor=M.+Cirilliauthor=C.+Linauthor=H.+W.+Xuauthor=K.+Takumaauthor=N.+Wangauthor=C.+Caspersenauthor=X.+Chenauthor=S.+Pollakauthor=M.+Chaneyauthor=F.+Trincheseauthor=S.+Liuauthor=F.+J.+Gunn-Mooreauthor=L.+F.+Lueauthor=D.+G.+Walkerauthor=P.+Kuppusamyauthor=Z.+L.+Zewierauthor=O.+Arancioauthor=D.+Sternauthor=S.+S.+Yanauthor=W.+H&title=ABAD+directly+links+A%CE%B2+to+mitochondrial+toxicity+in+Alzheimer%E2%80%99s+disease&doi=10.1126%2Fscience.1091230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">ABAD Directly Links Aβ to Mitochondrial Toxicity in Alzheimer's Disease</span></div><div class="casAuthors">Lustbader, Joyce W.; Cirilli, Maurizio; Lin, Chang; Xu, Hong Wei; Takuma, Kazuhiro; Wang, Ning; Caspersen, Casper; Chen, Xi; Pollak, Susan; Chaney, Michael; Trinchese, Fabrizio; Liu, Shumin; Gunn-Moore, Frank; Lue, Lih-Fen; Walker, Douglas G.; Kuppusamy, Periannan; Zewier, Zay L.; Arancio, Ottavio; Stern, David; Yan, Shirley ShiDu; Wu, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">5669</span>),
    <span class="NLM_cas:pages">448-452</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mitochondrial dysfunction is a hallmark of β-amyloid (Aβ)-induced neuronal toxicity in Alzheimer's disease (AD).  Here, the authors demonstrate that Aβ-binding alc. dehydrogenase (ABAD) is a direct mol. link from Aβ to mitochondrial toxicity.  Aβ interacts with ABAD in the mitochondria of AD patients and transgenic mice.  The crystal structure of Aβ-bound ABAD shows substantial deformation of the active site that prevents NAD binding.  An ABAD peptide specifically inhibits ABAD-Aβ interaction and suppresses Aβ-induced apoptosis and free-radical generation in neurons.  Transgenic mice overexpressing ABAD in an Aβ-rich environment manifest exaggerated neuronal oxidative stress and impaired memory.  These data suggest that the ABAD-Aβ interaction may be a therapeutic target in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-Mj3nwaRF1bVg90H21EOLACvtfcHk0lgTfS8hio176g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVWksrg%253D&md5=45b6e63c36e6b9ffac3492319c7035e0</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1126%2Fscience.1091230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1091230%26sid%3Dliteratum%253Aachs%26aulast%3DLustbader%26aufirst%3DJ.%2BW.%26aulast%3DCirilli%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DH.%2BW.%26aulast%3DTakuma%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCaspersen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DPollak%26aufirst%3DS.%26aulast%3DChaney%26aufirst%3DM.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DGunn-Moore%26aufirst%3DF.%2BJ.%26aulast%3DLue%26aufirst%3DL.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BG.%26aulast%3DKuppusamy%26aufirst%3DP.%26aulast%3DZewier%26aufirst%3DZ.%2BL.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DStern%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DS.%2BS.%26aulast%3DH%26aufirst%3DW.%26atitle%3DABAD%2520directly%2520links%2520A%25CE%25B2%2520to%2520mitochondrial%2520toxicity%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D448%26epage%3D452%26doi%3D10.1126%2Fscience.1091230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinton, R. D.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial bioenergetic deficit precedes Alzheimer’s pathology in female mouse model of Alzheimer’s disease</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">14670</span>– <span class="NLM_lpage">14675</span>, <span class="refDoi"> DOI: 10.1073/pnas.0903563106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1073%2Fpnas.0903563106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=19667196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWrt7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=14670-14675&author=J.+Yaoauthor=R.+W.+Irwinauthor=L.+Zhaoauthor=J.+Nilsenauthor=R.+T.+Hamiltonauthor=R.+D.+Brinton&title=Mitochondrial+bioenergetic+deficit+precedes+Alzheimer%E2%80%99s+pathology+in+female+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1073%2Fpnas.0903563106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease</span></div><div class="casAuthors">Yao, Jia; Irwin, Ronald W.; Zhao, Liqin; Nilsen, Jon; Hamilton, Ryan T.; Brinton, Roberta Diaz</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">14670-14675, S14670/1-S14670/3</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mitochondrial dysfunction has been proposed to play a pivotal role in neurodegenerative diseases, including Alzheimer's disease (AD).  To address whether mitochondrial dysfunction precedes the development of AD pathol., we conducted mitochondrial functional analyses in female triple transgenic Alzheimer's mice (3xTg-AD) and age-matched nontransgenic (nonTg).  Mitochondrial dysfunction in the 3xTg-AD brain was evidenced by decreased mitochondrial respiration and decreased pyruvate dehydrogenase (PDH) protein level and activity as early as 3 mo of age.  3XTg-AD mice also exhibited increased oxidative stress as manifested by increased hydrogen peroxide prodn. and lipid peroxidn.  Mitochondrial amyloid beta (Aβ) level in the 3xTg-AD mice was significantly increased at 9 mo and temporally correlated with increased level of Aβ binding to alc. dehydrogenase (ABAD).  Embryonic neurons derived from 3xTg-AD mouse hippocampus exhibited significantly decreased mitochondrial respiration and increased glycolysis.  Results of these analyses indicate that compromised mitochondrial function is evident in embryonic hippocampal neurons, continues unabated in females throughout the reproductive period, and is exacerbated during reproductive senescence.  In nontransgenic control mice, oxidative stress was coincident with reproductive senescence and accompanied by a significant decline in mitochondrial function.  Reproductive senescence in the 3xTg-AD mouse brain markedly exacerbated mitochondrial dysfunction.  Collectively, the data indicate significant mitochondrial dysfunction occurs early in AD pathogenesis in a female AD mouse model.  Mitochondrial dysfunction provides a plausible mechanistic rationale for the hypometabolism in brain that precedes AD diagnosis and suggests therapeutic targets for prevention of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvpVG7kli_pbVg90H21EOLACvtfcHk0lgTfS8hio176g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWrt7%252FM&md5=afa5516e1b8215b5ffdd072217336cac</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0903563106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0903563106%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DIrwin%26aufirst%3DR.%2BW.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DNilsen%26aufirst%3DJ.%26aulast%3DHamilton%26aufirst%3DR.%2BT.%26aulast%3DBrinton%26aufirst%3DR.%2BD.%26atitle%3DMitochondrial%2520bioenergetic%2520deficit%2520precedes%2520Alzheimer%25E2%2580%2599s%2520pathology%2520in%2520female%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D14670%26epage%3D14675%26doi%3D10.1073%2Fpnas.0903563106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Abundant type 10 17β-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer’s disease model</span>. <i>Mol. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1016/S0169-328X(02)00102-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS0169-328X%2802%2900102-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=11869808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsFalurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=46-53&author=X.+Y.+Heauthor=G.+Y.+Wenauthor=G.+Merzauthor=D.+Linauthor=Y.+Z.+Yangauthor=P.+Mehtaauthor=H.+Schulzauthor=S.+Y.+Yang&title=Abundant+type+10+17%CE%B2-hydroxysteroid+dehydrogenase+in+the+hippocampus+of+mouse+Alzheimer%E2%80%99s+disease+model&doi=10.1016%2FS0169-328X%2802%2900102-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Abundant type 10 17β-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model</span></div><div class="casAuthors">He, Xue-Ying; Wen, Guang-Yeong; Merz, George; Lin, Dawei; Yang, Ying-Zi; Mehta, Penkaj; Schulz, Horst; Yang, Song-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-53</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A full-length cDNA of mouse type 10 17β-hydroxysteroid dehydrogenase (17β-HSD10) was cloned from brain, representing the accurate nucleotide sequence information that rendered possible an accurate deduction of the amino acid sequence of the wild-type enzyme.  A comparison of sequences and three-dimensional models of this enzyme revealed that structures previously reported by other groups carry either a truncated or mutated amino-terminal sequence.  Fusion of the first 11 residues of the wild-type enzyme to the green fluorescent protein directed the reporter protein into mitochondria.  Thus, the N-terminus was identified as a mitochondrial targeting signal that accounts for the intracellular localization of the mouse enzyme.  This enzyme is normally assocd. with mitochondria, not with the endoplasmic reticulum as suggested by its trivial name 'endoplasmic reticulum-assocd. amyloid-β binding protein (ERAB)'.  After its C-terminal region was used to raise rabbit anti-17βHSD10 antibodies, immunogold electron microscopy showed that an abundance of this enzyme could be found in hippocampal synaptic mitochondria of βAPP transgenic mice, but not in normal controls.  High levels of this enzyme may disrupt steroid hormone homeostasis in synapses and contribute to synapse loss in the hippocampus of the mouse Alzheimer's disease model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA1NiJzDDAbLVg90H21EOLACvtfcHk0lg07Lu0zMY5pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsFalurs%253D&md5=62c6bdfcfd70ce58744d4e7b9fca9c64</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2FS0169-328X%2802%2900102-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-328X%252802%252900102-X%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%2BY.%26aulast%3DWen%26aufirst%3DG.%2BY.%26aulast%3DMerz%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DY.%2BZ.%26aulast%3DMehta%26aufirst%3DP.%26aulast%3DSchulz%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DAbundant%2520type%252010%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520in%2520the%2520hippocampus%2520of%2520mouse%2520Alzheimer%25E2%2580%2599s%2520disease%2520model%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D2002%26volume%3D99%26spage%3D46%26epage%3D53%26doi%3D10.1016%2FS0169-328X%2802%2900102-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span> <span> </span><span class="NLM_article-title">3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">4874</span>– <span class="NLM_lpage">4883</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2005.04911.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1111%2Fj.1742-4658.2005.04911.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=2005&pages=4874-4883&author=S.+Y.+Yangauthor=X.+Y.+Heauthor=H.+Schulz&title=3-Hydroxyacyl-CoA+dehydrogenase+and+short+chain+3-hydroxyacyl-CoA+dehydrogenase+in+human+health+and+disease&doi=10.1111%2Fj.1742-4658.2005.04911.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2005.04911.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2005.04911.x%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DHe%26aufirst%3DX.%2BY.%26aulast%3DSchulz%26aufirst%3DH.%26atitle%3D3-Hydroxyacyl-CoA%2520dehydrogenase%2520and%2520short%2520chain%25203-hydroxyacyl-CoA%2520dehydrogenase%2520in%2520human%2520health%2520and%2520disease%26jtitle%3DFEBS%2520J.%26date%3D2005%26volume%3D272%26spage%3D4874%26epage%3D4883%26doi%3D10.1111%2Fj.1742-4658.2005.04911.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Powell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfield, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lustbader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, R. L.</span></span> <span> </span><span class="NLM_article-title">Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-β binding alcohol dehydrogenase (ABAD)</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1006/jmbi.2000.4139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1006%2Fjmbi.2000.4139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=11023795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFWqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2000&pages=311-327&author=A.+J.+Powellauthor=J.+A.+Readauthor=M.+J.+Banfieldauthor=F.+Gunn-Mooreauthor=S.+D.+Yanauthor=J.+Lustbaderauthor=A.+R.+Sternauthor=D.+M.+Sternauthor=R.+L.+Brady&title=Recognition+of+structurally+diverse+substrates+by+type+II+3-hydroxyacyl-CoA+dehydrogenase+%28HADH+II%29%2Famyloid-%CE%B2+binding+alcohol+dehydrogenase+%28ABAD%29&doi=10.1006%2Fjmbi.2000.4139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Recognition of Structurally Diverse Substrates by Type II 3-Hydroxyacyl-CoA Dehydrogenase (HADH II)/Amyloid-β Binding Alcohol Dehydrogenase (ABAD)</span></div><div class="casAuthors">Powell, A. J.; Read, J. A.; Banfield, M. J.; Gunn-Moore, F.; Yan, S. D.; Lustbader, J.; Stern, A. R.; Stern, D. M.; Brady, R. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">311-327</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Human type II hydroxyacyl-CoA dehydrogenase/amyloid-β binding alc. dehydrogenase (HADH II/ABAD) is an oxidoreductase whose salient features include broad substrate specificity, encompassing 3-hydroxyacyl-CoA derivs., hydroxysteroids, alcs. and β-hydroxybutyrate, and the capacity to bind amyloid-β peptide, leading to propagation of amyloid-induced cell stress.  In this study, we examine the structure and enzymic activity of the homologous rat HADH II/ABAD enzyme.  We report the crystal structure of rat HADH II/ABAD as a binary complex with its NADH cofactor to 2.0 Å resoln., as a ternary complex with NAD+ and 3-ketobutyrate (acetoacetate) to 1.4 Å resoln., and as a ternary complex with NADH and 17β-estradiol to 1.7 Å resoln.  This first crystal structure of an HADH II confirms these enzymes are closely related to the short-chain hydroxysteroid dehydrogenases and differ substantially from the classic, type I 3-hydroxyacyl-CoA dehydrogenases.  Binding of the ketobutyrate substrate is accompanied by closure of the active site specificity loop, whereas the steroid substrate does not appear to require closure for binding.  Despite the different chem. nature of the two bound substrates, the presentation of chem. groups within the active site of each complex is remarkably similar, allowing a general mechanism for catalytic activity to be proposed.  There is a characteristic extension to the active site that is likely to accommodate the CoA moiety of 3-hydroxyacyl-CoA substrates.  Rat HADH II/ABAD also binds amyloid-β (1-40) peptide with a KD of 21 nM, which is similar to the interaction exhibited between this peptide and human HADH II/ABAD.  These studies provide the first structural insights into HADH II/ABAD interaction with its substrates, and indicate the relevance of the rodent enzyme and assocd. rodent models for anal. of HADH II/ABAD's physiol. and pathophysiol. properties.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7JHZthaDeDbVg90H21EOLACvtfcHk0lg07Lu0zMY5pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFWqtLk%253D&md5=f9337b16dc06510b449dceb903973bd1</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.2000.4139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.2000.4139%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DA.%2BJ.%26aulast%3DRead%26aufirst%3DJ.%2BA.%26aulast%3DBanfield%26aufirst%3DM.%2BJ.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DLustbader%26aufirst%3DJ.%26aulast%3DStern%26aufirst%3DA.%2BR.%26aulast%3DStern%26aufirst%3DD.%2BM.%26aulast%3DBrady%26aufirst%3DR.%2BL.%26atitle%3DRecognition%2520of%2520structurally%2520diverse%2520substrates%2520by%2520type%2520II%25203-hydroxyacyl-CoA%2520dehydrogenase%2520%2528HADH%2520II%2529%252Famyloid-%25CE%25B2%2520binding%2520alcohol%2520dehydrogenase%2520%2528ABAD%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D303%26spage%3D311%26epage%3D327%26doi%3D10.1006%2Fjmbi.2000.4139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kissinger, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rejto, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abreo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agree, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margosiak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aust, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderpool, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempczyk-Russell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villafranca, J. E.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer’s disease therapeutics</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">943</span>– <span class="NLM_lpage">952</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2004.07.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.jmb.2004.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15342248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlOgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2004&pages=943-952&author=C.+R.+Kissingerauthor=P.+A.+Rejtoauthor=L.+A.+Pelletierauthor=J.+A.+Thomsonauthor=R.+E.+Showalterauthor=M.+A.+Abreoauthor=C.+S.+Agreeauthor=S.+Margosiakauthor=J.+J.+Mengauthor=R.+M.+Austauthor=D.+Vanderpoolauthor=B.+Liauthor=A.+Tempczyk-Russellauthor=J.+E.+Villafranca&title=Crystal+structure+of+human+ABAD%2FHSD10+with+a+bound+inhibitor%3A+implications+for+design+of+Alzheimer%E2%80%99s+disease+therapeutics&doi=10.1016%2Fj.jmb.2004.07.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of Human ABAD/HSD10 with a Bound Inhibitor: Implications for Design of Alzheimer's Disease Therapeutics</span></div><div class="casAuthors">Kissinger, Charles R.; Rejto, Paul A.; Pelletier, Laura A.; Thomson, James A.; Showalter, Richard E.; Abreo, Melwyn A.; Agree, Charles S.; Margosiak, Stephen; Meng, Jerry J.; Aust, Robert M.; Vanderpool, Darin; Li, Bin; Tempczyk-Russell, Anna; Villafranca, J. Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">943-952</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The enzyme 17β-hydroxysteroid dehydrogenase type 10 (HSD10), also known as amyloid β-peptide-binding alc. dehydrogenase (ABAD), has been implicated in the development of Alzheimer's disease.  This protein, a member of the short-chain dehydrogenase/reductase family of enzymes, has been shown to bind β-amyloid and to participate in β-amyloid neurotoxicity.  We have detd. the crystal structure of human ABAD/HSD10 complexed with NAD+ and an inhibitory small mol.  The inhibitor occupies the substrate-binding site and forms a covalent adduct with the NAD+ cofactor.  The crystal structure provides a basis for the design of potent, highly specific ABAD/HSD10 inhibitors with potential application in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9CoeEHvGNpbVg90H21EOLACvtfcHk0ljYnHPeeAnfIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlOgsLw%253D&md5=42eda56430fb17232fa024879604d5bd</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2004.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2004.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DKissinger%26aufirst%3DC.%2BR.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DPelletier%26aufirst%3DL.%2BA.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DShowalter%26aufirst%3DR.%2BE.%26aulast%3DAbreo%26aufirst%3DM.%2BA.%26aulast%3DAgree%26aufirst%3DC.%2BS.%26aulast%3DMargosiak%26aufirst%3DS.%26aulast%3DMeng%26aufirst%3DJ.%2BJ.%26aulast%3DAust%26aufirst%3DR.%2BM.%26aulast%3DVanderpool%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DTempczyk-Russell%26aufirst%3DA.%26aulast%3DVillafranca%26aufirst%3DJ.%2BE.%26atitle%3DCrystal%2520structure%2520of%2520human%2520ABAD%252FHSD10%2520with%2520a%2520bound%2520inhibitor%253A%2520implications%2520for%2520design%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapeutics%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D342%26spage%3D943%26epage%3D952%26doi%3D10.1016%2Fj.jmb.2004.07.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ofman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiter, J. P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feenstra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poll-The, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zschocke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ensenauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehnert, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sass, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanders, R. J. A.</span></span> <span> </span><span class="NLM_article-title">2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene</span>. <i>Am. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1086/375116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1086%2F375116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12696021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslagu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2003&pages=1300-1307&author=R.+Ofmanauthor=J.+P.+N.+Ruiterauthor=M.+Feenstraauthor=M.+Duranauthor=B.+T.+Poll-Theauthor=J.+Zschockeauthor=R.+Ensenauerauthor=W.+Lehnertauthor=J.+O.+Sassauthor=W.+Sperlauthor=R.+J.+A.+Wanders&title=2-Methyl-3-hydroxybutyryl-CoA+dehydrogenase+deficiency+is+caused+by+mutations+in+the+HADH2+gene&doi=10.1086%2F375116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene</span></div><div class="casAuthors">Ofman, Rob; Ruiter, Jos P. N.; Feenstra, Marike; Duran, Marinus; Poll-The, Bwee Tien; Zschocke, Johannes; Ensenauer, Regina; Lehnert, Willy; Sass, Jorn Oliver; Sperl, Wolfgang; Wanders, Ronald J. A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1300-1307</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency is a novel inborn error of isoleucine degrdn.  In this article, we report the elucidation of the mol. basis of MHBD deficiency.  To this end, we purified the enzyme from bovine liver.  MALDI-TOF mass spectrometry anal. revealed that the purified protein was identical to bovine 3-hydroxyacyl-CoA dehydrogenase type II.  The human homolog of this bovine enzyme is a short-chain 3-hydroxyacyl-CoA dehydrogenase, also known as the "endoplasmic reticulum-assocd. amyloid-β binding protein" (ERAB).  This led to the identification of the X-chromosomal gene involved, which previously had been denoted "HADH2.".  Sequence anal. of the HADH2 gene from patients with MHBD deficiency revealed the presence of two missense mutations (R130C and L122V).  Heterologous expression of the mutant cDNAs in Escherichia coli showed that both mutations almost completely abolish enzyme activity.  This confirms that MHBD deficiency is caused by mutations in the HADH2 gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTeQLEzXyqJrVg90H21EOLACvtfcHk0ljJbA8rhxYGNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslagu7o%253D&md5=7fb6558c8a6db6c351cea92e5c3a91db</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1086%2F375116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F375116%26sid%3Dliteratum%253Aachs%26aulast%3DOfman%26aufirst%3DR.%26aulast%3DRuiter%26aufirst%3DJ.%2BP.%2BN.%26aulast%3DFeenstra%26aufirst%3DM.%26aulast%3DDuran%26aufirst%3DM.%26aulast%3DPoll-The%26aufirst%3DB.%2BT.%26aulast%3DZschocke%26aufirst%3DJ.%26aulast%3DEnsenauer%26aufirst%3DR.%26aulast%3DLehnert%26aufirst%3DW.%26aulast%3DSass%26aufirst%3DJ.%2BO.%26aulast%3DSperl%26aufirst%3DW.%26aulast%3DWanders%26aufirst%3DR.%2BJ.%2BA.%26atitle%3D2-Methyl-3-hydroxybutyryl-CoA%2520dehydrogenase%2520deficiency%2520is%2520caused%2520by%2520mutations%2520in%2520the%2520HADH2%2520gene%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2003%26volume%3D72%26spage%3D1300%26epage%3D1307%26doi%3D10.1086%2F375116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span> <span> </span><span class="NLM_article-title">Multiple functions of type 10 17β-hydroxysteroid dehydrogenase</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2005.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.tem.2005.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15860413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslKhu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=167-175&author=S.+Y.+Yangauthor=X.+Y.+Heauthor=H.+Schulz&title=Multiple+functions+of+type+10+17%CE%B2-hydroxysteroid+dehydrogenase&doi=10.1016%2Fj.tem.2005.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple functions of type 10 17β-hydroxysteroid dehydrogenase</span></div><div class="casAuthors">Yang, Song-Yu; He, Xue-Ying; Schulz, Horst</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">167-175</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Human 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10) is a mitochondrial enzyme encoded by the SCHAD gene, which escapes chromosome X inactivation.  17β-HSD10/SCHAD mutations cause a spectrum of clin. conditions, from mild mental retardation to progressive infantile neurodegeneration.  17β-HSD10/SCHAD is essential for the metab. of isoleucine and branched-chain fatty acids.  It can inactivate 17β-estradiol and steroid modulators of GABAA receptors, and convert 5α-androstanediol into 5α-dihydrotestosterone (DHT).  Certain malignant prostatic epithelial cells contain high levels of 17β-HSD10, generating 5α-DHT in the absence of testosterone.  17β-HSD10 has an affinity for amyloid-β peptide, and might be linked to the mitochondrial dysfunction seen in Alzheimer's disease.  This versatile enzyme might provide a new drug target for neuronal excitability control and for intervention in Alzheimer's disease and certain cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVGujFEvwPn7Vg90H21EOLACvtfcHk0ljJbA8rhxYGNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslKhu7Y%253D&md5=b081cbad136808fde8cdd1736377e656</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2005.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2005.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DHe%26aufirst%3DX.%2BY.%26aulast%3DSchulz%26aufirst%3DH.%26atitle%3DMultiple%2520functions%2520of%2520type%252010%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2005%26volume%3D16%26spage%3D167%26epage%3D175%26doi%3D10.1016%2Fj.tem.2005.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hroch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinklarova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisar, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musilek, K.</span></span> <span> </span><span class="NLM_article-title">1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">665</span>– <span class="NLM_lpage">670</span>, <span class="refDoi"> DOI: 10.1080/14756366.2018.1445736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1080%2F14756366.2018.1445736" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=29536773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks12mu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=665-670&author=O.+Benekauthor=L.+Hrochauthor=L.+Aitkenauthor=F.+Gunn-Mooreauthor=L.+Vinklarovaauthor=K.+Kucaauthor=D.+I.+Perezauthor=C.+Perezauthor=A.+Martinezauthor=Z.+Fisarauthor=K.+Musilek&title=1-%28Benzo%5Bd%5Dthiazol-2-yl%29-3-phenylureas+as+dual+inhibitors+of+casein+kinase+1+and+ABAD+enzymes+for+treatment+of+neurodegenerative+disorders&doi=10.1080%2F14756366.2018.1445736"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders</span></div><div class="casAuthors">Benek, Ondrej; Hroch, Lukas; Aitken, Laura; Gunn-Moore, Frank; Vinklarova, Lucie; Kuca, Kamil; Perez, Daniel I.; Perez, Concepcion; Martinez, Ana; Fisar, Zdenek; Musilek, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">665-670</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Several neurodegenerative disorders including Alzheimer's disease (AD) have been connected with deregulation of casein kinase 1 (CK1) activity.  Inhibition of CK1 therefore presents a potential therapeutic strategy against such pathologies.  Recently, novel class of CK1-specific inhibitors with N-(benzo[d]thiazol-2-yl)-2-phenylacetamide structural scaffold has been discovered. 1-(benzo[d]thiazol-2-yl)-3-phenylureas, on the other hand, are known inhibitors amyloid-beta binding alc. dehydrogenase (ABAD), an enzyme also involved in pathophysiol. of AD.  Based on their tight structural similarity, the authors decided to evaluate series of previously published benzothiazolylphenylureas, originally designed as ABAD inhibitors, for their inhibitory activity towards CK1.  Several compds. were found to be submicromolar CK1 inhibitors.  Moreover, two compds. were found to inhibit both, ABAD and CK1.  Such dual-activity could be of advantage for AD treatment, as it would simultaneously target two distinct pathol. processes involved in disease's progression.  Based on PAMPA testing both compds. were suggested to permeate the blood-brain barrier, which makes them, together with their unique dual activity, interesting lead compds. for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ZqR44ofgpLVg90H21EOLACvtfcHk0ljJbA8rhxYGNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks12mu7s%253D&md5=1230a25b26059d43bdbaad209f1d4495</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1080%2F14756366.2018.1445736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2018.1445736%26sid%3Dliteratum%253Aachs%26aulast%3DBenek%26aufirst%3DO.%26aulast%3DHroch%26aufirst%3DL.%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DVinklarova%26aufirst%3DL.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DFisar%26aufirst%3DZ.%26aulast%3DMusilek%26aufirst%3DK.%26atitle%3D1-%2528Benzo%255Bd%255Dthiazol-2-yl%2529-3-phenylureas%2520as%2520dual%2520inhibitors%2520of%2520casein%2520kinase%25201%2520and%2520ABAD%2520enzymes%2520for%2520treatment%2520of%2520neurodegenerative%2520disorders%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2018%26volume%3D33%26spage%3D665%26epage%3D670%26doi%3D10.1080%2F14756366.2018.1445736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balvers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paust, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, R.</span></span> <span> </span><span class="NLM_article-title">Differentiation-dependent expression of 17β-hydroxysteroid dehydrogenase, type 10, in the rodent testis: effect of aging in Leydig cells</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">3130</span>– <span class="NLM_lpage">3137</span>, <span class="refDoi"> DOI: 10.1210/en.2002-0082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1210%2Fen.2002-0082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12810569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvF2ktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2003&pages=3130-3137&author=R.+Ivellauthor=M.+Balversauthor=R.+J.+Anandauthor=H.+J.+Paustauthor=C.+McKinnellauthor=R.+Sharpe&title=Differentiation-dependent+expression+of+17%CE%B2-hydroxysteroid+dehydrogenase%2C+type+10%2C+in+the+rodent+testis%3A+effect+of+aging+in+Leydig+cells&doi=10.1210%2Fen.2002-0082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Differentiation-dependent expression of 17β-hydroxysteroid dehydrogenase, type 10, in the rodent testis: Effect of aging in Leydig cells</span></div><div class="casAuthors">Ivell, Richard; Balvers, Marga; Anand, Ravinder J. K.; Paust, Hans-Joachim; McKinnell, Chris; Sharpe, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3130-3137</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Expression of the new 17β-hydroxysteroid dehydrogenase (HSD), type 10 (17β-HSD-10), formerly known as endoplasmic reticulum-assocd. amyloid-binding protein, has been investigated in the testes of various mammals under normal and perturbed conditions.  Results show that 17β-HSD-10 is a major product of both fetal and adult-type Leydig cells.  In the former, protein persists until late in postnatal development; and in the short-day hamster model, it does not disappear when Leydig cells involute.  During puberty in the rat, immunohistochem. staining for 17β-HSD-10 in adult-type Leydig cells first becomes evident on d 20, increasing to maximal staining intensity by d 35.  In the rat, but not in the mouse or any other species examd., there is also staining in late spermatids.  Examn. of testes from rats subjected to perinatal treatment with either a GnRH antagonist or low and high doses of diethylstilbestrol revealed that expression of 17β-HSD-10 follows closely Leydig cell differentiation status, correlating with 3β-HSD expression in a previous study.  In aging (23 mo) rat testes, Leydig cell (but not germ cell) immunostaining for 17β-HSD-10 is markedly reduced.  17β-HSD-10 seems to preferentially convert 3α-androstanediol into dihydrotestosterone, and estradiol to estrone.  Thus, perinatal expression of this enzyme in fetal Leydig cells may contribute to protecting these cells from estrogens and encourage androgen formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnqAXJPlELArVg90H21EOLACvtfcHk0ljRkwhyNAplPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvF2ktLg%253D&md5=77c3974ad3f0a2208eeeeda3cb267dce</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1210%2Fen.2002-0082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2002-0082%26sid%3Dliteratum%253Aachs%26aulast%3DIvell%26aufirst%3DR.%26aulast%3DBalvers%26aufirst%3DM.%26aulast%3DAnand%26aufirst%3DR.%2BJ.%26aulast%3DPaust%26aufirst%3DH.%2BJ.%26aulast%3DMcKinnell%26aufirst%3DC.%26aulast%3DSharpe%26aufirst%3DR.%26atitle%3DDifferentiation-dependent%2520expression%2520of%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%252C%2520type%252010%252C%2520in%2520the%2520rodent%2520testis%253A%2520effect%2520of%2520aging%2520in%2520Leydig%2520cells%26jtitle%3DEndocrinology%26date%3D2003%26volume%3D144%26spage%3D3130%26epage%3D3137%26doi%3D10.1210%2Fen.2002-0082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peehl, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauderdale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Oxidative 3α-hydroxysteroid dehydrogenase activity of human type 10 17β-hydroxysteroid dehydrogenase</span>. <i>J. Steroid Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1016/j.jsbmb.2003.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.jsbmb.2003.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=14672739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD3srpt1WrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2003&pages=191-198&author=X.+Heauthor=Y.+Yangauthor=D.+M.+Peehlauthor=A.+Lauderdaleauthor=H.+Schulzauthor=S.+Y.+Yang&title=Oxidative+3%CE%B1-hydroxysteroid+dehydrogenase+activity+of+human+type+10+17%CE%B2-hydroxysteroid+dehydrogenase&doi=10.1016%2Fj.jsbmb.2003.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative 3alpha-hydroxysteroid dehydrogenase activity of human type 10 17beta-hydroxysteroid dehydrogenase</span></div><div class="casAuthors">He Xue-Ying; Yang Ying-Zi; Peehl Donna M; Lauderdale Alexander; Schulz Horst; Yang Song-Yu</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of steroid biochemistry and molecular biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">191-8</span>
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">In vitro enzyme assays have demonstrated that human type 10 17beta-hydroxysteroid dehydrogenase (17beta-HSD10) catalyzes the oxidation of 5alpha-androstane-3alpha,17beta-diol (adiol), an almost inactive androgen, to dihydrotestosterone (DHT) rather than androsterone or androstanedione.  To further investigate the role of this steroid-metabolizing enzyme in intact cells, we produced stable transfectants expressing 17beta-HSD10 or its catalytically inactive Y168F mutant in human embryonic kidney (HEK) 293 cells.  It was found that DHT levels in HEK 293 cells expressing 17beta-HSD10, but not its catalytically inactive mutant, will dramatically increase if adiol is added to culture media.  Moreover, certain malignant prostatic epithelial cells have more 17beta-HSD10 than normal controls, and can generate DHT, the most potent androgen, from adiol.  This event might promote prostate cancer growth.  Analysis of the 17beta-HSD10 sequence shows that this enzyme does not have any ER retention signal or transmembrane segments and has not originated by divergence from a retinol dehydrogenase.  The data suggest that the unique mitochondrial location of this HSD [Eur.  J.  Biochem. 268 (2001) 4899] does not prevent it from oxidizing the 3alpha-hydroxyl group of a C19 sterol in living cells.  The experimental results lead to the conclusion that mitochondrial 17beta-HSD10 plays a significant part in a non-classical androgen synthesis pathway along with microsomal retinol dehydrogenases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1nDP7lyirxxe4jJGKT5N0fW6udTcc2eYm000Lo2PqL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srpt1WrsQ%253D%253D&md5=012eacd22a911ae9bc7fce1141907772</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2003.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2003.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DPeehl%26aufirst%3DD.%2BM.%26aulast%3DLauderdale%26aufirst%3DA.%26aulast%3DSchulz%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DOxidative%25203%25CE%25B1-hydroxysteroid%2520dehydrogenase%2520activity%2520of%2520human%2520type%252010%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D87%26spage%3D191%26epage%3D198%26doi%3D10.1016%2Fj.jsbmb.2003.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Roles of mitochondrial 17β-hydroxysteroid dehydrogenase type 10 in Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">665</span>– <span class="NLM_lpage">673</span>, <span class="refDoi"> DOI: 10.3233/JAD-170974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-170974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=29480196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlWlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=665-673&author=X.+Y.+Heauthor=C.+Isaacsauthor=S.+Y.+Yang&title=Roles+of+mitochondrial+17%CE%B2-hydroxysteroid+dehydrogenase+type+10+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-170974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease</span></div><div class="casAuthors">He, Xue-Ying; Isaacs, Charles; Yang, Song-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">665-673</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">17β-Hydroxysteroid dehydrogenase type 10 is a multifunctional, homotetrameric, mitochondrial protein encoded by the HSD17B10 gene at Xp 11.2.  This protein, 17β-HSD10, is overexpressed in brain cells of Alzheimer's disease (AD) patients.  It was reported to be involved in AD pathogenesis as the endoplasmic reticulum-assocd. amyloid-β binding protein (ERAB) and as amyloid-β binding alc. dehydrogenase (ABAD).  However, the exaggerated catalytic efficiencies for ERAB/ABAD in these reports necessitated the re-characterization of the catalytic functions of this brain enzyme.  In addn. to isoleucine metab., 17β-HSD10 is also responsible for the mitochondrial metab. of neurosteroids such as 5α-androstane-3α,17β-diol and 17β-estradiol.  These neurosteroids are inactivated by the oxidn. catalyzed by 17β-HSD10.  Since neurosteroid homeostasis is presumably essential for cognitive function, anal. of the impact of 17β-HSD10 and its inhibitor, amyloid-β peptide (Aβ), on the metab. of neuroactive steroids offers a new approach to AD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg_TUu9Mmp17Vg90H21EOLACvtfcHk0ljkLO4GB75pAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlWlu78%253D&md5=78f6fb4d153bac39a2e2799d909acb29</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.3233%2FJAD-170974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-170974%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%2BY.%26aulast%3DIsaacs%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DRoles%2520of%2520mitochondrial%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%252010%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2018%26volume%3D62%26spage%3D665%26epage%3D673%26doi%3D10.3233%2FJAD-170974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siekevitz, P.</span></span> <span> </span><span class="NLM_article-title">The postsynaptic density: a possible role in long-lasting effects in the central nervous system</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">3494</span>– <span class="NLM_lpage">3498</span>, <span class="refDoi"> DOI: 10.1073/pnas.82.10.3494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1073%2Fpnas.82.10.3494" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1985&pages=3494-3498&author=P.+Siekevitz&title=The+postsynaptic+density%3A+a+possible+role+in+long-lasting+effects+in+the+central+nervous+system&doi=10.1073%2Fpnas.82.10.3494"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1073%2Fpnas.82.10.3494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.82.10.3494%26sid%3Dliteratum%253Aachs%26aulast%3DSiekevitz%26aufirst%3DP.%26atitle%3DThe%2520postsynaptic%2520density%253A%2520a%2520possible%2520role%2520in%2520long-lasting%2520effects%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1985%26volume%3D82%26spage%3D3494%26epage%3D3498%26doi%3D10.1073%2Fpnas.82.10.3494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laumonnier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuthbert, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, S. G. N.</span></span> <span> </span><span class="NLM_article-title">The role of neuronal complexes in human X-linked brain diseases</span>. <i>Am. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1086/511441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1086%2F511441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17236127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2007&pages=205-220&author=F.+Laumonnierauthor=P.+C.+Cuthbertauthor=S.+G.+N.+Grant&title=The+role+of+neuronal+complexes+in+human+X-linked+brain+diseases&doi=10.1086%2F511441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">The role of neuronal complexes in human X-linked brain diseases</span></div><div class="casAuthors">Laumonnier, Frederic; Cuthbert, Peter C.; Grant, Seth G. N.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-220</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  Beyond finding individual genes that are involved in medical disorders, an important challenge is the integration of sets of disease genes with the complexities of basic biol. processes.  We examine this issue by focusing on neuronal multiprotein complexes and their components encoded on the human X chromosome.  Multiprotein signaling complexes in the postsynaptic terminal of central nervous system synapses are essential for the induction of neuronal plasticity and cognitive processes in animals.  The prototype complex is the N-methyl-D-aspartate receptor complex/membrane-assocd. guanylate kinase-assocd. signaling complex (NRC/MASC) comprising 185 proteins and embedded within the postsynaptic d. (PSD), which is a set of complexes totaling ∼1,100 proteins.  It is striking that 86% (6 of 7) of X-linked NRC/MASC genes and 49% (19 of 39) of X-chromosomal PSD genes are already known to be involved in human psychiatric disorders.  Moreover, of the 69 known proteins mutated in X-linked mental retardation, 19 (28%) encode postsynaptic proteins.  The high incidence of involvement in cognitive disorders is also found in mouse mutants and indicates that the complexes are functioning as integrated entities or mol. machines and that disruption of different components impairs their overall role in cognitive processes.  We also noticed that NRC/MASC genes appear to be more strongly assocd. with mental retardation and autism spectrum disorders.  We propose that systematic studies of PSD and NRC/MASC genes in mice and humans will give a high yield of novel genes important for human disease and new mechanistic insights into higher cognitive functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYLYd31MKgAbVg90H21EOLACvtfcHk0ljkLO4GB75pAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOjurk%253D&md5=8be024c7338ddd81d34f18c69bb6c376</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1086%2F511441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F511441%26sid%3Dliteratum%253Aachs%26aulast%3DLaumonnier%26aufirst%3DF.%26aulast%3DCuthbert%26aufirst%3DP.%2BC.%26aulast%3DGrant%26aufirst%3DS.%2BG.%2BN.%26atitle%3DThe%2520role%2520of%2520neuronal%2520complexes%2520in%2520human%2520X-linked%2520brain%2520diseases%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2007%26volume%3D80%26spage%3D205%26epage%3D220%26doi%3D10.1086%2F511441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullarkat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of γ-aminobutyric acid type A receptors</span>. <i>Mol. Cell. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>229</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/j.mce.2004.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.mce.2004.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15607535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVyqs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=2005&pages=111-117&author=X.+Y.+Heauthor=J.+Wegielauthor=Y.+Z.+Yangauthor=R.+Pullarkatauthor=H.+Schulzauthor=S.+Y.+Yang&title=Type+10+17beta-hydroxysteroid+dehydrogenase+catalyzing+the+oxidation+of+steroid+modulators+of+%CE%B3-aminobutyric+acid+type+A+receptors&doi=10.1016%2Fj.mce.2004.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Type 10 17β-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of γ-aminobutyric acid type A receptors</span></div><div class="casAuthors">He, Xue-Ying; Wegiel, Jerzy; Yang, Ying-Zi; Pullarkat, Raju; Schulz, Horst; Yang, Song-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">111-117</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The steroids allopregnanolone and allotetrahydrodeoxycorticosterone (3α,5α-THDOC) are pos. allosteric modulators of GABAA receptors, generated by the redn. of 5α-dihydroprogesterone (5α-DHP) and 5α-DHDOC, resp., under the catalysis of human type 3 3α-hydroxysteroid dehydrogenase (HSD).  However, brain enzymes catalyzing the conversion of such tetrahydrosteroids back to the corresponding 5α-dihydrosteroids remain to be identified.  Characterization of human type 10 17β-HSD provides a new insight into its importance for the oxidn. of steroid modulators of GABAA receptors.  The apparent catalytic efficiency (kcat/Km) of this enzyme for the oxidn. of allopregnanolone and 3α,5α-THDOC are 432 and 1381 min-1 mM-1, resp.  This enzyme has negligible 3-ketosteroid reductase activity for 5α-DHP and 5α-DHDOC even in an acidic environment.  Immunoreactivity against 17β-HSD10 was found in a no. of neuronal populations.  Taken together, evidence suggests that 17β-HSD10 is the brain enzyme capable of catalyzing the oxidn. of steroid modulators of GABAA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr34wTAurbU37Vg90H21EOLACvtfcHk0ljkLO4GB75pAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVyqs7jL&md5=642e0e5be34b3853e8210b649622d895</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2004.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2004.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%2BY.%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%2BZ.%26aulast%3DPullarkat%26aufirst%3DR.%26aulast%3DSchulz%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DType%252010%252017beta-hydroxysteroid%2520dehydrogenase%2520catalyzing%2520the%2520oxidation%2520of%2520steroid%2520modulators%2520of%2520%25CE%25B3-aminobutyric%2520acid%2520type%2520A%2520receptors%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2005%26volume%3D229%26spage%3D111%26epage%3D117%26doi%3D10.1016%2Fj.mce.2004.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1040</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2005.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.brainres.2005.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15804423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1aitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1040&publication_year=2005&pages=29-35&author=X.+Y.+Heauthor=J.+Wegielauthor=S.+Y.+Yang&title=Intracellular+oxidation+of+allopregnanolone+by+human+brain+type+10+17beta-hydroxysteroid+dehydrogenase&doi=10.1016%2Fj.brainres.2005.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase</span></div><div class="casAuthors">He, Xue-Ying; Wegiel, Jerzy; Yang, Song-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1040</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">29-35</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Allopregnanolone is a pos. allosteric modulator of GABAA receptors, generated by the redn. of 5α-dihydroprogesterone (5α-DHP) in astrocytes.  This neuroactive steroid can be inactivated by its 3α-oxidn. to yield 5α-DHP.  It was found that 5α-DHP levels in HEK293 cells expressing type 10 17β-hydroxysteroid dehydrogenase (17β-HSD10), but not its catalytic inactive mutant, increased significantly as allopregnanolone was added to culture media.  The results demonstrate that mitochondrial 17β-HSD10 effectively catalyzes the intracellular oxidn. of allopregnanolone.  Moreover, brain astrocytes contain a moderate level of 17β-HSD10, which is elevated in activated astrocytes of brains with Alzheimer type pathol., including sporadic Alzheimer's disease (AD) and Down's syndrome with AD.  The distribution of 17β-HSD10 was found not to parallel that of 3α-HSD3.  Cerebral cortex has the lowest level of 17β-HSD10; whereas the hippocampus, hypothalamus, and amygdala possess relatively higher levels of this enzyme.  The catalysis of 17β-HSD10 appears to be essential for maintaining normal functions of GABAergic neurons.  The elevated level of 17β-HSD10 in activated astrocytes is a new feature found in brains of people with AD, and it may have important impact on AD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxMsnii75I3LVg90H21EOLACvtfcHk0ljbD_MiWDw7Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1aitLc%253D&md5=b5fff69396d74c0ef6f45ee1e31fcf29</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2005.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2005.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%2BY.%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DIntracellular%2520oxidation%2520of%2520allopregnanolone%2520by%2520human%2520brain%2520type%252010%252017beta-hydroxysteroid%2520dehydrogenase%26jtitle%3DBrain%2520Res.%26date%3D2005%26volume%3D1040%26spage%3D29%26epage%3D35%26doi%3D10.1016%2Fj.brainres.2005.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majewska, M. D.</span></span> <span> </span><span class="NLM_article-title">Neurosteroids: endogenous bimodal modulators of the GAB<sub>AA</sub> receptor. Mechanism of action and physiological significance</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1016/0301-0082(92)90025-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2F0301-0082%2892%2990025-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1349441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK38XisVymsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1992&pages=379-395&author=M.+D.+Majewska&title=Neurosteroids%3A+endogenous+bimodal+modulators+of+the+GABAA+receptor.+Mechanism+of+action+and+physiological+significance&doi=10.1016%2F0301-0082%2892%2990025-A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Neurosteroids:  endogenous bimodal modulators of the GABAA receptor.  Mechanism of action and physiological significance</span></div><div class="casAuthors">Majewska, Maria Dorota</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-95</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    </div><div class="casAbstract">A review, with 118 refs., on neurosteroids, their formation and catabolism, and their modulatory effects on GABAergicA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOK0hISaV6UbVg90H21EOLACvtfcHk0ljbD_MiWDw7Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XisVymsLw%253D&md5=a8dae7d53bc51af4733f7731793a2e23</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2F0301-0082%2892%2990025-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0301-0082%252892%252990025-A%26sid%3Dliteratum%253Aachs%26aulast%3DMajewska%26aufirst%3DM.%2BD.%26atitle%3DNeurosteroids%253A%2520endogenous%2520bimodal%2520modulators%2520of%2520the%2520GABAA%2520receptor.%2520Mechanism%2520of%2520action%2520and%2520physiological%2520significance%26jtitle%3DProg.%2520Neurobiol.%26date%3D1992%26volume%3D38%26spage%3D379%26epage%3D395%26doi%3D10.1016%2F0301-0082%2892%2990025-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tieu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vila, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspersen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teismann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson-Lewis, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przedborski, S.</span></span> <span> </span><span class="NLM_article-title"><sub>L</sub>-3-hydroxyacyl-CoA dehydrogenase II protects in a model of parkinson’s disease</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1002/ana.20133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1002%2Fana.20133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15236401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVSnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=51-60&author=K.+Tieuauthor=C.+Perierauthor=M.+Vilaauthor=C.+Caspersenauthor=H.+P.+Zhangauthor=P.+Teismannauthor=V.+Jackson-Lewisauthor=D.+M.+Sternauthor=S.+D.+Yanauthor=S.+Przedborski&title=L-3-hydroxyacyl-CoA+dehydrogenase+II+protects+in+a+model+of+parkinson%E2%80%99s+disease&doi=10.1002%2Fana.20133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">L-3-Hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease</span></div><div class="casAuthors">Tieu, Kim; Perier, Celine; Vila, Miquel; Caspersen, Casper; Zhang, Hui-Ping; Teismann, Peter; Jackson-Lewis, Vernice; Stern, David M.; Yan, Shi Du; Przedborski, Serge</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-60</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) impairs mitochondrial respiration and damages dopaminergic neurons as seen in Parkinson's disease (PD).  Here, the authors report that L-3-hydroxyacyl-CoA dehydrogenase type II/amyloid binding alc. dehydrogenase (HADH II/ABAD), a mitochondrial oxidoreductase enzyme involved in neuronal survival, is downregulated in PD patients and in MPTP-intoxicated mice.  The authors also show that transgenic mice with increased expression of human HADH II/ABAD are significantly more resistant to MPTP than their wild-type littermates.  This effect appears to be mediated by overexpression of HADH II/ABAD mitigating MPTP-induced impairment of oxidative phosphorylation and ATP prodn.  This study demonstrates that HADH II/ABAD modulates MPTP neurotoxicity and suggests that HADH II/ABAD mimetics may provide protective benefit in the treatment of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdiFF1YC82NLVg90H21EOLACvtfcHk0lgu4f52hBeVug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVSnsrY%253D&md5=475e43f621f1cf64dfb66e95e5261d06</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fana.20133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20133%26sid%3Dliteratum%253Aachs%26aulast%3DTieu%26aufirst%3DK.%26aulast%3DPerier%26aufirst%3DC.%26aulast%3DVila%26aufirst%3DM.%26aulast%3DCaspersen%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%2BP.%26aulast%3DTeismann%26aufirst%3DP.%26aulast%3DJackson-Lewis%26aufirst%3DV.%26aulast%3DStern%26aufirst%3DD.%2BM.%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DPrzedborski%26aufirst%3DS.%26atitle%3DL-3-hydroxyacyl-CoA%2520dehydrogenase%2520II%2520protects%2520in%2520a%2520model%2520of%2520parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2004%26volume%3D56%26spage%3D51%26epage%3D60%26doi%3D10.1002%2Fana.20133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frosch, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, E. S.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McTaggert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinsky, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramasamy, R.</span></span> <span> </span><span class="NLM_article-title">Amyloid beta-peptide binding alcohol dehydrogenase is a component of the cellular response to nutritional stress</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">27100</span>– <span class="NLM_lpage">27109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=27100-27109&author=S.+D.+Yanauthor=Y.+Zhuauthor=E.+D.+Sternauthor=Y.+C.+Hwangauthor=O.+Horiauthor=S.+Ogawaauthor=M.+P.+Froschauthor=E.+S.+Connollyauthor=R.+McTaggertauthor=D.+J.+Pinskyauthor=S.+G.+Clarkeauthor=D.+M.+Sternauthor=R.+Ramasamy&title=Amyloid+beta-peptide+binding+alcohol+dehydrogenase+is+a+component+of+the+cellular+response+to+nutritional+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DStern%26aufirst%3DE.%2BD.%26aulast%3DHwang%26aufirst%3DY.%2BC.%26aulast%3DHori%26aufirst%3DO.%26aulast%3DOgawa%26aufirst%3DS.%26aulast%3DFrosch%26aufirst%3DM.%2BP.%26aulast%3DConnolly%26aufirst%3DE.%2BS.%26aulast%3DMcTaggert%26aufirst%3DR.%26aulast%3DPinsky%26aufirst%3DD.%2BJ.%26aulast%3DClarke%26aufirst%3DS.%2BG.%26aulast%3DStern%26aufirst%3DD.%2BM.%26aulast%3DRamasamy%26aufirst%3DR.%26atitle%3DAmyloid%2520beta-peptide%2520binding%2520alcohol%2520dehydrogenase%2520is%2520a%2520component%2520of%2520the%2520cellular%2520response%2520to%2520nutritional%2520stress%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D27100%26epage%3D27109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Estrogen, β-amyloid metabolism/trafficking, and Alzheimer’s disease</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1089</i></span>,  <span class="NLM_fpage">324</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1196/annals.1386.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1196%2Fannals.1386.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1089&publication_year=2006&pages=324-342&author=H.+Xuauthor=R.+Wangauthor=Y.+W.+Zhangauthor=X.+Zhang&title=Estrogen%2C+%CE%B2-amyloid+metabolism%2Ftrafficking%2C+and+Alzheimer%E2%80%99s+disease&doi=10.1196%2Fannals.1386.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1196%2Fannals.1386.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1386.036%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%2BW.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DEstrogen%252C%2520%25CE%25B2-amyloid%2520metabolism%252Ftrafficking%252C%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2006%26volume%3D1089%26spage%3D324%26epage%3D342%26doi%3D10.1196%2Fannals.1386.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mensah-Nyagan, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, A.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease, oestrogen and mitochondria: an ambiguous relationship</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1007/s12035-012-8281-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1007%2Fs12035-012-8281-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=22678467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGmsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=151-160&author=A.+Grimmauthor=Y.+A.+Limauthor=A.+G.+Mensah-Nyaganauthor=J.+Gotzauthor=A.+Eckert&title=Alzheimer%E2%80%99s+disease%2C+oestrogen+and+mitochondria%3A+an+ambiguous+relationship&doi=10.1007%2Fs12035-012-8281-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's Disease, Oestrogen and Mitochondria: an Ambiguous Relationship</span></div><div class="casAuthors">Grimm, Amandine; Lim, Yun-An; Mensah-Nyagan, Ayikoe Guy; Goetz, Juergen; Eckert, Anne</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">151-160</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Hormonal deficit in post-menopausal women has been proposed to be one risk factor in Alzheimer's disease (AD) since two thirds of AD patients are women.  However, large treatment trials showed neg. effects of long-term treatment with estrogens in older women.  Thus, estrogen treatment after menopause is still under debate, and several hypotheses trying to explain the failure in outcome are under discussion.  Concurrently, it was shown that amyloid-beta (Aβ) peptide, the main constituent of senile plaques, as well as abnormally hyperphosphorylated tau protein, the main component of neurofibrillary tangles, can modulate the level of neurosteroids which notably represent neuroactive steroids synthesized within the nervous system, independently of peripheral endocrine glands.  In this review, we summarize the role of neurosteroids esp. that of estrogen in AD and discuss their potentially neuroprotective effects with specific regard to the role of estrogens on the maintenance and function of mitochondria, important organelles which are highly vulnerable to Aβ- and tau-induced toxicity.  We also discuss the role of Aβ-binding alc. dehydrogenase (ABAD), a mitochondrial enzyme able to bind Aβ peptide thereby modifying mitochondrial function as well as oestradiol levels suggesting possible modes of interaction between the three, and the potential therapeutic implication of inhibiting Aβ-ABAD interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGBhLwGqzGQrVg90H21EOLACvtfcHk0lgu4f52hBeVug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGmsb7O&md5=87ccafc3c1043727516f54ddb7e7e2ce</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs12035-012-8281-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-012-8281-x%26sid%3Dliteratum%253Aachs%26aulast%3DGrimm%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DY.%2BA.%26aulast%3DMensah-Nyagan%26aufirst%3DA.%2BG.%26aulast%3DGotz%26aufirst%3DJ.%26aulast%3DEckert%26aufirst%3DA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%252C%2520oestrogen%2520and%2520mitochondria%253A%2520an%2520ambiguous%2520relationship%26jtitle%3DMol.%2520Neurobiol.%26date%3D2012%26volume%3D46%26spage%3D151%26epage%3D160%26doi%3D10.1007%2Fs12035-012-8281-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amtul, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westaway, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozmahel, R. F.</span></span> <span> </span><span class="NLM_article-title">Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer’s disease</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2010.05.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.neuroscience.2010.05.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=20493928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ymtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2010&pages=781-786&author=Z.+Amtulauthor=L.+Wangauthor=D.+Westawayauthor=R.+F.+Rozmahel&title=Neuroprotective+mechanism+conferred+by+17beta-estradiol+on+the+biochemical+basis+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neuroscience.2010.05.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease</span></div><div class="casAuthors">Amtul, Z.; Wang, L.; Westaway, D.; Rozmahel, R. F.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">781-786</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Estrogen (17β-estradiol) plays key regulatory roles in a variety of physiol. and biol. processes.  Several lines of evidence also support its role as a protective factor in Alzheimer's disease; however, the basis of this effect is unclear.  Here we show that an early-onset Alzheimer's disease transgenic mouse model expressing the double-mutant form of human amyloid precursor protein (APP); Swedish (K670N/M671L) and Indiana (V717F) undergoing treatment with 17β-estradiol show significantly lower levels of APP processing through beta-secretase and enhanced alpha-secretase processing resulting in marked redns. of APP-CTFbeta, Abeta42 and plaque burden, along with increased levels of the non-amyloidogenic sAPPalpha.  Moreover, 17β-estradiol resulted in elevated brain levels of transthyretin, which inhibits aggregation of Abeta into plaques; though the insulin-degrading enzyme, which breaks down Abeta, was significantly reduced.  These results illustrate a multifaceted effect of 17β-estradiol on the biochem. basis of Alzheimer's disease, through effects on APP processing, Abeta levels and factors that affect its clearance and aggregation.  Overall, these results support the need for further long-term longitudinal studies to elucidate consequences of menopause as well as hormone therapy on Alzheimer's disease, and explore its potential as a therapeutic avenue for the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSgvUbp_acjrVg90H21EOLACvtfcHk0lhWDT2av9dADQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ymtLk%253D&md5=a14e582b0c2014e190e7b25d3c597594</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2010.05.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2010.05.031%26sid%3Dliteratum%253Aachs%26aulast%3DAmtul%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWestaway%26aufirst%3DD.%26aulast%3DRozmahel%26aufirst%3DR.%2BF.%26atitle%3DNeuroprotective%2520mechanism%2520conferred%2520by%252017beta-estradiol%2520on%2520the%2520biochemical%2520basis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuroscience%26date%3D2010%26volume%3D169%26spage%3D781%26epage%3D786%26doi%3D10.1016%2Fj.neuroscience.2010.05.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-de-la-Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Segura, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naftolin, F.</span></span> <span> </span><span class="NLM_article-title">Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer’s disease</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1052</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">224</span>, <span class="refDoi"> DOI: 10.1196/annals.1347.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1196%2Fannals.1347.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=16024764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFaktbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1052&publication_year=2005&pages=210-224&author=M.+Alvarez-de-la-Rosaauthor=I.+Silvaauthor=J.+Nilsenauthor=M.+M.+Perezauthor=L.+M.+Garcia-Seguraauthor=J.+Avilaauthor=F.+Naftolin&title=Estradiol+prevents+neural+tau+hyperphosphorylation+characteristic+of+Alzheimer%E2%80%99s+disease&doi=10.1196%2Fannals.1347.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease</span></div><div class="casAuthors">Alvarez-de-la-Rosa, Margarita; Silva, Ivaldo; Nilsen, Jon; Perez, M. M.; Garcia-Segura, Luis Miguel; Avila, Jesus; Naftolin, Frederick</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1052</span>
        (<span class="NLM_cas:issue">Future of Hormone Therapy</span>),
    <span class="NLM_cas:pages">210-224</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is three times more prevalent in women than men, and epidemiol. studies have shown that estrogen replacement in aging women forestalls the onset of AD.  Hyperphosphorylation of the tau protein that forms the neurofibrillary tangles found in AD brains might be responsible for the breakdown of microtubules in affected neurons.  The mechanisms by which tau protein is phosphorylated in the AD brain are not fully understood.  Using a human neuroblastoma cell line (SH-SY5Y) and primary cultures of newborn male or female rat cerebral cortical neurons, we investigated the effect of 17β-estradiol on tau protein expression and phosphorylation.  We found that estradiol increased total tau and induced dephosphorylation at the proline-directed site of the-mol.  Further, estradiol prevented okadaic acid-induced hyperphosphorylation of tau in both proline- and non-proline-directed sites, and antiestrogens blocked this effect.  To our knowledge, this is the first report of an effect of estradiol on naturally occurring and induced tau phosphorylation.  This assumes special significance because the estrogen action was found to be sexually dimorphic in rat cortical neurons and differentiation-sensitive in human neuroblastoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3F6O-Hs1NQrVg90H21EOLACvtfcHk0lhWDT2av9dADQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFaktbrJ&md5=1b1d83f77fad8c9a846361b3d745f5b2</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1196%2Fannals.1347.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1347.016%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez-de-la-Rosa%26aufirst%3DM.%26aulast%3DSilva%26aufirst%3DI.%26aulast%3DNilsen%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DM.%2BM.%26aulast%3DGarcia-Segura%26aufirst%3DL.%2BM.%26aulast%3DAvila%26aufirst%3DJ.%26aulast%3DNaftolin%26aufirst%3DF.%26atitle%3DEstradiol%2520prevents%2520neural%2520tau%2520hyperphosphorylation%2520characteristic%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2005%26volume%3D1052%26spage%3D210%26epage%3D224%26doi%3D10.1196%2Fannals.1347.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodenough, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleusner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrzik, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skutella, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behl, C.</span></span> <span> </span><span class="NLM_article-title">Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2004.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.neuroscience.2004.12.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15837120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlWrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2005&pages=581-589&author=S.+Goodenoughauthor=D.+Schleusnerauthor=C.+Pietrzikauthor=T.+Skutellaauthor=C.+Behl&title=Glycogen+synthase+kinase+3%CE%B2+links+neuroprotection+by+17%CE%B2-estradiol+to+key+Alzheimer+processes&doi=10.1016%2Fj.neuroscience.2004.12.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes</span></div><div class="casAuthors">Goodenough, S.; Schleusner, D.; Pietrzik, C.; Skutella, T.; Behl, C.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">581-589</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Estrogen exerts many of its receptor-mediated neuroprotective functions through the activation of various intracellular signal transduction pathways including the mitogen activating protein kinase (MAPK), phospho inositol-3 kinase and protein kinase C pathways.  Here we have used a hippocampal slice culture model of kainic acid-induced neurotoxic cell death to show that estrogen can protect against oxidative cell death.  We have previously shown that MAPK and glycogen synthase kinase-3β (GSK-3β) are involved in the cell death/cell survival induced by kainic acid.  In this model and other cellular and in vivo models we have shown that estrogen can also cause the phosphorylation and hence inactivation of GSK-3β, a known mediator of neuronal cell death.  The effect of estrogen on GSK-3β activity is estrogen receptor mediated.  Further, this estrogen/GSK-3β interaction may have functional consequences in cellular models of some key pathogenic pathways assocd. with Alzheimer's disease.  More specifically, estrogen affects the basal levels of tau phosphorylation at a site known to be phosphorylated by GSK-3β.  Taken together, these data indicate a novel mol. and functional link between estrogen and GSK-3β and may have implications for estrogen receptor modulation as a target for the prevention of neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGAu9tPhbiwLVg90H21EOLACvtfcHk0lhWDT2av9dADQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlWrtbY%253D&md5=952e48c75c7a96661cbb40ada6240e68</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2004.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2004.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DGoodenough%26aufirst%3DS.%26aulast%3DSchleusner%26aufirst%3DD.%26aulast%3DPietrzik%26aufirst%3DC.%26aulast%3DSkutella%26aufirst%3DT.%26aulast%3DBehl%26aufirst%3DC.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%25CE%25B2%2520links%2520neuroprotection%2520by%252017%25CE%25B2-estradiol%2520to%2520key%2520Alzheimer%2520processes%26jtitle%3DNeuroscience%26date%3D2005%26volume%3D132%26spage%3D581%26epage%3D589%26doi%3D10.1016%2Fj.neuroscience.2004.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pike, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosario, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barron, A. M.</span></span> <span> </span><span class="NLM_article-title">Protective actions of sex steroid hormones in Alzheimer’s disease</span>. <i>Front. Neuroendocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1016/j.yfrne.2009.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.yfrne.2009.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=19427328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsV2rsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=239-258&author=C.+J.+Pikeauthor=J.+C.+Carrollauthor=E.+R.+Rosarioauthor=A.+M.+Barron&title=Protective+actions+of+sex+steroid+hormones+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.yfrne.2009.04.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Protective actions of sex steroid hormones in Alzheimer's disease</span></div><div class="casAuthors">Pike, Christian J.; Carroll, Jenna C.; Rosario, Emily R.; Barron, Anna M.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Neuroendocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-258</span>CODEN:
                <span class="NLM_cas:coden">FNEDA7</span>;
        ISSN:<span class="NLM_cas:issn">0091-3022</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Risk for Alzheimer's disease (AD) is assocd. with age-related loss of sex steroid hormones in both women and men.  In post-menopausal women, the precipitous depletion of estrogens and progestogens is hypothesized to increase susceptibility to AD pathogenesis, a concept largely supported by epidemiol. evidence but refuted by some clin. findings.  Exptl. evidence suggests that estrogens have numerous neuroprotective actions relevant to prevention of AD, in particular promotion of neuron viability and redn. of β-amyloid accumulation, a crit. factor in the initiation and progression of AD.  Recent findings suggest neural responsiveness to estrogen can diminish with age, reducing neuroprotective actions of estrogen and, consequently, potentially limiting the utility of hormone therapies in aged women.  In addn., estrogen neuroprotective actions are also modulated by progestogens.  Specifically, continuous progestogen exposure is assocd. with inhibition of estrogen actions whereas cyclic delivery of progestogens may enhance neural benefits of estrogen.  In recent years, emerging literature has begun to elucidate a parallel relationship of sex steroid hormones and AD risk in men.  Normal age-related testosterone loss in men is assocd. with increased risk to several diseases including AD.  Like estrogen, testosterone has been established as an endogenous neuroprotective factor that not only increases neuronal resilience against AD-related insults, but also reduces β-amyloid accumulation.  Androgen neuroprotective effects are mediated both directly by activation of androgen pathways and indirectly by aromatization to estradiol and initiation of protective estrogen signaling mechanisms.  The successful use of hormone therapies in aging men and women to delay, prevent, and or treat AD will require addnl. research to optimize key parameters of hormone therapy and may benefit from the continuing development of selective estrogen and androgen receptor modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbdS4omTYJC7Vg90H21EOLACvtfcHk0lhWDT2av9dADQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsV2rsbw%253D&md5=72830b36e50e6132298ed4e8c9954125</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.yfrne.2009.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yfrne.2009.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DC.%2BJ.%26aulast%3DCarroll%26aufirst%3DJ.%2BC.%26aulast%3DRosario%26aufirst%3DE.%2BR.%26aulast%3DBarron%26aufirst%3DA.%2BM.%26atitle%3DProtective%2520actions%2520of%2520sex%2520steroid%2520hormones%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Neuroendocrinol.%26date%3D2009%26volume%3D30%26spage%3D239%26epage%3D258%26doi%3D10.1016%2Fj.yfrne.2009.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorke, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petroianu, G. A.</span></span> <span> </span><span class="NLM_article-title">Methylene blue and Alzheimer’s disease</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">927</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2009.04.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.bcp.2009.04.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=19433072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFSns77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=927-932&author=M.+Ozauthor=D.+E.+Lorkeauthor=G.+A.+Petroianu&title=Methylene+blue+and+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bcp.2009.04.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Methylene blue and Alzheimer's disease</span></div><div class="casAuthors">Oz, Murat; Lorke, Dietrich E.; Petroianu, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">927-932</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The relationship between methylene blue (MB) and Alzheimer's disease (AD) has recently attracted increasing scientific attention since it has been suggested that MB may slow down the progression of this disease.  In fact, MB, in addn. to its well characterized inhibitory actions on the cGMP pathway, affects numerous cellular and mol. events closely related to the progression of AD.  Currently, MB has been shown to attenuate the formations of amyloid plaques and neurofibrillary tangles, and to partially repair impairments in mitochondrial function and cellular metab.  Furthermore, various neurotransmitter systems (cholinergic, serotonergic and glutamatergic), believed to play important roles in the pathogenesis of AD and other cognitive disorders, are also influenced by MB.  Recent studies suggest that the combination of diverse actions of MB on these cellular functions is likely to mediate potential beneficial effects of MB.  This has lead to attempts to develop novel MB-based treatment modalities for AD.  In this review article, actions of MB on neurotransmitter systems and multiple cellular and mol. targets are summarized with regard to their relevance to AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohIvSWd8UnA7Vg90H21EOLACvtfcHk0liGZgTYJ14i8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFSns77L&md5=f73feddb5c859463d4cd75b16c7d1a02</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DOz%26aufirst%3DM.%26aulast%3DLorke%26aufirst%3DD.%2BE.%26aulast%3DPetroianu%26aufirst%3DG.%2BA.%26atitle%3DMethylene%2520blue%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D927%26epage%3D932%26doi%3D10.1016%2Fj.bcp.2009.04.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wischik, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staff, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wischik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kook, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, C. R.</span></span> <span> </span><span class="NLM_article-title">Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">720</span>, <span class="refDoi"> DOI: 10.3233/JAD-142874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-142874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=25550228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslensbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=705-720&author=C.+M.+Wischikauthor=R.+T.+Staffauthor=D.+J.+Wischikauthor=P.+Benthamauthor=A.+D.+Murrayauthor=J.+M.+Storeyauthor=K.+A.+Kookauthor=C.+R.+Harrington&title=Tau+aggregation+inhibitor+therapy%3A+an+exploratory+phase+2+study+in+mild+or+moderate+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-142874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Tau Aggregation Inhibitor Therapy: An Exploratory Phase 2 Study in Mild or Moderate Alzheimer's Disease</span></div><div class="casAuthors">Wischik, Claude M.; Staff, Roger T.; Wischik, Damon J.; Bentham, Peter; Murray, Alison D.; Storey, John M. D.; Kook, Karin A.; Harrington, Charles R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">705-720</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Background: As tau aggregation pathol. correlates with clin. dementia in Alzheimer's disease (AD), a tau aggregation inhibitor (TAI) could have therapeutic utility.  Methylthioninium (MT) acts as a selective TAI in vitro and reduces tau pathol. in transgenic mouse models.  Objective: To det. the min. safe and ED of MT required to prevent disease progression on clin. and functional mol. imaging outcomes.  Methods: An exploratory double-blind, randomized, placebo-controlled, dose-finding trial of MT (69, 138, and 228 mg/day) was conducted in 321 mild/moderate AD subjects.  The primary outcome was change on the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) at 24 wk relative to baseline severity.  Effect of treatment on regional cerebral blood flow decline was detd. in a sub-study in 135 subjects.  After 24 wk, subjects were re-consented to enter sequential 6- and 12-mo blinded extension phases.  Registered with ClinicalTrials.gov (NCT00515333).  Results: At 24 wk, there were significant treatment benefits in two independent populations at the 138 mg/day dose: in moderate subjects on the ADAS-cog scale (treatment effect: -5.42 units, cor. p = 0.047) and two other clin. scales; in mild subjects on the more sensitive regional cerebral blood flow measure (treatment effect: 1.97%, cor. p < 0.001).  With continued treatment for 50 wk, benefit was seen on the ADAS-cog scale in both mild and moderate subjects.  The delivery of the highest dose was impaired due to dose-dependent dissoln. and absorption limitations.  Conclusion: The min. safe and effective daily MT dose is 138 mg and suggests that further study of MT is warranted in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ3bEMLyUxIrVg90H21EOLACvtfcHk0liGZgTYJ14i8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslensbw%253D&md5=d478518b72d5a82ed3685a6312f2d51c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.3233%2FJAD-142874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-142874%26sid%3Dliteratum%253Aachs%26aulast%3DWischik%26aufirst%3DC.%2BM.%26aulast%3DStaff%26aufirst%3DR.%2BT.%26aulast%3DWischik%26aufirst%3DD.%2BJ.%26aulast%3DBentham%26aufirst%3DP.%26aulast%3DMurray%26aufirst%3DA.%2BD.%26aulast%3DStorey%26aufirst%3DJ.%2BM.%26aulast%3DKook%26aufirst%3DK.%2BA.%26aulast%3DHarrington%26aufirst%3DC.%2BR.%26atitle%3DTau%2520aggregation%2520inhibitor%2520therapy%253A%2520an%2520exploratory%2520phase%25202%2520study%2520in%2520mild%2520or%2520moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2015%26volume%3D44%26spage%3D705%26epage%3D720%26doi%3D10.3233%2FJAD-142874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zakaria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamdi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Kader, R. M.</span></span> <span> </span><span class="NLM_article-title">Methylene blue improves brain mitochondrial ABAD functions and decreases Aβ in a neuroinflammatory Alzheimer’s disease mouse model</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1220</span>– <span class="NLM_lpage">1228</span>, <span class="refDoi"> DOI: 10.1007/s12035-014-9088-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1007%2Fs12035-014-9088-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=25601181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2016&pages=1220-1228&author=A.+Zakariaauthor=N.+Hamdiauthor=R.+M.+Abdel-Kader&title=Methylene+blue+improves+brain+mitochondrial+ABAD+functions+and+decreases+A%CE%B2+in+a+neuroinflammatory+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1007%2Fs12035-014-9088-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model</span></div><div class="casAuthors">Zakaria, Aya; Hamdi, Nabila; Abdel-Kader, Reham Mahmoud</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1220-1228</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Methylene blue (MB) phase II clin. trials reported improvements in cognitive functions of Alzheimer's disease (AD) patients.  Regarding MB mechanism of action, its antioxidant and mitochondrial protective effects have been previously described.  In relation to AD, it has been recently reported that MB reduced amyloid beta (Aβ) levels in AD models.  The mitochondrial enzyme amyloid-binding alc. dehydrogenase (ABAD) has been shown to bind Aβ inducing mitochondrial dysfunction, providing a direct relation between Aβ toxicity and mitochondrial dysfunction occurring in AD.  Since it has been reported that inhibiting ABAD protects mitochondrial functions and prevents Aβ-induced toxicity, the aim of the current study was to investigate if the protective effects of MB could be assocd. with an effect on ABAD levels and functions.  The current study shows that MB is able to enhance cell viability, reduce both reactive oxygen species levels and importantly Aβ oligomers in a lipopolysaccharide (LPS) mouse model.  Interestingly, ABAD levels were increased in the brains of the LPS mouse model and MB treatment was able to reduce its levels.  Given that regulation of the estradiol level is a well-established function of ABAD, brain estradiol level was compared in LPS mouse model and in MB-treated mice.  The results of the current study show that MB treatment is able to improve significantly the LPS-induced decrease of estradiol levels in mice brains, indicating its ability to modulate both levels and function of ABAD.  These results give a new insight to possible mechanisms of MB in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocECBFrT6UEbVg90H21EOLACvtfcHk0liGZgTYJ14i8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOltb8%253D&md5=ab8ea34e98ac5878eba619a5e77bae5d</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1007%2Fs12035-014-9088-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-014-9088-8%26sid%3Dliteratum%253Aachs%26aulast%3DZakaria%26aufirst%3DA.%26aulast%3DHamdi%26aufirst%3DN.%26aulast%3DAbdel-Kader%26aufirst%3DR.%2BM.%26atitle%3DMethylene%2520blue%2520improves%2520brain%2520mitochondrial%2520ABAD%2520functions%2520and%2520decreases%2520A%25CE%25B2%2520in%2520a%2520neuroinflammatory%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DMol.%2520Neurobiol.%26date%3D2016%26volume%3D53%26spage%3D1220%26epage%3D1228%26doi%3D10.1007%2Fs12035-014-9088-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, D. W.</span></span> <span> </span><span class="NLM_article-title">Identification of small-molecule inhibitors of the Aβ-ABAD interaction</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">4657</span>– <span class="NLM_lpage">4660</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.05.099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.bmcl.2006.05.099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=16781151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFOlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4657-4660&author=Y.+Xieauthor=S.+Dengauthor=Z.+Chenauthor=S.+Yanauthor=D.+W.+Landry&title=Identification+of+small-molecule+inhibitors+of+the+A%CE%B2-ABAD+interaction&doi=10.1016%2Fj.bmcl.2006.05.099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of small-molecule inhibitors of the Aβ-ABAD interaction</span></div><div class="casAuthors">Xie, Yuli; Deng, Shixian; Chen, Zhenzhang; Yan, Shidu; Landry, Donald W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4657-4660</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The interaction of amyloid beta peptide (Aβ) and Aβ-binding alc. dehydrogenase (ABAD) was recently implicated in the pathogenesis of Alzheimer's disease (AD).  Using an ELISA-based screening assay, the authors identified frentizole, an FDA-approved immunosuppressive drug, as a novel inhibitor of the Aβ-ABAD interaction.  Anal. of the frentizole structure-activity relationship led to identification of a novel benzothiazole urea (I) with a 30-fold improvement in potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjbbBYe22v7bVg90H21EOLACvtfcHk0lghoz8XV1QoAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFOlurY%253D&md5=edef30ddfd57348ffbe3d49fbca6400d</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.05.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.05.099%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26atitle%3DIdentification%2520of%2520small-molecule%2520inhibitors%2520of%2520the%2520A%25CE%25B2-ABAD%2520interaction%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4657%26epage%3D4660%26doi%3D10.1016%2Fj.bmcl.2006.05.099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfort, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lustbader, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">Surface plasmon resonance and nuclear magnetic resonance studies of ABAD–Aβ interaction</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1724</span>– <span class="NLM_lpage">1731</span>, <span class="refDoi"> DOI: 10.1021/bi061314n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi061314n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1Wqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=1724-1731&author=Y.+Yanauthor=Y.+Liuauthor=M.+Sorciauthor=G.+Belfortauthor=J.+W.+Lustbaderauthor=S.+S.+Yanauthor=C.+Wang&title=Surface+plasmon+resonance+and+nuclear+magnetic+resonance+studies+of+ABAD%E2%80%93A%CE%B2+interaction&doi=10.1021%2Fbi061314n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Surface Plasmon Resonance and Nuclear Magnetic Resonance Studies of ABAD-Aβ Interaction</span></div><div class="casAuthors">Yan, Yilin; Liu, Yangzhong; Sorci, Mirco; Belfort, Georges; Lustbader, Joyce W.; Yan, Shirley ShiDu; Wang, Chunyu</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1724-1731</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aβ binding alc. dehydrogenase (ABAD) is an NAD-dependent mitochondrial dehydrogenase.  The binding between ABAD and Aβ is likely a direct link between Aβ and mitochondrial toxicity in Alzheimer's disease.  In this study, surface plasmon resonance (SPR) was employed to det. the temp. dependence of the affinity of the ABAD-Aβ interaction.  A van't Hoff anal. revealed that the ABAD-Aβ assocn. is driven by a favorable entropic change (ΔS = 300 ± 30 J mol-1 K-1) which overcomes an unfavorable enthalpy change (ΔH = 49 ± 7 kJ/mol).  Therefore, hydrophobic interactions and changes in protein dynamics are the dominant driving forces of the ABAD-Aβ interaction.  This is the first dissection of the entropic and enthalpic contribution to the energetics of a protein-protein interaction involving Aβ.  SPR confirmed the conformational changes in the ABAD-Aβ complex after Aβ binding, consistent with differences seen in the crystal structures of free ABAD and the ABAD-Aβ complex.  Satn. transfer difference (STD) NMR expts. directly and unambiguously demonstrated the inhibitory effect of Aβ on the ABAD-NAD interaction.  Conversely, NAD inhibits the Aβ-ABAD interaction.  Binding of Aβ and binding of NAD to ABAD are likely mutually exclusive.  Thus, Aβ binding induces conformational and subsequently functional changes in ABAD, which may have a role in the mechanism of Aβ toxicity in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSbTtXw94QS7Vg90H21EOLACvtfcHk0lghoz8XV1QoAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1Wqsg%253D%253D&md5=94a2f50f08320939b83af9a2019a6dc5</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fbi061314n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi061314n%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSorci%26aufirst%3DM.%26aulast%3DBelfort%26aufirst%3DG.%26aulast%3DLustbader%26aufirst%3DJ.%2BW.%26aulast%3DYan%26aufirst%3DS.%2BS.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DSurface%2520plasmon%2520resonance%2520and%2520nuclear%2520magnetic%2520resonance%2520studies%2520of%2520ABAD%25E2%2580%2593A%25CE%25B2%2520interaction%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D1724%26epage%3D1731%26doi%3D10.1021%2Fbi061314n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marques, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, M. J.</span></span> <span> </span><span class="NLM_article-title">Molecular dynamics simulations of the amyloid-beta binding alcohol dehydrogenase (ABAD) enzyme</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">9511</span>– <span class="NLM_lpage">9518</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.09.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.bmc.2008.09.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=9511-9518&author=A.+T.+Marquesauthor=P.+A.+Fernandesauthor=M.+J.+Ramos&title=Molecular+dynamics+simulations+of+the+amyloid-beta+binding+alcohol+dehydrogenase+%28ABAD%29+enzyme&doi=10.1016%2Fj.bmc.2008.09.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.09.043%26sid%3Dliteratum%253Aachs%26aulast%3DMarques%26aufirst%3DA.%2BT.%26aulast%3DFernandes%26aufirst%3DP.%2BA.%26aulast%3DRamos%26aufirst%3DM.%2BJ.%26atitle%3DMolecular%2520dynamics%2520simulations%2520of%2520the%2520amyloid-beta%2520binding%2520alcohol%2520dehydrogenase%2520%2528ABAD%2529%2520enzyme%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D9511%26epage%3D9518%26doi%3D10.1016%2Fj.bmc.2008.09.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Human brain short chain <sub>L</sub>-3-hydroxyacyl coenzyme a dehydrogenase is a single-domain multifunctional enzyme</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">15014</span>– <span class="NLM_lpage">15019</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.21.15014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1074%2Fjbc.274.21.15014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=15014-15019&author=X.-Y.+Heauthor=G.+Merzauthor=P.+Mehtaauthor=H.+Schulzauthor=S.+Y.+Yang&title=Human+brain+short+chain+L-3-hydroxyacyl+coenzyme+a+dehydrogenase+is+a+single-domain+multifunctional+enzyme&doi=10.1074%2Fjbc.274.21.15014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.21.15014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.21.15014%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.-Y.%26aulast%3DMerz%26aufirst%3DG.%26aulast%3DMehta%26aufirst%3DP.%26aulast%3DSchulz%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DHuman%2520brain%2520short%2520chain%2520L-3-hydroxyacyl%2520coenzyme%2520a%2520dehydrogenase%2520is%2520a%2520single-domain%2520multifunctional%2520enzyme%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D15014%26epage%3D15019%26doi%3D10.1074%2Fjbc.274.21.15014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lue, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn Moore, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of amyloid-β (Aβ) peptide-binding alcohol dehydrogenase-Aβ interaction reduces Aβ accumulation and improves mitochondrial function in a mouse model of Alzheimer’s disease</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">2313</span>– <span class="NLM_lpage">2320</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4717-10.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1523%2FJNEUROSCI.4717-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=21307267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1antb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=2313-2320&author=J.+Yaoauthor=H.+Duauthor=S.+Yanauthor=F.+Fangauthor=C.+Wangauthor=L.+F.+Lueauthor=L.+Guoauthor=D.+Chenauthor=D.+M.+Sternauthor=F.+J.+Gunn+Mooreauthor=J.+Xi+Chenauthor=O.+Arancioauthor=S.+S.+Yan&title=Inhibition+of+amyloid-%CE%B2+%28A%CE%B2%29+peptide-binding+alcohol+dehydrogenase-A%CE%B2+interaction+reduces+A%CE%B2+accumulation+and+improves+mitochondrial+function+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1523%2FJNEUROSCI.4717-10.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of amyloid-β (Aβ) peptide-binding alcohol dehydrogenase-Aβ interaction reduces Aβ accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Yao, Jun; Du, Heng; Yan, Shiqiang; Fang, Fang; Wang, Chaodong; Lue, Lih-Fen; Guo, Lan; Chen, Doris; Stern, David M.; Gunn-Moore, Frank J.; Alikhani, Nyosha; Glaser, Elzbieta; Chen, John Xi; Arancio, Ottavio; Yan, Shirley Shi Du</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2313-2320</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ) peptide-binding alc. dehydrogenase (ABAD), an enzyme present in neuronal mitochondria, exacerbates Aβ-induced cell stress.  The interaction of ABAD with Aβ exacerbates Aβ-induced mitochondrial and neuronal dysfunction.  Here, we show that inhibition of the ABAD-Aβ interaction, using a decoy peptide (DP) in vitro and in vivo, protects against aberrant mitochondrial and neuronal function and improves spatial learning/memory.  I.p. administration of ABAD-DP [fused to the transduction of human immunodeficiency virus 1-transactivator (Tat) protein and linked to the mitochondrial targeting sequence (Mito) (TAT-mito-DP) to transgenic APP mice (Tg mAPP)] blocked formation of ABAD-Aβ complex in mitochondria, increased oxygen consumption and enzyme activity assocd. with the mitochondrial respiratory chain, attenuated mitochondrial oxidative stress, and improved spatial memory.  Similar protective effects were obsd. in Tg mAPP mice overexpressing neuronal ABAD decoy peptide (Tg mAPP/mito-ABAD).  Notably, inhibition of the ABAD-Aβ interaction significantly reduced mitochondrial Aβ accumulation.  In parallel, the activity of mitochondrial Aβ-degrading enzyme PreP (presequence peptidase) was enhanced in Tg mAPP mitochondria expressing the ABAD decoy peptide.  These data indicate that segregating ABAD from Aβ protects mitochondria/neurons from Aβ toxicity; thus, ABAD-Aβ interaction is an important mechanism underlying Aβ-mediated mitochondrial and neuronal perturbation.  Inhibitors of ABAD-Aβ interaction may hold promise as targets for the prevention and treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiiqnew5jVmLVg90H21EOLACvtfcHk0lgjET8M7U45Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1antb4%253D&md5=aca1cd465a2dde082410d3d8a1116292</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4717-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4717-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DH.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLue%26aufirst%3DL.%2BF.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DStern%26aufirst%3DD.%2BM.%26aulast%3DGunn%2BMoore%26aufirst%3DF.%2BJ.%26aulast%3DXi%2BChen%26aufirst%3DJ.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DYan%26aufirst%3DS.%2BS.%26atitle%3DInhibition%2520of%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520peptide-binding%2520alcohol%2520dehydrogenase-A%25CE%25B2%2520interaction%2520reduces%2520A%25CE%25B2%2520accumulation%2520and%2520improves%2520mitochondrial%2520function%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D2313%26epage%3D2320%26doi%3D10.1523%2FJNEUROSCI.4717-10.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohsawa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2007.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.neurobiolaging.2007.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17707551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFChtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=325-329&author=Y.+Murakamiauthor=I.+Ohsawaauthor=T.+Kasaharaauthor=S.+Ohta&title=Cytoprotective+role+of+mitochondrial+amyloid+beta+peptide-binding+alcohol+dehydrogenase+against+a+cytotoxic+aldehyde&doi=10.1016%2Fj.neurobiolaging.2007.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoprotective role of mitochondrial amyloid β peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde</span></div><div class="casAuthors">Murakami, Yayoi; Ohsawa, Ikuroh; Kasahara, Tadashi; Ohta, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">325-329</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Recent reports on amyloid β peptide (Aβ) binding-alc. dehydrogenase (ABAD) have revealed the link of Aβ with oxidative stress derived from mitochondria in the pathogenesis of Alzheimer's disease (AD).  As a novel function of ABAD, we speculate that ABAD may detoxify aldehydes, such as 4-hydroxy-2-nonenal (4-HNE).  To verify this speculation, we transfected cDNA encoding ABAD into cultured cells (HeLa and SH-SY5Y), where ABAD was localized to mitochondria.  ABAD-transfectants decreased the levels of externally added 4-HNE in cultured medium as detected by TLC and became resistant against external 4-HNE.  Moreover, ABAD suppressed the cytotoxic effects caused by cellular 4-HNE, which were produced through excess reactive oxygen species (ROS) by treatment with an inhibitor of mitochondrial respiration, antimycin A or by adding H2O2.  Catabolism of 4-HNE by ABAD was inhibited by Aβ, resulting in the abolishment of the cytoprotective function by ABAD against ROS.  These results propose an addnl. role of ABAD in neural cell death in AD: ABAD detoxifies aldehydes, such as 4-HNE derived from lipid peroxides in healthy brains, and inhibited by Aβ in the development of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd49E5QN4nzrVg90H21EOLACvtfcHk0lgjET8M7U45Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFChtL7E&md5=0905b0141ea0a46b33d0de4e91f4906b</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2007.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2007.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DY.%26aulast%3DOhsawa%26aufirst%3DI.%26aulast%3DKasahara%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DCytoprotective%2520role%2520of%2520mitochondrial%2520amyloid%2520beta%2520peptide-binding%2520alcohol%2520dehydrogenase%2520against%2520a%2520cytotoxic%2520aldehyde%26jtitle%3DNeurobiol.%2520Aging%26date%3D2009%26volume%3D30%26spage%3D325%26epage%3D329%26doi%3D10.1016%2Fj.neurobiolaging.2007.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simpkins, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykens, J. A.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial mechanisms of estrogen neuroprotection</span>. <i>Brain Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1016/j.brainresrev.2007.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.brainresrev.2007.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17512984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Srtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=421-430&author=J.+W.+Simpkinsauthor=J.+A.+Dykens&title=Mitochondrial+mechanisms+of+estrogen+neuroprotection&doi=10.1016%2Fj.brainresrev.2007.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial mechanisms of estrogen neuroprotection</span></div><div class="casAuthors">Simpkins, James W.; Dykens, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">421-430</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress, bioenergetic failure and mitochondrial dysfunction are all implicated in the etiol. of neurodegenerative diseases such as Alzheimer's disease (AD).  The mitochondrial involvement in neurodegenerative diseases reflects the regulatory role mitochondrial failure plays in both necrotic cell death and apoptosis.  The potent feminizing hormone, 17 β-estradiol (E2), is neuroprotective in a host of cell and animal models of stroke and neurodegenerative diseases.  The discovery that 17α-estradiol, an isomer of E2, is equally as neuroprotective as E2 yet is > 200-fold less active as a hormone, has permitted development of novel, more potent analogs where neuroprotection is independent of hormonal potency.  Studies of structure-activity relationships and mitochondrial function have led to a mechanistic model in which these steroidal phenols intercalate into cell membranes where they block lipid peroxidn. reactions, and are in turn recycled.  Indeed, the parental estrogens and novel analogs stabilize mitochondria under Ca2+ loading otherwise sufficient to collapse membrane potential.  The neuroprotective and mitoprotective potencies for a series of estrogen analogs are significantly correlated, suggesting that these compds. prevent cell death in large measure by maintaining functionally intact mitochondria.  This therapeutic strategy is germane not only to sudden mitochondrial failure in acute circumstances, such as during a stroke or myocardial infarction, but also to gradual mitochondrial dysfunction assocd. with chronic degenerative disorders such as AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWP8-NuNKvpLVg90H21EOLACvtfcHk0lgjET8M7U45Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Srtbc%253D&md5=c8de974d3a5c3230c04ef17b942cd068</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresrev.2007.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresrev.2007.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DSimpkins%26aufirst%3DJ.%2BW.%26aulast%3DDykens%26aufirst%3DJ.%2BA.%26atitle%3DMitochondrial%2520mechanisms%2520of%2520estrogen%2520neuroprotection%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2008%26volume%3D57%26spage%3D421%26epage%3D430%26doi%3D10.1016%2Fj.brainresrev.2007.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, J.</span></span> <span> </span><span class="NLM_article-title">Estradiol and neurodegenerative oxidative stress</span>. <i>Front. Neuroendocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1016/j.yfrne.2007.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.yfrne.2007.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=18275991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCktLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=463-475&author=J.+Nilsen&title=Estradiol+and+neurodegenerative+oxidative+stress&doi=10.1016%2Fj.yfrne.2007.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Estradiol and neurodegenerative oxidative stress</span></div><div class="casAuthors">Nilsen, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Neuroendocrinology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">463-475</span>CODEN:
                <span class="NLM_cas:coden">FNEDA7</span>;
        ISSN:<span class="NLM_cas:issn">0091-3022</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Estradiol is a potent preventative against neurodegenerative disease, in part, by activating antioxidant defense systems scavenging reactive oxygen species, limiting mitochondrial protein damage, improving electron transport chain activity and reducing mitochondrial DNA damage.  Estradiol also increases the activity of complex IV of the electron transport chain, improving mitochondrial respiration and ATP prodn. under normal and stressful conditions.  However, the high oxidative cellular environment present during neurodegeneration makes estradiol a poor agent for treatment of existing disease.  Oxidative stress stimulates the prodn. of the hydroperoxide-dependent hydroxylation of estradiol to the catecholestrogen metabolites, which can undergo reactive oxygen species producing redox cycling, setting up a self-generating toxic cascade offsetting any antioxidant/antiapoptotic effects generated by the parent estradiol.  Addnl. disease-induced factors can further perpetuate this cycle.  For example dysregulation of the catecholamine system could alter catechol-O-methyltransferase-catalyzed methylation, preventing removal of redox cycling catecholestrogens from the system enhancing pro-oxidant effects of estradiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT0O2NBTuNc7Vg90H21EOLACvtfcHk0lgjET8M7U45Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCktLzK&md5=99788befcd14217abe3f0c5d346232d8</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.yfrne.2007.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yfrne.2007.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DNilsen%26aufirst%3DJ.%26atitle%3DEstradiol%2520and%2520neurodegenerative%2520oxidative%2520stress%26jtitle%3DFront.%2520Neuroendocrinol.%26date%3D2008%26volume%3D29%26spage%3D463%26epage%3D475%26doi%3D10.1016%2Fj.yfrne.2007.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borras, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Grueso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallardo, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vina, J.</span></span> <span> </span><span class="NLM_article-title">Direct antioxidant and protective effect of estradiol on isolated mitochondria</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1802</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2009.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.bbadis.2009.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=19751829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFanurnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1802&publication_year=2010&pages=205-211&author=C.+Borrasauthor=J.+Gambiniauthor=R.+Lopez-Gruesoauthor=F.+V.+Pallardoauthor=J.+Vina&title=Direct+antioxidant+and+protective+effect+of+estradiol+on+isolated+mitochondria&doi=10.1016%2Fj.bbadis.2009.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Direct antioxidant and protective effect of estradiol on isolated mitochondria</span></div><div class="casAuthors">Borras, Consuelo; Gambini, Juan; Lopez-Grueso, Raul; Pallardo, Federico V.; Vina, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1802</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">205-211</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Estrogens have antioxidant properties which are due to their ability to bind to estrogen receptors and to up-regulate the expression of antioxidant enzymes via intracellular signaling pathways.  Mitochondria are key organelles in the development of age-assocd. cellular damage.  Recently, estrogen receptors were identified in mitochondria.  The aim of this paper was to test whether estradiol directly affects mitochondria by preventing oxidative stress and protecting frail mitochondria.  Incubation with estradiol at normal intracellular concns. prevents the formation of reactive oxygen species by mitochondria in a saturable manner.  Moreover, estradiol protects mitochondrial integrity as indicated by an increase in mitochondrial membrane potential.  It also prevents the apoptogenic leakage of cytochrome c from mitochondria and as a result the mitochondrial content of this cytochrome c is maintained high.  Thus, estradiol prevents the onset of the mitochondrial pathway of apoptosis by a direct effect on the organelle.  Genistein, a phytoestrogen present at high concn. in soy, mimics the protective effect of estradiol by both decreasing the rate of formation of reactive oxygen species and preventing the release of cytochrome c from mitochondria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouZCB-G8saELVg90H21EOLACvtfcHk0lgG1Zo4GjRgxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFanurnI&md5=744959a648db8c39bd602e5cf6eab896</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2009.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2009.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DBorras%26aufirst%3DC.%26aulast%3DGambini%26aufirst%3DJ.%26aulast%3DLopez-Grueso%26aufirst%3DR.%26aulast%3DPallardo%26aufirst%3DF.%2BV.%26aulast%3DVina%26aufirst%3DJ.%26atitle%3DDirect%2520antioxidant%2520and%2520protective%2520effect%2520of%2520estradiol%2520on%2520isolated%2520mitochondria%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2010%26volume%3D1802%26spage%3D205%26epage%3D211%26doi%3D10.1016%2Fj.bbadis.2009.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hy, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, D. M.</span></span> <span> </span><span class="NLM_article-title">Prevalence of AD among whites: a summary by levels of severity</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1212/WNL.55.2.198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1212%2FWNL.55.2.198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10908890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD3czpvVaksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2000&pages=198-204&author=L.+X.+Hyauthor=D.+M.+Keller&title=Prevalence+of+AD+among+whites%3A+a+summary+by+levels+of+severity&doi=10.1212%2FWNL.55.2.198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of AD among whites: a summary by levels of severity</span></div><div class="casAuthors">Hy L X; Keller D M</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">198-204</span>
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    </div><div class="casAbstract">OBJECTIVE:  To determine age- and sex-specific AD prevalence rates for whites using each of four severity-based definitions of a case: a person diagnosed as having at least questionable AD, one diagnosed as having at least mild AD, one diagnosed as having moderate or severe AD, and one diagnosed as having severe AD.  METHODS:  Data from 21 studies of Europeans and North Americans were pooled.  RESULTS:  Empirically, one study, from East Boston, is an outlier.  Applied to the US population of 1996, the obtained estimates yield a prevalence of 1.7 to 1.9 million cases, depending on whether the outlier study is excluded or included.  CONCLUSIONS:  With disease severity taken into account, estimates of AD prevalence from white populations are more consistent than is usually acknowledged.  By including disease severity in the case definition, variations in reported rates are much reduced.  The outlier status of the East Boston study appears to result from the use of a definition of AD that differs from that used in the other 20 studies.  Alternative explanations of the discrepancy between these estimates and the common estimate of 4 million cases are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7AokzmMvbnEloaUqgkFHkfW6udTcc2ebjwzRDiw8Py7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3czpvVaksw%253D%253D&md5=8c568009d12cc64cfd953d41d02cfa2d</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1212%2FWNL.55.2.198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.55.2.198%26sid%3Dliteratum%253Aachs%26aulast%3DHy%26aufirst%3DL.%2BX.%26aulast%3DKeller%26aufirst%3DD.%2BM.%26atitle%3DPrevalence%2520of%2520AD%2520among%2520whites%253A%2520a%2520summary%2520by%2520levels%2520of%2520severity%26jtitle%3DNeurology%26date%3D2000%26volume%3D55%26spage%3D198%26epage%3D204%26doi%3D10.1212%2FWNL.55.2.198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corder, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghebremedhin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thal, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohm, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braak, H.</span></span> <span> </span><span class="NLM_article-title">The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>1019</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1196/annals.1297.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1196%2Fannals.1297.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1019&publication_year=2004&pages=24-28&author=E.+H.+Corderauthor=E.+Ghebremedhinauthor=M.+G.+Taylorauthor=D.+R.+Thalauthor=T.+G.+Ohmauthor=H.+Braak&title=The+biphasic+relationship+between+regional+brain+senile+plaque+and+neurofibrillary+tangle+distributions%3A+modification+by+age%2C+sex%2C+and+APOE+polymorphism&doi=10.1196%2Fannals.1297.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1196%2Fannals.1297.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1297.005%26sid%3Dliteratum%253Aachs%26aulast%3DCorder%26aufirst%3DE.%2BH.%26aulast%3DGhebremedhin%26aufirst%3DE.%26aulast%3DTaylor%26aufirst%3DM.%2BG.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DOhm%26aufirst%3DT.%2BG.%26aulast%3DBraak%26aufirst%3DH.%26atitle%3DThe%2520biphasic%2520relationship%2520between%2520regional%2520brain%2520senile%2520plaque%2520and%2520neurofibrillary%2520tangle%2520distributions%253A%2520modification%2520by%2520age%252C%2520sex%252C%2520and%2520APOE%2520polymorphism%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D1019%26spage%3D24%26epage%3D28%26doi%3D10.1196%2Fannals.1297.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borrás, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Sala, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloret, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallardó, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viña, J.</span></span> <span> </span><span class="NLM_article-title">Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.1016/S0891-5849(02)01356-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS0891-5849%2802%2901356-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12614843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsVant7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=546-552&author=C.+Borr%C3%A1sauthor=J.+Sastreauthor=D.+Garc%C3%ADa-Salaauthor=A.+Lloretauthor=F.+V.+Pallard%C3%B3author=J.+Vi%C3%B1a&title=Mitochondria+from+females+exhibit+higher+antioxidant+gene+expression+and+lower+oxidative+damage+than+males&doi=10.1016%2FS0891-5849%2802%2901356-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males</span></div><div class="casAuthors">Borras, Consuelo; Sastre, Juan; Garcia-Sala, David; Lloret, Ana; Pallardo, Federico V.; Vina, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">546-552</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">We have investigated the differential mitochondrial oxidative stress between males and females to understand the mol. mechanisms enabling females to live longer than males.  Mitochondria are a major source of free radicals in cells.  Those from female rats generate half the amt. of peroxides than those of males.  This does not occur in ovariectomized animals.  Estrogen replacement therapy prevents the effect of ovariectomy.  Mitochondria from females have higher levels of reduced glutathione than those from males.  Those from ovariectomized rats have similar levels to males, and estrogen therapy prevents the fall in glutathione levels that occurs in ovariectomized animals.  Oxidative damage to mitochondrial DNA in males is 4-fold higher than that in females.  This is due to higher expression and activities of Mn-superoxide dismutase and of glutathione peroxidase in females, which behave as double transgenics overexpressing superoxide dismutase and glutathione peroxidase, conferring protection against free-radical-mediated damage in aging.  Moreover, 16S rRNA expression, which decreases significantly with aging, is four times higher in mitochondria from females than in those from males of the same chronol. age.  The facts reported here provide mol. evidence to explain the different life span in males and females.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnryDgHoXOcbVg90H21EOLACvtfcHk0lhdxY5TzHK92A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsVant7c%253D&md5=69135f8b531bc7036184ea60f50faedc</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2802%2901356-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252802%252901356-4%26sid%3Dliteratum%253Aachs%26aulast%3DBorr%25C3%25A1s%26aufirst%3DC.%26aulast%3DSastre%26aufirst%3DJ.%26aulast%3DGarc%25C3%25ADa-Sala%26aufirst%3DD.%26aulast%3DLloret%26aufirst%3DA.%26aulast%3DPallard%25C3%25B3%26aufirst%3DF.%2BV.%26aulast%3DVi%25C3%25B1a%26aufirst%3DJ.%26atitle%3DMitochondria%2520from%2520females%2520exhibit%2520higher%2520antioxidant%2520gene%2520expression%2520and%2520lower%2520oxidative%2520damage%2520than%2520males%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2003%26volume%3D34%26spage%3D546%26epage%3D552%26doi%3D10.1016%2FS0891-5849%2802%2901356-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coote, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F. J.</span></span> <span> </span><span class="NLM_article-title">Interaction of amyloid binding alcohol dehydrogenase/Aβ mediates up-regulation of peroxiredoxin II in the brains of Alzheimer’s disease patients and a transgenic Alzheimer’s disease mouse model</span>. <i>Mol. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1016/j.mcn.2007.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.mcn.2007.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17490890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVOksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=377-382&author=J.+Yaoauthor=M.+Taylorauthor=F.+Daveyauthor=Y.+Renauthor=J.+Aitonauthor=P.+Cooteauthor=F.+Fangauthor=J.+X.+Chenauthor=S.+D.+Yanauthor=F.+J.+Gunn-Moore&title=Interaction+of+amyloid+binding+alcohol+dehydrogenase%2FA%CE%B2+mediates+up-regulation+of+peroxiredoxin+II+in+the+brains+of+Alzheimer%E2%80%99s+disease+patients+and+a+transgenic+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1016%2Fj.mcn.2007.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of amyloid binding alcohol dehydrogenase/Aβ mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model</span></div><div class="casAuthors">Yao, Jun; Taylor, Margaret; Davey, Fleur; Ren, Yimin; Aiton, Jim; Coote, Peter; Fang, Fang; Chen, John Xi; Yan, Shi Du; Gunn-Moore, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">377-382</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alzheimer's patients have increased levels of both the 42 beta amyloid-β-peptide (Aβ) and amyloid binding alc. dehydrogenase (ABAD) which is an intracellular binding site for Aβ.  The over-expression of Aβ and ABAD in transgenic mice has shown that the binding of Aβ to ABAD results in exaggerating neuronal stress and impairment of learning and memory.  From a proteomic anal. of the brains from these animals the authors identified that peroxiredoxin II levels increase in Alzheimer's diseased brain.  This increase in peroxiredoxin II levels protects neurons against Aβ induced toxicity.  The authors also demonstrate, for the first time in living animals, that the expression level of peroxiredoxin II is an indicator for the interaction of ABAD and Aβ as its expression levels return to normal if this interaction is perturbed.  Therefore this indicates the possibility of reversing changes obsd. in Alzheimer's disease and that the Aβ-ABAD interaction is a suitable drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6lUam7lMLrrVg90H21EOLACvtfcHk0lhdxY5TzHK92A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVOksLg%253D&md5=6dd751b16e28568c8a3e31657e87a391</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2007.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2007.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DDavey%26aufirst%3DF.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DAiton%26aufirst%3DJ.%26aulast%3DCoote%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DJ.%2BX.%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DGunn-Moore%26aufirst%3DF.%2BJ.%26atitle%3DInteraction%2520of%2520amyloid%2520binding%2520alcohol%2520dehydrogenase%252FA%25CE%25B2%2520mediates%2520up-regulation%2520of%2520peroxiredoxin%2520II%2520in%2520the%2520brains%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%2520and%2520a%2520transgenic%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2007%26volume%3D35%26spage%3D377%26epage%3D382%26doi%3D10.1016%2Fj.mcn.2007.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pei, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundke-Iqbal, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdanovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winblad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowburn, R. F.</span></span> <span> </span><span class="NLM_article-title">Accumulation of cyclin-dependent kinase 5 (Cdk5) in neurons with early stages of Alzheimer’s disease neurofibrillary degeneration</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>797</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1016/S0006-8993(98)00296-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS0006-8993%2898%2900296-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=9666145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFOjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=797&publication_year=1998&pages=267-277&author=J.-J.+Peiauthor=I.+Grundke-Iqbalauthor=K.+Iqbalauthor=N.+Bogdanovicauthor=B.+Winbladauthor=R.+F.+Cowburn&title=Accumulation+of+cyclin-dependent+kinase+5+%28Cdk5%29+in+neurons+with+early+stages+of+Alzheimer%E2%80%99s+disease+neurofibrillary+degeneration&doi=10.1016%2FS0006-8993%2898%2900296-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration</span></div><div class="casAuthors">Pei, Jin-Jing; Grundke-Iqbal, Inge; Iqbal, Khalid; Bogdanovic, Nenad; Winblad, Bengt; Cowburn, Richard F.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">797</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-277</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Cyclin-dependent kinase 5 (cdk5) is one of the candidate kinases involved in the abnormal hyperphosphorylation of tau.  To have a direct effect on tau hyperphosphorylation, cdk5 protein levels and enzyme activity should be upregulated in esp. those neurons that develop neurofibrillary tangles (NFTs).  The authors studied the distribution of cdk5 immunoreactivity in neurons with or without early- and late-stage NFTs in hippocampal, entorhinal, transentorhinal, temporal and frontal cortices, and cerebellum of Alzheimer's disease (AD) and control brain.  The immunocytochem. localization of cdk5 was compared with that obtained using antibodies to PHF-tau (tau in paired helical filaments of NFTs, mAb AT8) and ubiquitin as markers of early and late stage NFTs, resp.  Immunoreactivities of cdk5 and PHF-tau were found in neuronal perikarya and processes of hippocampal, entorhinal, transentorhinal, temporal and frontal, and cerebellar cortices.  An apparent increase of cdk5 immunoreactivity was seen in pretangle neurons and in neurons bearing early stage NFTs.  These findings suggest that this kinase might be involved in the formation of NFTs at a relatively early stage in the neocortex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpVMpfGtv2I7Vg90H21EOLACvtfcHk0ligxiKKGXKfRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFOjsb4%253D&md5=c74e8a03eadfd368ef6e70a25c311237</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2898%2900296-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252898%252900296-0%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DJ.-J.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DBogdanovic%26aufirst%3DN.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DCowburn%26aufirst%3DR.%2BF.%26atitle%3DAccumulation%2520of%2520cyclin-dependent%2520kinase%25205%2520%2528Cdk5%2529%2520in%2520neurons%2520with%2520early%2520stages%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520neurofibrillary%2520degeneration%26jtitle%3DBrain%2520Res.%26date%3D1998%26volume%3D797%26spage%3D267%26epage%3D277%26doi%3D10.1016%2FS0006-8993%2898%2900296-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swatton, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faull, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iritani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahn, S.</span></span> <span> </span><span class="NLM_article-title">Increased MAP kinase activity in Alzheimer’s and down syndrome but not in schizophrenia human brain</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2711</span>– <span class="NLM_lpage">2719</span>, <span class="refDoi"> DOI: 10.1111/j.0953-816X.2004.03365.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1111%2Fj.0953-816X.2004.03365.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15147305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD2c3kvFygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=2711-2719&author=J.+E.+Swattonauthor=L.+A.+Sellersauthor=R.+L.+M.+Faullauthor=A.+Hollandauthor=S.+Iritaniauthor=S.+Bahn&title=Increased+MAP+kinase+activity+in+Alzheimer%E2%80%99s+and+down+syndrome+but+not+in+schizophrenia+human+brain&doi=10.1111%2Fj.0953-816X.2004.03365.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain</span></div><div class="casAuthors">Swatton Jane E; Sellers Lynda A; Faull Richard L M; Holland Anthony; Iritani Shuji; Bahn Sabine</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2711-9</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Abnormal phosphorylation of tau is a feature of Alzheimer's disease (AD), which develops prematurely in Down syndrome (DS) patients.  Cognitive impairment is also recognized as a clinical characteristic of schizophrenia, which does not appear to be associated with tau-aggregate formation.  Several kinases can phosphorylate tau in cell-free assays.  Here we show increased activity of mitogen-activated protein kinases (MAPKs) (including ERK1/2, SAPKs and p38) in post mortem AD and DS brains, which could not be accounted for by expression changes.  In contrast, glycogen synthase kinase-3 activity (GSK-3 alpha beta) was reduced significantly.  Examination of tau in AD and DS using antibodies selective for MAPK phosphorylation sites showed increased immunoreactivity.  In addition, phosphorylation of S(199), reportedly a selective substrate for cyclin-dependent kinase-5 (cdk5) or GSK-3 alpha beta was only observed in AD samples, which showed a concomitant increase in the expression of p25, the enhancing cofactor for cdk5 activity.  However, in schizophrenia brain, MAPK-phosphorylated tau was unchanged compared to matched controls, despite similar expression levels to those in AD.  The activities of the MAPKs and GSK-3 alpha beta were also unchanged.  These data demonstrate that in AD and DS, enhanced MAPK activity, which has an established role in regulating neuronal plasticity and survival, can account for irregular tau phosphorylation, and that the molecular processes involved in these neurodegenerative disorders are distinct from those in schizophrenia.  These data also question the significance of GSK-3 alpha beta, as much previous work carried out in vitro has placed this kinase as a favoured candidate for involvement in the pathological phosphorylation of tau.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRV8rechdy1IXELvajU9pjPfW6udTcc2eZm9tsidyKNS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3kvFygtg%253D%253D&md5=8760fef23803bbc0ceac5597a85d6cb9</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1111%2Fj.0953-816X.2004.03365.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.0953-816X.2004.03365.x%26sid%3Dliteratum%253Aachs%26aulast%3DSwatton%26aufirst%3DJ.%2BE.%26aulast%3DSellers%26aufirst%3DL.%2BA.%26aulast%3DFaull%26aufirst%3DR.%2BL.%2BM.%26aulast%3DHolland%26aufirst%3DA.%26aulast%3DIritani%26aufirst%3DS.%26aulast%3DBahn%26aufirst%3DS.%26atitle%3DIncreased%2520MAP%2520kinase%2520activity%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520down%2520syndrome%2520but%2520not%2520in%2520schizophrenia%2520human%2520brain%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2004%26volume%3D19%26spage%3D2711%26epage%3D2719%26doi%3D10.1111%2Fj.0953-816X.2004.03365.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashidian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mount, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleyasin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsanejad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousseaux, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slack, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woulfe, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, D. S.</span></span> <span> </span><span class="NLM_article-title">Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and parkinson’s disease</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2007.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.neuron.2007.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17610816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1eltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=37-52&author=D.+Quauthor=J.+Rashidianauthor=M.+P.+Mountauthor=H.+Aleyasinauthor=M.+Parsanejadauthor=A.+Liraauthor=E.+Haqueauthor=Y.+Zhangauthor=S.+Callaghanauthor=M.+Daigleauthor=M.+W.+Rousseauxauthor=R.+S.+Slackauthor=P.+R.+Albertauthor=I.+Vincentauthor=J.+M.+Woulfeauthor=D.+S.+Park&title=Role+of+Cdk5-mediated+phosphorylation+of+Prx2+in+MPTP+toxicity+and+parkinson%E2%80%99s+disease&doi=10.1016%2Fj.neuron.2007.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease</span></div><div class="casAuthors">Qu, Dianbo; Rashidian, Juliet; Mount, Matthew P.; Aleyasin, Hossein; Parsanejad, Mohammad; Lira, Arman; Haque, Emdadul; Zhang, Yi; Callaghan, Steve; Daigle, Mireille; Rousseaux, Maxime W. C.; Slack, Ruth S.; Albert, Paul R.; Vincent, Inez; Woulfe, John M.; Park, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-52</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We reported previously that calpain-mediated Cdk5 activation is crit. for mitochondrial toxin-induced dopaminergic death.  Here, we report a target that mediates this loss.  Prx2, an antioxidant enzyme, binds Cdk5/p35.  Prx2 is phosphorylated at T89 in neurons treated with MPP+ and/or MPTP in animals in a calpain/Cdk5/p35-dependent manner.  This phosphorylation reduces Prx2 peroxidase activity.  Consistent with this, p35-/- neurons show reduced oxidative stress upon MPP+ treatment.  Expression of Prx2 and Prx2T89A, but not the phosphorylation mimic Prx2T89E, protects cultured and adult neurons following mitochondrial insult.  Finally, downregulation of Prx2 increases oxidative stress and sensitivity to MPP+.  We propose a mechanistic model by which mitochondrial toxin leads to calpain-mediated Cdk5 activation, reduced Prx2 activity, and decreased capacity to eliminate ROS.  Importantly, increased Prx2 phosphorylation also occurs in nigral neurons from postmortem tissue from Parkinson's disease patients when compared to control, suggesting the relevance of this pathway in the human condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6qVdsMNGrP7Vg90H21EOLACvtfcHk0lh6vPlvFsjePA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1eltro%253D&md5=b7dd368d334fbbcdcae8d9ee573fbad0</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2007.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2007.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DD.%26aulast%3DRashidian%26aufirst%3DJ.%26aulast%3DMount%26aufirst%3DM.%2BP.%26aulast%3DAleyasin%26aufirst%3DH.%26aulast%3DParsanejad%26aufirst%3DM.%26aulast%3DLira%26aufirst%3DA.%26aulast%3DHaque%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCallaghan%26aufirst%3DS.%26aulast%3DDaigle%26aufirst%3DM.%26aulast%3DRousseaux%26aufirst%3DM.%2BW.%26aulast%3DSlack%26aufirst%3DR.%2BS.%26aulast%3DAlbert%26aufirst%3DP.%2BR.%26aulast%3DVincent%26aufirst%3DI.%26aulast%3DWoulfe%26aufirst%3DJ.%2BM.%26aulast%3DPark%26aufirst%3DD.%2BS.%26atitle%3DRole%2520of%2520Cdk5-mediated%2520phosphorylation%2520of%2520Prx2%2520in%2520MPTP%2520toxicity%2520and%2520parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2007%26volume%3D55%26spage%3D37%26epage%3D52%26doi%3D10.1016%2Fj.neuron.2007.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kjaerulff, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, A.</span></span> <span> </span><span class="NLM_article-title">The structure and function of endophilin proteins</span>. <i>Cell Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1007/s12013-010-9137-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1007%2Fs12013-010-9137-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=21184288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntlagtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=137-154&author=O.+Kjaerulffauthor=L.+Brodinauthor=A.+Jung&title=The+structure+and+function+of+endophilin+proteins&doi=10.1007%2Fs12013-010-9137-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">The structure and function of endophilin proteins</span></div><div class="casAuthors">Kjaerulff, Ole; Brodin, Lennart; Jung, Anita</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-154</span>CODEN:
                <span class="NLM_cas:coden">CBBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1085-9195</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Members of the BAR domain protein superfamily are essential elements of cellular traffic.  Endophilins are among the best studied BAR domain proteins.  They have a prominent function in synaptic vesicle endocytosis (SVE), receptor trafficking, and apoptosis, and in other processes that require remodeling of the membrane structure.  Here, the authors discuss the role of endophilins in these processes and summarize novel insights into the mol. aspects of endophilin function.  The authors also discuss the phosphorylation of endophilins and how this and other mechanisms may contribute to disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWGbvSQ1NdGbVg90H21EOLACvtfcHk0lh6vPlvFsjePA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntlagtLY%253D&md5=1b7bd3a1669b1e69d33df4f78cf12617</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1007%2Fs12013-010-9137-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12013-010-9137-5%26sid%3Dliteratum%253Aachs%26aulast%3DKjaerulff%26aufirst%3DO.%26aulast%3DBrodin%26aufirst%3DL.%26aulast%3DJung%26aufirst%3DA.%26atitle%3DThe%2520structure%2520and%2520function%2520of%2520endophilin%2520proteins%26jtitle%3DCell%2520Biochem.%2520Biophys.%26date%3D2011%26volume%3D60%26spage%3D137%26epage%3D154%26doi%3D10.1007%2Fs12013-010-9137-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reutens, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, C. G.</span></span> <span> </span><span class="NLM_article-title">Endophilin-1: a multifunctional protein</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1173</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi"> DOI: 10.1016/S1357-2725(02)00063-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS1357-2725%2802%2900063-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12127567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVOmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=1173-1177&author=A.+T.+Reutensauthor=C.+G.+Begley&title=Endophilin-1%3A+a+multifunctional+protein&doi=10.1016%2FS1357-2725%2802%2900063-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Endophilin-1: a multifunctional protein</span></div><div class="casAuthors">Reutens, Anne T.; Glenn Begley, C.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1173-1177</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Endophilin-1, a cytoplasmic Src homol. 3 (SH3) domain-contg. protein, localizes in brain presynaptic nerve termini.  Endophilin dimerizes through its N-terminus, and participates at multiple stages in clathrin-coated endocytosis, from early membrane invagination to synaptic vesicle uncoating.  Both its C-terminal SH3 domain and N-terminus are required for endocytosis.  Through its SH3 domain, endophilin bound to proline-rich domains (PRDs) in other endocytic proteins, including synaptojanin and dynamin.  The N-terminal region possesses unique functions affecting lipid membrane curvature, through lysophosphatidic acid acyl transferase (LPAAT) activity and direct binding and tubulating activity.  In addn. to synaptic vesicle formation, endophilin-1 complexes with signaling mols., including cell surface receptors, metalloprotease disintegrins and germinal center kinase-like kinase (GLK).  Therefore, endophilin-1 may serve to couple vesicle biogenesis with intracellular signaling cascades.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUYzr1Fq4AFrVg90H21EOLACvtfcHk0lh6vPlvFsjePA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVOmsrw%253D&md5=d8e1191bc4a302a24a6b1427085a259f</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2FS1357-2725%2802%2900063-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-2725%252802%252900063-8%26sid%3Dliteratum%253Aachs%26aulast%3DReutens%26aufirst%3DA.%2BT.%26aulast%3DBegley%26aufirst%3DC.%2BG.%26atitle%3DEndophilin-1%253A%2520a%2520multifunctional%2520protein%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2002%26volume%3D34%26spage%3D1173%26epage%3D1177%26doi%3D10.1016%2FS1357-2725%2802%2900063-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coote, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F. J.</span></span> <span> </span><span class="NLM_article-title">Endophilin I expression is increased in the brains of Alzheimer disease patients</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">5685</span>– <span class="NLM_lpage">5691</span>, <span class="refDoi"> DOI: 10.1074/jbc.M707932200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1074%2Fjbc.M707932200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=5685-5691&author=Y.+Renauthor=H.+W.+Xuauthor=F.+Daveyauthor=M.+Taylorauthor=J.+Aitonauthor=P.+Cooteauthor=F.+Fangauthor=J.+Yaoauthor=D.+Chenauthor=J.+X.+Chenauthor=S.+D.+Yanauthor=F.+J.+Gunn-Moore&title=Endophilin+I+expression+is+increased+in+the+brains+of+Alzheimer+disease+patients&doi=10.1074%2Fjbc.M707932200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M707932200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M707932200%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DH.%2BW.%26aulast%3DDavey%26aufirst%3DF.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DAiton%26aufirst%3DJ.%26aulast%3DCoote%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DJ.%2BX.%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DGunn-Moore%26aufirst%3DF.%2BJ.%26atitle%3DEndophilin%2520I%2520expression%2520is%2520increased%2520in%2520the%2520brains%2520of%2520Alzheimer%2520disease%2520patients%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D5685%26epage%3D5691%26doi%3D10.1074%2Fjbc.M707932200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramjaun, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legendre-Guillemin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, P. S.</span></span> <span> </span><span class="NLM_article-title">Endophilin regulates JNK activation through its interaction with the germinal center kinase-like kinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">28913</span>– <span class="NLM_lpage">28919</span>, <span class="refDoi"> DOI: 10.1074/jbc.M103198200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1074%2Fjbc.M103198200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=28913-28919&author=A.+R.+Ramjaunauthor=A.+Angersauthor=V.+Legendre-Guilleminauthor=X.+K.+Tongauthor=P.+S.+McPherson&title=Endophilin+regulates+JNK+activation+through+its+interaction+with+the+germinal+center+kinase-like+kinase&doi=10.1074%2Fjbc.M103198200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M103198200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M103198200%26sid%3Dliteratum%253Aachs%26aulast%3DRamjaun%26aufirst%3DA.%2BR.%26aulast%3DAngers%26aufirst%3DA.%26aulast%3DLegendre-Guillemin%26aufirst%3DV.%26aulast%3DTong%26aufirst%3DX.%2BK.%26aulast%3DMcPherson%26aufirst%3DP.%2BS.%26atitle%3DEndophilin%2520regulates%2520JNK%2520activation%2520through%2520its%2520interaction%2520with%2520the%2520germinal%2520center%2520kinase-like%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D28913%26epage%3D28919%26doi%3D10.1074%2Fjbc.M103198200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diener, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keesler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Z.</span></span> <span> </span><span class="NLM_article-title">Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">9687</span>– <span class="NLM_lpage">9692</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.18.9687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1073%2Fpnas.94.18.9687" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=9687-9692&author=K.+Dienerauthor=X.+S.+Wangauthor=C.+Chenauthor=C.+F.+Meyerauthor=G.+Keeslerauthor=M.+Zukowskiauthor=T.+Tanauthor=Z.+Yao&title=Activation+of+the+c-Jun+N-terminal+kinase+pathway+by+a+novel+protein+kinase+related+to+human+germinal+center+kinase&doi=10.1073%2Fpnas.94.18.9687"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.18.9687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.18.9687%26sid%3Dliteratum%253Aachs%26aulast%3DDiener%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%2BS.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DMeyer%26aufirst%3DC.%2BF.%26aulast%3DKeesler%26aufirst%3DG.%26aulast%3DZukowski%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DT.%26aulast%3DYao%26aufirst%3DZ.%26atitle%3DActivation%2520of%2520the%2520c-Jun%2520N-terminal%2520kinase%2520pathway%2520by%2520a%2520novel%2520protein%2520kinase%2520related%2520to%2520human%2520germinal%2520center%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D9687%26epage%3D9692%26doi%3D10.1073%2Fpnas.94.18.9687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mehan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meena, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankhla, R.</span></span> <span> </span><span class="NLM_article-title">JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer’s and various neurodegenerative abnormalities</span>. <i>J. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">376</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1007/s12031-010-9454-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1007%2Fs12031-010-9454-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=20878262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1KiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=376-390&author=S.+Mehanauthor=H.+Meenaauthor=D.+Sharmaauthor=R.+Sankhla&title=JNK%3A+a+stress-activated+protein+kinase+therapeutic+strategies+and+involvement+in+Alzheimer%E2%80%99s+and+various+neurodegenerative+abnormalities&doi=10.1007%2Fs12031-010-9454-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">JNK: A Stress-Activated Protein Kinase Therapeutic Strategies and Involvement in Alzheimer's and Various Neurodegenerative Abnormalities</span></div><div class="casAuthors">Mehan, Sidharth; Meena, Harikesh; Sharma, Deepak; Sankhla, Rameshwar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">376-390</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  The c-Jun N-terminal kinase (JNKs), also known as stress-activated protein kinase (SAPK), is one such family of multifunctional-signaling mols., activated in response to wide range of cellular stresses as well as in response to inflammatory mediators.  JNKs regulate various processes such as brain development, repair, and memory formation; but on the other hand, JNKs are potent effectors of neuroinflammation and neuronal death.  A large body of evidence indicates that JNK activity is crit. for normal immune and inflammatory response.  Indeed, aberrant activation of JNK was implicated in the pathogenesis of Alzheimer's disease.  Moreover, the JNK pathway is considered to be a key regulator of various inflammatory pathways which are activated during normal aging and Alzheimer's disease therapy as well as key regulator of pro-inflammatory cytokines biosynthesis at the transcriptional and translational levels, which makes different components of these pathway potential targets for the treatment of autoimmune and inflammatory diseases.  Pharmacol. inhibition of JNK was demonstrated to attenuate microglial activation and the release of neurotoxic chems. including pro-inflammatory cytokines.  In this review, we provide an overview on implications and therapeutic strategies of JNK in neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogA33KBGCnFbVg90H21EOLACvtfcHk0lgB3Oyzdk_p4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1KiurY%253D&md5=b78c940bd4df0a03a64493bcbe90af26</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1007%2Fs12031-010-9454-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12031-010-9454-6%26sid%3Dliteratum%253Aachs%26aulast%3DMehan%26aufirst%3DS.%26aulast%3DMeena%26aufirst%3DH.%26aulast%3DSharma%26aufirst%3DD.%26aulast%3DSankhla%26aufirst%3DR.%26atitle%3DJNK%253A%2520a%2520stress-activated%2520protein%2520kinase%2520therapeutic%2520strategies%2520and%2520involvement%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520various%2520neurodegenerative%2520abnormalities%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2011%26volume%3D43%26spage%3D376%26epage%3D390%26doi%3D10.1007%2Fs12031-010-9454-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klunk, W. E.</span></span> <span> </span><span class="NLM_article-title">Imaging β-amyloid plaques and neurofibrillary tangles in the aging human brain</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1469</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.2174/1381612043384772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F1381612043384772" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1469-1492&author=C.+A.+Mathisauthor=Y.+Wangauthor=W.+E.+Klunk&title=Imaging+%CE%B2-amyloid+plaques+and+neurofibrillary+tangles+in+the+aging+human+brain&doi=10.2174%2F1381612043384772"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.2174%2F1381612043384772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043384772%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DImaging%2520%25CE%25B2-amyloid%2520plaques%2520and%2520neurofibrillary%2520tangles%2520in%2520the%2520aging%2520human%2520brain%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D1469%26epage%3D1492%26doi%3D10.2174%2F1381612043384772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Froemming, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sames, D.</span></span> <span> </span><span class="NLM_article-title">Harnessing functional plasticity of enzymes: a fluorogenic probe for imaging 17β-HSD10 dehydrogenase, an enzyme involved in Alzheimer’s and parkinson’s diseases</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">14518</span>– <span class="NLM_lpage">14522</span>, <span class="refDoi"> DOI: 10.1021/ja072601x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja072601x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=14518-14522&author=M.+K.+Froemmingauthor=D.+Sames&title=Harnessing+functional+plasticity+of+enzymes%3A+a+fluorogenic+probe+for+imaging+17%CE%B2-HSD10+dehydrogenase%2C+an+enzyme+involved+in+Alzheimer%E2%80%99s+and+parkinson%E2%80%99s+diseases&doi=10.1021%2Fja072601x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fja072601x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja072601x%26sid%3Dliteratum%253Aachs%26aulast%3DFroemming%26aufirst%3DM.%2BK.%26aulast%3DSames%26aufirst%3DD.%26atitle%3DHarnessing%2520functional%2520plasticity%2520of%2520enzymes%253A%2520a%2520fluorogenic%2520probe%2520for%2520imaging%252017%25CE%25B2-HSD10%2520dehydrogenase%252C%2520an%2520enzyme%2520involved%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520parkinson%25E2%2580%2599s%2520diseases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D14518%26epage%3D14522%26doi%3D10.1021%2Fja072601x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muirhead, K. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froemming, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musilek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sames, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F. J.</span></span> <span> </span><span class="NLM_article-title">(−)-CHANA, a fluorogenic probe for detecting amyloid binding alcohol dehydrogenase HSD10 activity in living cells</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1105</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.1021/cb100199m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100199m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1105-1114&author=K.+E.+A.+Muirheadauthor=M.+Froemmingauthor=X.+Liauthor=K.+Musilekauthor=S.+J.+Conwayauthor=D.+Samesauthor=F.+J.+Gunn-Moore&title=%28%E2%88%92%29-CHANA%2C+a+fluorogenic+probe+for+detecting+amyloid+binding+alcohol+dehydrogenase+HSD10+activity+in+living+cells&doi=10.1021%2Fcb100199m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fcb100199m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100199m%26sid%3Dliteratum%253Aachs%26aulast%3DMuirhead%26aufirst%3DK.%2BE.%2BA.%26aulast%3DFroemming%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DMusilek%26aufirst%3DK.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DSames%26aufirst%3DD.%26aulast%3DGunn-Moore%26aufirst%3DF.%2BJ.%26atitle%3D%2528%25E2%2588%2592%2529-CHANA%252C%2520a%2520fluorogenic%2520probe%2520for%2520detecting%2520amyloid%2520binding%2520alcohol%2520dehydrogenase%2520HSD10%2520activity%2520in%2520living%2520cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D1105%26epage%3D1114%26doi%3D10.1021%2Fcb100199m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hroch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolezal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musilek, K.</span></span> <span> </span><span class="NLM_article-title">Benzothiazoles - scaffold of interest for CNS targeted drugs</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.2174/0929867322666141212120631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F0929867322666141212120631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=25515509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=730-747&author=L.+Hrochauthor=L.+Aitkenauthor=O.+Benekauthor=M.+Dolezalauthor=K.+Kucaauthor=F.+Gunn-Mooreauthor=K.+Musilek&title=Benzothiazoles+-+scaffold+of+interest+for+CNS+targeted+drugs&doi=10.2174%2F0929867322666141212120631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Benzothiazoles - Scaffold of Interest for CNS Targeted Drugs</span></div><div class="casAuthors">Hroch, Lukas; Aitken, Laura; Benek, Ondrej; Dolezal, Martin; Kuca, Kamil; Gunn-Moore, Frank; Musilek, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">730-747</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Benzothiazole compds. represent heterocyclic systems comprising a benzene ring fused with a thiazole ring contg. nitrogen and sulfur in its structure.  Besides the presence of a benzothiazole core in naturally occurring mols., synthesized compds. contg. a benzothiazole moiety in their structure proved to be a significant class of potential therapeutics, as they exhibit biol. effects such as antitumor, antibacterial, antitubercular, antiviral, anthelmintic, antidiabetic and many others.  Apart from the aforementioned peripheral or microbial active sites, benzothiazole analogs are also biol. active compds. in the central nervous system, where some approved drugs contg. a benzothiazole moiety have already been identified and are used in the treatment of various neurol. disorders.  New benzothiazole mols. are currently under development and are being evaluated for several uses including diagnostics and as therapeutic drug candidates for the treatment of epilepsy and neurodegenerative diseases such as Alzheimer's disease, Huntington's disease and amyotrophic lateral sclerosis amongst others.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL0PHaGhRsPrVg90H21EOLACvtfcHk0lin_FSqbHESqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKiu7c%253D&md5=bc4f88a2a6020eabbe4b67b54d26b155</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.2174%2F0929867322666141212120631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666141212120631%26sid%3Dliteratum%253Aachs%26aulast%3DHroch%26aufirst%3DL.%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DBenek%26aufirst%3DO.%26aulast%3DDolezal%26aufirst%3DM.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DMusilek%26aufirst%3DK.%26atitle%3DBenzothiazoles%2520-%2520scaffold%2520of%2520interest%2520for%2520CNS%2520targeted%2520drugs%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D730%26epage%3D747%26doi%3D10.2174%2F0929867322666141212120631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mensah-Nyagan, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villafranca, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ittner, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotz, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e28887</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0028887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1371%2Fjournal.pone.0028887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=22174920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslKj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e28887&author=Y.+A.+Limauthor=A.+Grimmauthor=M.+Gieseauthor=A.+G.+Mensah-Nyaganauthor=J.+E.+Villafrancaauthor=L.+M.+Ittnerauthor=A.+Eckertauthor=J.+Gotz&title=Inhibition+of+the+mitochondrial+enzyme+ABAD+restores+the+amyloid-%CE%B2-mediated+deregulation+of+estradiol&doi=10.1371%2Fjournal.pone.0028887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol</span></div><div class="casAuthors">Lim, Yun-An; Grimm, Amandine; Giese, Maria; Mensah-Nyagan, Ayikoe Guy; Villafranca, J. Ernest; Ittner, Lars M.; Eckert, Anne; Gotz, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e28887</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a conformational disease that is characterized by amyloid-β (Aβ) deposition in the brain.  Aβ exerts its toxicity in part by receptor-mediated interactions that cause down-stream protein misfolding and aggregation, as well as mitochondrial dysfunction.  Recent reports indicate that Aβ may also interact directly with intracellular proteins such as the mitochondrial enzyme ABAD (Aβ binding alc. dehydrogenase) in executing its toxic effects.  Mitochondrial dysfunction occurs early in AD, and Aβ's toxicity is in part mediated by inhibition of ABAD as shown previously with an ABAD decoy peptide.  Here, we employed AG18051, a novel small ABAD-specific compd. inhibitor, to investigate the role of ABAD in Aβ toxicity.  Using SH-SY5Y neuroblastoma cells, we found that AG18051 partially blocked the Aβ-ABAD interaction in a pull-down assay while it also prevented the Aβ42-induced down-regulation of ABAD activity, as measured by levels of estradiol, a known hormone and product of ABAD activity.  Furthermore, AG18051 is protective against Aβ42 toxicity, as measured by LDH release and MTT absorbance.  Specifically, AG18051 reduced Aβ42-induced impairment of mitochondrial respiration and oxidative stress as shown by reduced ROS (reactive oxygen species) levels.  Guided by our previous finding of shared aspects of the toxicity of Aβ and human amylin (HA), with the latter forming aggregates in Type 2 diabetes mellitus (T2DM) pancreas, we detd. whether AG18051 would also confer protection from HA toxicity.  We found that the inhibitor conferred only partial protection from HA toxicity indicating distinct pathomechanisms of the two amyloidogenic agents.  Taken together, our results present the inhibition of ABAD by compds. such as AG18051 as a promising therapeutic strategy for the prevention and treatment of AD, and suggest levels of estradiol as a suitable read-out.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc1Q22AuUmybVg90H21EOLACvtfcHk0lhd7IuyZUIj3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslKj&md5=c3689b882868341914b2c66878ef8f7b</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0028887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0028887%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DY.%2BA.%26aulast%3DGrimm%26aufirst%3DA.%26aulast%3DGiese%26aufirst%3DM.%26aulast%3DMensah-Nyagan%26aufirst%3DA.%2BG.%26aulast%3DVillafranca%26aufirst%3DJ.%2BE.%26aulast%3DIttner%26aufirst%3DL.%2BM.%26aulast%3DEckert%26aufirst%3DA.%26aulast%3DGotz%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520the%2520mitochondrial%2520enzyme%2520ABAD%2520restores%2520the%2520amyloid-%25CE%25B2-mediated%2520deregulation%2520of%2520estradiol%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De28887%26doi%3D10.1371%2Fjournal.pone.0028887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannifer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F. J.</span></span> <span> </span><span class="NLM_article-title">In vitro assay development and HTS of small-molecule human ABAD/17β-HSD10 inhibitors as therapeutics in Alzheimer’s disease</span>. <i>SLAS Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">676</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1177/2472555217697964</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1177%2F2472555217697964" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=676-685&author=L.+Aitkenauthor=G.+Baillieauthor=A.+Panniferauthor=A.+Morrisonauthor=P.+S.+Jonesauthor=T.+K.+Smithauthor=S.+P.+McElroyauthor=F.+J.+Gunn-Moore&title=In+vitro+assay+development+and+HTS+of+small-molecule+human+ABAD%2F17%CE%B2-HSD10+inhibitors+as+therapeutics+in+Alzheimer%E2%80%99s+disease&doi=10.1177%2F2472555217697964"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1177%2F2472555217697964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2472555217697964%26sid%3Dliteratum%253Aachs%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DBaillie%26aufirst%3DG.%26aulast%3DPannifer%26aufirst%3DA.%26aulast%3DMorrison%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DP.%2BS.%26aulast%3DSmith%26aufirst%3DT.%2BK.%26aulast%3DMcElroy%26aufirst%3DS.%2BP.%26aulast%3DGunn-Moore%26aufirst%3DF.%2BJ.%26atitle%3DIn%2520vitro%2520assay%2520development%2520and%2520HTS%2520of%2520small-molecule%2520human%2520ABAD%252F17%25CE%25B2-HSD10%2520inhibitors%2520as%2520therapeutics%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DSLAS%2520Discovery%26date%3D2017%26volume%3D22%26spage%3D676%26epage%3D685%26doi%3D10.1177%2F2472555217697964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ayan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, D.</span></span> <span> </span><span class="NLM_article-title">Identification of a 17β-hydroxysteroid dehydrogenase type 10 steroidal inhibitor: a tool to investigate the role of type 10 in Alzheimer’s disease and prostate cancer</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1002%2Fcmdc.201200129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=22674910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVertbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1181-1184&author=D.+Ayanauthor=R.+Maltaisauthor=D.+Poirier&title=Identification+of+a+17%CE%B2-hydroxysteroid+dehydrogenase+type+10+steroidal+inhibitor%3A+a+tool+to+investigate+the+role+of+type+10+in+Alzheimer%E2%80%99s+disease+and+prostate+cancer&doi=10.1002%2Fcmdc.201200129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a 17β-Hydroxysteroid Dehydrogenase Type 10 Steroidal Inhibitor: A Tool to Investigate the Role of Type 10 in Alzheimer's Disease and Prostate Cancer</span></div><div class="casAuthors">Ayan, Diana; Maltais, Rene; Poirier, Donald</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1181-1184, S1181/1-S1181/18</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In continuation of our efforts to develop 17β-hydroxysteroid dehydrogenase type 10 steroidal inhibitors for the treatment of androgen- and estrogen-dependent diseases, we report initial results regarding the development of such inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNkwHFbnNs8LVg90H21EOLACvtfcHk0lhd7IuyZUIj3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVertbg%253D&md5=bc8f320e1fc910ddc7dcb0299c4c616a</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200129%26sid%3Dliteratum%253Aachs%26aulast%3DAyan%26aufirst%3DD.%26aulast%3DMaltais%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520a%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%252010%2520steroidal%2520inhibitor%253A%2520a%2520tool%2520to%2520investigate%2520the%2520role%2520of%2520type%252010%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520prostate%2520cancer%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1181%26epage%3D1184%26doi%3D10.1002%2Fcmdc.201200129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boutin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alata, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, D.</span></span> <span> </span><span class="NLM_article-title">Identification of steroidal derivatives inhibiting the transformations of allopregnanolone and estradiol by 17β-hydroxysteroid dehydrogenase type 10</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3554</span>– <span class="NLM_lpage">3559</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.09.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.bmcl.2018.09.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=3554-3559&author=S.+Boutinauthor=J.+Royauthor=R.+Maltaisauthor=W.+Alataauthor=F.+Calonauthor=D.+Poirier&title=Identification+of+steroidal+derivatives+inhibiting+the+transformations+of+allopregnanolone+and+estradiol+by+17%CE%B2-hydroxysteroid+dehydrogenase+type+10&doi=10.1016%2Fj.bmcl.2018.09.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.09.031%26sid%3Dliteratum%253Aachs%26aulast%3DBoutin%26aufirst%3DS.%26aulast%3DRoy%26aufirst%3DJ.%26aulast%3DMaltais%26aufirst%3DR.%26aulast%3DAlata%26aufirst%3DW.%26aulast%3DCalon%26aufirst%3DF.%26aulast%3DPoirier%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520steroidal%2520derivatives%2520inhibiting%2520the%2520transformations%2520of%2520allopregnanolone%2520and%2520estradiol%2520by%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%252010%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D3554%26epage%3D3559%26doi%3D10.1016%2Fj.bmcl.2018.09.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D.</span></span> <span> </span><span class="NLM_article-title">The future of peptide-based drugs</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1111%2Fcbdd.12055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=23253135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1yktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=136-147&author=D.+J.+Craikauthor=D.+P.+Fairlieauthor=S.+Lirasauthor=D.+Price&title=The+future+of+peptide-based+drugs&doi=10.1111%2Fcbdd.12055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">The future of peptide-based drugs</span></div><div class="casAuthors">Craik, David J.; Fairlie, David P.; Liras, Spiros; Price, David</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">136-147</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The suite of currently used drugs can be divided into two categories - traditional "small mol." drugs with typical mol. wts. of <500 Da but with oral bioavailability, and much larger "biologics" typically >5000 Da that are not orally bioavailable and need to be delivered via injection.  Due to their small size, conventional small mol. drugs may suffer from reduced target selectivity that often ultimately manifests in human side-effects, whereas protein therapeutics tend to be exquisitely specific for their targets due to many more interactions with them, but this comes at a cost of low bioavailability, poor membrane permeability, and metabolic instability.  The time has now come to reinvestigate new drug leads that fit between these two mol. wt. extremes, with the goal of combining advantages of small mols. (cost, conformational restriction, membrane permeability, metabolic stability, oral bioavailability) with those of proteins (natural components, target specificity, high potency).  This article uses selected examples of peptides to highlight the importance of peptide drugs, some potential new opportunities for their exploitation, and some difficult challenges ahead in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlaEZbrPXLPbVg90H21EOLACvtfcHk0lhFqY8g9bGi7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1yktA%253D%253D&md5=1e7e4b7e725541587fad855e6a28cadf</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12055%26sid%3Dliteratum%253Aachs%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DD.%26atitle%3DThe%2520future%2520of%2520peptide-based%2520drugs%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2013%26volume%3D81%26spage%3D136%26epage%3D147%26doi%3D10.1111%2Fcbdd.12055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abreo, M. A.</span>; <span class="NLM_string-name">Meng, J. J.</span>; <span class="NLM_string-name">Agree, C. S.</span></span> <span> </span><span class="NLM_article-title">Fused Pyrazole Compounds, Pharmaceutical Compositions, and Methods for Modulating or Inhibiting ERAB or HADH2 Activity</span>. U.S. Patent <span class="NLM_patent">US6,964,957 B2</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=M.+A.+Abreo&author=J.+J.+Meng&author=C.+S.+Agree&title=Fused+Pyrazole+Compounds%2C+Pharmaceutical+Compositions%2C+and+Methods+for+Modulating+or+Inhibiting+ERAB+or+HADH2+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAbreo%26aufirst%3DM.%2BA.%26atitle%3DFused%2520Pyrazole%2520Compounds%252C%2520Pharmaceutical%2520Compositions%252C%2520and%2520Methods%2520for%2520Modulating%2520or%2520Inhibiting%2520ERAB%2520or%2520HADH2%2520Activity%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marques, A.
T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antunes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, M. J.</span></span> <span> </span><span class="NLM_article-title">Computational optimization of AG18051 inhibitor for amyloid-β binding alcohol dehydrogenase enzyme</span>. <i>Int. J. Quantum Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1982</span>– <span class="NLM_lpage">1991</span>, <span class="refDoi"> DOI: 10.1002/qua.21716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1002%2Fqua.21716" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=1982-1991&author=A.%0AT.+Marquesauthor=A.+Antunesauthor=P.+A.+Fernandesauthor=M.+J.+Ramos&title=Computational+optimization+of+AG18051+inhibitor+for+amyloid-%CE%B2+binding+alcohol+dehydrogenase+enzyme&doi=10.1002%2Fqua.21716"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1002%2Fqua.21716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fqua.21716%26sid%3Dliteratum%253Aachs%26aulast%3DMarques%26aufirst%3DA.%2BT.%26aulast%3DAntunes%26aufirst%3DA.%26aulast%3DFernandes%26aufirst%3DP.%2BA.%26aulast%3DRamos%26aufirst%3DM.%2BJ.%26atitle%3DComputational%2520optimization%2520of%2520AG18051%2520inhibitor%2520for%2520amyloid-%25CE%25B2%2520binding%2520alcohol%2520dehydrogenase%2520enzyme%26jtitle%3DInt.%2520J.%2520Quantum%2520Chem.%26date%3D2008%26volume%3D108%26spage%3D1982%26epage%3D1991%26doi%3D10.1002%2Fqua.21716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, D.</span></span> <span> </span><span class="NLM_article-title">Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: key tools for studying and treating estrogen-dependent diseases</span>. <i>J. Steroid Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1016/j.jsbmb.2010.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.jsbmb.2010.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=21182944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvVeit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2011&pages=83-94&author=D.+Poirier&title=Contribution+to+the+development+of+inhibitors+of+17%CE%B2-hydroxysteroid+dehydrogenase+types+1+and+7%3A+key+tools+for+studying+and+treating+estrogen-dependent+diseases&doi=10.1016%2Fj.jsbmb.2010.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: Key tools for studying and treating estrogen-dependent diseases</span></div><div class="casAuthors">Poirier, Donald</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">83-94</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  17β-Hydroxysteroid dehydrogenases (17β-HSDs) belong to a group of key enzymes involved in the biosynthesis of steroidal hormones by catalyzing the redn. of 17-ketosteroids or the oxidn. of 17β-hydroxysteroids.  From three members known in the early nineties, the 17β-HSD functional family has grown to 15 members over the last 20 years.  This growing no. of 17β-HSD isoforms questioned the importance of each member, esp. in their implication in estrogen- and androgen-dependent diseases, such as breast and prostate cancers.  One of the strategies used to address the physiol. importance of 17β-HSDs is to use potent and selective inhibitors.  Furthermore, enzyme inhibitors could also be of therapeutic interest by reducing the level of estradiol (E2).  Focusing on estrogens, we targeted 17β-HSD types 1 and 7, 2 enzymes able to transform the weak estrogen estrone (E1) into the potent estrogen E2.  The present review article gives a description of different classes of inhibitors of 17β-HSD1 (C6-derivs. of E2, C16-derivs. of E2 as alkylating and dual action compds., E2-adenosine hybrids, E2-simplified adenosine hybrids, and C16-derivs. of E1 or E2) and of inhibitors of 17β-HSD7, all these inhibitors developed in our lab.  The chem. structures and inhibitory activity of these steroidal inhibitors, their potential as therapeutic agents, and their use as tools to elucidate the role of these enzymes in particular biol. systems will be discussed.  Article from the Special issue on Targeted Inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Dv30uPIxDLVg90H21EOLACvtfcHk0lhFqY8g9bGi7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvVeit74%253D&md5=c917967b0ec79fe76af40f1c1c942325</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2010.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2010.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DPoirier%26aufirst%3DD.%26atitle%3DContribution%2520to%2520the%2520development%2520of%2520inhibitors%2520of%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520types%25201%2520and%25207%253A%2520key%2520tools%2520for%2520studying%2520and%2520treating%2520estrogen-dependent%2520diseases%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D125%26spage%3D83%26epage%3D94%26doi%3D10.1016%2Fj.jsbmb.2010.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hroch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guest, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janockova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dohnal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolezal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musilek, K.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer’s disease treatment</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3675</span>– <span class="NLM_lpage">3678</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.05.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.bmcl.2016.05.087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=27287370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC28Xps1yntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3675-3678&author=L.+Hrochauthor=O.+Benekauthor=P.+Guestauthor=L.+Aitkenauthor=O.+Soukupauthor=J.+Janockovaauthor=K.+Musilauthor=V.+Dohnalauthor=R.+Dolezalauthor=K.+Kucaauthor=T.+K.+Smithauthor=F.+Gunn-Mooreauthor=K.+Musilek&title=Design%2C+synthesis+and+in+vitro+evaluation+of+benzothiazole-based+ureas+as+potential+ABAD%2F17%CE%B2-HSD10+modulators+for+Alzheimer%E2%80%99s+disease+treatment&doi=10.1016%2Fj.bmcl.2016.05.087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment</span></div><div class="casAuthors">Hroch, Lukas; Benek, Ondrej; Guest, Patrick; Aitken, Laura; Soukup, Ondrej; Janockova, Jana; Musil, Karel; Dohnal, Vlastimil; Dolezal, Rafael; Kuca, Kamil; Smith, Terry K.; Gunn-Moore, Frank; Musilek, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3675-3678</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Amyloid-beta peptide (Aβ) was recognized to interact with numerous proteins, which may lead to pathol. changes in cell metab. of Alzheimer's disease (AD) patients.  One such known metabolic enzyme is mitochondrial amyloid-binding alc. dehydrogenase (ABAD), also known as 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10).  Altered enzyme function caused by the Aβ-ABAD interaction, was previously shown to cause mitochondrial distress and a consequent cytotoxic effect, therefore providing a feasible target in AD drug development.  Based on previous frentizole derivs. studies, the authors report two novel series of benzothiazolyl ureas along with novel insights into the structure and activity relations for inhibition of ABAD.  Two benzothiazolylureas were identified as potent ABAD inhibitors, where one compd. exhibited comparable cytotoxicity with the frentizole std.; however, 1-fold higher cytotoxicity than the parent riluzole std.  The calcd. and exptl. phys. chem. properties of the most potent compds. showed promising features for blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEMtwJbI1gEbVg90H21EOLACvtfcHk0lhFqY8g9bGi7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xps1yntrc%253D&md5=d293defe7d0bfa51dfc98de7a520cbc2</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.05.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.05.087%26sid%3Dliteratum%253Aachs%26aulast%3DHroch%26aufirst%3DL.%26aulast%3DBenek%26aufirst%3DO.%26aulast%3DGuest%26aufirst%3DP.%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DJanockova%26aufirst%3DJ.%26aulast%3DMusil%26aufirst%3DK.%26aulast%3DDohnal%26aufirst%3DV.%26aulast%3DDolezal%26aufirst%3DR.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DT.%2BK.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DMusilek%26aufirst%3DK.%26atitle%3DDesign%252C%2520synthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520benzothiazole-based%2520ureas%2520as%2520potential%2520ABAD%252F17%25CE%25B2-HSD10%2520modulators%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3675%26epage%3D3678%26doi%3D10.1016%2Fj.bmcl.2016.05.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuret, J.</span></span> <span> </span><span class="NLM_article-title">Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">15938</span>– <span class="NLM_lpage">15945</span>, <span class="refDoi"> DOI: 10.1074/jbc.M314116200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1074%2Fjbc.M314116200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=14761950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivF2ru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15938-15945&author=G.+Liauthor=H.+Yinauthor=J.+Kuret&title=Casein+kinase+1+delta+phosphorylates+tau+and+disrupts+its+binding+to+microtubules&doi=10.1074%2Fjbc.M314116200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Casein Kinase 1 Delta Phosphorylates Tau and Disrupts Its Binding to Microtubules</span></div><div class="casAuthors">Li, Guibin; Yin, Haishan; Kuret, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">15938-15945</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tau hyperphosphorylation precedes neuritic lesion formation in Alzheimer's disease, suggesting it participates in the tau fibrillization reaction pathway.  Candidate tau protein kinases include members of the casein kinase 1 (CK1) family of phosphotransferases, which are highly overexpressed in Alzheimer's disease brain and colocalize with neuritic and granulovacuolar lesions.  Here we characterized the contribution of one CK1 isoform, Ckiδ, to the phosphorylation of tau at residues Ser202/Thr205 and Ser396/Ser404 in human embryonic kidney 293 cells using immunodetection and fluorescence microscopy.  Treatment of cells with membrane permeable CK1 inhibitor 3-[(2,3,6-trimethoxyphenyl)methylidenyl]-indolin-2-one (IC261) lowered occupancy of Ser396/Ser404 phosphorylation sites by >70% at satn., suggesting that endogenous CK1 was the major source of basal phosphorylation activity at these sites.  Overexpression of Ckiδ increased CK1 enzyme activity and further raised tau phosphorylation at residues Ser202/Thr205 and Ser396/Ser404 in situ.  Inhibitor IC261 reversed tau hyperphosphorylation induced by Ckiδ overexpression.  Co-immunopptn. assays showed direct assocn. of tau and Ckiδ in situ, consistent with tau being a Ckiδ substrate.  Ckiδ overexpression also produced a decrease in the fraction of bulk tau bound to detergent-insol. microtubules.  These results suggest that Ckiδ phosphorylates tau at sites that modulate tau/microtubule binding, and that the expression pattern of Ckiδ in Alzheimer's disease is consistent with it playing an important role in tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs-5xMF88DsbVg90H21EOLACvtfcHk0ljEPLzElUF1jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivF2ru7c%253D&md5=04a7d8fd87778a68d4b8e941f9ec7abf</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M314116200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M314116200%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DCasein%2520kinase%25201%2520delta%2520phosphorylates%2520tau%2520and%2520disrupts%2520its%2520binding%2520to%2520microtubules%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15938%26epage%3D15945%26doi%3D10.1074%2Fjbc.M314116200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flajolet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nairn, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greengard, P.</span></span> <span> </span><span class="NLM_article-title">Regulation of Alzheimer’s disease amyloid-β formation by casein kinase I</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">4159</span>– <span class="NLM_lpage">4164</span>, <span class="refDoi"> DOI: 10.1073/pnas.0611236104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1073%2Fpnas.0611236104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=4159-4164&author=M.+Flajoletauthor=G.+Heauthor=M.+Heimanauthor=A.+Linauthor=A.+C.+Nairnauthor=P.+Greengard&title=Regulation+of+Alzheimer%E2%80%99s+disease+amyloid-%CE%B2+formation+by+casein+kinase+I&doi=10.1073%2Fpnas.0611236104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0611236104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0611236104%26sid%3Dliteratum%253Aachs%26aulast%3DFlajolet%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DG.%26aulast%3DHeiman%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DGreengard%26aufirst%3DP.%26atitle%3DRegulation%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520amyloid-%25CE%25B2%2520formation%2520by%2520casein%2520kinase%2520I%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D4159%26epage%3D4164%26doi%3D10.1073%2Fpnas.0611236104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valasani, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaney, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer’s disease</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1111%2Fcbdd.12068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=23039767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=238-249&author=K.+R.+Valasaniauthor=G.+Huauthor=M.+O.+Chaneyauthor=S.+S.+Yan&title=Structure-based+design+and+synthesis+of+benzothiazole+phosphonate+analogues+with+inhibitors+of+human+ABAD-A%CE%B2+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fcbdd.12068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design and synthesis of benzothiazole phosphonate analogs with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease</span></div><div class="casAuthors">Valasani, Koteswara R.; Hu, Gang; Chaney, Michael O.; Yan, Shirley S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">238-249</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Amyloid binding alc. dehydrogenase, a mitochondrial protein, is a cofactor facilitating amyloid-β peptide (Aβ) induced cell stress.  Antagonizing Aβ-ABAD interaction protects against aberrant mitochondrial and neuronal function and improves learning memory in the Alzheimer's disease mouse model.  Therefore, it offers a potential target for Alzheimer's drug design, by identifying potential inhibitors of Aβ-ABAD interaction.  2D QSAR methods were applied to novel compds. with known IC50 values, which formed a training set.  A correlation anal. was carried out comparing the statistics of the measured IC50 with predicted values.  These selectivity-detg. descriptors were interpreted graphically in terms of principal component analyses, which are highly informative for the lead optimization process with respect to activity enhancement.  A 3D pharmacophore model also was created.  The 2D QSAR and 3D pharmacophore models will assist in high-throughput screening.  In addn., ADME descriptors were also detd. to study their pharmacokinetic properties.  Finally, amyloid binding alc. dehydrogenase mol. docking study of these novel mols. was undertaken to det. whether these compds. exhibit significant binding affinity with the binding site.  We have synthesized only the compds. that have shown the best drug-like properties as candidates for further studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5GFoI2vsRwLVg90H21EOLACvtfcHk0ljEPLzElUF1jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKht78%253D&md5=d7d8f98616c5754cd82a7cd5d5b140da</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12068%26sid%3Dliteratum%253Aachs%26aulast%3DValasani%26aufirst%3DK.%2BR.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DChaney%26aufirst%3DM.%2BO.%26aulast%3DYan%26aufirst%3DS.%2BS.%26atitle%3DStructure-based%2520design%2520and%2520synthesis%2520of%2520benzothiazole%2520phosphonate%2520analogues%2520with%2520inhibitors%2520of%2520human%2520ABAD-A%25CE%25B2%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2013%26volume%3D81%26spage%3D238%26epage%3D249%26doi%3D10.1111%2Fcbdd.12068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valasani, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. S.</span></span> <span> </span><span class="NLM_article-title">Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.2174/1567205011666140130150108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F1567205011666140130150108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=24479630" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=128-136&author=K.+R.+Valasaniauthor=Q.+Sunauthor=G.+Huauthor=J.+Liauthor=F.+Duauthor=Y.+Guoauthor=E.+A.+Carlsonauthor=X.+Ganauthor=S.+S.+Yan&title=Identification+of+human+ABAD+inhibitors+for+rescuing+A%CE%B2-mediated+mitochondrial+dysfunction&doi=10.2174%2F1567205011666140130150108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.2174%2F1567205011666140130150108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205011666140130150108%26sid%3Dliteratum%253Aachs%26aulast%3DValasani%26aufirst%3DK.%2BR.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DCarlson%26aufirst%3DE.%2BA.%26aulast%3DGan%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DS.%2BS.%26atitle%3DIdentification%2520of%2520human%2520ABAD%2520inhibitors%2520for%2520rescuing%2520A%25CE%25B2-mediated%2520mitochondrial%2520dysfunction%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2014%26volume%3D11%26spage%3D128%26epage%3D136%26doi%3D10.2174%2F1567205011666140130150108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trippier, P. C.</span></span> <span> </span><span class="NLM_article-title">Selecting good ‘drug-like’ properties to optimize small molecule blood-brain barrier penetration</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1392</span>– <span class="NLM_lpage">1407</span>, <span class="refDoi"> DOI: 10.2174/0929867323666160405112353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F0929867323666160405112353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=27048339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVWlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1392-1407&author=P.+C.+Trippier&title=Selecting+good+%E2%80%98drug-like%E2%80%99+properties+to+optimize+small+molecule+blood-brain+barrier+penetration&doi=10.2174%2F0929867323666160405112353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Selecting Good 'Drug-Like' Properties to Optimize Small Molecule Blood-Brain Barrier Penetration</span></div><div class="casAuthors">Trippier, Paul C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1392-1407</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The success rate to achieve clin. approval of drugs developed to treat diseases of the central nervous system (CNS) is the lowest of all disease indications.  A large contributor to this poor success rate is failure of small mols. to pass through the blood-brain barrier (BBB), a barrier composed of capillary endothelial cells connected by tight junctions that functions to extrude xenobiotics from the brain.  Designing small mols. to be BBB penetrant has been the subject of intensive research and has resulted in a series of guidelines to attain the best possible chances of BBB penetration.  This review will analyze the current state of thinking in ranking the importance of various physicochem. properties required to select BBB penetrant mols., describe model systems to det. BBB penetration, summarize data anal. methods and provide an outlook on further developments in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozPwAxKg1WLrVg90H21EOLACvtfcHk0ligPppeYg4-6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVWlurw%253D&md5=8edfbeec9c34759a5ecc809b645794d5</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.2174%2F0929867323666160405112353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666160405112353%26sid%3Dliteratum%253Aachs%26aulast%3DTrippier%26aufirst%3DP.%2BC.%26atitle%3DSelecting%2520good%2520%25E2%2580%2598drug-like%25E2%2580%2599%2520properties%2520to%2520optimize%2520small%2520molecule%2520blood-brain%2520barrier%2520penetration%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2016%26volume%3D23%26spage%3D1392%26epage%3D1407%26doi%3D10.2174%2F0929867323666160405112353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vangavaragu, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valasani, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. S.</span></span> <span> </span><span class="NLM_article-title">Determination of small molecule ABAD inhibitors crossing blood-brain barrier and pharmacokinetics</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.3233/JAD-140252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-140252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=24858403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlaktL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=333-344&author=J.+R.+Vangavaraguauthor=K.+R.+Valasaniauthor=D.+Fangauthor=T.+D.+Williamsauthor=S.+S.+Yan&title=Determination+of+small+molecule+ABAD+inhibitors+crossing+blood-brain+barrier+and+pharmacokinetics&doi=10.3233%2FJAD-140252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of Small Molecule ABAD Inhibitors Crossing Blood-Brain Barrier and Pharmacokinetics</span></div><div class="casAuthors">Vangavaragu, Jhansi Rani; Valasani, Koteswara Rao; Fang, Du; Williams, Todd D.; Yan, Shirley ShiDu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">333-344</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A major obstacle to the development of effective treatment of Alzheimer's disease (AD) is successfully delivery of drugs to the brain.  We have previously identified a series of benzothiazole phosphonate compds. that block the interaction of amyloid-β peptide with amyloid-β binding alc. dehydrogenase (ABAD).  A selective and sensitive method for the presence of three new benzothiazole ABAD inhibitors in mouse plasma, brain, and artificial cerebrospinal fluid has been developed and validated based on high performance liq. chromatog. tandem mass spectrometry.  Mass spectra were generated using Micromass Quattro Ultima "triple" quadrupole mass spectrometer equipped with an Electrospray Ionization interface.  Good linearity was obtained over a concn. range of 0.05-2.5 μg/mL.  The lowest limit of quantification and detection was found to be 0.05 μg/mL.  All inter-day accuracies and precisions were within ± 15% of the nominal value and ± 20%, resp., at the lower limit of quantitation.  The tested compds. were stable at various conditions with recoveries >90.0% (RSD <10%).  The method used for pharmacokinetic studies of compds. in mouse cerebrospinal fluid, plasma, and brain is accurate, precise, and specific with no matrix effect.  Pharmacokinetic data showed that these compds. penetrate the blood-brain barrier (BBB) yielding 4-50 ng/mL peak brain concns. and 2 μg/mL peak plasma concns. from a 10 mg/kg dose.  These results indicate that our newly synthesized small mol. ABAD inhibitors have a good drug properties with the ability to cross the blood-brain barrier, which holds a great potential for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3525aF5LeNLVg90H21EOLACvtfcHk0ligPppeYg4-6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlaktL%252FK&md5=d7b9d02803840c674e5d59217ee10cd1</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.3233%2FJAD-140252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-140252%26sid%3Dliteratum%253Aachs%26aulast%3DVangavaragu%26aufirst%3DJ.%2BR.%26aulast%3DValasani%26aufirst%3DK.%2BR.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DT.%2BD.%26aulast%3DYan%26aufirst%3DS.%2BS.%26atitle%3DDetermination%2520of%2520small%2520molecule%2520ABAD%2520inhibitors%2520crossing%2520blood-brain%2520barrier%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2014%26volume%3D42%26spage%3D333%26epage%3D344%26doi%3D10.3233%2FJAD-140252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hroch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolezal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guest, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benkova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musilek, K.</span></span> <span> </span><span class="NLM_article-title">6-Benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17β-HSD10 and potential drugs for Alzheimer’s disease treatment: design, synthesis and in vitro evaluation</span>. <i>Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.2174/1573406413666170109142725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F1573406413666170109142725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsl2htLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=345-358&author=O.+Benekauthor=L.+Hrochauthor=L.+Aitkenauthor=R.+Dolezalauthor=P.+Guestauthor=M.+Benkovaauthor=O.+Soukupauthor=K.+Musilauthor=K.+Kucaauthor=T.+K.+Smithauthor=F.+Gunn-Mooreauthor=K.+Musilek&title=6-Benzothiazolyl+ureas%2C+thioureas+and+guanidines+are+potent+inhibitors+of+ABAD%2F17%CE%B2-HSD10+and+potential+drugs+for+Alzheimer%E2%80%99s+disease+treatment%3A+design%2C+synthesis+and+in+vitro+evaluation&doi=10.2174%2F1573406413666170109142725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">6-Benzothiazolyl Ureas, Thioureas and Guanidines are Potent Inhibitors of ABAD/17β-HSD10 and Potential Drugs for Alzheimer"s Disease Treatment: Design, Synthesis and in vitro Evaluation</span></div><div class="casAuthors">Benek, Ondrej; Hroch, Lukas; Aitken, Laura; Dolezal, Rafael; Guest, Patrick; Benkova, Marketa; Soukup, Ondrej; Musil, Karel; Kuca, Kamil; Smith, Terry K.; Gunn-Moore, Frank; Musilek, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">345-358</span>CODEN:
                <span class="NLM_cas:coden">MCEHAJ</span>;
        ISSN:<span class="NLM_cas:issn">1573-4064</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: The mitochondrial enzyme amyloid beta-binding alc. dehydrogenase (ABAD) also known as 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10) has been connected with the pathogenesis of Alzheimer's disease (AD).  ABAD/17β-HSD10 is a binding site for the amyloid-beta peptide (Aβ) inside the mitochondrial matrix where it exacerbates Aβtoxicity.  Interaction between these two proteins triggers a series of events leading to mitochondrial dysfunction as seen in AD.  Methods: As ABAD's enzymic activity is required for mediating Aβ toxicity, its inhibition presents a promising strategy for AD treatment.  In this study, a series of new benzothiazolylurea analogs have been prepd. and evaluated in vitro for their potency to inhibit ABAD/17β-HSD10 enzymic activity.  The most potent compds. have also been tested for their cytotoxic properties and their ability to permeate through blood-brain barrier has been predicted.  To explain the structureactivity relationship QSAR and pharmacophore studies have been performed.  Results and Conclusion: Compd. 12 was identified being the most promising hit compd. with good inhibitory activity (IC50 = 3.06 ± 0.40 μ M) and acceptable cytotoxicity profile comparable to the parent compd. of frentizole.  The satisfactory phys.-chem. properties suggesting its capability to permeate through BBB make compd. 12 a novel lead structure for further development and biol. assessment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRkx9qgN5Jd7Vg90H21EOLACvtfcHk0ligPppeYg4-6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsl2htLg%253D&md5=c2c863ab2dd0df887736880fc9d5a3d9</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.2174%2F1573406413666170109142725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1573406413666170109142725%26sid%3Dliteratum%253Aachs%26aulast%3DBenek%26aufirst%3DO.%26aulast%3DHroch%26aufirst%3DL.%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DDolezal%26aufirst%3DR.%26aulast%3DGuest%26aufirst%3DP.%26aulast%3DBenkova%26aufirst%3DM.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DMusil%26aufirst%3DK.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DT.%2BK.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DMusilek%26aufirst%3DK.%26atitle%3D6-Benzothiazolyl%2520ureas%252C%2520thioureas%2520and%2520guanidines%2520are%2520potent%2520inhibitors%2520of%2520ABAD%252F17%25CE%25B2-HSD10%2520and%2520potential%2520drugs%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%253A%2520design%252C%2520synthesis%2520and%2520in%2520vitro%2520evaluation%26jtitle%3DMed.%2520Chem.%26date%3D2017%26volume%3D13%26spage%3D345%26epage%3D358%26doi%3D10.2174%2F1573406413666170109142725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hroch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guest, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janockova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolezal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zala, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musilek, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer’s disease treatment</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1152</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.bmc.2016.12.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1143-1152&author=L.+Hrochauthor=P.+Guestauthor=O.+Benekauthor=O.+Soukupauthor=J.+Janockovaauthor=R.+Dolezalauthor=K.+Kucaauthor=L.+Aitkenauthor=T.+K.+Smithauthor=F.+Gunn-Mooreauthor=D.+Zalaauthor=R.+R.+Ramsayauthor=K.+Musilek&title=Synthesis+and+evaluation+of+frentizole-based+indolyl+thiourea+analogues+as+MAO%2FABAD+inhibitors+for+Alzheimer%E2%80%99s+disease+treatment&doi=10.1016%2Fj.bmc.2016.12.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DHroch%26aufirst%3DL.%26aulast%3DGuest%26aufirst%3DP.%26aulast%3DBenek%26aufirst%3DO.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DJanockova%26aufirst%3DJ.%26aulast%3DDolezal%26aufirst%3DR.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DT.%2BK.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DZala%26aufirst%3DD.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26aulast%3DMusilek%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520frentizole-based%2520indolyl%2520thiourea%2520analogues%2520as%2520MAO%252FABAD%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D1143%26epage%3D1152%26doi%3D10.1016%2Fj.bmc.2016.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Viswanath, A. N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span> <span> </span><span class="NLM_article-title">In silico-designed novel non-peptidic ABAD L<sub>D</sub> hot spot mimetics reverse Aβ-induced mitochondrial impairments in vitro</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">1041</span>– <span class="NLM_lpage">1055</span>, <span class="refDoi"> DOI: 10.1111/cbdd.13065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1111%2Fcbdd.13065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=28660722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1arsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2017&pages=1041-1055&author=A.+N.+I.+Viswanathauthor=T.+Kimauthor=S.+Y.+Jungauthor=S.+M.+Limauthor=A.+N.+Pae&title=In+silico-designed+novel+non-peptidic+ABAD+LD+hot+spot+mimetics+reverse+A%CE%B2-induced+mitochondrial+impairments+in+vitro&doi=10.1111%2Fcbdd.13065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">In silico-designed novel non-peptidic ABAD LD hot spot mimetics reverse Aβ-induced mitochondrial impairments in vitro</span></div><div class="casAuthors">Viswanath, Ambily Nath Indu; Kim, Tae Hun; Jung, Seo Yun; Lim, Sang Min; Pae, Ae Nim</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1041-1055</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Present work aimed to introduce non-peptidic ABAD loop D (LD) hot spot mimetics as ABAD-Aβ inhibitors.  A full-length atomistic model of ABAD-Aβ complex was built as a scaffold to launch the lead design and its topol. later verified by cross-checking the computational mutagenesis results with that of in vitro data.  Thereafter, the interactions of prime Aβ-binding LD residues-Tyr101, Thr108, and Thr110-were translated into specific pharmacophore features and this hypothesis subsequently used as a virtual screen query.  ELISA-based screening of 20 hits identified two promising lead candidates, VC15 and VC19 with an IC50 of 4.4 ± 0.3 and 9.6 ± 0.1 μm, resp.  They productively reversed Aβ-induced mitochondrial dysfunctions such as mitochondrial membrane potential loss (JC-1 assay), toxicity (MTT assay), and ATP redn. (ATP assay) in addn. to increased cell viabilities.  This is the first reporting of LD hot spot-centric in silico scheme to discover novel compds. with promising ABAD-Aβ inhibitory potential.  These chemotypes are proposed for further structural optimization to derive novel Alzheimer's disease (AD) therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFfWyRk0Air7Vg90H21EOLACvtfcHk0lhdNyhzp0e3Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1arsr%252FO&md5=aef10ded69474131abc4b4c4b6515607</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.13065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.13065%26sid%3Dliteratum%253Aachs%26aulast%3DViswanath%26aufirst%3DA.%2BN.%2BI.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DS.%2BY.%26aulast%3DLim%26aufirst%3DS.%2BM.%26aulast%3DPae%26aufirst%3DA.%2BN.%26atitle%3DIn%2520silico-designed%2520novel%2520non-peptidic%2520ABAD%2520LD%2520hot%2520spot%2520mimetics%2520reverse%2520A%25CE%25B2-induced%2520mitochondrial%2520impairments%2520in%2520vitro%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2017%26volume%3D90%26spage%3D1041%26epage%3D1055%26doi%3D10.1111%2Fcbdd.13065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sukriti  Srivastava</span>, <span class="hlFld-ContribAuthor ">Razi  Ahmad</span>, <span class="hlFld-ContribAuthor ">Sunil Kumar  Khare</span>. </span><span class="cited-content_cbyCitation_article-title">Alzheimer’s disease and its treatment by different approaches: A review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113320. <a href="https://doi.org/10.1016/j.ejmech.2021.113320" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113320</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113320%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAlzheimer%2525E2%252580%252599s%252Bdisease%252Band%252Bits%252Btreatment%252Bby%252Bdifferent%252Bapproaches%25253A%252BA%252Breview%26aulast%3DSrivastava%26aufirst%3DSukriti%26date%3D2021%26volume%3D216%26spage%3D113320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eugenie  Nepovimova</span>, <span class="hlFld-ContribAuthor ">Lucie  Svobodova</span>, <span class="hlFld-ContribAuthor ">Rafael  Dolezal</span>, <span class="hlFld-ContribAuthor ">Vendula  Hepnarova</span>, <span class="hlFld-ContribAuthor ">Lucie  Junova</span>, <span class="hlFld-ContribAuthor ">Daniel  Jun</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Tomas  Kucera</span>, <span class="hlFld-ContribAuthor ">Zuzana  Gazova</span>, <span class="hlFld-ContribAuthor ">Katarina  Motykova</span>, <span class="hlFld-ContribAuthor ">Jana  Kubackova</span>, <span class="hlFld-ContribAuthor ">Zuzana  Bednarikova</span>, <span class="hlFld-ContribAuthor ">Jana  Janockova</span>, <span class="hlFld-ContribAuthor ">Catarina  Jesus</span>, <span class="hlFld-ContribAuthor ">Luisa  Cortes</span>, <span class="hlFld-ContribAuthor ">Joao  Pina</span>, <span class="hlFld-ContribAuthor ">Danijela  Rostohar</span>, <span class="hlFld-ContribAuthor ">Carlos  Serpa</span>, <span class="hlFld-ContribAuthor ">Ondrej  Soukup</span>, <span class="hlFld-ContribAuthor ">Laura  Aitken</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  Hughes</span>, <span class="hlFld-ContribAuthor ">Kamil  Musilek</span>, <span class="hlFld-ContribAuthor ">Lubica  Muckova</span>, <span class="hlFld-ContribAuthor ">Petr  Jost</span>, <span class="hlFld-ContribAuthor ">Marketa  Chvojkova</span>, <span class="hlFld-ContribAuthor ">Karel  Vales</span>, <span class="hlFld-ContribAuthor ">Martin  Valis</span>, <span class="hlFld-ContribAuthor ">Zofia  Chrienova</span>, <span class="hlFld-ContribAuthor ">Katarina  Chalupova</span>, <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>. </span><span class="cited-content_cbyCitation_article-title">Tacrine – Benzothiazoles: Novel class of potential multitarget anti-Alzheimeŕs drugs dealing with cholinergic, amyloid and mitochondrial systems. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>107 </em>, 104596. <a href="https://doi.org/10.1016/j.bioorg.2020.104596" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104596%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DTacrine%252B%2525E2%252580%252593%252BBenzothiazoles%25253A%252BNovel%252Bclass%252Bof%252Bpotential%252Bmultitarget%252Banti-Alzheime%2525C5%252595s%252Bdrugs%252Bdealing%252Bwith%252Bcholinergic%25252C%252Bamyloid%252Band%252Bmitochondrial%252Bsystems%26aulast%3DNepovimova%26aufirst%3DEugenie%26date%3D2021%26volume%3D107%26spage%3D104596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jéssica  Silva dos Santos</span>, <span class="hlFld-ContribAuthor ">João Pedro  Gonçalves Cirino</span>, <span class="hlFld-ContribAuthor ">Patrícia  de Oliveira Carvalho</span>, <span class="hlFld-ContribAuthor ">Manoela Marques  Ortega</span>. </span><span class="cited-content_cbyCitation_article-title">The Pharmacological Action of Kaempferol in Central Nervous System Diseases: A Review. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.565700" title="DOI URL">https://doi.org/10.3389/fphar.2020.565700</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.565700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.565700%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DThe%252BPharmacological%252BAction%252Bof%252BKaempferol%252Bin%252BCentral%252BNervous%252BSystem%252BDiseases%25253A%252BA%252BReview%26aulast%3DSilva%2Bdos%2BSantos%26aufirst%3DJ%25C3%25A9ssica%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sophie  Boutin</span>, <span class="hlFld-ContribAuthor ">René  Maltais</span>, <span class="hlFld-ContribAuthor ">Jenny  Roy</span>, <span class="hlFld-ContribAuthor ">Donald  Poirier</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 17β-hydroxysteroid dehydrogenase type 10 steroidal inhibitors: Selectivity, metabolic stability and enhanced potency. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112909. <a href="https://doi.org/10.1016/j.ejmech.2020.112909" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112909</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112909%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252B17%2525CE%2525B2-hydroxysteroid%252Bdehydrogenase%252Btype%252B10%252Bsteroidal%252Binhibitors%25253A%252BSelectivity%25252C%252Bmetabolic%252Bstability%252Band%252Benhanced%252Bpotency%26aulast%3DBoutin%26aufirst%3DSophie%26date%3D2021%26volume%3D209%26spage%3D112909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabriela Dumitrita  Stanciu</span>, <span class="hlFld-ContribAuthor ">Veronica  Bild</span>, <span class="hlFld-ContribAuthor ">Daniela Carmen  Ababei</span>, <span class="hlFld-ContribAuthor ">Razvan Nicolae  Rusu</span>, <span class="hlFld-ContribAuthor ">Alina  Cobzaru</span>, <span class="hlFld-ContribAuthor ">Luminita  Paduraru</span>, <span class="hlFld-ContribAuthor ">Delia  Bulea</span>. </span><span class="cited-content_cbyCitation_article-title">Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular Damages. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Medicine</span><span> <strong>2020,</strong> <em>9 </em>
                                    (6)
                                     , 1713. <a href="https://doi.org/10.3390/jcm9061713" title="DOI URL">https://doi.org/10.3390/jcm9061713</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jcm9061713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjcm9061713%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Medicine%26atitle%3DLink%252Bbetween%252BDiabetes%252Band%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BDue%252Bto%252Bthe%252BShared%252BAmyloid%252BAggregation%252Band%252BDeposition%252BInvolving%252BBoth%252BNeurodegenerative%252BChanges%252Band%252BNeurovascular%252BDamages%26aulast%3DStanciu%26aufirst%3DGabriela%2BDumitrita%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D6%26spage%3D1713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chaska C.  Walton</span>, <span class="hlFld-ContribAuthor ">David  Begelman</span>, <span class="hlFld-ContribAuthor ">Wynnie  Nguyen</span>, <span class="hlFld-ContribAuthor ">Julie K.  Andersen</span>. </span><span class="cited-content_cbyCitation_article-title">Senescence as an Amyloid Cascade: The Amyloid Senescence Hypothesis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cellular Neuroscience</span><span> <strong>2020,</strong> <em>14 </em><a href="https://doi.org/10.3389/fncel.2020.00129" title="DOI URL">https://doi.org/10.3389/fncel.2020.00129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fncel.2020.00129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffncel.2020.00129%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cellular%2520Neuroscience%26atitle%3DSenescence%252Bas%252Ban%252BAmyloid%252BCascade%25253A%252BThe%252BAmyloid%252BSenescence%252BHypothesis%26aulast%3DWalton%26aufirst%3DChaska%2BC.%26date%3D2020%26date%3D2020%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nurul  Husna Ibrahim</span>, <span class="hlFld-ContribAuthor ">Mohamad Fairuz  Yahaya</span>, <span class="hlFld-ContribAuthor ">Wael  Mohamed</span>, <span class="hlFld-ContribAuthor ">Seong Lin  Teoh</span>, <span class="hlFld-ContribAuthor ">Chua Kien  Hui</span>, <span class="hlFld-ContribAuthor ">Jaya  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00261" title="DOI URL">https://doi.org/10.3389/fphar.2020.00261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00261%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DPharmacotherapy%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BSeeking%252BClarity%252Bin%252Ba%252BTime%252Bof%252BUncertainty%26aulast%3DHusna%2BIbrahim%26aufirst%3DNurul%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji Woong  Lim</span>, <span class="hlFld-ContribAuthor ">Jiyoun  Lee</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>. </span><span class="cited-content_cbyCitation_article-title">Mitochondrial dysfunction and Alzheimer's disease: prospects for therapeutic intervention. </span><span class="cited-content_cbyCitation_journal-name">BMB Reports</span><span> <strong>2020,</strong> <em>53 </em>
                                    (1)
                                     , 47-55. <a href="https://doi.org/10.5483/BMBRep.2020.53.1.279" title="DOI URL">https://doi.org/10.5483/BMBRep.2020.53.1.279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5483/BMBRep.2020.53.1.279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5483%2FBMBRep.2020.53.1.279%26sid%3Dliteratum%253Aachs%26jtitle%3DBMB%2520Reports%26atitle%3DMitochondrial%252Bdysfunction%252Band%252BAlzheimer%252527s%252Bdisease%25253A%252Bprospects%252Bfor%252Btherapeutic%252Bintervention%26aulast%3DLim%26aufirst%3DJi%2BWoong%26date%3D2020%26volume%3D53%26issue%3D1%26spage%3D47%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela Carmen  Oniciu</span>. </span><span class="cited-content_cbyCitation_article-title">Eight-membered Rings With One Nitrogen. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00011-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00011-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00011-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00011-1%26sid%3Dliteratum%253Aachs%26atitle%3DEight-membered%252BRings%252BWith%252BOne%252BNitrogen%26aulast%3DOniciu%26aufirst%3DDaniela%2BCarmen%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%25207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed  Morsy</span>, <span class="hlFld-ContribAuthor ">Paul C.  Trippier</span>, . </span><span class="cited-content_cbyCitation_article-title">Current and Emerging Pharmacological Targets for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2019,</strong> <em>72 </em>
                                    (s1)
                                     , S145-S176. <a href="https://doi.org/10.3233/JAD-190744" title="DOI URL">https://doi.org/10.3233/JAD-190744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-190744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-190744%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DCurrent%252Band%252BEmerging%252BPharmacological%252BTargets%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DMorsy%26aufirst%3DAhmed%26date%3D2019%26volume%3D72%26issue%3Ds1%26spage%3DS145%26epage%3DS176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sávio Monteiro  dos Santos</span>, <span class="hlFld-ContribAuthor ">Camila Fernanda Rodrigues  Romeiro</span>, <span class="hlFld-ContribAuthor ">Caroline Azulay  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Alícia Renata Lima  Cerqueira</span>, <span class="hlFld-ContribAuthor ">Marta Chagas  Monteiro</span>. </span><span class="cited-content_cbyCitation_article-title">Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer’s Disease?. </span><span class="cited-content_cbyCitation_journal-name">Oxidative Medicine and Cellular Longevity</span><span> <strong>2019,</strong> <em>2019 </em>, 1-14. <a href="https://doi.org/10.1155/2019/8409329" title="DOI URL">https://doi.org/10.1155/2019/8409329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2019/8409329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2019%2F8409329%26sid%3Dliteratum%253Aachs%26jtitle%3DOxidative%2520Medicine%2520and%2520Cellular%2520Longevity%26atitle%3DMitochondrial%252BDysfunction%252Band%252BAlpha-Lipoic%252BAcid%25253A%252BBeneficial%252Bor%252BHarmful%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253F%26aulast%3Ddos%2BSantos%26aufirst%3DS%25C3%25A1vio%2BMonteiro%26date%3D2019%26volume%3D2019%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01530&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of clinically approved drugs for the treatment of Alzheimer’s disease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01530&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Diagram illustrating Aβ–ABAD complex induced toxicity. (1) Upregulation of endophilin-1 (Ep-1) by ABAD activates the JNK pathway which leads to cytotoxicity. (2) Upregulation of peroxiredoxin-2 (Prdx-2), which is responsible for degradation of peroxides, by ABAD. However, due to elevated levels of CdK5, elevated Prdx-2 is deactivated which leads to peroxide accumulation. (3) Conversion of estradiol to estrone is upregulated with complex interaction leading to reduced levels of estradiol in the mitochondria. Estradiol has remarkable effects in neuron protection (a–i). (a) Deactivation of estradiol leads to the inability of the mitochondria to sequestrate Ca<sup>2+</sup> ions from the cytosol. This effect is induced by Aβ leading to accumulation of Ca<sup>2+</sup> ions in the cytosol which results in Cdk5 activation. The accumulation of Ca<sup>2+</sup> ions in the cytosol also leads to ROS generation. (b) Estradiol increases the production of antioxidants by increasing glutathione levels, decreasing oxidative DNA damage in the mitochondria. (c) Estradiol reduces amyloid precursor protein (APP) processing, decreasing Aβ levels and concomitantly its aggregation into plaques. (d) Estradiol induces the phosphorylation of glycogen synthase kinase-3β (GSK-3β) which inactivates the enzyme and reduces tau phosphorylation. (e, f) Estradiol functions to enhance the downregulation of proapoptotic proteins (e.g., Bim) and the expression of antiapoptotic proteins (e.g., Bcl-2 and Bcl-xL). (g, i) Estradiol exerts an effect on the electron transport chain by increasing the expression of some complexes in the mitochondrial respiratory chain, including complex I (CI) and complex IV (CIV). (h) Estradiol has been shown to prevent mitochondrial release of cytochrome <i>c</i>, which activates the caspase cascade in the cytoplasm leading to apoptosis. (4) Participation of ABAD in the final degradation steps of the amino acid isoleucine is inhibited by Aβ binding, which leads to the accumulation of 2-methyl-3-hydroxybutyrate. The latter has toxic effects in inhibiting Krebs cycle enzymes and complex IV activity. (5) Toxic aldehydes that accumulate in the mitochondria are degraded by ABAD. This degradation is inhibited by Aβ binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01530&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Using NAD<sup>+</sup> as a Cofactor, ABAD Catalyzes the Oxidation of CHANA to the Ketone CHANK<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01530&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/medium/jm-2018-01530h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Map of interactions between an inhibitor and the ABAD enzyme. Compound <b>1</b> (red) interacts with ABAD amino acid residues (black) and the cofactor NAD<sup>+</sup> (blue), forming a covalent adduct between the N2 atom of <b>1</b> and the C4 atom of NAD<sup>+</sup>. Shown are hydrophobic interactions (black wavy lines), hydrogen bonding (black dashed lines), and π–π interactions (green wavy lines), Protein Data Bank code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1U7T">1U7T</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.8b01530/20190502/images/large/jm-2018-01530h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01530&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 137 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albert, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeKosky, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagust, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thies, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phelps, C. H.</span></span> <span> </span><span class="NLM_article-title">The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease</span>. <i>Alzheimer's Dementia</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">270</span>– <span class="NLM_lpage">279</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2011.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.jalz.2011.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=21514249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BC3MrhsFaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=270-279&author=M.+S.+Albertauthor=S.+T.+DeKoskyauthor=D.+Dicksonauthor=B.+Duboisauthor=H.+H.+Feldmanauthor=N.+C.+Foxauthor=A.+Gamstauthor=D.+M.+Holtzmanauthor=W.+J.+Jagustauthor=R.+C.+Petersenauthor=P.+J.+Snyderauthor=M.+C.+Carrilloauthor=B.+Thiesauthor=C.+H.+Phelps&title=The+diagnosis+of+mild+cognitive+impairment+due+to+Alzheimer%E2%80%99s+disease%3A+recommendations+from+the+national+institute+on+aging-Alzheimer%E2%80%99s+association+workgroups+on+diagnostic+guidelines+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.jalz.2011.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</span></div><div class="casAuthors">Albert Marilyn S; DeKosky Steven T; Dickson Dennis; Dubois Bruno; Feldman Howard H; Fox Nick C; Gamst Anthony; Holtzman David M; Jagust William J; Petersen Ronald C; Snyder Peter J; Carrillo Maria C; Thies Bill; Phelps Creighton H</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">270-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of developing criteria for the symptomatic predementia phase of Alzheimer's disease (AD), referred to in this article as mild cognitive impairment due to AD.  The workgroup developed the following two sets of criteria: (1) core clinical criteria that could be used by healthcare providers without access to advanced imaging techniques or cerebrospinal fluid analysis, and (2) research criteria that could be used in clinical research settings, including clinical trials.  The second set of criteria incorporate the use of biomarkers based on imaging and cerebrospinal fluid measures.  The final set of criteria for mild cognitive impairment due to AD has four levels of certainty, depending on the presence and nature of the biomarker findings.  Considerable work is needed to validate the criteria that use biomarkers and to standardize biomarker analysis for use in community settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQog-HW7g5tSOqrn-c4Of3KfW6udTcc2eadNzwhzmQDFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrhsFaktA%253D%253D&md5=609df181936d75a42ae8db4826713f85</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2011.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2011.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DM.%2BS.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DDickson%26aufirst%3DD.%26aulast%3DDubois%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DH.%2BH.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DGamst%26aufirst%3DA.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DSnyder%26aufirst%3DP.%2BJ.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DThies%26aufirst%3DB.%26aulast%3DPhelps%26aufirst%3DC.%2BH.%26atitle%3DThe%2520diagnosis%2520of%2520mild%2520cognitive%2520impairment%2520due%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520recommendations%2520from%2520the%2520national%2520institute%2520on%2520aging-Alzheimer%25E2%2580%2599s%2520association%2520workgroups%2520on%2520diagnostic%2520guidelines%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2011%26volume%3D7%26spage%3D270%26epage%3D279%26doi%3D10.1016%2Fj.jalz.2011.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisodia, S. S.</span></span> <span> </span><span class="NLM_article-title">Mutant genes in familial Alzheimer’s disease and transgenic models</span>. <i>Annu. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">505</span>, <span class="refDoi"> DOI: 10.1146/annurev.neuro.21.1.479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1146%2Fannurev.neuro.21.1.479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=9530504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK1cXhsFyhtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=479-505&author=D.+L.+Priceauthor=S.+S.+Sisodia&title=Mutant+genes+in+familial+Alzheimer%E2%80%99s+disease+and+transgenic+models&doi=10.1146%2Fannurev.neuro.21.1.479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mutant genes in familial Alzheimer's disease and transgenic models</span></div><div class="casAuthors">Price, Donald L.; Sisodia, Sangram S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">479-505</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with 163 refs.  The most common cause of dementia occurring in mid- to late-life is Alzheimer's disease (AD).  Some cases of AD, particularly those of early onset, are familial and inherited as autosomal dominant disorders linked to the presence of mutant genes that encode the amyloid precursor protein (APP) or the presenilins (PS1 or PS2).  These mutant gene products cause dysfunction/death of vulnerable populations of nerve cells important in memory, higher cognitive processes, and behavior.  AD affects 7-10% of individuals >65 yr of age and perhaps 40% of individuals >80 yr of age.  For the late-onset cases, the principal risk factors are age and apolipoprotein (apoE) allele type, with apoE4 allele being a susceptibility factor.  In this review, we briefly discuss the clin. syndrome of AD and the neurobiol./neuropathol. of the disease and then focus attention on mutant genes linked to autosomal dominant familial AD (FAD), the biol. of the proteins encoded by these genes, and the recent exciting progress in investigations of genetically engineered animal models that express these mutant genes and develop some features of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowUt4ulmJ7ErVg90H21EOLACvtfcHk0lgtf-ijjdisWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsFyhtLY%253D&md5=fa1bf9dbad95faabcd6854eca46bad83</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.21.1.479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.21.1.479%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26atitle%3DMutant%2520genes%2520in%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520transgenic%2520models%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1998%26volume%3D21%26spage%3D479%26epage%3D505%26doi%3D10.1146%2Fannurev.neuro.21.1.479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Translating cell biology into therapeutic advances in Alzheimer’s disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>399</i></span>,  <span class="NLM_fpage">A23</span>– <span class="NLM_lpage">A31</span>, <span class="refDoi"> DOI: 10.1038/399a023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1038%2F399a023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10392577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK1MXktlejsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=A23-A31&author=D.+J.+Selkoe&title=Translating+cell+biology+into+therapeutic+advances+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2F399a023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Translating cell biology into therapeutic advances in Alzheimer's disease</span></div><div class="casAuthors">Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">399</span>
        (<span class="NLM_cas:issue">6738, Suppl.</span>),
    <span class="NLM_cas:pages">A23-A31</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">A review, with 100 refs.  Studies of the mol. basis of Alzheimer's disease exemplify the increasingly blurred distinction between basic and applied biomedical research.  The four genes so far implicated in familial Alzheimer's disease have each been shown to elevate brain levels of the self-aggregating amyloid-β protein, leading gradually to profound neuronal and glial alteration, synaptic loss, and dementia.  Progress in understanding this cascade has helped to identify specific therapeutic targets and provides a model for elucidating other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmIBdNyGPXN7Vg90H21EOLACvtfcHk0lgtf-ijjdisWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktlejsLg%253D&md5=617535c8a17e13091e330acb6bfcf8b2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F399a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F399a023%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DTranslating%2520cell%2520biology%2520into%2520therapeutic%2520advances%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D1999%26volume%3D399%26spage%3DA23%26epage%3DA31%26doi%3D10.1038%2F399a023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease at 25 years</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.15252/emmm.201606210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.15252%2Femmm.201606210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=27025652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=595-608&author=D.+J.+Selkoeauthor=J.+Hardy&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease+at+25+years&doi=10.15252%2Femmm.201606210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease at 25 years</span></div><div class="casAuthors">Selkoe, Dennis J.; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">595-608</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Despite continuing debate about the amyloid β-protein or Aβ hypothesis, new lines of evidence from labs. and clinics worldwide support the concept that an imbalance between prodn. and clearance of Aβ42 and related Aβ peptides is a very early, often initiating factor in Alzheimer's disease AD.  Confirmation that presenilin is the catalytic site of γ-secretase has provided a linchpin: all dominant mutations causing early-onset AD occur either in the substrate amyloid precursor protein, APP or the protease presenilin of the reaction that generates Aβ.  Duplication of the wild-type APP gene in Down's syndrome leads to Aβ deposits in the teens, followed by microgliosis, astrocytosis, and neurofibrillary tangles typical of AD.  Apolipoprotein E4, which predisposes to AD in > 40% of cases, has been found to impair Aβ clearance from the brain.  Sol. oligomers of Aβ42 isolated from AD patients' brains can decrease synapse no., inhibit long-term potentiation, and enhance long-term synaptic depression in rodent hippocampus, and injecting them into healthy rats impairs memory.  The human oligomers also induce hyperphosphorylation of tau at AD-relevant epitopes and cause neuritic dystrophy in cultured neurons.  Crossing human APP with human tau transgenic mice enhances tau-pos. neurotoxicity.  In humans, new studies show that low cerebrospinal fluid CSF Aβ42 and amyloid-PET positivity precede other AD manifestations by many years.  Most importantly, recent trials of three different Aβ antibodies solanezumab, crenezumab, and aducanumab have suggested a slowing of cognitive decline in post hoc analyses of mild AD subjects.  Although many factors contribute to AD pathogenesis, Aβ dyshomeostasis has emerged as the most extensively validated and compelling therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGo1qmyvVtbVg90H21EOLACvtfcHk0lgtf-ijjdisWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D&md5=b7a2003ba5d341f5eef5c7e9454235ce</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.15252%2Femmm.201606210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201606210%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520at%252025%2520years%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D595%26epage%3D608%26doi%3D10.15252%2Femmm.201606210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenk, D.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: molecular understanding predicts amyloid-based therapeutics</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1146/annurev.pharmtox.43.100901.140248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1146%2Fannurev.pharmtox.43.100901.140248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12415125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFWqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2003&pages=545-584&author=D.+J.+Selkoeauthor=D.+Schenk&title=Alzheimer%E2%80%99s+disease%3A+molecular+understanding+predicts+amyloid-based+therapeutics&doi=10.1146%2Fannurev.pharmtox.43.100901.140248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: Molecular understanding predicts amyloid-based therapeutics</span></div><div class="casAuthors">Selkoe, Dennis J.; Schenk, Dale</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">545-584</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Degenerative diseases of the brain were long considered among the most obscure and intractable of human maladies.  However, recent advances in understanding their mechanisms have brought us to the verge of potential disease-modifying agents.  This progress is perhaps best exemplified by the case of Alzheimer's disease.  The application of mol. pathol. and genetics has led to the recognition that the 4 genes implicated to date in familial Alzheimer's disease all chronically elevate cerebral levels of the amyloid β-protein (Aβ).  Accordingly, small mol. inhibitors of the β- and γ-secretases, the proteases that generate Aβ from its precursor, are under active development, and some have shown in vivo efficacy in mouse models.  An alternative approach, active or passive immunization against Aβ, has received extensive pre-clin. validation in mice, but an effective prepn. free of significant side effects in humans is still awaited.  Several other potential therapies are also reviewed here.  If one or more of these varied approaches is ultimately proven to slow or prevent dementia, Alzheimer's disease will become a salient example of the successful application of reductionist biol. to the most complex of organs, the human cerebral cortex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJVtpoYKa-LVg90H21EOLACvtfcHk0lieSit9fLGuWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFWqt74%253D&md5=5298d8939885e0b94bf43472721f0455</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.43.100901.140248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.43.100901.140248%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DSchenk%26aufirst%3DD.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520molecular%2520understanding%2520predicts%2520amyloid-based%2520therapeutics%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2003%26volume%3D43%26spage%3D545%26epage%3D584%26doi%3D10.1146%2Fannurev.pharmtox.43.100901.140248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J.</span></span> <span> </span><span class="NLM_article-title">Lessons learned from Alzheimer disease: clinical trials with negative outcomes</span>. <i>Clin. Transl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">147</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1111/cts.12491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1111%2Fcts.12491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=28767185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BC1cfjsVyqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=147-152&author=J.+Cummings&title=Lessons+learned+from+Alzheimer+disease%3A+clinical+trials+with+negative+outcomes&doi=10.1111%2Fcts.12491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes</span></div><div class="casAuthors">Cummings Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and translational science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-152</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4EcVa2l0ofS86Js-BCLiifW6udTcc2eaAQXY2r7ap57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfjsVyqtA%253D%253D&md5=6318eac19ef6e09ab99933284f55bf96</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fcts.12491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcts.12491%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%26atitle%3DLessons%2520learned%2520from%2520Alzheimer%2520disease%253A%2520clinical%2520trials%2520with%2520negative%2520outcomes%26jtitle%3DClin.%2520Transl.%2520Sci.%26date%3D2018%26volume%3D11%26spage%3D147%26epage%3D152%26doi%3D10.1111%2Fcts.12491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbagh, M.</span></span> <span> </span><span class="NLM_article-title">Why do trials for Alzheimer’s disease drugs keep failing? a discontinued drug perspective for 2010–2015</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1080/13543784.2017.1323868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1080%2F13543784.2017.1323868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=28460541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2sXot1Shu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=735-739&author=D.+Mehtaauthor=R.+Jacksonauthor=G.+Paulauthor=J.+Shiauthor=M.+Sabbagh&title=Why+do+trials+for+Alzheimer%E2%80%99s+disease+drugs+keep+failing%3F+a+discontinued+drug+perspective+for+2010%E2%80%932015&doi=10.1080%2F13543784.2017.1323868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015</span></div><div class="casAuthors">Mehta, Dev; Jackson, Robert; Paul, Gaurav; Shi, Jiong; Sabbagh, Marwan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">735-739</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: There are dozens of drugs in development for AD with billions of dollars invested.  Despite the massive investment in AD drugs and a burgeoning pipeline, there have been more setbacks and failures than treatment successes.: The classes of drugs that have failed to date include the monoclonal antibodies, the gamma secretase inhibitors, dimebon, neurochem. enhancers, and one tau drug.  Data for these compds. were sought through a PubMed search and a clin. trials.gov search.: The obvious question to be posed is: Why are they failing.  Is the treatment of symptomatic dementia too late.  Are the therapeutic targets incorrect.  Are the clin. methodologies imprecise, misleading, or inaccurate.  This review summarizes the drugs that have failed during 2010-2015 and offers possible theories as to why they have failed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphTh-OjoTzgbVg90H21EOLACvtfcHk0lieSit9fLGuWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXot1Shu7Y%253D&md5=efa88fffd86b5674b1b3f19342947933</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1080%2F13543784.2017.1323868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543784.2017.1323868%26sid%3Dliteratum%253Aachs%26aulast%3DMehta%26aufirst%3DD.%26aulast%3DJackson%26aufirst%3DR.%26aulast%3DPaul%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DSabbagh%26aufirst%3DM.%26atitle%3DWhy%2520do%2520trials%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520drugs%2520keep%2520failing%253F%2520a%2520discontinued%2520drug%2520perspective%2520for%25202010%25E2%2580%25932015%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2017%26volume%3D26%26spage%3D735%26epage%3D739%26doi%3D10.1080%2F13543784.2017.1323868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Small, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, C. A.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease and the amyloid β protein: what is the role of amyloid?</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.1999.0730443.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1046%2Fj.1471-4159.1999.0730443.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10428038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK1MXkslOqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1999&pages=443-449&author=D.+H.+Smallauthor=C.+A.+McLean&title=Alzheimer%E2%80%99s+disease+and+the+amyloid+%CE%B2+protein%3A+what+is+the+role+of+amyloid%3F&doi=10.1046%2Fj.1471-4159.1999.0730443.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease and the amyloid β protein: what is the role of amyloid?</span></div><div class="casAuthors">Small, David H.; McLean, Catriona A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">443-449</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 96 refs.  Topics include: amyloid protein and amyloid precursor protein; role of amyloid β in Alzheimer's disease pathogenesis; amyloid precursor protein transgenic mice; amyloid toxicity in vitro; apolipoprotein E and amyloid β toxicity; is sol. amyloid β important in Alzheimer's pathogenesis; a novel variant of Alzheimer's disease; is amyloid β1-42/43 the only toxic form of amyloid β.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAFMWJKeKhjLVg90H21EOLACvtfcHk0ljfjMgv6isUsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkslOqsr4%253D&md5=af8c07e499b2f64f4d0a38d35afce700</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1999.0730443.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1999.0730443.x%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DD.%2BH.%26aulast%3DMcLean%26aufirst%3DC.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520and%2520the%2520amyloid%2520%25CE%25B2%2520protein%253A%2520what%2520is%2520the%2520role%2520of%2520amyloid%253F%26jtitle%3DJ.%2520Neurochem.%26date%3D1999%26volume%3D73%26spage%3D443%26epage%3D449%26doi%3D10.1046%2Fj.1471-4159.1999.0730443.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cleary, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmeister, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuskowski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashe, K. H.</span></span> <span> </span><span class="NLM_article-title">Natural oligomers of the amyloid-β protein specifically disrupt cognitive function</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1038/nn1372</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1038%2Fnn1372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15608634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD2cnksFeqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=79-84&author=J.+P.+Clearyauthor=D.+M.+Walshauthor=J.+J.+Hofmeisterauthor=G.+M.+Shankarauthor=M.+A.+Kuskowskiauthor=D.+J.+Selkoeauthor=K.+H.+Ashe&title=Natural+oligomers+of+the+amyloid-%CE%B2+protein+specifically+disrupt+cognitive+function&doi=10.1038%2Fnn1372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function</span></div><div class="casAuthors">Cleary James P; Walsh Dominic M; Hofmeister Jacki J; Shankar Ganesh M; Kuskowski Michael A; Selkoe Dennis J; Ashe Karen H</div><div class="citationInfo"><span class="NLM_cas:title">Nature neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-84</span>
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    </div><div class="casAbstract">A central unresolved problem in research on Alzheimer disease is the nature of the molecular entity causing dementia.  Here we provide the first direct experimental evidence that a defined molecular species of the amyloid-beta protein interferes with cognitive function.  Soluble oligomeric forms of amyloid-beta, including trimers and dimers, were both necessary and sufficient to disrupt learned behavior in a manner that was rapid, potent and transient; they produced impaired cognitive function without inducing permanent neurological deficits.  Although beta-amyloidosis has long been hypothesized to affect cognition, the abnormally folded protein species associated with this or any other neurodegenerative disease has not previously been isolated, defined biochemically and then specifically characterized with regard to its effects on cognitive function.  The biochemical isolation of discrete amyloid-beta moieties with pathophysiological properties sets the stage for a new approach to studying the molecular mechanisms of cognitive impairment in Alzheimer disease and related neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxJ50jZifCN56KlWarZTAzfW6udTcc2eaDtFHIt_p437ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cnksFeqsQ%253D%253D&md5=538ad375375c965463e33ae791da930d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnn1372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1372%26sid%3Dliteratum%253Aachs%26aulast%3DCleary%26aufirst%3DJ.%2BP.%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DHofmeister%26aufirst%3DJ.%2BJ.%26aulast%3DShankar%26aufirst%3DG.%2BM.%26aulast%3DKuskowski%26aufirst%3DM.%2BA.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DAshe%26aufirst%3DK.%2BH.%26atitle%3DNatural%2520oligomers%2520of%2520the%2520amyloid-%25CE%25B2%2520protein%2520specifically%2520disrupt%2520cognitive%2520function%26jtitle%3DNat.%2520Neurosci.%26date%3D2005%26volume%3D8%26spage%3D79%26epage%3D84%26doi%3D10.1038%2Fnn1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manczak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anekonda, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. H.</span></span> <span> </span><span class="NLM_article-title">Mitochondria are a direct site of Aβ accumulation in Alzheimer’s disease neurons: implications for free radical generation and oxidative damage in disease progression</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1437</span>– <span class="NLM_lpage">1449</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddl066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1093%2Fhmg%2Fddl066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=16551656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslGhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=1437-1449&author=M.+Manczakauthor=T.+S.+Anekondaauthor=E.+Hensonauthor=B.+S.+Parkauthor=J.+Quinnauthor=P.+H.+Reddy&title=Mitochondria+are+a+direct+site+of+A%CE%B2+accumulation+in+Alzheimer%E2%80%99s+disease+neurons%3A+implications+for+free+radical+generation+and+oxidative+damage+in+disease+progression&doi=10.1093%2Fhmg%2Fddl066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression</span></div><div class="casAuthors">Manczak, Maria; Anekonda, Thimmappa S.; Henson, Edward; Park, Byung S.; Quinn, Joseph; Reddy, P. Hemachandra</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1437-1449</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a complex, neurodegenerative disease characterized by the impairment of cognitive function in elderly individuals.  In a recent global gene expression study of APP transgenic mice, we found elevated expression of mitochondrial genes, which we hypothesize represents a compensatory response because of mitochondrial oxidative damage caused by the over-expression of mutant APP and/or amyloid beta (Aβ).  We investigated this hypothesis in a series of expts. examg. what forms of APP and Aβ localize to the mitochondria, and whether the presence of these species is assocd. with mitochondrial dysfunction and oxidative damage.  Using immunoblotting, digitonin fractionation, immunofluorescence, and electron microscopy techniques, we found a relationship between mutant APP derivs. and mitochondria in brain slices from Tg2576 mice and in mouse neuroblastoma cells expressing mutant human APP.  Further, to det. the functional relationship between mutant APP/Aβ and oxidative damage, we quantified Aβ levels, hydrogen peroxide prodn., cytochrome oxidase activity and carbonyl proteins in Tg2576 mice and age-matched wild-type (WT) littermates.  Hydrogen peroxide levels were found to be significantly increased in Tg2576 mice when compared with age-matched WT littermates and directly correlated with levels of sol. Aβ in Tg2576 mice, suggesting that sol. Aβ may be responsible for the prodn. of hydrogen peroxide in AD progression in Tg2576 mice.  Cytochrome c oxidase activity was found to be decreased in Tg2576 mice when compared with age-matched WT littermates, suggesting that mutant APP and sol. Aβ impair mitochondrial metab. in AD development and progression.  An increase in hydrogen peroxide and a decrease in cytochrome oxidase activity were found in young Tg2576 mice, prior to the appearance of Aβ plaques.  These findings suggest that early mitochondrially targeted therapeutic interventions may be effective in delaying AD progression in elderly individuals and in treating AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN8u5Rx5XNe7Vg90H21EOLACvtfcHk0ljfjMgv6isUsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslGhsLs%253D&md5=c2f689e07c3b0b7950d1758684c263f7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddl066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddl066%26sid%3Dliteratum%253Aachs%26aulast%3DManczak%26aufirst%3DM.%26aulast%3DAnekonda%26aufirst%3DT.%2BS.%26aulast%3DHenson%26aufirst%3DE.%26aulast%3DPark%26aufirst%3DB.%2BS.%26aulast%3DQuinn%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DP.%2BH.%26atitle%3DMitochondria%2520are%2520a%2520direct%2520site%2520of%2520A%25CE%25B2%2520accumulation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520neurons%253A%2520implications%2520for%2520free%2520radical%2520generation%2520and%2520oxidative%2520damage%2520in%2520disease%2520progression%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2006%26volume%3D15%26spage%3D1437%26epage%3D1449%26doi%3D10.1093%2Fhmg%2Fddl066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacques, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdoch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whetsell,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaye, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manczak, M.</span></span> <span> </span><span class="NLM_article-title">Differential loss of synaptic proteins in Alzheimer’s disease: implications for synaptic dysfunction</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.3233/JAD-2005-7203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-2005-7203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15851848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsVSjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=103-117&author=P.+H.+Reddyauthor=G.+Maniauthor=B.+S.+Parkauthor=J.+Jacquesauthor=G.+Murdochauthor=+Whetsellauthor=J.+Kayeauthor=M.+Manczak&title=Differential+loss+of+synaptic+proteins+in+Alzheimer%E2%80%99s+disease%3A+implications+for+synaptic+dysfunction&doi=10.3233%2FJAD-2005-7203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction</span></div><div class="casAuthors">Reddy, P. Hemachandra; Mani, Geethalakshmi; Park, Byung S.; Jacques, Joline; Murdoch, Geoffrey; Whetsell, William, Jr.; Kaye, Jeffrey; Manczak, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">103-117</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The objective of our research was to det. synaptic protein levels in brain specimens from AD subjects and age-matched control subjects.  Further, to det. whether presynaptic or postsynaptic compartments of neurons are preferentially affected in AD patients, we studied 3 presynaptic vesicle proteins (synaptotagmin, synaptophysin, and Rab 3A), 2 synaptic membrane proteins (Gap 43 and synaptobrevin), and 2 postsynaptic proteins (neurogranin and synaptopodin) in specimens from AD and age-matched control brains.  Two brain regions - the frontal and parietal cortices - were assessed for protein levels by immunoblotting anal.  We found a loss of both presynaptic vesicle proteins and postsynaptic proteins in all brain specimens from AD patients compared to those from age-matched control subjects.  Further, we found that the loss of synaptic proteins was more severe in the frontal cortex brain specimens than in the parietal cortex brain specimens from the AD subjects compared to those from the control subjects, suggesting that the frontal brain may be crit. for synaptic function in AD.  Using immunohistochem. techniques, we also detd. the distribution pattern of all synaptic proteins in both the frontal and parietal cortices brain specimens from control subjects.  Of the 7 synaptic proteins studied, the presynaptic proteins synaptophysin and rab 3A and the postsynaptic protein synaptopodin were the most down-regulated.  Our study suggests that postsynaptic proteins and presynaptic proteins are important for synaptic function and may be related to cognitive impairments in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriUMUM1XJKZ7Vg90H21EOLACvtfcHk0lgJ1258S7IpZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsVSjs70%253D&md5=5de577ab06fd74e163f4f264d11a9843</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3233%2FJAD-2005-7203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2005-7203%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DP.%2BH.%26aulast%3DMani%26aufirst%3DG.%26aulast%3DPark%26aufirst%3DB.%2BS.%26aulast%3DJacques%26aufirst%3DJ.%26aulast%3DMurdoch%26aufirst%3DG.%26aulast%3DWhetsell%26aulast%3DKaye%26aufirst%3DJ.%26aulast%3DManczak%26aufirst%3DM.%26atitle%3DDifferential%2520loss%2520of%2520synaptic%2520proteins%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520synaptic%2520dysfunction%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2005%26volume%3D7%26spage%3D103%26epage%3D117%26doi%3D10.3233%2FJAD-2005-7203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWeeney, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manczak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutala, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partovi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yau, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searles, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, J.</span></span> <span> </span><span class="NLM_article-title">Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer’s disease</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1240</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddh140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1093%2Fhmg%2Fddh140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15115763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktF2qtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=1225-1240&author=P.+H.+Reddyauthor=S.+McWeeneyauthor=B.+S.+Parkauthor=M.+Manczakauthor=R.+V.+Gutalaauthor=D.+Partoviauthor=Y.+Jungauthor=V.+Yauauthor=R.+Searlesauthor=M.+Moriauthor=J.+Quinn&title=Gene+expression+profiles+of+transcripts+in+amyloid+precursor+protein+transgenic+mice%3A+up-regulation+of+mitochondrial+metabolism+and+apoptotic+genes+is+an+early+cellular+change+in+Alzheimer%E2%80%99s+disease&doi=10.1093%2Fhmg%2Fddh140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease</span></div><div class="casAuthors">Reddy, P. Hemachandra; McWeeney, Shannon; Park, Byung S.; Manczak, Maria; Gutala, Ramana V.; Partovi, Dara; Jung, Youngsin; Yau, Vincent; Searles, Robert; Mori, Motomi; Quinn, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1225-1240</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by the impairment of cognitive functions and by beta amyloid (Aβ) plaques in the cerebral cortex and the hippocampus.  Our objective was to det. genes that are crit. for cellular changes in AD progression, with particular emphasis on changes early in disease progression.  We investigated an established amyloid precursor protein (APP) transgenic mouse model (the Tg2576 mouse model) for gene expression profiles at three stages of disease progression: long before (2 mo of age), immediately before (5 mo) and after (18 mo) the appearance of Aβ plaques.  Using cDNA microarray techniques, we measured mRNA levels in 11 283 cDNA clones from the cerebral cortex of Tg2576 mice and age-matched wild-type (WT) mice at each of the three time points.  This gene expression anal. revealed that the genes related to mitochondrial energy metab. and apoptosis were up-regulated in 2-mo-old Tg2576 mice and that the same genes were up-regulated at 5 and 18 mo of age.  These microarray results were confirmed using northern blot anal.  Results from in situ hybridization of mitochondrial genes-ATPase-6, heat-shock protein 86 and programmed cell death gene 8-suggest that the granule cells of the hippocampal dentate gyrus and the pyramidal neurons in the hippocampus and the cerebral cortex are up-regulated in Tg2576 mice compared with WT mice.  Results from double-labeling in situ hybridization suggest that in Tg2576 mice only selective, over-expressed neurons with the mitochondrial gene ATPase-6 undergo oxidative damage.  These results, therefore, suggest that mitochondrial energy metab. is impaired by the expression of mutant APP and/or Aβ, and that the up-regulation of mitochondrial genes is a compensatory response.  These findings have important implications for understanding the mechanism of Aβ toxicity in AD and for developing therapeutic strategies for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRxZE0Angzw7Vg90H21EOLACvtfcHk0lgJ1258S7IpZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktF2qtLg%253D&md5=4ab7f2b86af2799003dda9676ff64dac</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddh140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddh140%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DP.%2BH.%26aulast%3DMcWeeney%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DB.%2BS.%26aulast%3DManczak%26aufirst%3DM.%26aulast%3DGutala%26aufirst%3DR.%2BV.%26aulast%3DPartovi%26aufirst%3DD.%26aulast%3DJung%26aufirst%3DY.%26aulast%3DYau%26aufirst%3DV.%26aulast%3DSearles%26aufirst%3DR.%26aulast%3DMori%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DJ.%26atitle%3DGene%2520expression%2520profiles%2520of%2520transcripts%2520in%2520amyloid%2520precursor%2520protein%2520transgenic%2520mice%253A%2520up-regulation%2520of%2520mitochondrial%2520metabolism%2520and%2520apoptotic%2520genes%2520is%2520an%2520early%2520cellular%2520change%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2004%26volume%3D13%26spage%3D1225%26epage%3D1240%26doi%3D10.1093%2Fhmg%2Fddh140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, M. F.</span></span> <span> </span><span class="NLM_article-title">Are mitochondria critical in the pathogenesis of Alzheimer’s disease?</span>. <i>Brain Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">618</span>– <span class="NLM_lpage">632</span>, <span class="refDoi"> DOI: 10.1016/j.brainresrev.2005.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.brainresrev.2005.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=16269322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFOhsbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=618-632&author=P.+H.+Reddyauthor=M.+F.+Beal&title=Are+mitochondria+critical+in+the+pathogenesis+of+Alzheimer%E2%80%99s+disease%3F&doi=10.1016%2Fj.brainresrev.2005.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Are mitochondria critical in the pathogenesis of Alzheimer's disease?</span></div><div class="casAuthors">Reddy, P. Hemachandra; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">618-632</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review summarizes recent findings that suggest a causal connection between mitochondrial abnormalities and sporadic Alzheimer's disease (AD).  Genetic causes of AD are known only for a small proportion of familial AD patients, but for a majority of sporadic AD patients, genetic causal factors are still unknown.  Currently, there are no early detectable biomarkers for sporadic AD, and there is a lack of understanding of the pathophysiol. of the disease.  Findings from recent genetic studies of AD pathogenesis suggest that mitochondrial defects may play an important role in sporadic AD progression, and that mitochondrial abnormalities and oxidative damage may play a significant role in the progression of familial AD.  Findings from biochem. studies, in vitro studies, gene expression studies, and animal model studies of AD are reviewed, and the possible contribution of mitochondrial mutations to late-onset sporadic AD is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplwJeNzXHyqrVg90H21EOLACvtfcHk0lgJ1258S7IpZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFOhsbrL&md5=eb375220b5f5eccb90b2b119f97f3377</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresrev.2005.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresrev.2005.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DP.%2BH.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DAre%2520mitochondria%2520critical%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2005%26volume%3D49%26spage%3D618%26epage%3D632%26doi%3D10.1016%2Fj.brainresrev.2005.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trippier, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen Labby, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawker, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mataka, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <span> </span><span class="NLM_article-title">Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3121</span>– <span class="NLM_lpage">3147</span>, <span class="refDoi"> DOI: 10.1021/jm3015926</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3015926" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFeju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3121-3147&author=P.+C.+Trippierauthor=K.+Jansen+Labbyauthor=D.+D.+Hawkerauthor=J.+J.+Matakaauthor=R.+B.+Silverman&title=Target-+and+mechanism-based+therapeutics+for+neurodegenerative+diseases%3A+strength+in+numbers&doi=10.1021%2Fjm3015926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers</span></div><div class="casAuthors">Trippier, Paul C.; Jansen Labby, Kristin; Hawker, Dustin D.; Mataka, Jan J.; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3121-3147</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of new therapeutics for the treatment of neurodegenerative pathophysiologies currently stands at a crossroads.  This presents an opportunity to transition future drug discovery efforts to target disease modification, an area in which much still remains unknown.  In this Perspective we examine recent progress in the areas of neurodegenerative drug discovery, focusing on some of the most common targets and mechanisms: N-methyl-d-aspartic acid (NMDA) receptors, voltage gated calcium channels (VGCCs), neuronal nitric oxide synthase (nNOS), oxidative stress from reactive oxygen species, and protein aggregation.  These represent the key players identified in neurodegeneration and are part of a complex, intertwined signaling cascade.  The synergistic delivery of two or more compds. directed against these targets, along with the design of small mols. with multiple modes of action, should be explored in pursuit of more effective clin. treatments for neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjl83DGjxqKrVg90H21EOLACvtfcHk0lh8TOyTuRdrTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFeju78%253D&md5=a8ea6d8cf4f9d3bba76d40ceacc9c26d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm3015926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3015926%26sid%3Dliteratum%253Aachs%26aulast%3DTrippier%26aufirst%3DP.%2BC.%26aulast%3DJansen%2BLabby%26aufirst%3DK.%26aulast%3DHawker%26aufirst%3DD.%2BD.%26aulast%3DMataka%26aufirst%3DJ.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DTarget-%2520and%2520mechanism-based%2520therapeutics%2520for%2520neurodegenerative%2520diseases%253A%2520strength%2520in%2520numbers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3121%26epage%3D3147%26doi%3D10.1021%2Fjm3015926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sameem, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeedi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahdavi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafiee, A.</span></span> <span> </span><span class="NLM_article-title">A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.10.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.ejmech.2016.10.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=27876467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFait77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2017&pages=332-345&author=B.+Sameemauthor=M.+Saeediauthor=M.+Mahdaviauthor=A.+Shafiee&title=A+review+on+tacrine-based+scaffolds+as+multi-target+drugs+%28MTDLs%29+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2016.10.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease</span></div><div class="casAuthors">Sameem, Bilqees; Saeedi, Mina; Mahdavi, Mohammad; Shafiee, Abbas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">332-345</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a multifactorial neurol. disorder among elderly people and combinatorial factors such as genetic, lifestyle, and environmental are involved in onset and disease progression.  It has been demonstrated that loss of cholinergic transmission is one of the most significant causes of AD.  One strategy currently being investigated for the development of new therapeutics relates to the enhancement of cholinergic system through several ways.  At this juncture, anticholinesterase inhibitors have absorbed lots of attention and different marketed drugs such as donepezil, rivastigmine, tacrine, and galantamine have been developed. 9-Amino-1,2,3,4-tetrahydroacridine known as tacrine was introduced in 1945 as an efficient anticholinesterase agent.  The mechanism of action of tacrine was proved to inhibit the metab. of acetylcholine and therefore extending its activity and raising levels in the cerebral cortex.  However, extensive use of tacrine was limited since it showed various side effects and toxicity.  Thus, lots of efforts were carried out to prep. tacrine analogs to overcome the related adverse effects.  This review describes differently synthesized tacrine-based scaffolds as cholinesterase inhibitors to manage Alzheimer's disease (AD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrURdMfJvk17bVg90H21EOLACvtfcHk0lh8TOyTuRdrTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFait77F&md5=2462b18c5601b6491dfe553452268f40</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.10.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.10.060%26sid%3Dliteratum%253Aachs%26aulast%3DSameem%26aufirst%3DB.%26aulast%3DSaeedi%26aufirst%3DM.%26aulast%3DMahdavi%26aufirst%3DM.%26aulast%3DShafiee%26aufirst%3DA.%26atitle%3DA%2520review%2520on%2520tacrine-based%2520scaffolds%2520as%2520multi-target%2520drugs%2520%2528MTDLs%2529%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D128%26spage%3D332%26epage%3D345%26doi%3D10.1016%2Fj.ejmech.2016.10.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farlow, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doody, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedhoff, L. T.</span></span> <span> </span><span class="NLM_article-title">A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1212/WNL.50.1.136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1212%2FWNL.50.1.136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=9443470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK1cXotVKjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=136-145&author=S.+L.+Rogersauthor=M.+R.+Farlowauthor=R.+S.+Doodyauthor=R.+Mohsauthor=L.+T.+Friedhoff&title=A+24-week%2C+double-blind%2C+placebo-controlled+trial+of+donepezil+in+patients+with+Alzheimer%E2%80%99s+disease&doi=10.1212%2FWNL.50.1.136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease</span></div><div class="casAuthors">Rogers, S. L.; Farlow, M. R.; Doody, R. S.; Mohs, R.; Friedhoff, L. T.; Donepezil Study Group</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">136-145</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">The efficacy and safety of donepezil as a treatment for patients with mild to moderate Alzheimer's disease (AD) was investigated in a multicenter, double-blind study.  Patients were randomly assigned to treatment with placebo, 5 mg/d donepezil, or 10 mg/d donepezil for 24 wk followed by a 6-wk, single-blind placebo washout.  The primary efficacy measures were the cognitive portion of the Alzheimer's Disease Assessment Scale (ADAS-cog) and the Clinician's Interview Based Assessment of Change-Plus (CIBIC plus), with the Mini-Mental State Examn. (MMSE), Clin. Dementia Rating Scale-Sum of the Boxes (CDR-SB), and patient rated Quality of Life (QoL) used as secondary measures.  Cognitive function, as measured by the ADAS-cog, was improved in the 5- and 10-mg/d donepezil groups as compared with the placebo group at weeks 12, 18, and 24.  Clinician's global ratings on the CIBIC plus also improved in both the 5- and 10-mg/d donepezil groups relative to placebo.  At the end of the 6-wk placebo washout phase, ADAS-cog scores and CIBIC plus ratings were not different for the three groups.  Significant treatment benefits were also obsd. consistently in both the 5- and 10-mg/d groups on the MMSE and the CDR-SB, but there was no consistent effect on the patient-rated QoL.  Cholinergic side effects (primarily diarrhea, nausea, and vomiting) were reported more often in the 10-mg/d group than either the 5-mg/d or placebo groups.  Side effects were transient and generally mild in severity.  Thus, that donepezil is a well-tolerated drug that improves cognition and global function in patients with mild to moderate AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhyp_qMswETbVg90H21EOLACvtfcHk0lh8TOyTuRdrTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVKjsA%253D%253D&md5=b6a9326804fdeb58d057ce2f35771455</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1212%2FWNL.50.1.136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.50.1.136%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DS.%2BL.%26aulast%3DFarlow%26aufirst%3DM.%2BR.%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DMohs%26aufirst%3DR.%26aulast%3DFriedhoff%26aufirst%3DL.%2BT.%26atitle%3DA%252024-week%252C%2520double-blind%252C%2520placebo-controlled%2520trial%2520of%2520donepezil%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1998%26volume%3D50%26spage%3D136%26epage%3D145%26doi%3D10.1212%2FWNL.50.1.136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rösler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicin-Sain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agid, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal-Bianco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stähelin, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharabawi, M.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomised controlled trial</span>. <i>BMJ</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>318</i></span>,  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1136/bmj.318.7184.633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1136%2Fbmj.318.7184.633" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=1999&pages=633-640&author=M.+R%C3%B6slerauthor=R.+Anandauthor=A.+Cicin-Sainauthor=S.+Gauthierauthor=Y.+Agidauthor=P.+Dal-Biancoauthor=H.+B.+St%C3%A4helinauthor=R.+Hartmanauthor=M.+Gharabawi&title=Efficacy+and+safety+of+rivastigmine+in+patients+with+Alzheimer%E2%80%99s+disease%3A+international+randomised+controlled+trial&doi=10.1136%2Fbmj.318.7184.633"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1136%2Fbmj.318.7184.633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.318.7184.633%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25B6sler%26aufirst%3DM.%26aulast%3DAnand%26aufirst%3DR.%26aulast%3DCicin-Sain%26aufirst%3DA.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DAgid%26aufirst%3DY.%26aulast%3DDal-Bianco%26aufirst%3DP.%26aulast%3DSt%25C3%25A4helin%26aufirst%3DH.%2BB.%26aulast%3DHartman%26aufirst%3DR.%26aulast%3DGharabawi%26aufirst%3DM.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520rivastigmine%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520international%2520randomised%2520controlled%2520trial%26jtitle%3DBMJ%26date%3D1999%26volume%3D318%26spage%3D633%26epage%3D640%26doi%3D10.1136%2Fbmj.318.7184.633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kershaw, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilienfeld, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span> <span> </span><span class="NLM_article-title">A 5-month, randomized, placebo-controlled trial of galantamine in AD</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2269</span>– <span class="NLM_lpage">2276</span>, <span class="refDoi"> DOI: 10.1212/WNL.54.12.2269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1212%2FWNL.54.12.2269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10881251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFSmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2000&pages=2269-2276&author=P.+N.+Tariotauthor=P.+R.+Solomonauthor=J.+C.+Morrisauthor=P.+Kershawauthor=S.+Lilienfeldauthor=C.+Ding&title=A+5-month%2C+randomized%2C+placebo-controlled+trial+of+galantamine+in+AD&doi=10.1212%2FWNL.54.12.2269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A 5-month, randomized, placebo-controlled trial of galantamine in AD</span></div><div class="casAuthors">Tariot, P. N.; Solomon, P. R.; Morris, J. C.; Kershaw, P.; Lilienfeld, S.; Ding, C.; Ahern, G.; Aronson, S.; Brenner, R.; Burke, W.; Cochran, J.; Cohen, S.; Cummins, H.; Drachman, D.; Duboff, E.; Farlow, M.; Ferris, S.; Forchetti, C.; Frey, J.; Grossberg, G.; Harrell, L.; Hoffstetter, M.; Holub, R.; Kaye, J.; Landbloom, R.; Levin, K.; Lindahl, L.; Londborg, P.; Lyketsos, C.; Maguire, G.; Mallya, G.; Merideth, C.; Mintzer, J.; Morris, J.; Newhouse, P.; Ng, K.; Plopper, M.; Porteinsson, A.; Probst, T.; Raskind, M.; Reichman, W.; Richardson, B.; Richter, R.; Ross, J.; Sadowsky, C.; Saur, D.; Sauter, M.; Scharre, D.; Schindler, R.; Schneider, L.; Scinto, L.; Siegal, A.; Smith, W.; Solomon, P.; Steinberg, A.; Stone, W.; Tariot, P. N.; Thein, S.; Van Dyck, C.; Visser, J.; Walshe, T., III; Weiner, M.; West, S.</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2269-2276</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The efficacy and tolerability of galantamine, using a slow dose escalation schedule of up to 8 wk, were evaluated in 978 patients with mild to moderate AD.  The study consisted of a 5-mo multicenter, placebo-controlled, double-blind trial.  Following a 4-wk placebo run-in, patients were randomized to one of four treatment arms: placebo or galantamine escalated to final maintenance doses of 8, 16, or 24 mg/day.  Outcome measures included the cognitive subscale of the AD Assessment Scale (ADAS-cog), the Clinician's Interview-Based Impression of Change plus Caregiver Input (CIBIC-plus), the AD Cooperative Study Activities of Daily Living inventory, and the Neuropsychiatric Inventory.  Std. safety evaluations and adverse event monitoring were carried out.  After 5 mo, the galantamine-placebo differences on ADAS-cog were 3.3 points for the 16 mg/day group and 3.6 points for the 24 mg/day group (p < 0.001 vs. placebo, both doses).  Compared with placebo, the galantamine 16- and 24-mg/day groups also had a significantly better outcome on CIBIC-plus, activities of daily living, and behavioral symptoms.  Treatment discontinuations due to adverse events were low in all galantamine groups (6 to 10%) and comparable with the discontinuation rate in the placebo group (7%).  The incidence of adverse events in the galantamine groups, notably gastrointestinal symptoms, was low and most adverse events were mild.  Galantamine 16 and 24 mg/day significantly benefits the cognitive, functional, and behavioral symptoms of AD as compared with placebo.  Slow dose escalation appears to enhance the tolerability of galantamine, minimizing the incidence and severity of adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn9bdC2XgNr7Vg90H21EOLACvtfcHk0lixU2yufR1pJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFSmsL8%253D&md5=1833030f74b7331699a45fbe3f750dcb</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1212%2FWNL.54.12.2269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.54.12.2269%26sid%3Dliteratum%253Aachs%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DSolomon%26aufirst%3DP.%2BR.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DKershaw%26aufirst%3DP.%26aulast%3DLilienfeld%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DC.%26atitle%3DA%25205-month%252C%2520randomized%252C%2520placebo-controlled%2520trial%2520of%2520galantamine%2520in%2520AD%26jtitle%3DNeurology%26date%3D2000%26volume%3D54%26spage%3D2269%26epage%3D2276%26doi%3D10.1212%2FWNL.54.12.2269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, N.</span></span> <span> </span><span class="NLM_article-title">Memantine monotherapy for Alzheimer’s disease: a systematic review and meta-analysis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0123289</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0123289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1371%2Fjournal.pone.0123289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=25860130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOjsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0123289&author=S.+Matsunagaauthor=T.+Kishiauthor=N.+Iwata&title=Memantine+monotherapy+for+Alzheimer%E2%80%99s+disease%3A+a+systematic+review+and+meta-analysis&doi=10.1371%2Fjournal.pone.0123289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis</span></div><div class="casAuthors">Matsunaga, Shinji; Kishi, Taro; Iwata, Nakao</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0123289/1-e0123289/16</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">We performed an updated meta-anal. of randomized placebo-controlled trials testing memantine monotherapy for patients with Alzheimer's disease (AD).  The meta-anal. included randomized controlled trials of memantine monotherapy for AD, omitting those in which patients were also administered a cholinesterase inhibitor.  Cognitive function, activities of daily living, behavioral disturbances, global function, stage of dementia, drug discontinuation rate, and individual side effects were compared between memantine monotherapy and placebo groups.  The primary outcomes were cognitive function and behavioral disturbances; the others were secondary outcomes.  Nine studies including 2433 patients that met the study's inclusion criteria were identified.Memantine monotherapy significantly improved cognitive function [standardized mean difference(SMD) =-0.27, 95% confidence interval (CI) =-0.39 to-0.14, p = 0.0001], behavioral disturbances (SMD =-0.12, 95% CI =-0.22 to-0.01, p = 0.03), activities of daily living(SMD =-0.09, 95% CI =-0.19 to-0.00, p = 0.05), global function assessment (SMD =-0.18,95% CI =-0.27 to-0.09, p = 0.0001), and stage of dementia (SMD =-0.23, 95% CI =-0.33 to -0.12, p = 0.0001) scores.  Memantine was superior to placebo in terms of discontinuation because of inefficacy [risk ratio (RR) = 0.36, 95% CI = 0.17 - to 0.74, p = 0.006, no. needed to harm (NNH)=non significant].  Moreover, memantine was assocd. with less agitation compared with placebo (RR=0.68, 95% CI = 0.49 to 0.94, p = 0.02, NNH=non significant).  There were no significant differences in the rate of discontinuation because of all causes, all adverse events, and individual side effects other than agitation between the memantine monotherapy and placebo groups.  Memantine monotherapy improved cognition, behavior, activities of daily living, global function, and stage of dementia and was well-tolerated by AD patients.  However, the effect size in terms of efficacy outcomes was small and thus there is limited evidence of clin. benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxxAhpchXSEbVg90H21EOLACvtfcHk0lixU2yufR1pJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOjsrbN&md5=258bbdd8ceaa9f456ac6406b3788a7df</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0123289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0123289%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DIwata%26aufirst%3DN.%26atitle%3DMemantine%2520monotherapy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0123289%26doi%3D10.1371%2Fjournal.pone.0123289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J. L.</span></span> <span> </span><span class="NLM_article-title">Cholinesterase inhibitors: a new class of psychotropic compounds</span>. <i>Am. J. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1176/ajp.157.1.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1176%2Fajp.157.1.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10618007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD3c%252FosVyisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2000&pages=4-15&author=J.+L.+Cummings&title=Cholinesterase+inhibitors%3A+a+new+class+of+psychotropic+compounds&doi=10.1176%2Fajp.157.1.4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Cholinesterase inhibitors: A new class of psychotropic compounds</span></div><div class="casAuthors">Cummings J L</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-15</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  This article reviews evidence indicating that acetylcholinesterase inhibitors have psychotropic properties.  METHOD:  The author reviewed the English-language literature pertinent to the response of neuropsychiatric symptoms in Alzheimer's disease and related conditions to cholinergic agents.  RESULTS:  The cholinergic system originates in the basal forebrain and projects diffusely to the cerebral cortex; the limbic and paralimbic regions receive the most abundant cholinergic projections.  The basal forebrain nuclei are positioned at the interface of the limbic system and cerebral cortex, where they play a role in mediating emotional responses.  The basal forebrain nuclei are atrophic in Alzheimer's disease, leading to a widespread cholinergic deficit.  The cholinergic disturbance may contribute to neuropsychiatric manifestations of the disease.  The treatment of patients with Alzheimer's disease with acetylcholinesterase inhibitors reduces neuropsychiatric symptoms, particularly apathy and visual hallucinations.  In some studies, a variety of other neuropsychiatric symptoms have been reported to respond to treatment with acetylcholinesterase inhibitors.  Response profiles vary among acetylcholinesterase inhibitors.  CONCLUSIONS:  Acetylcholinesterase inhibitors have psychotropic effects and may play an important role in controlling neuropsychiatric and behavioral disturbances in patients with Alzheimer's disease.  These agents also may contribute to the management of other disorders with cholinergic system abnormalities and neuropsychiatric symptoms.  The beneficial response is most likely mediated through limbic cholinergic structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBmZ73YslrSXwOGIfWJ7-GfW6udTcc2eYxaPNksmsc0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c%252FosVyisw%253D%253D&md5=ecdf0b8be61b64add937ec55b3820997</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1176%2Fajp.157.1.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fajp.157.1.4%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DCholinesterase%2520inhibitors%253A%2520a%2520new%2520class%2520of%2520psychotropic%2520compounds%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2000%26volume%3D157%26spage%3D4%26epage%3D15%26doi%3D10.1176%2Fajp.157.1.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geldmacher, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provenzano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McRae, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mastey, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ieni, J. R.</span></span> <span> </span><span class="NLM_article-title">Donepezil is associated with delayed nursing home placement in patients with Alzheimer’s disease</span>. <i>J. Am. Geriatr. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">937</span>– <span class="NLM_lpage">944</span>, <span class="refDoi"> DOI: 10.1046/j.1365-2389.2003.51306.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1046%2Fj.1365-2389.2003.51306.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12834513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD3sznsFyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=937-944&author=D.+S.+Geldmacherauthor=G.+Provenzanoauthor=T.+McRaeauthor=V.+Masteyauthor=J.+R.+Ieni&title=Donepezil+is+associated+with+delayed+nursing+home+placement+in+patients+with+Alzheimer%E2%80%99s+disease&doi=10.1046%2Fj.1365-2389.2003.51306.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease</span></div><div class="casAuthors">Geldmacher David S; Provenzano George; McRae Thomas; Mastey Vera; Ieni John R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Geriatrics Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">937-44</span>
        ISSN:<span class="NLM_cas:issn">0002-8614</span>.
    </div><div class="casAbstract">OBJECTIVES:  To assess the relationship between donepezil treatment and time to nursing home placement (NHP) for patients with Alzheimer's disease (AD).  DESIGN:  Observational follow-up of patient NHP and vital status.  SETTING:  Community.  PARTICIPANTS:  Patients previously enrolled in one of three randomized, double-blind, placebo-controlled clinical trials of donepezil and two subsequent open-label studies (total N = 1,115); 671 patients provided complete data for analysis.  MEASUREMENTS:  Data were obtained through follow-up interviews with caregivers and chart reviews of patients with AD.  Comparison groups were defined by whether patients received an effective dose of donepezil (>/=5 mg/d; >/=80% compliance) for specific numbers of weeks during the double-blind or open-label trial phase, in both phases, or in neither.  Cox proportional hazards models were used to estimate risk ratios for NHP and survival curves from which median times to NHP were estimated for first dementia-related placement of longer than 2 weeks and permanent placement.  The models were adjusted for age, sex, baseline Mini-Mental State Examination score, whether the caregiver was a spouse, caregiver continuity, and use of other cholinesterase inhibitors after the clinical trials.  RESULTS:  Use of donepezil of 5 mg/d or more was associated with significant delays in NHP.  A cumulative dose-response relationship was observed between longer-term sustained donepezil use and delay of NHP.  When donepezil was taken at an effective dose for at least 9 to 12 months, conservative estimates of the time gained before NHP were 21.4 months for first dementia-related NHP and 17.5 months for permanent NHP.  CONCLUSION:  Use of donepezil by AD patients resulted in significant delays in NHP.  Long-term use of donepezil may help AD patients live longer in community settings, with consequent personal, social, and economic benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXmoyhFZauwfcsfMJQC1ZdfW6udTcc2ebhPPMhMYBjcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sznsFyrsw%253D%253D&md5=ba06fb717bec801eb57215ea4d53185e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2389.2003.51306.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2389.2003.51306.x%26sid%3Dliteratum%253Aachs%26aulast%3DGeldmacher%26aufirst%3DD.%2BS.%26aulast%3DProvenzano%26aufirst%3DG.%26aulast%3DMcRae%26aufirst%3DT.%26aulast%3DMastey%26aufirst%3DV.%26aulast%3DIeni%26aufirst%3DJ.%2BR.%26atitle%3DDonepezil%2520is%2520associated%2520with%2520delayed%2520nursing%2520home%2520placement%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Am.%2520Geriatr.%2520Soc.%26date%3D2003%26volume%3D51%26spage%3D937%26epage%3D944%26doi%3D10.1046%2Fj.1365-2389.2003.51306.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganeshpurkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span> <span> </span><span class="NLM_article-title">Secretase inhibitors for the treatment of Alzheimer’s disease: long road ahead</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">436</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.02.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.ejmech.2018.02.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2018&pages=436-452&author=D.+Kumarauthor=A.+Ganeshpurkarauthor=D.+Kumarauthor=G.+Modiauthor=S.+K.+Guptaauthor=S.+K.+Singh&title=Secretase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+long+road+ahead&doi=10.1016%2Fj.ejmech.2018.02.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.02.035%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DGaneshpurkar%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DModi%26aufirst%3DG.%26aulast%3DGupta%26aufirst%3DS.%2BK.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26atitle%3DSecretase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520long%2520road%2520ahead%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D148%26spage%3D436%26epage%3D452%26doi%3D10.1016%2Fj.ejmech.2018.02.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. S.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of anti-amyloid-β immunotherapy for Alzheimer’s disease: a systematic review and network meta-analysis</span>. <i>Ann. Clin. Transl. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">931</span>– <span class="NLM_lpage">942</span>, <span class="refDoi"> DOI: 10.1002/acn3.469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1002%2Facn3.469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=29296624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1aisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2017&pages=931-942&author=J.+J.+Moauthor=J.+Y.+Liauthor=Z.+Yangauthor=Z.+Liuauthor=J.+S.+Feng&title=Efficacy+and+safety+of+anti-amyloid-%CE%B2+immunotherapy+for+Alzheimer%E2%80%99s+disease%3A+a+systematic+review+and+network+meta-analysis&doi=10.1002%2Facn3.469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of anti-amyloid-β immunotherapy for Alzheimer's disease: a systematic review and network meta-analysis</span></div><div class="casAuthors">Mo, Jia-Jie; Li, Jin-yu; Yang, Zheng; Liu, Zhou; Feng, Jin-Shan</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Clinical and Translational Neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">931-942</span>CODEN:
                <span class="NLM_cas:coden">ACTNCG</span>;
        ISSN:<span class="NLM_cas:issn">2328-9503</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To review the optimality and safety of different anti-Amyloid-β(Aβ) immunotherapies for Alzheimer's disease (AD).  Published randomized controlled trials were comprehensively reviewed from electronic databases (Cochrane library, Embase, Pubmed, and Google scholar).  Pooled outcomes as mean difference or odds ratio values with 95% confidence interval were reported.  The network ests. with confidence and predictive intervals for all pairwise relative effects was evaluated.  Optimal intervention was ranked by benefit-risk ratio based on the surface under the cumulative ranking curve.  Eleven eligible RCTs from 9 literatures, including 5141 patients and 5 interventions were included.  The quality of evidence was rated low in comparisons.  For efficacy, in terms of Mini-Mental State Examn., aducanumab and solanezumab are significantly effective than placebo.  For safety, in terms of Amyloid-Related Imaging Abnormalities (ARIA), bapineuzumab and aducanumab are significantly worse than placebo.  There were no significant differences in outcomes of Alzheimer's disease Assessment Scale-Cognitive subscale, Disability Assessment for Dementia, Adverse Events, and mortality.  Given the clin. therapeutic effects of anti-Aβ immunotherapies for AD, aducanumab and solanezumab improve the cognitive function, while aducanumab and bapineuzumab may increase the risks of ARIA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn_fg1tzcXi7Vg90H21EOLACvtfcHk0lhK5OFPoaQYHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1aisw%253D%253D&md5=a0a2234699269313e850fb54e7e90bcd</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Facn3.469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Facn3.469%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DJ.%2BJ.%26aulast%3DLi%26aufirst%3DJ.%2BY.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DFeng%26aufirst%3DJ.%2BS.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520anti-amyloid-%25CE%25B2%2520immunotherapy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520systematic%2520review%2520and%2520network%2520meta-analysis%26jtitle%3DAnn.%2520Clin.%2520Transl.%2520Neurol.%26date%3D2017%26volume%3D4%26spage%3D931%26epage%3D942%26doi%3D10.1002%2Facn3.469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gold, M.</span></span> <span> </span><span class="NLM_article-title">Phase II clinical trials of anti-amyloid β antibodies: when is enough, enough?</span>. <i>Alzheimers Dement.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2017.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.trci.2017.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BC1M7kt1ahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=402-409&author=M.+Gold&title=Phase+II+clinical+trials+of+anti-amyloid+%CE%B2+antibodies%3A+when+is+enough%2C+enough%3F&doi=10.1016%2Fj.trci.2017.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II clinical trials of anti-amyloid β antibodies: When is enough, enough?</span></div><div class="casAuthors">Gold Michael</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">402-409</span>
        ISSN:<span class="NLM_cas:issn">2352-8737</span>.
    </div><div class="casAbstract">Efforts to develop new therapies to combat Alzheimer's disease suffer from extraordinarily high failure rates that make it difficult to justify continued investment in the field.  Although there are a number of plausible explanations for this extremely high attrition rate, one of the explanations that has received little attention is the lack of compelling data from Phase II studies for compounds that have been pushed into Phase III trials and then have failed.  An analysis of publicly available data from the Phase II studies for bapineuzumab and solanezumab indicates that neither compound produced compelling evidence of drug-like behavior that would justify their progression into pivotal trials.  The published data suggest that sponsors took decisions to move these compounds into Phase III on the basis of vastly limited data that were rife with type I error and probably driven by commercial concerns.  The continued push to move compounds that are not likely to succeed in later stage clinical trials threatens to erode trust in the clinical research enterprise making it much harder to properly test truly promising compounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRC88SOrTJcQHp3bfzSLaX5fW6udTcc2ebhPPMhMYBjcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7kt1ahsQ%253D%253D&md5=50060bb8c54f52030c388b88d0c4904a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2017.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2017.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DGold%26aufirst%3DM.%26atitle%3DPhase%2520II%2520clinical%2520trials%2520of%2520anti-amyloid%2520%25CE%25B2%2520antibodies%253A%2520when%2520is%2520enough%252C%2520enough%253F%26jtitle%3DAlzheimers%2520Dement.%26date%3D2017%26volume%3D3%26spage%3D402%26epage%3D409%26doi%3D10.1016%2Fj.trci.2017.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panza, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logroscino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imbimbo, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solfrizzi, V.</span></span> <span> </span><span class="NLM_article-title">Is there still any hope for amyloid-based immunotherapy for Alzheimer’s disease?</span>. <i>Curr. Opin. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1097/YCO.0000000000000041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1097%2FYCO.0000000000000041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=24445401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BC2czntVOmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=128-137&author=F.+Panzaauthor=G.+Logroscinoauthor=B.+P.+Imbimboauthor=V.+Solfrizzi&title=Is+there+still+any+hope+for+amyloid-based+immunotherapy+for+Alzheimer%E2%80%99s+disease%3F&doi=10.1097%2FYCO.0000000000000041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?</span></div><div class="casAuthors">Panza Francesco; Logroscino Giancarlo; Imbimbo Bruno P; Solfrizzi Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">128-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  We reviewed clinical trials on active and passive anti-β-amyloid (Aβ) immunotherapy for the treatment of Alzheimer's disease with a particular focus on monoclonal antibodies against Aβ.  RECENT FINDINGS:  Studies on anti-Alzheimer's disease immunotherapy published in the period from January 2012 to October 2013 were reviewed.  SUMMARY:  Both active and passive anti-Aβ immunotherapies were shown to clear brain Aβ deposits.  However, an active anti-Aβ vaccine (AN1792) has been discontinued because it caused meningoencephalitis in 6% of Alzheimer's disease patients treated.  Among passive immunotherapeutics, two Phase III clinical trials in mild-to-moderate Alzheimer's disease patients with bapineuzumab, a humanized monoclonal antibody directed at the N-terminal sequence of Aβ, were disappointing.  Another antibody, solanezumab, directed at the mid-region of Aβ, failed in two Phase III clinical trials in mild-to-moderate Alzheimer's disease patients.  A third Phase III study with solanezumab is ongoing in mildly affected Alzheimer's disease patients based on encouraging results in this subgroup of patients.  Second-generation active Aβ vaccines (ACC-001, CAD106, and Affitope AD02) and new passive anti-Aβ immunotherapies (gantenerumab and crenezumab) are being tested in prodromal Alzheimer's disease patients, in presymptomatic individuals with Alzheimer's disease-related mutations, or in asymptomatic individuals at risk of developing Alzheimer's disease to definitely test the Aβ cascade hypothesis of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3vSyGxuaMyax48Rj5GnGofW6udTcc2eaydYfxb02ClLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czntVOmuw%253D%253D&md5=f03e24b748ee62cae91aec8786629f17</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1097%2FYCO.0000000000000041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FYCO.0000000000000041%26sid%3Dliteratum%253Aachs%26aulast%3DPanza%26aufirst%3DF.%26aulast%3DLogroscino%26aufirst%3DG.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DSolfrizzi%26aufirst%3DV.%26atitle%3DIs%2520there%2520still%2520any%2520hope%2520for%2520amyloid-based%2520immunotherapy%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DCurr.%2520Opin.%2520Psychiatry%26date%3D2014%26volume%3D27%26spage%3D128%26epage%3D137%26doi%3D10.1097%2FYCO.0000000000000041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, C. S.</span></span> <span> </span><span class="NLM_article-title">Cognitive decline in preclinical Alzheimer’s disease: amyloid-beta versus tauopathy</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.3233/JAD-170490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-170490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=29154274" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWhsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=265-281&author=C.+M.+Huberauthor=C.+Yeeauthor=T.+Mayauthor=A.+Dhanalaauthor=C.+S.+Mitchell&title=Cognitive+decline+in+preclinical+Alzheimer%E2%80%99s+disease%3A+amyloid-beta+versus+tauopathy&doi=10.3233%2FJAD-170490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy</span></div><div class="casAuthors">Huber, Colin M.; Yee, Connor; May, Taylor; Dhanala, Apoorva; Mitchell, Cassie S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">265-281</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">We perform a large-scale meta-anal. of 51 peer-reviewed 3xTg-AD mouse publications to compare Alzheimer's disease (AD) quant. clin. outcome measures, including amyloid-β (Aβ), total tau, and phosphorylated tau (pTau), with cognitive performance in Morris water maze (MWM) and Novel Object Recognition (NOR).  "High" levels of Aβ (Aβ40, Aβ42) showed significant but weak trends with cognitive decline (MWM: slope=0.336, R2=0.149, n=259, p<0.001; NOR: slope=0.156, R2=0.064, n=116, p<0.05); only sol. Aβ or directly measured Aβ meaningfully contribute.  Tau expression in 3xTg-AD mice was within 10-20% of wild type and not assocd. with cognitive decline.  In contrast, increased pTau is directly and significantly correlated with cognitive decline in MWM (slope=0.408, R2=0.275, n=371, p< <0.01) and NOR (slope=0.319, R2=0.176, n=113, p<0.05).  While a variety of pTau epitopes (AT8, AT270, AT180, PHF-1) were examd., AT8 correlated most strongly with cognition (slope=0.586, R2=0.521, n=185, p< <0.001).  Multiple linear regression confirmed pTau is a stronger predictor of MWM performance than Aβ.  Despite pTau's lower phys. concn. than Aβ, pTau levels more directly and quant. correlate with 3xTg-AD cognitive decline. pTau's contribution to neurofibrillary tangles well after Aβ levels plateau makes pTau a viable treatment target even in late-stage clin. AD.  Principal component anal., which included hyperphosphorylation induced by kinases (pGSK3β, GSK3β, CDK5), identified phosphorylated ser9 GSK3β as the primary contributor to MWM variance.  In summary, meta-anal. of cognitive decline in preclin. AD finds tauopathy more impactful than Aβ.  Nonetheless, complex AD interactions dictate successful therapeutics harness synergy between Aβ and pTau, possibly through the GSK3 pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm4_iPfdFiMbVg90H21EOLACvtfcHk0ljbB7SAUSmslQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWhsbnN&md5=ae00c194a044b3ee5ddaf5097c2f592f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3233%2FJAD-170490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-170490%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DC.%2BM.%26aulast%3DYee%26aufirst%3DC.%26aulast%3DMay%26aufirst%3DT.%26aulast%3DDhanala%26aufirst%3DA.%26aulast%3DMitchell%26aufirst%3DC.%2BS.%26atitle%3DCognitive%2520decline%2520in%2520preclinical%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520amyloid-beta%2520versus%2520tauopathy%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2018%26volume%3D61%26spage%3D265%26epage%3D281%26doi%3D10.3233%2FJAD-170490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wekstein, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashford, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markesbery, W. R.</span></span> <span> </span><span class="NLM_article-title">“Preclinical” AD revisited: neuropathology of cognitively normal older adults</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.1212/WNL.55.3.370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1212%2FWNL.55.3.370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10932270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD3cvgs1Gjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2000&pages=370-376&author=F.+A.+Schmittauthor=D.+G.+Davisauthor=D.+R.+Weksteinauthor=C.+D.+Smithauthor=J.+W.+Ashfordauthor=W.+R.+Markesbery&title=%E2%80%9CPreclinical%E2%80%9D+AD+revisited%3A+neuropathology+of+cognitively+normal+older+adults&doi=10.1212%2FWNL.55.3.370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">"Preclinical" AD revisited: neuropathology of cognitively normal older adults</span></div><div class="casAuthors">Schmitt F A; Davis D G; Wekstein D R; Smith C D; Ashford J W; Markesbery W R</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">370-6</span>
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    </div><div class="casAbstract">OBJECTIVE:  To classify neuropathologic alterations in the brains of nondemented older adults using current sets of criteria for AD.  BACKGROUND:  AD neuropathologic alterations are found in the brains of some nondemented elderly subjects and suggest the possibility of presymptomatic AD.  Three sets of guidelines have been developed to classify AD using senile plaques, neuritic plaques, and neurofibrillary tangles (NFT).  METHODS:  Neuropathologic changes in 59 older adults followed longitudinally with a standard battery of mental status measures were investigated using Khachaturian, Consortium to Establish a Registry for Alzheimer's Disease (CERAD), and National Institute on Aging-Reagan Institute (NIA-RI) guidelines.  AD neuropathologic markers were evaluated in neocortical and allocortical regions.  Cases were categorized as neuropathologically "normal" or "AD-like" and compared for possible mental status differences.  RESULTS:  Between 11 and 49% of cases met one or more of the three classifications of AD.  With adjustments for multiple comparisons, only NFT in hippocampal CA1 region were associated with autopsy age, suggesting that this may represent a pathologic process associated with normal brain aging.  Using the NIA-RI guidelines, subjects in the AD-like group performed less well on the immediate paragraph recall and word-list delayed recall than their counterparts who did not meet these guidelines.  CONCLUSIONS:  These data indicate that the prevalence of "preclinical" AD in our population is relatively low based on the NIA-RI classification.  Although many subjects had AD-like changes based on CERAD and Khachaturian guidelines, they exhibited no differences in mental performance, suggesting that the aging brain may be able to withstand such structural changes without meaningful impact on mental functioning.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtwE-qlOsc2bGbPKh4T9eAfW6udTcc2eaydYfxb02ClLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3cvgs1Gjsg%253D%253D&md5=694e3894918918a091a82e935212d401</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1212%2FWNL.55.3.370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.55.3.370%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DF.%2BA.%26aulast%3DDavis%26aufirst%3DD.%2BG.%26aulast%3DWekstein%26aufirst%3DD.%2BR.%26aulast%3DSmith%26aufirst%3DC.%2BD.%26aulast%3DAshford%26aufirst%3DJ.%2BW.%26aulast%3DMarkesbery%26aufirst%3DW.%2BR.%26atitle%3D%25E2%2580%259CPreclinical%25E2%2580%259D%2520AD%2520revisited%253A%2520neuropathology%2520of%2520cognitively%2520normal%2520older%2520adults%26jtitle%3DNeurology%26date%3D2000%26volume%3D55%26spage%3D370%26epage%3D376%26doi%3D10.1212%2FWNL.55.3.370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storandt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKeel, D. W.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, L.</span></span> <span> </span><span class="NLM_article-title">Cerebral amyloid deposition and diffuse plaques in “normal” aging: evidence for presymptomatic and very mild Alzheimer’s disease</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">707</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1212/WNL.46.3.707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1212%2FWNL.46.3.707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=8618671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADyaK287ntlKrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1996&pages=707-719&author=J.+C.+Morrisauthor=M.+Storandtauthor=D.+W.+McKeelauthor=E.+H.+Rubinauthor=J.+L.+Priceauthor=E.+A.+Grantauthor=L.+Berg&title=Cerebral+amyloid+deposition+and+diffuse+plaques+in+%E2%80%9Cnormal%E2%80%9D+aging%3A+evidence+for+presymptomatic+and+very+mild+Alzheimer%E2%80%99s+disease&doi=10.1212%2FWNL.46.3.707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease</span></div><div class="casAuthors">Morris J C; Storandt M; McKeel D W Jr; Rubin E H; Price J L; Grant E A; Berg L</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">707-19</span>
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    </div><div class="casAbstract">The presence of senile plaques in the neocortex of apparently nondemented elderly persons often is accepted as part of "normal" aging.  Alternatively, because cerebral deposition of beta-amyloid may be a key mechanism in the development of Alzheimer's disease (AD), the presence of beta-amyloid-containing plaques may represent very early AD.  To examine the relationships of cognitively normal aging, very mild dementia of the Alzheimer type, and the presence of neocortical senile plaques, we performed clinicopathologic correlation in 21 longitudinally studied healthy elderly subjects (84.5 +/- 6.6 years old at death).  Nine subjects had strikingly high plaque densities in the neocortex; two of these subjects died of head injury before which there was no evidence of cognitive impairment.  The other seven subjects with high plaque densities had clinical evidence for very mild cognitive impairment (Clinical Dementia Rating score of 0.5) at some time during their course and mildly impaired psychometric performance at last assessment before death.  The remaining 12 subjects had no clinical or psychometric impairment and had few or no neocortical AD lesions.  These results suggest that senile plaques may not be part of normal aging but instead represent presymptomatic or unrecognized early symptomatic AD.  The high density of senile plaques (predominately of the diffuse subtype) in the cortex of subjects just at the threshold of detectable dementia is consistent with the hypothesis that beta-amyloid deposition is an initial pathogenetic event in the development of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS7hpkD840LCEodMGTatQ7LfW6udTcc2ebeqd3qO5yV2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK287ntlKrsg%253D%253D&md5=074f0b988d557ba2704057bf7dea22aa</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1212%2FWNL.46.3.707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.46.3.707%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DStorandt%26aufirst%3DM.%26aulast%3DMcKeel%26aufirst%3DD.%2BW.%26aulast%3DRubin%26aufirst%3DE.%2BH.%26aulast%3DPrice%26aufirst%3DJ.%2BL.%26aulast%3DGrant%26aufirst%3DE.%2BA.%26aulast%3DBerg%26aufirst%3DL.%26atitle%3DCerebral%2520amyloid%2520deposition%2520and%2520diffuse%2520plaques%2520in%2520%25E2%2580%259Cnormal%25E2%2580%259D%2520aging%253A%2520evidence%2520for%2520presymptomatic%2520and%2520very%2520mild%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1996%26volume%3D46%26spage%3D707%26epage%3D719%26doi%3D10.1212%2FWNL.46.3.707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tepper, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronicke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soom, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaether, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrich, M.</span></span> <span> </span><span class="NLM_article-title">Mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1942</span>– <span class="NLM_lpage">1947</span>, <span class="refDoi"> DOI: 10.1073/pnas.0904532106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1073%2Fpnas.0904532106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=1942-1947&author=R.+P.+Friedrichauthor=K.+Tepperauthor=R.+Ronickeauthor=M.+Soomauthor=M.+Westermannauthor=K.+Reymannauthor=C.+Kaetherauthor=M.+Fandrich&title=Mechanism+of+amyloid+plaque+formation+suggests+an+intracellular+basis+of+A%CE%B2+pathogenicity&doi=10.1073%2Fpnas.0904532106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0904532106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0904532106%26sid%3Dliteratum%253Aachs%26aulast%3DFriedrich%26aufirst%3DR.%2BP.%26aulast%3DTepper%26aufirst%3DK.%26aulast%3DRonicke%26aufirst%3DR.%26aulast%3DSoom%26aufirst%3DM.%26aulast%3DWestermann%26aufirst%3DM.%26aulast%3DReymann%26aufirst%3DK.%26aulast%3DKaether%26aufirst%3DC.%26aulast%3DFandrich%26aufirst%3DM.%26atitle%3DMechanism%2520of%2520amyloid%2520plaque%2520formation%2520suggests%2520an%2520intracellular%2520basis%2520of%2520A%25CE%25B2%2520pathogenicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D1942%26epage%3D1947%26doi%3D10.1073%2Fpnas.0904532106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mantzavinos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexiou, A.</span></span> <span> </span><span class="NLM_article-title">Biomarkers for Alzheimer’s disease diagnosis</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.2174/1567205014666170203125942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F1567205014666170203125942" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=28164766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KgsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=1149-1154&author=V.+Mantzavinosauthor=A.+Alexiou&title=Biomarkers+for+Alzheimer%E2%80%99s+disease+diagnosis&doi=10.2174%2F1567205014666170203125942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Biomarkers for Alzheimer's Disease Diagnosis</span></div><div class="casAuthors">Mantzavinos, Vasileios; Alexiou, Athanasios</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1149-1154</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Objective: The dramatic increase in the population with dementia expected in the next decades is accompanied by the establishment of novel and innovated methods that will offer accurate and efficient detection of the disease in its early stages.  While Alzheimer's disease is the most common cause of dementia, by the time it is typically diagnosed, substantial neuronal loss and neuropathol. lesions can damage many brain regions.  The aim of this study is to investigate the main risk factors that affect and increase Alzheimer's disease progression over time even in cases with no significant memory impairment present.  Several potential markers are discussed such as oxidative stress, metal ions, vascular disorders, protein dysfunctions and alterations in the mitochondrial populations.  Conclusion: A multiparametric model of Alzheimer's biomarkers is presented according to the latest classification of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN6gse_lUKI7Vg90H21EOLACvtfcHk0lhaJoSoh5g2tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KgsLvP&md5=c50ce37874def79fb57d88790bd7346e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F1567205014666170203125942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205014666170203125942%26sid%3Dliteratum%253Aachs%26aulast%3DMantzavinos%26aufirst%3DV.%26aulast%3DAlexiou%26aufirst%3DA.%26atitle%3DBiomarkers%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520diagnosis%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2017%26volume%3D14%26spage%3D1149%26epage%3D1154%26doi%3D10.2174%2F1567205014666170203125942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frisoni, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boccardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barkhof, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blennow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiotis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Démonet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garibotto, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gietl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herholz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jack, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nobili, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ten Kate, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albanese, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossuyt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerami, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacobini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lönneborg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovblad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattsson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinuevo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monsch, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosimann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padovani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porteri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratib, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Aubert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scerri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheltens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schott, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonni, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teipel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vineis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visser, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winblad, B.</span></span> <span> </span><span class="NLM_article-title">Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(17)30159-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS1474-4422%2817%2930159-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=28721928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BC1cjovFyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=661-676&author=G.+B.+Frisoniauthor=M.+Boccardiauthor=F.+Barkhofauthor=K.+Blennowauthor=S.+Cappaauthor=K.+Chiotisauthor=J.+D%C3%A9monetauthor=V.+Garibottoauthor=P.+Giannakopoulosauthor=A.+Gietlauthor=O.+Hanssonauthor=K.+Herholzauthor=C.+R.+Jackauthor=F.+Nobiliauthor=A.+Nordbergauthor=H.+M.+Snyderauthor=M.+Ten+Kateauthor=A.+Varroneauthor=E.+Albaneseauthor=S.+Beckerauthor=P.+Bossuytauthor=M.+C.+Carrilloauthor=C.+Ceramiauthor=B.+Duboisauthor=V.+Galloauthor=E.+Giacobiniauthor=G.+Goldauthor=S.+Hurstauthor=A.+L%C3%B6nneborgauthor=K.+Lovbladauthor=N.+Mattssonauthor=J.+Molinuevoauthor=A.+U.+Monschauthor=U.+Mosimannauthor=A.+Padovaniauthor=A.+Piccoauthor=C.+Porteriauthor=O.+Ratibauthor=L.+Saint-Aubertauthor=C.+Scerriauthor=P.+Scheltensauthor=J.+M.+Schottauthor=I.+Sonniauthor=S.+Teipelauthor=P.+Vineisauthor=P.+J.+Visserauthor=Y.+Yasuiauthor=B.+Winblad&title=Strategic+roadmap+for+an+early+diagnosis+of+Alzheimer%E2%80%99s+disease+based+on+biomarkers&doi=10.1016%2FS1474-4422%2817%2930159-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers</span></div><div class="casAuthors">Frisoni Giovanni B; Boccardi Marina; Barkhof Frederik; Blennow Kaj; Cappa Stefano; Chiotis Konstantinos; Saint-Aubert Laure; Demonet Jean-Francois; Garibotto Valentina; Giannakopoulos Panteleimon; Albanese Emiliano; Gietl Anton; Hansson Oskar; Herholz Karl; Jack Clifford R Jr; Nobili Flavio; Nordberg Agneta; Snyder Heather M; Carrillo Maria C; Ten Kate Mara; Scheltens Philip; Varrone Andrea; Becker Stefanie; Bossuyt Patrick; Cerami Chiara; Dubois Bruno; Gallo Valentina; Giacobini Ezio; Gold Gabriel; Hurst Samia; Lonneborg Anders; Lovblad Karl-Olof; Mattsson Niklas; Molinuevo Jose-Luis; Monsch Andreas U; Mosimann Urs; Padovani Alessandro; Picco Agnese; Porteri Corinna; Ratib Osman; Scerri Charles; Schott Jonathan M; Sonni Ida; Teipel Stefan; Vineis Paolo; Visser Pieter Jelle; Yasui Yutaka; Winblad Bengt</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">661-676</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The diagnosis of Alzheimer's disease can be improved by the use of biological measures.  Biomarkers of functional impairment, neuronal loss, and protein deposition that can be assessed by neuroimaging (ie, MRI and PET) or CSF analysis are increasingly being used to diagnose Alzheimer's disease in research studies and specialist clinical settings.  However, the validation of the clinical usefulness of these biomarkers is incomplete, and that is hampering reimbursement for these tests by health insurance providers, their widespread clinical implementation, and improvements in quality of health care.  We have developed a strategic five-phase roadmap to foster the clinical validation of biomarkers in Alzheimer's disease, adapted from the approach for cancer biomarkers.  Sufficient evidence of analytical validity (phase 1 of a structured framework adapted from oncology) is available for all biomarkers, but their clinical validity (phases 2 and 3) and clinical utility (phases 4 and 5) are incomplete.  To complete these phases, research priorities include the standardisation of the readout of these assays and thresholds for normality, the evaluation of their performance in detecting early disease, the development of diagnostic algorithms comprising combinations of biomarkers, and the development of clinical guidelines for the use of biomarkers in qualified memory clinics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQQsaQSaJb_kCXXDYhVZBdlfW6udTcc2eYrrTzUGHr8wbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjovFyrsw%253D%253D&md5=a274f11320b0bbcd56943e5e3f709c21</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2817%2930159-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252817%252930159-X%26sid%3Dliteratum%253Aachs%26aulast%3DFrisoni%26aufirst%3DG.%2BB.%26aulast%3DBoccardi%26aufirst%3DM.%26aulast%3DBarkhof%26aufirst%3DF.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DCappa%26aufirst%3DS.%26aulast%3DChiotis%26aufirst%3DK.%26aulast%3DD%25C3%25A9monet%26aufirst%3DJ.%26aulast%3DGaribotto%26aufirst%3DV.%26aulast%3DGiannakopoulos%26aufirst%3DP.%26aulast%3DGietl%26aufirst%3DA.%26aulast%3DHansson%26aufirst%3DO.%26aulast%3DHerholz%26aufirst%3DK.%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DNobili%26aufirst%3DF.%26aulast%3DNordberg%26aufirst%3DA.%26aulast%3DSnyder%26aufirst%3DH.%2BM.%26aulast%3DTen%2BKate%26aufirst%3DM.%26aulast%3DVarrone%26aufirst%3DA.%26aulast%3DAlbanese%26aufirst%3DE.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DBossuyt%26aufirst%3DP.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DCerami%26aufirst%3DC.%26aulast%3DDubois%26aufirst%3DB.%26aulast%3DGallo%26aufirst%3DV.%26aulast%3DGiacobini%26aufirst%3DE.%26aulast%3DGold%26aufirst%3DG.%26aulast%3DHurst%26aufirst%3DS.%26aulast%3DL%25C3%25B6nneborg%26aufirst%3DA.%26aulast%3DLovblad%26aufirst%3DK.%26aulast%3DMattsson%26aufirst%3DN.%26aulast%3DMolinuevo%26aufirst%3DJ.%26aulast%3DMonsch%26aufirst%3DA.%2BU.%26aulast%3DMosimann%26aufirst%3DU.%26aulast%3DPadovani%26aufirst%3DA.%26aulast%3DPicco%26aufirst%3DA.%26aulast%3DPorteri%26aufirst%3DC.%26aulast%3DRatib%26aufirst%3DO.%26aulast%3DSaint-Aubert%26aufirst%3DL.%26aulast%3DScerri%26aufirst%3DC.%26aulast%3DScheltens%26aufirst%3DP.%26aulast%3DSchott%26aufirst%3DJ.%2BM.%26aulast%3DSonni%26aufirst%3DI.%26aulast%3DTeipel%26aufirst%3DS.%26aulast%3DVineis%26aufirst%3DP.%26aulast%3DVisser%26aufirst%3DP.%2BJ.%26aulast%3DYasui%26aufirst%3DY.%26aulast%3DWinblad%26aufirst%3DB.%26atitle%3DStrategic%2520roadmap%2520for%2520an%2520early%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520based%2520on%2520biomarkers%26jtitle%3DLancet%2520Neurol.%26date%3D2017%26volume%3D16%26spage%3D661%26epage%3D676%26doi%3D10.1016%2FS1474-4422%2817%2930159-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C. R.</span></span> <span> </span><span class="NLM_article-title">The key role of mitochondria in Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.3233/JAD-2006-9202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-2006-9202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=16873957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFWksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=101-110&author=P.+I.+Moreiraauthor=S.+M.+Cardosoauthor=M.+S.+Santosauthor=C.+R.+Oliveira&title=The+key+role+of+mitochondria+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2006-9202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The key role of mitochondria in Alzheimer's disease</span></div><div class="casAuthors">Moreira, Paula I.; Oliveira, Catarina; Moreira, P. I.; Cardoso, S. M.; Santos, M. S.; Oliveira, C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-110</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Mitochondria are uniquely poised to play a pivotal role in neuronal cell survival or death because they are regulators of both energy metab. and apoptotic pathways.  This review is mainly focused in the discussion of evidence suggesting a clear assocn. between amyloid-β toxicity, mitochondrial dysfunction, oxidative stress and neuronal damage/death in Alzheimer's disease pathophysiol.  The knowledge that mitochondrial dysfunction has a preponderant role in Alzheimer's disease opened a window for new therapeutic strategies aimed to preserve/ameliorate mitochondrial function.  Based on recent developments in mitochondrial research, increased pharmacol. and pharmaceutical efforts have lead to the emergence of 'Mitochondrial Medicine' as a whole new field of biomedical research being this topic discussed in the last section of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzsD89dmGMrLVg90H21EOLACvtfcHk0ljV6RFIPDMvsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFWksbc%253D&md5=1fbca5d81ff757752825d3ad2a68b95f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3233%2FJAD-2006-9202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2006-9202%26sid%3Dliteratum%253Aachs%26aulast%3DMoreira%26aufirst%3DP.%2BI.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DSantos%26aufirst%3DM.%2BS.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26atitle%3DThe%2520key%2520role%2520of%2520mitochondria%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2006%26volume%3D9%26spage%3D101%26epage%3D110%26doi%3D10.3233%2FJAD-2006-9202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C. R.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: a lesson from mitochondrial dysfunction</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1621</span>– <span class="NLM_lpage">1630</span>, <span class="refDoi"> DOI: 10.1089/ars.2007.1703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1089%2Fars.2007.1703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17678440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqs7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=1621-1630&author=P.+I.+Moreiraauthor=M.+S.+Santosauthor=C.+R.+Oliveira&title=Alzheimer%E2%80%99s+disease%3A+a+lesson+from+mitochondrial+dysfunction&doi=10.1089%2Fars.2007.1703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: a lesson from mitochondrial dysfunction</span></div><div class="casAuthors">Moreira, Paula I.; Santos, Maria S.; Oliveira, Catarina R.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1621-1630</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Extensive literature exists supporting a role for mitochondrial dysfunction and oxidative damage in the pathogenesis of Alzheimer's disease.  Mitochondria are a major source of intracellular reactive oxygen species and are particularly vulnerable to oxidative stress.  This review discusses evidence supporting the notion that mitochondrial dysfunction is intimately assocd. with Alzheimer's disease pathogenesis.  Furthermore, the potential connection between mitochondrial dysfunction/oxidative stress and autophagy in Alzheimer's disease is also discussed.  As a result of insufficient digestion of oxidatively damaged macromols. and organelles by autophagy, neurons progressively accumulate lipofuscin (biol. garbage) that could exacerbate neuronal dysfunction.  The knowledge that mitochondrial dysfunction has a preponderant role in several pathol. conditions instigated the development of mitochondrial antioxidant therapies.  Mitochondria-targeted antioxidant treatments are briefly discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0S9m8V-vH2bVg90H21EOLACvtfcHk0ljV6RFIPDMvsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqs7bK&md5=3b730dafa94880be4dfd3a671c7c72a8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1089%2Fars.2007.1703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2007.1703%26sid%3Dliteratum%253Aachs%26aulast%3DMoreira%26aufirst%3DP.%2BI.%26aulast%3DSantos%26aufirst%3DM.%2BS.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520lesson%2520from%2520mitochondrial%2520dysfunction%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2007%26volume%3D9%26spage%3D1621%26epage%3D1630%26doi%3D10.1089%2Fars.2007.1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunomura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress signaling in Alzheimer’s disease</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">532</span>, <span class="refDoi"> DOI: 10.2174/156720508786898451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F156720508786898451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=19075578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKgsbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=525-532&author=B.+Suauthor=X.+Wangauthor=A.+Nunomuraauthor=P.+Moreiraauthor=H.+Leeauthor=G.+Perryauthor=M.+Smithauthor=X.+Zhu&title=Oxidative+stress+signaling+in+Alzheimer%E2%80%99s+disease&doi=10.2174%2F156720508786898451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress signaling in Alzheimer's disease</span></div><div class="casAuthors">Su, B.; Wang, X.; Nunomura, A.; Moreira, P. I.; Lee, H.-gon; Perry, G.; Smith, M. A.; Zhu, X.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">525-532</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Multiple lines of evidence demonstrate that oxidative stress is an early event in Alzheimer's disease (AD), occurring prior to cytopathol., and therefore may play a key pathogenic role in AD.  Oxidative stress not only temporally precedes the pathol. lesions of the disease but also activates cell signaling pathways, which, in turn, contribute to lesion formation and, at the same time, provoke cellular responses such as compensatory upregulation of antioxidant enzymes found in vulnerable neurons in AD.  In this review, we provide an overview of the evidence of oxidative stress and compensatory responses that occur in AD, particularly focused on potential sources of oxidative stress and the roles and mechanism of activation of stress-activated protein kinase pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNWDrffmgJnbVg90H21EOLACvtfcHk0lidJcIp_h75GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKgsbzK&md5=824f978a3325a0d6901f9c56c39f599c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F156720508786898451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720508786898451%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DNunomura%26aufirst%3DA.%26aulast%3DMoreira%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DOxidative%2520stress%2520signaling%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2008%26volume%3D5%26spage%3D525%26epage%3D532%26doi%3D10.2174%2F156720508786898451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rego, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C. R.</span></span> <span> </span><span class="NLM_article-title">An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">741</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.3233/JAD-2009-0972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-2009-0972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=19387110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVansbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=741-761&author=P.+I.+Moreiraauthor=A.+I.+Duarteauthor=M.+S.+Santosauthor=A.+C.+Regoauthor=C.+R.+Oliveira&title=An+integrative+view+of+the+role+of+oxidative+stress%2C+mitochondria+and+insulin+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2009-0972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">An Integrative View of the Role of Oxidative Stress, Mitochondria and Insulin in Alzheimer's Disease</span></div><div class="casAuthors">Bierhaus, Angelika; Moreira, Paula I.; Duarte, Ana I.; Santos, Maria S.; Rego, A. Cristina; Oliveira, Catarina R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">741-761</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  The processes underlying the pathogenesis of Alzheimer's disease involve several factors including impaired glucose/energy metab., mitochondrial dysfunction, oxidative stress and altered insulin-signaling pathways.  This review is mainly devoted to discuss evidence supporting the notion that mitochondrial dysfunction and oxidative stress are interconnected and intimately assocd. with the development and progression of Alzheimer's disease.  Furthermore, the review explores the role of insulin signaling in the pathophysiol. of the disease.  Indeed, several studies have begun to find links between insulin and mechanisms with clear pathogenic implications for this disorder.  Understanding the key mechanisms involved in the etiopathogenesis of Alzheimer's disease may provide opportunities for the design of efficacious preventive and therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrLUlhiU4CjbVg90H21EOLACvtfcHk0lidJcIp_h75GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVansbs%253D&md5=960303a887281e0297b84c025c5f6933</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3233%2FJAD-2009-0972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2009-0972%26sid%3Dliteratum%253Aachs%26aulast%3DMoreira%26aufirst%3DP.%2BI.%26aulast%3DDuarte%26aufirst%3DA.%2BI.%26aulast%3DSantos%26aufirst%3DM.%2BS.%26aulast%3DRego%26aufirst%3DA.%2BC.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26atitle%3DAn%2520integrative%2520view%2520of%2520the%2520role%2520of%2520oxidative%2520stress%252C%2520mitochondria%2520and%2520insulin%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2009%26volume%3D16%26spage%3D741%26epage%3D761%26doi%3D10.3233%2FJAD-2009-0972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rovelet-Lecrux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannequin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Meur, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laquerriere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vital, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumanchin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuillette, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brice, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vercelletto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frebourg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campion, D.</span></span> <span> </span><span class="NLM_article-title">APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1038/ng1718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1038%2Fng1718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=16369530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCmtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=24-26&author=A.+Rovelet-Lecruxauthor=D.+Hannequinauthor=G.+Rauxauthor=N.+Le+Meurauthor=A.+Laquerriereauthor=A.+Vitalauthor=C.+Dumanchinauthor=S.+Feuilletteauthor=A.+Briceauthor=M.+Vercellettoauthor=F.+Dubasauthor=T.+Frebourgauthor=D.+Campion&title=APP+locus+duplication+causes+autosomal+dominant+early-onset+Alzheimer+disease+with+cerebral+amyloid+angiopathy&doi=10.1038%2Fng1718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy</span></div><div class="casAuthors">Rovelet-Lecrux, Anne; Hannequin, Didier; Raux, Gregory; Le Meur, Nathalie; Laquerriere, Annie; Vital, Anne; Dumanchin, Cecile; Feuillette, Sebastien; Brice, Alexis; Vercelletto, Martine; Dubas, Frederic; Frebourg, Thierry; Campion, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-26</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report duplication of the APP locus on chromosome 21 in five families with autosomal dominant early-onset Alzheimer disease (ADEOAD) and cerebral amyloid angiopathy (CAA).  Among these families, the duplicated segments had a minimal size ranging from 0.58 to 6.37 Mb.  Brains from individuals with APP duplication showed abundant parenchymal and vascular deposits of amyloid-β peptides.  Duplication of the APP locus, resulting in accumulation of amyloid-β peptides, causes ADEOAD with CAA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6mApoy_JS5bVg90H21EOLACvtfcHk0lidJcIp_h75GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCmtrzO&md5=0752ab2fe84de169286b75e9d01f457e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fng1718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1718%26sid%3Dliteratum%253Aachs%26aulast%3DRovelet-Lecrux%26aufirst%3DA.%26aulast%3DHannequin%26aufirst%3DD.%26aulast%3DRaux%26aufirst%3DG.%26aulast%3DLe%2BMeur%26aufirst%3DN.%26aulast%3DLaquerriere%26aufirst%3DA.%26aulast%3DVital%26aufirst%3DA.%26aulast%3DDumanchin%26aufirst%3DC.%26aulast%3DFeuillette%26aufirst%3DS.%26aulast%3DBrice%26aufirst%3DA.%26aulast%3DVercelletto%26aufirst%3DM.%26aulast%3DDubas%26aufirst%3DF.%26aulast%3DFrebourg%26aufirst%3DT.%26aulast%3DCampion%26aufirst%3DD.%26atitle%3DAPP%2520locus%2520duplication%2520causes%2520autosomal%2520dominant%2520early-onset%2520Alzheimer%2520disease%2520with%2520cerebral%2520amyloid%2520angiopathy%26jtitle%3DNat.%2520Genet.%26date%3D2006%26volume%3D38%26spage%3D24%26epage%3D26%26doi%3D10.1038%2Fng1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strittmatter, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmechel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. George-Hyslop, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pericak-Vance, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joo, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosi, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gusella, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crapper-MacLachlan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crain, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldgaber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roses, A. D.</span></span> <span> </span><span class="NLM_article-title">Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">1467</span>– <span class="NLM_lpage">1472</span>, <span class="refDoi"> DOI: 10.1212/WNL.43.8.1467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1212%2FWNL.43.8.1467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=8350998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK2cXhvVyksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1993&pages=1467-1472&author=A.+M.+Saundersauthor=W.+J.+Strittmatterauthor=D.+Schmechelauthor=P.+H.+St.+George-Hyslopauthor=M.+A.+Pericak-Vanceauthor=S.+H.+Jooauthor=B.+L.+Rosiauthor=J.+F.+Gusellaauthor=D.+R.+Crapper-MacLachlanauthor=M.+J.+Albertsauthor=C.+Huletteauthor=B.+Crainauthor=D.+Goldgaberauthor=A.+D.+Roses&title=Association+of+apolipoprotein+E+allele+epsilon+4+with+late-onset+familial+and+sporadic+Alzheimer%E2%80%99s+disease&doi=10.1212%2FWNL.43.8.1467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease</span></div><div class="casAuthors">Saunders, A.M.; Strittmatter, W.J.; Schmechel, D.; St. George-Hyslop, P.H.; Pericak-Vance, M.A.; Joo, S.H.; Rosi, B.L.; Gusella, J.F.; Crapper-MacLachlan, D.R.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1467-72</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    </div><div class="casAbstract">Apolipoprotein E, type ε4 allele (APOE ε4), is assocd. with late-onset familial Alzheimer's disease (AD).  There is high avidity and specific binding of amyloid β-peptide with the protein ApoE.  To test the hypothesis that late-onset familial AD may represent the clustering of sporadic AD in families large enough to be studied, the authors extended the analyses of APOE alleles to several series of sporadic AD patients.  APOE ε4 is significantly assocd. with a series of probable sporadic AD patients.  Spouse controls did not differ from CEPH grandparent controls from the Center d'Etude du Polymorphisme Humain (CEPH) or from literature controls.  A large combined series of autopsy-documented sporadic AD patients also demonstrated highly significant assocn. with the APOE ε4 allele.  These data support the involvement of ApoE ε4 in the pathogenesis of late-onset familial and sporadic AD.  ApoE isoforms may play an important role in the metab. of β-peptide, and APOE ε4 may operate as a susceptibility gene (risk factor) for the clin. expression of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0dhnjdKkrybVg90H21EOLACvtfcHk0lgQ7waUvHHciA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhvVyksbc%253D&md5=f4430df7ead1b04c44ccc1e7bd25648d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1212%2FWNL.43.8.1467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.43.8.1467%26sid%3Dliteratum%253Aachs%26aulast%3DSaunders%26aufirst%3DA.%2BM.%26aulast%3DStrittmatter%26aufirst%3DW.%2BJ.%26aulast%3DSchmechel%26aufirst%3DD.%26aulast%3DSt.%2BGeorge-Hyslop%26aufirst%3DP.%2BH.%26aulast%3DPericak-Vance%26aufirst%3DM.%2BA.%26aulast%3DJoo%26aufirst%3DS.%2BH.%26aulast%3DRosi%26aufirst%3DB.%2BL.%26aulast%3DGusella%26aufirst%3DJ.%2BF.%26aulast%3DCrapper-MacLachlan%26aufirst%3DD.%2BR.%26aulast%3DAlberts%26aufirst%3DM.%2BJ.%26aulast%3DHulette%26aufirst%3DC.%26aulast%3DCrain%26aufirst%3DB.%26aulast%3DGoldgaber%26aufirst%3DD.%26aulast%3DRoses%26aufirst%3DA.%2BD.%26atitle%3DAssociation%2520of%2520apolipoprotein%2520E%2520allele%2520epsilon%25204%2520with%2520late-onset%2520familial%2520and%2520sporadic%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1993%26volume%3D43%26spage%3D1467%26epage%3D1472%26doi%3D10.1212%2FWNL.43.8.1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">Amyloid, the presenilins and Alzheimer’s disease</span>. <i>Trends Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">154</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/S0166-2236(96)01030-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS0166-2236%2896%2901030-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=9106355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK2sXitVKnt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1997&pages=154-159&author=J.+Hardy&title=Amyloid%2C+the+presenilins+and+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0166-2236%2896%2901030-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid, the presenilins and Alzheimer's disease</span></div><div class="casAuthors">Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">154-159</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 53 refs.  Various mutations in the amyloid protein precursor and presenilin genes can lead to early onset, autosomal Alzheimer's disease.  A series of mis-sense mutations (with one exception) in each of these genes has been shown to cause disease in a fully penetrant fashion.  It has recently been shown, both in vivo and in model systems, that tissues expressing these mutations have increased prodn. of amyloid (Aβ) ending at residue 42.  It has also recently been shown that this form of Aβ is deposited early and selectively in the disease process and is more fibrillogenic in vitro.  It is argued that these genetic and mol. biol. data provide strong support for the veracity of the 'amyloid cascade hypothesis' for disease pathogenesis, and that this hypothesis offers a coherent framework for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5cIu4TWX4f7Vg90H21EOLACvtfcHk0lgQ7waUvHHciA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitVKnt7Y%253D&md5=e79e6df0cf82f21a9b7d7738193b3830</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0166-2236%2896%2901030-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-2236%252896%252901030-2%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DAmyloid%252C%2520the%2520presenilins%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Neurosci.%26date%3D1997%26volume%3D20%26spage%3D154%26epage%3D159%26doi%3D10.1016%2FS0166-2236%2896%2901030-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glenner, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. W.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">885</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(84)80190-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS0006-291X%2884%2980190-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=6375662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaL2cXitVOntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1984&pages=885-890&author=G.+G.+Glennerauthor=C.+W.+Wong&title=Alzheimer%E2%80%99s+disease%3A+initial+report+of+the+purification+and+characterization+of+a+novel+cerebrovascular+amyloid+protein&doi=10.1016%2FS0006-291X%2884%2980190-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  initial report of the purification and characterization of a novel cerebrovascular amyloid protein</span></div><div class="casAuthors">Glenner, George G.; Wong, Caine W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">885-90</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">A purified protein derived from the twisted β-pleated sheet fibrils in cerebrovascular amyloidosis assocd. with Alzheimer's disease was isolated by Sephadex G-100 column chromatog. with 5 M guanidine-HCl in 1 N acetic acid and by HPLC.  Partial amino acid sequence anal. and a computer search reveals this protein to have nohomol. with any protein sequenced thus far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqimb5yE9JMLrVg90H21EOLACvtfcHk0lgQ7waUvHHciA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXitVOntLw%253D&md5=e30caf2b0d9c41ee223b53ffe7a690dd</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2884%2980190-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252884%252980190-4%26sid%3Dliteratum%253Aachs%26aulast%3DGlenner%26aufirst%3DG.%2BG.%26aulast%3DWong%26aufirst%3DC.%2BW.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520initial%2520report%2520of%2520the%2520purification%2520and%2520characterization%2520of%2520a%2520novel%2520cerebrovascular%2520amyloid%2520protein%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1984%26volume%3D120%26spage%3D885%26epage%3D890%26doi%3D10.1016%2FS0006-291X%2884%2980190-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reiman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1073/pnas.2635903100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1073%2Fpnas.2635903100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=14688411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvFamtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=284-289&author=E.+M.+Reimanauthor=K.+Chenauthor=G.+E.+Alexanderauthor=R.+J.+Caselliauthor=D.+Bandyauthor=D.+Osborneauthor=A.+M.+Saundersauthor=J.+Hardy&title=Functional+brain+abnormalities+in+young+adults+at+genetic+risk+for+late-onset+Alzheimer%E2%80%99s+dementia&doi=10.1073%2Fpnas.2635903100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia</span></div><div class="casAuthors">Reiman, Eric M.; Chen, Kewei; Alexander, Gene E.; Caselli, Richard J.; Bandy, Daniel; Osborne, David; Saunders, Ann M.; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">284-289</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fluorodeoxyglucose positron emission tomog. (PET) studies have found that patients with Alzheimer's dementia (AD) have abnormally low rates of cerebral glucose metab. in posterior cingulate, parietal, temporal, and prefrontal cortex.  We previously found that cognitively normal, late-middle-aged carriers of the apolipoprotein E ε4 allele, a common susceptibility gene for late-onset Alzheimer's dementia, have abnormally low rates of glucose metab. in the same brain regions as patients with probable AD.  We now consider whether ε4 carriers have these regional brain abnormalities as relatively young adults.  Apolipoprotein E genotypes were established in normal volunteers 20-39 yr of age.  Clin. ratings, neuro-psychol. tests, magnetic resonance imaging, and PET were performed in 12 ε4 heterozygotes, all with the ε3/ε4 genotype, and 15 non-carriers of the ε4 allele, 12 of whom were individually matched for sex, age, and educational level.  An automated algorithm was used to generate an aggregate surface-projection map that compared regional PET measurements in the two groups.  The young adult ε4 carriers and non-carriers did not differ significantly in their sex, age, educational level, clin. ratings, or neuro-psychol. test scores.  Like previously studied patients with probable AD and late-middle-aged ε4 carriers, the young ε4 carriers had abnormally low rates of glucose metab. bilaterally in the posterior cingulate, parietal, temporal, and prefrontal cortex.  Carriers of a common Alzheimer's susceptibility gene have functional brain abnormalities in young adulthood, several decades before the possible onset of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKUTJEVcwSX7Vg90H21EOLACvtfcHk0lgQ7waUvHHciA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvFamtg%253D%253D&md5=7bf636ff7cc591b9757bf86cfb8099ff</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2635903100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2635903100%26sid%3Dliteratum%253Aachs%26aulast%3DReiman%26aufirst%3DE.%2BM.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DAlexander%26aufirst%3DG.%2BE.%26aulast%3DCaselli%26aufirst%3DR.%2BJ.%26aulast%3DBandy%26aufirst%3DD.%26aulast%3DOsborne%26aufirst%3DD.%26aulast%3DSaunders%26aufirst%3DA.%2BM.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DFunctional%2520brain%2520abnormalities%2520in%2520young%2520adults%2520at%2520genetic%2520risk%2520for%2520late-onset%2520Alzheimer%25E2%2580%2599s%2520dementia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D284%26epage%3D289%26doi%3D10.1073%2Fpnas.2635903100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span> <span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1038/nrd3505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1038%2Fnrd3505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=21852788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics&doi=10.1038%2Fnrd3505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics</span></div><div class="casAuthors">Karran, Eric; Mercken, Marc; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">698-712</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The amyloid cascade hypothesis, which posits that the deposition of the amyloid-β peptide in the brain is a central event in Alzheimer's disease pathol., has dominated research for the past twenty years.  Several therapeutics that were purported to reduce amyloid-β prodn. or aggregation have failed in Phase III clin. testing, and many others are in various stages of development.  Therefore, it is timely to review the science underpinning the amyloid cascade hypothesis, consider what type of clin. trials will constitute a valid test of this hypothesis and explore whether amyloid-β-directed therapeutics will provide the medicines that are urgently needed by society for treating this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-zjcfHaQ87Vg90H21EOLACvtfcHk0lggG7alu2w_Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L&md5=cf2824a56a4c3df6e265d8788970729d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnrd3505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3505%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712%26doi%3D10.1038%2Fnrd3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manelli, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stine, W. B.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krafft, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaDu, M. J.</span></span> <span> </span><span class="NLM_article-title">Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">32046</span>– <span class="NLM_lpage">32053</span>, <span class="refDoi"> DOI: 10.1074/jbc.M201750200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1074%2Fjbc.M201750200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12058030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD38XmslOqu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=32046-32053&author=K.+N.+Dahlgrenauthor=A.+M.+Manelliauthor=W.+B.+Stineauthor=L.+K.+Bakerauthor=G.+A.+Krafftauthor=M.+J.+LaDu&title=Oligomeric+and+fibrillar+species+of+amyloid-%CE%B2+peptides+differentially+affect+neuronal+viability&doi=10.1074%2Fjbc.M201750200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability</span></div><div class="casAuthors">Dahlgren, Karie N.; Manelli, Arlene M.; Stine, W. Blaine, Jr.; Baker, Lorinda K.; Krafft, Grant A.; LaDu, Mary Jo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">32046-32053</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Genetic evidence predicts a causative role for amyloid-β (Aβ) in Alzheimer's disease.  Recent debate has focused on whether fibrils (amyloid) or sol. oligomers of Aβ are the active species that contribute to neurodegeneration and dementia.  We developed two aggregation protocols for the consistent prodn. of stable oligomeric or fibrillar prepns. of Aβ-(1-42).  Here we report that oligomers inhibit neuronal viability 10-fold more than fibrils and ∼40-fold more than unaggregated peptide, with oligomeric Aβ-(1-42)-induced inhibition significant at 10 nM.  Under Aβ-(1-42) oligomer- and fibril-forming conditions, Aβ-(1-40) remains predominantly as unassembled monomer and had significantly less effect on neuronal viability than prepns. of Aβ-(1-42).  We applied the aggregation protocols developed for wild type Aβ-(1-42) to Aβ-(1-42) with the Dutch (E22Q) or Arctic (E22G) mutations.  Oligomeric prepns. of the mutations exhibited extensive protofibril and fibril formation, resp., but were not consistently different from wild type Aβ-(1-42) in terms of inhibition of neuronal viability.  However, fibrillar prepns. of the mutants appeared larger and induced significantly more inhibition of neuronal viability than wild type Aβ-(1-42) fibril prepns.  These data demonstrate that protocols developed to produce oligomeric and fibrillar Aβ-(1-42) are useful in distinguishing the structural and functional differences between Aβ-(1-42) and Aβ-(1-40) and genetic mutations of Aβ-(1-42).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm0s9ysdX6drVg90H21EOLACvtfcHk0lggG7alu2w_Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmslOqu7Y%253D&md5=1e31e90f856d7c6f881686839a383f37</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M201750200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M201750200%26sid%3Dliteratum%253Aachs%26aulast%3DDahlgren%26aufirst%3DK.%2BN.%26aulast%3DManelli%26aufirst%3DA.%2BM.%26aulast%3DStine%26aufirst%3DW.%2BB.%26aulast%3DBaker%26aufirst%3DL.%2BK.%26aulast%3DKrafft%26aufirst%3DG.%2BA.%26aulast%3DLaDu%26aufirst%3DM.%2BJ.%26atitle%3DOligomeric%2520and%2520fibrillar%2520species%2520of%2520amyloid-%25CE%25B2%2520peptides%2520differentially%2520affect%2520neuronal%2520viability%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D32046%26epage%3D32053%26doi%3D10.1074%2Fjbc.M201750200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Multhaup, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">A modified β-amyloid hypothesis: intraneuronal accumulation of the β-amyloid peptide – the first step of a fatal cascade</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">520</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2004.02737.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1111%2Fj.1471-4159.2004.02737.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15485483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsFelsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2004&pages=513-520&author=O.+Wirthsauthor=G.+Multhaupauthor=T.+A.+Bayer&title=A+modified+%CE%B2-amyloid+hypothesis%3A+intraneuronal+accumulation+of+the+%CE%B2-amyloid+peptide+%E2%80%93+the+first+step+of+a+fatal+cascade&doi=10.1111%2Fj.1471-4159.2004.02737.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A modified β-amyloid hypothesis: Intraneuronal accumulation of the β-amyloid peptide - the first step of a fatal cascade</span></div><div class="casAuthors">Wirths, Oliver; Multhaup, Gerd; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">513-520</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Accumulating evidence points to an important role of intraneuronal Aβ as a trigger of the pathol. cascade of events leading to neurodegeneration and eventually to Alzheimer's disease (AD) with its typical clin. symptoms, like memory impairment and change in personality.  In the present article, the authors review recent findings on intracellular monomeric and oligomeric β-amyloid (Aβ) generation and its pathol. function in cell culture, transgenic AD mouse models and post mortem brain tissue of AD and Down syndrome patients, as well as its interaction with oxidative stress and its relevance in apoptotic cell death.  Based on these results, a modified Aβ hypothesis is formulated, that integrates biochem., neuropathol. and genetic observations with AD-typical neuron loss and plaque formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpXHxnoi6kZbVg90H21EOLACvtfcHk0lggG7alu2w_Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsFelsLw%253D&md5=e3db96ce783f5601f419017611f353a7</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2004.02737.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2004.02737.x%26sid%3Dliteratum%253Aachs%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DMulthaup%26aufirst%3DG.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DA%2520modified%2520%25CE%25B2-amyloid%2520hypothesis%253A%2520intraneuronal%2520accumulation%2520of%2520the%2520%25CE%25B2-amyloid%2520peptide%2520%25E2%2580%2593%2520the%2520first%2520step%2520of%2520a%2520fatal%2520cascade%26jtitle%3DJ.%2520Neurochem.%26date%3D2004%26volume%3D91%26spage%3D513%26epage%3D520%26doi%3D10.1111%2Fj.1471-4159.2004.02737.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostinho, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C. R.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease-associated neurotoxic mechanisms and neuroprotective strategies</span>. <i>Curr. Drug Targets: CNS Neurol. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.2174/1568007054546117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F1568007054546117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=16101556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVyktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=383-403&author=C.+Pereiraauthor=P.+Agostinhoauthor=P.+I.+Moreiraauthor=S.+M.+Cardosoauthor=C.+R.+Oliveira&title=Alzheimer%E2%80%99s+disease-associated+neurotoxic+mechanisms+and+neuroprotective+strategies&doi=10.2174%2F1568007054546117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies</span></div><div class="casAuthors">Pereira, C.; Agostinho, P.; Moreira, P. I.; Cardoso, S. M.; Oliveira, C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-403</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The characteristic hallmarks of Alzheimer's disease (AD), the most common form of dementia in the elderly, include senile plaques, mainly composed of beta-amyloid (Aβ) peptide, neurofibrillary tangles and selective synaptic and neuronal loss in brain regions involved in learning and memory.  Genetic studies, together with the demonstration of Aβ neurotoxicity, led to the development of the amyloid cascade hypothesis to explain the AD-assocd. neurodegenerative process.  However, a modified version of this hypothesis has emerged, the Aβ cascade hypothesis, which takes into account the fact that sol. oligomeric forms and protofibrils of Aβ and its intraneuronal accumulation also play a key role in the pathogenesis of the disease.  Recent evidence posit that synaptic dysfunction triggered by non fibrillar Aβ species is an early event involved in memory decline in AD.  The current understanding of the mol. mechanisms responsible for impaired synaptic function and cognitive deficits is outlined in this review, focusing on oxidative stress and disturbed metal ion homeostasis, Ca2+ dysregulation, mitochondria and endoplasmic reticulum dysfunction, cholesterol dyshomeostasis and impaired neurotransmission.  The activation of apoptotic cell death as a mechanism of neuronal loss in AD, and the prominent role of neuroinflammation in this neurodegenerative disorder, are also reviewed herein.  Furthermore, we will focus on the more relevant therapeutical strategies currently used, namely those involving antioxidants, drugs for neurotransmission improvement, hormonal replacement, γ- and β- secretase inhibitors, Aβ clearance agents (Aβ immunization, disruption of Aβ fibrils, modulation of the cholesterol-mediated Aβ transport), non-steroidal anti-inflammatory drugs (NSAIDs), microtubules stabilizing drugs and kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd7Y_ekx0ttrVg90H21EOLACvtfcHk0lgOzFL6bHjeUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVyktL8%253D&md5=bf7c8fe2bfa5e81dd6d0975edfd745a9</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2174%2F1568007054546117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007054546117%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DC.%26aulast%3DAgostinho%26aufirst%3DP.%26aulast%3DMoreira%26aufirst%3DP.%2BI.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease-associated%2520neurotoxic%2520mechanisms%2520and%2520neuroprotective%2520strategies%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2005%26volume%3D4%26spage%3D383%26epage%3D403%26doi%3D10.2174%2F1568007054546117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Mohanna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D. M.</span></span> <span> </span><span class="NLM_article-title">Role of ERAB/<span class="smallcaps smallerCapital">l</span>-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Aβ-induced cytotoxicity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">2145</span>– <span class="NLM_lpage">2156</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.4.2145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1074%2Fjbc.274.4.2145" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=2145-2156&author=S.+D.+Yanauthor=Y.+Shiauthor=A.+Zhuauthor=J.+Fuauthor=H.+Zhuauthor=Y.+Zhuauthor=L.+Gibsonauthor=E.+Sternauthor=K.+Collisonauthor=F.+Al-Mohannaauthor=S.+Ogawaauthor=A.+Roherauthor=S.+G.+Clarkeauthor=D.+M.+Stern&title=Role+of+ERAB%2Fl-3-hydroxyacyl-coenzyme+A+dehydrogenase+type+II+activity+in+A%CE%B2-induced+cytotoxicity&doi=10.1074%2Fjbc.274.4.2145"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.4.2145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.4.2145%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DA.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DGibson%26aufirst%3DL.%26aulast%3DStern%26aufirst%3DE.%26aulast%3DCollison%26aufirst%3DK.%26aulast%3DAl-Mohanna%26aufirst%3DF.%26aulast%3DOgawa%26aufirst%3DS.%26aulast%3DRoher%26aufirst%3DA.%26aulast%3DClarke%26aufirst%3DS.%2BG.%26aulast%3DStern%26aufirst%3DD.%2BM.%26atitle%3DRole%2520of%2520ERAB%252Fl-3-hydroxyacyl-coenzyme%2520A%2520dehydrogenase%2520type%2520II%2520activity%2520in%2520A%25CE%25B2-induced%2520cytotoxicity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D2145%26epage%3D2156%26doi%3D10.1074%2Fjbc.274.4.2145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu-Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendiaz, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teplow, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amarante, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeloff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edenson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lile, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biere, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span> <span> </span><span class="NLM_article-title">β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=%CE%B2-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0lgbDfFW-onu-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3D%25CE%25B2-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saftig, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craessaerts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderstichele, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guhde, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annaert, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Figura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Leuven, F.</span></span> <span> </span><span class="NLM_article-title">Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>391</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1038/34910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1038%2F34910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=9450754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK1cXot1GrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=1998&pages=387-390&author=B.+De%0AStrooperauthor=P.+Saftigauthor=K.+Craessaertsauthor=H.+Vandersticheleauthor=G.+Guhdeauthor=W.+Annaertauthor=K.+Von+Figuraauthor=F.+Van+Leuven&title=Deficiency+of+presenilin-1+inhibits+the+normal+cleavage+of+amyloid+precursor+protein&doi=10.1038%2F34910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein</span></div><div class="casAuthors">De Strooper, Bart; Saftig, Paul; Craessaerts, Katleen; Vanderstichele, Hugo; Guhde, Gundula; Annaert, Wim; Von Figura, Kurt; Van Leuven, Fred</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">391</span>
        (<span class="NLM_cas:issue">6665</span>),
    <span class="NLM_cas:pages">387-390</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Point mutations in the presenilin-1 gene (PS1) are a major cause of familial Alzheimer's disease.  They result in a selective increase in the prodn. of the amyloidogenic peptide amyloid-β (1-42) by proteolytic processing of the amyloid precursor protein (APP).  Here the authors investigate whether PS1 is also involved in normal APP processing in neuronal cultures derived from PS1-deficient mouse embryos.  Cleavage by α- and β-secretase of the extracellular domain of APP was not affected by the absence of PS1, whereas cleavage by γ-secretase of the transmembrane domain of APP was prevented, causing carboxyl-terminal fragments of APP to accumulate and a fivefold drop in the prodn. of amyloid peptide.  Pulse-chase expts. indicated that PS1 deficiency specifically decreased the turnover of the membrane-assocd. fragments of APP.  As in the regulation of cholesterol metab. by proteolysis of a membrane-bound transcription factor, PS1 appears to facilitate a proteolytic activity that cleaves the integral membrane domain of APP.  The results indicate that mutations in PS1 that manifest clin. cause a gain of function and that inhibition of PS1 activity is a potential target for anti-amyloidogenic therapy in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_3BuiX5XxmLVg90H21EOLACvtfcHk0lhCaUdMOj2m7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXot1GrtQ%253D%253D&md5=4327e88b436a201cd4c01938ae01e9f0</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2F34910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F34910%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DCraessaerts%26aufirst%3DK.%26aulast%3DVanderstichele%26aufirst%3DH.%26aulast%3DGuhde%26aufirst%3DG.%26aulast%3DAnnaert%26aufirst%3DW.%26aulast%3DVon%2BFigura%26aufirst%3DK.%26aulast%3DVan%2BLeuven%26aufirst%3DF.%26atitle%3DDeficiency%2520of%2520presenilin-1%2520inhibits%2520the%2520normal%2520cleavage%2520of%2520amyloid%2520precursor%2520protein%26jtitle%3DNature%26date%3D1998%26volume%3D391%26spage%3D387%26epage%3D390%26doi%3D10.1038%2F34910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, G.</span></span> <span> </span><span class="NLM_article-title">Toward a rational design to regulate β-amyloid fibrillation for Alzheimer’s disease treatment</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00477</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00477" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFyhsL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=198-210&author=X.+Hanauthor=G.+He&title=Toward+a+rational+design+to+regulate+%CE%B2-amyloid+fibrillation+for+Alzheimer%E2%80%99s+disease+treatment&doi=10.1021%2Facschemneuro.7b00477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Toward a Rational Design to Regulate β-Amyloid Fibrillation for Alzheimer's Disease Treatment</span></div><div class="casAuthors">Han, Xu; He, Gefei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">198-210</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The last decades have witnessed a growing global burden of Alzheimer's disease (AD).  Evidence indicates that the onset and progression of AD is assocd. with β-amyloid (Aβ) peptide fibrillation.  As such, there is a strong passion with discovering potent Aβ fibrillation inhibitors that can be developed into anti-amyloidogenic agents for AD treatment.  Current challenges that have arisen with this development involve with Aβ oligomer toxicity suppression and Blood Brain Barrier penetration capability.  Considering most natural or biol. events, one would observe that there is usually a "seed" to direct natural materials to assemble in response to a certain stimulation.  Inspired by this, several materials or compds., including nanoparticle, peptide or peptide mimics, and org. mols., have been designed for the purpose of redirecting or impeding Aβ aggregation.  Achieving these tasks requires comprehensive understanding on initial Aβ assembly into insol. deposits, main concerns with fibrillation inhibition, and current major methodologies to disrupt the aggregation.  Herein, the objective of this review is to address these three areas, and enable the pathway for a promising therapeutic agent design for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlO7qg2ReQI7Vg90H21EOLACvtfcHk0lhCaUdMOj2m7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFyhsL%252FP&md5=f9331d8eed6fa7d057c78d9234ac2d6c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00477%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DG.%26atitle%3DToward%2520a%2520rational%2520design%2520to%2520regulate%2520%25CE%25B2-amyloid%2520fibrillation%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D198%26epage%3D210%26doi%3D10.1021%2Facschemneuro.7b00477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gokce, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luthi-Carter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lashuel, H. A.</span></span> <span> </span><span class="NLM_article-title">The ratio of monomeric to aggregated forms of Aβ40 and Aβ42 Is an important determinant of amyloid-β aggregation, fibrillogenesis, and toxicity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">28176</span>– <span class="NLM_lpage">28189</span>, <span class="refDoi"> DOI: 10.1074/jbc.M803159200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1074%2Fjbc.M803159200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=28176-28189&author=A.+Janauthor=O.+Gokceauthor=R.+Luthi-Carterauthor=H.+A.+Lashuel&title=The+ratio+of+monomeric+to+aggregated+forms+of+A%CE%B240+and+A%CE%B242+Is+an+important+determinant+of+amyloid-%CE%B2+aggregation%2C+fibrillogenesis%2C+and+toxicity&doi=10.1074%2Fjbc.M803159200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M803159200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M803159200%26sid%3Dliteratum%253Aachs%26aulast%3DJan%26aufirst%3DA.%26aulast%3DGokce%26aufirst%3DO.%26aulast%3DLuthi-Carter%26aufirst%3DR.%26aulast%3DLashuel%26aufirst%3DH.%2BA.%26atitle%3DThe%2520ratio%2520of%2520monomeric%2520to%2520aggregated%2520forms%2520of%2520A%25CE%25B240%2520and%2520A%25CE%25B242%2520Is%2520an%2520important%2520determinant%2520of%2520amyloid-%25CE%25B2%2520aggregation%252C%2520fibrillogenesis%252C%2520and%2520toxicity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D28176%26epage%3D28189%26doi%3D10.1074%2Fjbc.M803159200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span> <span> </span><span class="NLM_article-title">Amyloid-β-induced mitochondrial dysfunction</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">184</span>, <span class="refDoi"> DOI: 10.3233/JAD-2007-12208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-2007-12208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17917162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtV2isrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=177-184&author=J.+X.+Chenauthor=S.+D.+Yan&title=Amyloid-%CE%B2-induced+mitochondrial+dysfunction&doi=10.3233%2FJAD-2007-12208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β-induced mitochondrial dysfunction</span></div><div class="casAuthors">Chen, John Xi; Yan, Shi Du</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-184</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  As an important mol. in the pathogenesis of Alzheimer's disease (AD), amyloid-β (Aβ) interferes with multiple aspects of mitochondrial function, including energy metab. failure, prodn. of reactive oxygen species (ROS) and permeability transition pore formation.  Recent studies have demonstrated that Aβ progressively accumulates within mitochondrial matrix, providing a direct link to mitochondrial toxicity.  Aβ-binding alc. dehydrogenase (ABAD) is localized to the mitochondrial matrix and binds to mitochondrial Aβ.  Interaction of ABAD with Aβ exaggerates Aβ-mediated mitochondrial and neuronal perturbation, leading to impaired synaptic function, and dysfunctional spatial learning/memory.  Thus, blockade of ABAD/Aβ interaction may be a potential therapeutic strategy for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD6drXohcejrVg90H21EOLACvtfcHk0ljU5xMY45WXNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtV2isrnJ&md5=5e242b0989da66c0178c3cbc45877d04</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.3233%2FJAD-2007-12208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2007-12208%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BX.%26aulast%3DYan%26aufirst%3DS.%2BD.%26atitle%3DAmyloid-%25CE%25B2-induced%2520mitochondrial%2520dysfunction%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2007%26volume%3D12%26spage%3D177%26epage%3D184%26doi%3D10.3233%2FJAD-2007-12208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manczak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calkins, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirendeb, U.</span></span> <span> </span><span class="NLM_article-title">Amyloid-beta and mitochondria in aging and Alzheimer’s disease: implications for synaptic damage and cognitive decline</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">499</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.3233/JAD-2010-100504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-2010-100504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnt12gs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=499-512&author=P.+H.+Reddyauthor=M.+Manczakauthor=P.+Maoauthor=M.+J.+Calkinsauthor=A.+P.+Reddyauthor=U.+Shirendeb&title=Amyloid-beta+and+mitochondria+in+aging+and+Alzheimer%E2%80%99s+disease%3A+implications+for+synaptic+damage+and+cognitive+decline&doi=10.3233%2FJAD-2010-100504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β and Mitochondria in Aging and Alzheimer's Disease: Implications for Synaptic Damage and Cognitive Decline</span></div><div class="casAuthors">Zhu, Xiongwei; Beal, M. Flint; Wang, Xinglong; Perry, George; Smith, Mark A.; Reddy, P. Hemachandra; Manczak, Maria; Mao, Peizhong; Calkins, Marcus J.; Reddy, Arubala P.; Shirendeb, Ulziibat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">S499-S512</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  This article reviews the role of amyloid-β (Aβ) and mitochondria in synaptic damage and cognitive decline found in patients with Alzheimer's disease (AD).  Recent mol., cellular, animal model, and postmortem brain studies have revealed that Aβ and mitochondrial abnormalities are key factors that cause synaptic damage and cognitive decline in AD.  Aβ is reported to accumulate in subcellular compartments and to impair the normal function of neurons in AD patients.  Further, recent studies using biochem. methods and electron microscopy have revealed that the accumulation of Aβ at nerve terminals affect synaptic activities, including the release of neurotransmitters and synaptic vesicles.  Recent studies of the relationship between mitochondria and Aβ in AD patients suggest that in mitochondria, structural changes caused by Aβ result in increased mitochondrial fragmentation, decreased mitochondrial fusion, mitochondrial dysfunction, and synaptic damage.  This paper discusses the latest research on Aβ, mitochondria, age-dependent factors of AD in the brain, and synaptic damage in AD.  This paper also briefly discusses potential mitochondrial therapeutics in the treatment of patients with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_CuDhga_-PLVg90H21EOLACvtfcHk0ljU5xMY45WXNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnt12gs7Y%253D&md5=e9c3b35d27164661ee6a242112d004b8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3233%2FJAD-2010-100504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2010-100504%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DP.%2BH.%26aulast%3DManczak%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DP.%26aulast%3DCalkins%26aufirst%3DM.%2BJ.%26aulast%3DReddy%26aufirst%3DA.%2BP.%26aulast%3DShirendeb%26aufirst%3DU.%26atitle%3DAmyloid-beta%2520and%2520mitochondria%2520in%2520aging%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520synaptic%2520damage%2520and%2520cognitive%2520decline%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2010%26volume%3D20%26spage%3D499%26epage%3D512%26doi%3D10.3233%2FJAD-2010-100504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casley, C.</span></span> <span> </span><span class="NLM_article-title">β-Amyloid fragment 25–35 causes mitochondrial dysfunction in primary cortical neurons</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">258</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1006/nbdi.2002.0516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1006%2Fnbdi.2002.0516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12270688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvFais7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=258-267&author=C.+Casley&title=%CE%B2-Amyloid+fragment+25%E2%80%9335+causes+mitochondrial+dysfunction+in+primary+cortical+neurons&doi=10.1006%2Fnbdi.2002.0516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid Fragment 25-35 Causes Mitochondrial Dysfunction in Primary Cortical Neurons</span></div><div class="casAuthors">Casley, C. S.; Land, J. M.; Sharpe, M. A.; Clark, J. B.; Duchen, M. R.; Canevari, L.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">258-267</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">β-Amyloid deposition and compromised energy metab. both occur in vulnerable brain regions in Alzheimer's disease.  It is not known whether β-amyloid is the cause of impairment of energy metab., nor whether impaired energy metab. is specific to neurons.  The authors' results, using primary neuronal cultures, show that 24-h incubation with Aβ25-35 caused a generalized decrease in the specific activity of mitochondrial enzymes per mg of cellular protein, induced mitochondrial swelling, and decreased total mitochondrial no.  Incubation with Aβ25-35 decreased ATP concn. to 58% of control in neurons and 71% of control in astrocytes.  Levels of reduced glutathione were also lowered by Aβ25-35 in both neurons (from 5.1 to 2.9 nmol/mg protein) and astrocytes (from 25.2 to 14.9 nmol/mg protein).  The authors conclude that 24-h treatment with extracellular Aβ25-35 causes mitochondrial dysfunction in both astrocytes and neurons, the latter being more seriously affected.  In astrocytes mitochondrial impairment was confined to complex I inhibition, whereas in neurons a generalized loss of mitochondria was seen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkuf21I9zDr7Vg90H21EOLACvtfcHk0ljU5xMY45WXNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvFais7c%253D&md5=6d8941571c2441dd70de6554ccdc98c4</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1006%2Fnbdi.2002.0516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnbdi.2002.0516%26sid%3Dliteratum%253Aachs%26aulast%3DCasley%26aufirst%3DC.%26atitle%3D%25CE%25B2-Amyloid%2520fragment%252025%25E2%2580%259335%2520causes%2520mitochondrial%2520dysfunction%2520in%2520primary%2520cortical%2520neurons%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2002%26volume%3D10%26spage%3D258%26epage%3D267%26doi%3D10.1006%2Fnbdi.2002.0516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mosconi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorbi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacmias, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cristofaro, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fayyaz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracco, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herholz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pupi, A.</span></span> <span> </span><span class="NLM_article-title">Age and ApoE genotype interaction in Alzheimer’s disease: an FDG-PET study</span>. <i>Psychiatry Res., Neuroimaging</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1016/j.pscychresns.2003.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.pscychresns.2003.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15033184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVGisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2004&pages=141-151&author=L.+Mosconiauthor=S.+Sorbiauthor=B.+Nacmiasauthor=M.+T.+De+Cristofaroauthor=M.+Fayyazauthor=L.+Braccoauthor=K.+Herholzauthor=A.+Pupi&title=Age+and+ApoE+genotype+interaction+in+Alzheimer%E2%80%99s+disease%3A+an+FDG-PET+study&doi=10.1016%2Fj.pscychresns.2003.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study</span></div><div class="casAuthors">Mosconi, Lisa; Sorbi, Sandro; Nacmias, Benedetta; de Cristofaro, Maria Teresa R.; Fayyaz, Mozhgan; Bracco, Laura; Herholz, Karl; Pupi, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Psychiatry Research, Neuroimaging</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-151</span>CODEN:
                <span class="NLM_cas:coden">PSREEK</span>;
        ISSN:<span class="NLM_cas:issn">0925-4927</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Previous positron emission tomog. (PET) studies with fluorodeoxyglucose (FDG) as tracer in healthy elders showed that the epsilon4 allele of the apolipoprotein E (ApoE) gene is disruptive to cerebral glucose metab. (rCMRglu), possibly through the interaction with the aging process.  The present study was aimed at assessing whether this interaction occurs in patients with Alzheimer's disease (AD).  Eight-six AD patients, including 40 ApoE4 carriers and 46 non-carriers, underwent 18F-FDG PET scanning at rest.  ApoE groups were comparable for age, gender, age at onset and disease duration.  SPM'99 was used to assess rCMRGlu correlations with age, differences between ApoE groups and ApoE by age interaction, correcting for disease severity.  Results were reported at P < 0.001, uncorrected.  Correlations between age and rCMRGlu confirmed the well-known neg. relationship for both groups.  Lower rCMRGlu was found within the frontal and cingulate areas for ApoE4 carriers as compared with the non-carriers.  Addnl., a significant ApoE by age interaction was detected in the frontal and anterior cingulate cortex, with the ApoE4 carriers having a steeper regression slope with respect to the non-carriers.  These results indicate that age-related regional rCMRglu decreases within the frontal and anterior cingulate areas may be more severe in AD patients carrying the ApoE4 allele.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Hqozg80eWLVg90H21EOLACvtfcHk0ljU5xMY45WXNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVGisL8%253D&md5=47fda669ddfa15ae92f49b49a21ab453</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.pscychresns.2003.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pscychresns.2003.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DMosconi%26aufirst%3DL.%26aulast%3DSorbi%26aufirst%3DS.%26aulast%3DNacmias%26aufirst%3DB.%26aulast%3DDe%2BCristofaro%26aufirst%3DM.%2BT.%26aulast%3DFayyaz%26aufirst%3DM.%26aulast%3DBracco%26aufirst%3DL.%26aulast%3DHerholz%26aufirst%3DK.%26aulast%3DPupi%26aufirst%3DA.%26atitle%3DAge%2520and%2520ApoE%2520genotype%2520interaction%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520FDG-PET%2520study%26jtitle%3DPsychiatry%2520Res.%252C%2520Neuroimaging%26date%3D2004%26volume%3D130%26spage%3D141%26epage%3D151%26doi%3D10.1016%2Fj.pscychresns.2003.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mosconi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacmias, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorbi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cristofaro, M. T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fayazz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracco, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herholz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pupi, A.</span></span> <span> </span><span class="NLM_article-title">Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer’s disease</span>. <i>J. Neurol., Neurosurg. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">370</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.1136/jnnp.2003.014993</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1136%2Fjnnp.2003.014993" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=14966149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD2c7isVSmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2004&pages=370-376&author=L.+Mosconiauthor=B.+Nacmiasauthor=S.+Sorbiauthor=M.+T.+R.+De+Cristofaroauthor=M.+Fayazzauthor=A.+Teddeauthor=L.+Braccoauthor=K.+Herholzauthor=A.+Pupi&title=Brain+metabolic+decreases+related+to+the+dose+of+the+ApoE+e4+allele+in+Alzheimer%E2%80%99s+disease&doi=10.1136%2Fjnnp.2003.014993"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease</span></div><div class="casAuthors">Mosconi L; Nacmias B; Sorbi S; De Cristofaro M T R; Fayazz M; Tedde A; Bracco L; Herholz K; Pupi A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">370-6</span>
        ISSN:<span class="NLM_cas:issn">0022-3050</span>.
    </div><div class="casAbstract">OBJECTIVES:  Declines in brain glucose metabolism have been described early in Alzheimer's disease (AD), and there is evidence that a genetic predisposition to AD contributes to accelerate this process.  The epsilon 4 (e4) allele of the apolipoprotein E (ApoE) gene has been implicated as a major risk factor in this process.  The aim of this FDG-PET study was to assess the ApoE e4 dose related effect on regional cerebral glucose metabolism (METglc) in clinical AD patients, with statistical voxel based methods.  METHODS:  Eighty six consecutive mild to moderate AD patients included in the Network for Efficiency and Standardisation of Dementia Diagnosis database underwent FDG-PET scans at rest.  PCR was used to determine the ApoE genotype.  Patients were grouped as e4 non-carriers (n = 46), e3/e4 (n = 27) and e4/e4 (n = 13) carriers.  A voxel-based mapping program was used to compare each AD subgroup with a database of 35 sex and age matched controls (p<0.001, corrected for cluster extent) and also to compare between the subgroups (p<0.001, uncorrected).  RESULTS:  No difference was found as to age at examination, age at onset, sex, disease duration, educational level, or severity of dementia between AD subgroups.  Compared with controls, all AD subgroups had equivalent METglc reductions in the precuneus, posterior cingulate, parietotemporal, and frontal regions.  Direct comparisons between AD subgroups indicated that patients with at least one e4 allele had METglc reductions within additional associative and limbic areas compared with e4 non-carriers.  CONCLUSIONS:  The present FDG-PET study showed different metabolic phenotypes related to the ApoE genotype in clinical AD patients, as revealed with voxel based statistical methods.  The results suggest a generalised disorder in e4 carriers impairing metabolism globally, in addition to the more localised changes typical of AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKuIltGlqwETMsgLhIoICsfW6udTcc2ebVA8Hj4KMZfbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7isVSmtg%253D%253D&md5=089ae01afa58e9e10e299a82585fd078</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.2003.014993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.2003.014993%26sid%3Dliteratum%253Aachs%26aulast%3DMosconi%26aufirst%3DL.%26aulast%3DNacmias%26aufirst%3DB.%26aulast%3DSorbi%26aufirst%3DS.%26aulast%3DDe%2BCristofaro%26aufirst%3DM.%2BT.%2BR.%26aulast%3DFayazz%26aufirst%3DM.%26aulast%3DTedde%26aufirst%3DA.%26aulast%3DBracco%26aufirst%3DL.%26aulast%3DHerholz%26aufirst%3DK.%26aulast%3DPupi%26aufirst%3DA.%26atitle%3DBrain%2520metabolic%2520decreases%2520related%2520to%2520the%2520dose%2520of%2520the%2520ApoE%2520e4%2520allele%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2004%26volume%3D75%26spage%3D370%26epage%3D376%26doi%3D10.1136%2Fjnnp.2003.014993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bubber, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haroutunian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blass, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, G. E.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial abnormalities in Alzheimer brain: mechanistic implications</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">703</span>, <span class="refDoi"> DOI: 10.1002/ana.20474</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1002%2Fana.20474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15852400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFykt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=695-703&author=P.+Bubberauthor=V.+Haroutunianauthor=G.+Fischauthor=J.+P.+Blassauthor=G.+E.+Gibson&title=Mitochondrial+abnormalities+in+Alzheimer+brain%3A+mechanistic+implications&doi=10.1002%2Fana.20474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial abnormalities in Alzheimer brain: mechanistic implications</span></div><div class="casAuthors">Bubber, Parvesh; Haroutunian, Vahram; Fisch, Gene; Blass, John P.; Gibson, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">695-703</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Redns. in cerebral metab. sufficient to impair cognition in normal individuals also occur in Alzheimer's disease (AD).  The degree of clin. disability in AD correlates closely to the magnitude of the redn. in brain metab.  Therefore, we tested whether impairments in tricarboxylic acid (TCA) cycle enzymes of mitochondria correlate with disability.  Brains were from patients with autopsy-confirmed AD and clin. dementia ratings (CDRs) before death.  Significant (p < 0.01) decreases occurred in the activities of the pyruvate dehydrogenase complex (-41%), isocitrate dehydrogenase (-27%), and the α-ketoglutarate dehydrogenase complex (-57%).  Activities of succinate dehydrogenase (complex II) (+44%) and malate dehydrogenase (+54%) were increased (p < 0.01).  Activities of the other four TCA cycle enzymes were unchanged.  All of the changes in TCA cycle activities correlated with the clin. state (p < 0.01), suggesting a coordinated mitochondrial alteration.  The highest correlation was with pyruvate dehydrogenase complex (r = 0.77, r2 = 0.59).  Measures to improve TCA cycle metab. might benefit AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLpCZoHPwibbVg90H21EOLACvtfcHk0lh13Bvxuezu7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFykt70%253D&md5=64bd54a9e0e3a95f1466504235cce613</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fana.20474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20474%26sid%3Dliteratum%253Aachs%26aulast%3DBubber%26aufirst%3DP.%26aulast%3DHaroutunian%26aufirst%3DV.%26aulast%3DFisch%26aufirst%3DG.%26aulast%3DBlass%26aufirst%3DJ.%2BP.%26aulast%3DGibson%26aufirst%3DG.%2BE.%26atitle%3DMitochondrial%2520abnormalities%2520in%2520Alzheimer%2520brain%253A%2520mechanistic%2520implications%26jtitle%3DAnn.%2520Neurol.%26date%3D2005%26volume%3D57%26spage%3D695%26epage%3D703%26doi%3D10.1002%2Fana.20474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casley, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Land, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, M. A.</span></span> <span> </span><span class="NLM_article-title">β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1046/j.0022-3042.2001.00681.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1046%2Fj.0022-3042.2001.00681.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=11796747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1ajsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2002&pages=91-100&author=C.+S.+Casleyauthor=L.+Canevariauthor=J.+M.+Landauthor=J.+B.+Clarkauthor=M.+A.+Sharpe&title=%CE%B2-Amyloid+inhibits+integrated+mitochondrial+respiration+and+key+enzyme+activities&doi=10.1046%2Fj.0022-3042.2001.00681.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities</span></div><div class="casAuthors">Casley, C. S.; Canevari, L.; Land, J. M.; Clark, J. B.; Sharpe, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-100</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Disrupted energy metab., in particular reduced activity of cytochrome oxidase (EC 1.9.3.1), α-ketoglutarate dehydrogenase (EC 1.2.4.2) and pyruvate dehydrogenase (EC 1.2.4.1) have been reported in post-mortem Alzheimer's disease brain.  β-Amyloid is strongly implicated in Alzheimer's pathol. and can be formed intracellularly in neurons.  The authors have investigated the possibility that β-amyloid itself disrupts mitochondrial function.  Isolated rat brain mitochondria have been incubated with the β-amyloid alone or together with nitric oxide, which is known to be elevated in Alzheimer's brain.  Mitochondrial respiration, electron transport chain complex activities, α-ketoglutarate dehydrogenase activity and pyruvate dehydrogenase activity have been measured.  β-Amyloid caused a significant redn. in state 3 and state 4 mitochondrial respiration that was further diminished by the addn. of nitric oxide.  Cytochrome oxidase, α-ketoglutarate dehydrogenase and pyruvate dehydrogenase activities were inhibited by β-amyloid.  The Km of cytochrome oxidase for reduced cytochrome c was raised by β-amyloid.  The authors conclude that β-amyloid can directly disrupt mitochondrial function, inhibits key enzymes and may contribute to the deficiency of energy metab. seen in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoibWtfeyLcTbVg90H21EOLACvtfcHk0lh13Bvxuezu7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1ajsQ%253D%253D&md5=f957475eedd775a66bef955818edf3a9</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1046%2Fj.0022-3042.2001.00681.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0022-3042.2001.00681.x%26sid%3Dliteratum%253Aachs%26aulast%3DCasley%26aufirst%3DC.%2BS.%26aulast%3DCanevari%26aufirst%3DL.%26aulast%3DLand%26aufirst%3DJ.%2BM.%26aulast%3DClark%26aufirst%3DJ.%2BB.%26aulast%3DSharpe%26aufirst%3DM.%2BA.%26atitle%3D%25CE%25B2-Amyloid%2520inhibits%2520integrated%2520mitochondrial%2520respiration%2520and%2520key%2520enzyme%2520activities%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D80%26spage%3D91%26epage%3D100%26doi%3D10.1046%2Fj.0022-3042.2001.00681.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreiro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Resende de Oliveira, C.</span></span> <span> </span><span class="NLM_article-title">Cell degeneration induced by amyloid-β peptides</span>. <i>J. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1385/JMN:23:1-2:097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1385%2FJMN%3A23%3A1-2%3A097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15126695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks12jsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=97-104&author=C.+Pereiraauthor=E.+Ferreiroauthor=S.+M.+Cardosoauthor=C.+Resende+de+Oliveira&title=Cell+degeneration+induced+by+amyloid-%CE%B2+peptides&doi=10.1385%2FJMN%3A23%3A1-2%3A097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Cell degeneration induced by amyloid-β peptides. Implications for Alzheimer's disease</span></div><div class="casAuthors">Pereira, Claudia; Ferreiro, Elisabete; Cardoso, Sandra Morais; De Oliveira, Catarina Resende</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">97-104</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Extracellular accumulation of amyloid-β (Aβ) peptide and death of neurons in brain regions involved in learning and memory, particularly the cortex and the hippocampus, are central features of Alzheimer's disease (AD).  Neuronal Ca2+ overload and apoptosis are known to occur in AD.  Aβ might play a role in disrupting Ca2+ homeostasis, and this AD-assocd. amyloidogenic peptide has been reported to induce apoptotic death in cultured cells.  However, the specific intracellular signaling pathways by which Aβ triggers cell death are not yet well defined.  This article provides evidence for the involvement of mitochondrial dysfunction in Aβ-induced toxicity and for the role of mitochondria in apoptosis triggered by Aβ.  In addn., the endoplasmic reticulum (ER) seems to play a role in Aβ-induced apoptotic neuronal death, the ER stress being mediated by the perturbation of ER Ca2+ homeostasis.  It is likely that a better understanding of how Aβ induces neuronal apoptosis will lead to the identification of potential mol. targets for the development of therapies for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq_FVF_epParVg90H21EOLACvtfcHk0lh2W8E0iNReKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks12jsbc%253D&md5=2d77e6efd27d7dac2166ecb0beae6e42</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1385%2FJMN%3A23%3A1-2%3A097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FJMN%253A23%253A1-2%253A097%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DC.%26aulast%3DFerreiro%26aufirst%3DE.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DResende%2Bde%2BOliveira%26aufirst%3DC.%26atitle%3DCell%2520degeneration%2520induced%2520by%2520amyloid-%25CE%25B2%2520peptides%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2004%26volume%3D23%26spage%3D97%26epage%3D104%26doi%3D10.1385%2FJMN%3A23%3A1-2%3A097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luddy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trillat, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. S.</span></span> <span> </span><span class="NLM_article-title">ABAD enhances Aβ-induced cell stress via mitochondrial dysfunction</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">598</span>, <span class="refDoi"> DOI: 10.1096/fj.04-2582fje</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1096%2Ffj.04-2582fje" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=597-598&author=K.+Takumaauthor=J.+Yaoauthor=J.+Huangauthor=H.+Xuauthor=X.+Chenauthor=J.+Luddyauthor=A.+C.+Trillatauthor=D.+M.+Sternauthor=O.+Arancioauthor=S.+S.+Yan&title=ABAD+enhances+A%CE%B2-induced+cell+stress+via+mitochondrial+dysfunction&doi=10.1096%2Ffj.04-2582fje"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1096%2Ffj.04-2582fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.04-2582fje%26sid%3Dliteratum%253Aachs%26aulast%3DTakuma%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLuddy%26aufirst%3DJ.%26aulast%3DTrillat%26aufirst%3DA.%2BC.%26aulast%3DStern%26aufirst%3DD.%2BM.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DYan%26aufirst%3DS.%2BS.%26atitle%3DABAD%2520enhances%2520A%25CE%25B2-induced%2520cell%2520stress%2520via%2520mitochondrial%2520dysfunction%26jtitle%3DFASEB%2520J.%26date%3D2005%26volume%3D19%26spage%3D597%26epage%3D598%26doi%3D10.1096%2Ffj.04-2582fje" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosunov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKhann, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molkentin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vonsattel, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span> <span> </span><span class="NLM_article-title">Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer’s disease</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1097</span>– <span class="NLM_lpage">1105</span>, <span class="refDoi"> DOI: 10.1038/nm.1868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1038%2Fnm.1868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=18806802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1097-1105&author=H.+Duauthor=L.+Guoauthor=F.+Fangauthor=D.+Chenauthor=A.+A.+Sosunovauthor=G.+M.+McKhannauthor=Y.+Yanauthor=C.+Wangauthor=H.+Zhangauthor=J.+D.+Molkentinauthor=F.+J.+Gunn-Mooreauthor=J.+P.+Vonsattelauthor=O.+Arancioauthor=J.+X.+Chenauthor=S.+D.+Yan&title=Cyclophilin+D+deficiency+attenuates+mitochondrial+and+neuronal+perturbation+and+ameliorates+learning+and+memory+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnm.1868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease</span></div><div class="casAuthors">Du, Heng; Guo, Lan; Fang, Fang; Chen, Doris; Sosunov, Alexander A.; McKhann, Guy M.; Yan, Yilin; Wang, Chunyu; Zhang, Hong; Molkentin, Jeffery D.; Gunn-Moore, Frank J.; Vonsattel, Jean Paul; Arancio, Ottavio; Chen, John Xi; Yan, Shi Du</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1097-1105</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cyclophilin D (CypD, encoded by Ppif) is an integral part of the mitochondrial permeability transition pore, whose opening leads to cell death.  Here we show that interaction of CypD with mitochondrial amyloid-β protein (Aβ) potentiates mitochondrial, neuronal and synaptic stress.  The CypD-deficient cortical mitochondria are resistant to Aβ- and Ca2+-induced mitochondrial swelling and permeability transition.  Addnl., they have an increased calcium buffering capacity and generate fewer mitochondrial reactive oxygen species.  Furthermore, the absence of CypD protects neurons from Aβ- and oxidative stress-induced cell death.  Notably, CypD deficiency substantially improves learning and memory and synaptic function in an Alzheimer's disease mouse model and alleviates Aβ-mediated redn. of long-term potentiation.  Thus, the CypD-mediated mitochondrial permeability transition pore is directly linked to the cellular and synaptic perturbations obsd. in the pathogenesis of Alzheimer's disease.  Blockade of CypD may be a therapeutic strategy in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIHTwc-GU4IbVg90H21EOLACvtfcHk0lh2W8E0iNReKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7vJ&md5=0105abbf8a32cc0638ddde7223df1966</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fnm.1868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1868%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DSosunov%26aufirst%3DA.%2BA.%26aulast%3DMcKhann%26aufirst%3DG.%2BM.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMolkentin%26aufirst%3DJ.%2BD.%26aulast%3DGunn-Moore%26aufirst%3DF.%2BJ.%26aulast%3DVonsattel%26aufirst%3DJ.%2BP.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DChen%26aufirst%3DJ.%2BX.%26aulast%3DYan%26aufirst%3DS.%2BD.%26atitle%3DCyclophilin%2520D%2520deficiency%2520attenuates%2520mitochondrial%2520and%2520neuronal%2520perturbation%2520and%2520ameliorates%2520learning%2520and%2520memory%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D1097%26epage%3D1105%26doi%3D10.1038%2Fnm.1868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bobba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amadoro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lassandro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atlante, A.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial respiratory chain complexes I and IV are impaired by β-amyloid via direct interaction and through complex I-dependent ROS production, respectively</span>. <i>Mitochondrion</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">298</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1016/j.mito.2013.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.mito.2013.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=23562762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVGnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=298-311&author=A.+Bobbaauthor=G.+Amadoroauthor=D.+Valentiauthor=V.+Corsettiauthor=R.+Lassandroauthor=A.+Atlante&title=Mitochondrial+respiratory+chain+complexes+I+and+IV+are+impaired+by+%CE%B2-amyloid+via+direct+interaction+and+through+complex+I-dependent+ROS+production%2C+respectively&doi=10.1016%2Fj.mito.2013.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial respiratory chain Complexes I and IV are impaired by β-amyloid via direct interaction and through Complex I-dependent ROS production, respectively</span></div><div class="casAuthors">Bobba, A.; Amadoro, G.; Valenti, D.; Corsetti, V.; Lassandro, R.; Atlante, A.</div><div class="citationInfo"><span class="NLM_cas:title">Mitochondrion</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">298-311</span>CODEN:
                <span class="NLM_cas:coden">MITOCN</span>;
        ISSN:<span class="NLM_cas:issn">1567-7249</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here we investigate the effect of β-amyloid on mitochondrial respiratory function, i.e. mitochondrial oxygen consumption and membrane potential generation as well as the individual activities of both the mitochondrial Complexes I-IV, that compose mitochondrial electron transport chain, and the ATP synthase, by using homogenate from cerebellar granule cells, treated with low concns. of β-amyloid, and Alzheimer synaptic-enriched brain samples.  We found that β-amyloid caused both a selective defect in Complex I activity assocd. with an increase (5 fold) of intracellular reactive oxygen species and an impairment of Complex IV likely due to membrane lipid peroxidn.  In addn., a 130% increase of the GSSG/GSH ratio was measured in Alzheimer brains with respect to age-matched controls.  Knowing the mechanisms of action of β-amyloid could allow to mitigate or even to interrupt the toxic cascade that leads a cell to death.  The results of this study represent an important innovation because they offer the possibility to act at mitochondrial level and on specific sites to protect cells, for example by preventing the interaction of β-amyloid with the identified targets, by stabilizing or by restoring mitochondrial function or by interfering with the energy metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5gnysjBl9MLVg90H21EOLACvtfcHk0lh2W8E0iNReKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVGnt74%253D&md5=da94e05feb9bb4a635a75c6eff140d26</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.mito.2013.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mito.2013.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DBobba%26aufirst%3DA.%26aulast%3DAmadoro%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DD.%26aulast%3DCorsetti%26aufirst%3DV.%26aulast%3DLassandro%26aufirst%3DR.%26aulast%3DAtlante%26aufirst%3DA.%26atitle%3DMitochondrial%2520respiratory%2520chain%2520complexes%2520I%2520and%2520IV%2520are%2520impaired%2520by%2520%25CE%25B2-amyloid%2520via%2520direct%2520interaction%2520and%2520through%2520complex%2520I-dependent%2520ROS%2520production%252C%2520respectively%26jtitle%3DMitochondrion%26date%3D2013%26volume%3D13%26spage%3D298%26epage%3D311%26doi%3D10.1016%2Fj.mito.2013.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oppermann, U. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjernberg, L. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terenius, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jornvall, H.</span></span> <span> </span><span class="NLM_article-title">Binding of amyloid β-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer’s disease</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>451</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(99)00586-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS0014-5793%2899%2900586-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=451&publication_year=1999&pages=238-242&author=U.+C.+Oppermannauthor=S.+Salimauthor=L.+O.+Tjernbergauthor=L.+Tereniusauthor=H.+Jornvall&title=Binding+of+amyloid+%CE%B2-peptide+to+mitochondrial+hydroxyacyl-CoA+dehydrogenase+%28ERAB%29%3A+regulation+of+an+SDR+enzyme+activity+with+implications+for+apoptosis+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0014-5793%2899%2900586-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2899%2900586-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252899%252900586-4%26sid%3Dliteratum%253Aachs%26aulast%3DOppermann%26aufirst%3DU.%2BC.%26aulast%3DSalim%26aufirst%3DS.%26aulast%3DTjernberg%26aufirst%3DL.%2BO.%26aulast%3DTerenius%26aufirst%3DL.%26aulast%3DJornvall%26aufirst%3DH.%26atitle%3DBinding%2520of%2520amyloid%2520%25CE%25B2-peptide%2520to%2520mitochondrial%2520hydroxyacyl-CoA%2520dehydrogenase%2520%2528ERAB%2529%253A%2520regulation%2520of%2520an%2520SDR%2520enzyme%2520activity%2520with%2520implications%2520for%2520apoptosis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFEBS%2520Lett.%26date%3D1999%26volume%3D451%26spage%3D238%26epage%3D242%26doi%3D10.1016%2FS0014-5793%2899%2900586-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hroch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musilek, K.</span></span> <span> </span><span class="NLM_article-title">A direct interaction between mitochondrial proteins and amyloid-β peptide and its significance for the progression and treatment of Alzheimer’s disease</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1056</span>– <span class="NLM_lpage">1085</span>, <span class="refDoi"> DOI: 10.2174/0929867322666150114163051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F0929867322666150114163051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=25620098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1ynsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=1056-1085&author=O.+Benekauthor=L.+Aitkenauthor=L.+Hrochauthor=K.+Kucaauthor=F.+Gunn-Mooreauthor=K.+Musilek&title=A+direct+interaction+between+mitochondrial+proteins+and+amyloid-%CE%B2+peptide+and+its+significance+for+the+progression+and+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F0929867322666150114163051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Benek, O.; Aitken, L.; Hroch, L.; Kuca, K.; Gunn-Moore, F.; Musilek, K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1056-1085</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The amyloid-β peptide (Aβ) has been assocd. with Alzheimer's disease (AD) for decades.  The original amyloid cascade hypothesis declared that the insol. extracellular plaques were responsible for Aβ toxicity.  Later, this hypothesis has been updated and sol. intracellular Aβ forms and their effects within the cell have come into focus.  Mitochondrial dysfunction plays an important role in the pathophysiol. of AD.  Aβ was detected inside mitochondria and several mitochondrial proteins were found to interact directly with Aβ.  Such interactions can affect a protein's function and cause damage to the mitochondria and finally to the whole cell.  This review summarizes the current knowledge of mitochondrial proteins directly interacting with A and discusses their significance for the development of therapeutics in the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwmL6_sO-FArVg90H21EOLACvtfcHk0ljC6LDN6GthCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1ynsrc%253D&md5=889326c4c39e7e84adf9ad2117f37f6d</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.2174%2F0929867322666150114163051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666150114163051%26sid%3Dliteratum%253Aachs%26aulast%3DBenek%26aufirst%3DO.%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DHroch%26aufirst%3DL.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DMusilek%26aufirst%3DK.%26atitle%3DA%2520direct%2520interaction%2520between%2520mitochondrial%2520proteins%2520and%2520amyloid-%25CE%25B2%2520peptide%2520and%2520its%2520significance%2520for%2520the%2520progression%2520and%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D1056%26epage%3D1085%26doi%3D10.2174%2F0929867322666150114163051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muirhead, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F. J.</span></span> <span> </span><span class="NLM_article-title">The consequences of mitochondrial amyloid β-peptide in Alzheimer’s disease</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>426</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1042/BJ20091941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1042%2FBJ20091941" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=20175748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlKiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2010&pages=255-270&author=K.+E.+Muirheadauthor=E.+Borgerauthor=L.+Aitkenauthor=S.+J.+Conwayauthor=F.+J.+Gunn-Moore&title=The+consequences+of+mitochondrial+amyloid+%CE%B2-peptide+in+Alzheimer%E2%80%99s+disease&doi=10.1042%2FBJ20091941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The consequences of mitochondrial amyloid β-peptide in Alzheimer's disease</span></div><div class="casAuthors">Muirhead, Kirsty E. A.; Borger, Eva; Aitken, Laura; Conway, Stuart J.; Gunn-Moore, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-270</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The Aβ (amyloid-β peptide) has long been assocd. with Alzheimer's disease, originally in the form of extracellular plaques.  However, in the present paper we review the growing evidence for the role of sol. intracellular Aβ in the disease progression, with particular ref. to Aβ found within the mitochondria.  Once inside the cell, Aβ is able to interact with a no. of targets, including the mitochondrial proteins ABAD (amyloid-binding alc. dehydrogenase) and CypD (cyclophilin D), which is a component of the mitochondrial permeability transition pore.  Interference with the normal functions of these proteins results in disruption of cell homeostasis and ultimately cell death.  The present review explores the possible mechanisms by which cell death occurs, considering the evidence presented on a mol., cellular and in vivo level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8b1oOK_xbzLVg90H21EOLACvtfcHk0ljC6LDN6GthCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlKiu74%253D&md5=680a8762fe166e0602221e75e64f5aac</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1042%2FBJ20091941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20091941%26sid%3Dliteratum%253Aachs%26aulast%3DMuirhead%26aufirst%3DK.%2BE.%26aulast%3DBorger%26aufirst%3DE.%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DGunn-Moore%26aufirst%3DF.%2BJ.%26atitle%3DThe%2520consequences%2520of%2520mitochondrial%2520amyloid%2520%25CE%25B2-peptide%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D426%26spage%3D255%26epage%3D270%26doi%3D10.1042%2FBJ20091941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Mohanna, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tohyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roherk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D.</span></span> <span> </span><span class="NLM_article-title">An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer’s disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>389</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1038/39522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1038%2F39522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=9338779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVSjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=1997&pages=689-695&author=S.+D.+Yanauthor=J.+Fuauthor=C.+Sotoauthor=X.+Chenauthor=H.+Zhuauthor=F.+Al-Mohannaauthor=K.+Collisonauthor=A.+Zhuauthor=E.+Sternauthor=T.+Saidoauthor=M.+Tohyamaauthor=S.+Ogawaauthor=A.+Roherkauthor=D.+Stern&title=An+intracellular+protein+that+binds+amyloid-%CE%B2+peptide+and+mediates+neurotoxicity+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2F39522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease</span></div><div class="casAuthors">Yan, Shi Du; Fu, Jin; Soto, Claudio; Chen, Xi; Zhu, Huaijie; Al-Mohanna, Futwan; Collison, Kate; Zhu, Aiping; Stern, Eric; Saido, Takaomi; Tohyama, Masaya; Ogawa, Satoshi; Roher, Alex; Stern, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">6652</span>),
    <span class="NLM_cas:pages">689-695</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Amyloid-β is a neurotoxic peptide which is implicated in the pathogenesis of Alzheimer's disease.  It binds an intracellular polypeptide known as ERAB, thought to be a hydroxysteroid dehydrogenase enzyme, which is expressed in normal tissues, but is overexpressed in neurons affected in Alzheimer's disease.  ERAB immunoppts. with amyloid-β, and when cell cultures are exposed to amyloid-β, ERAB inside the cell is rapidly redistributed to the plasma membrane.  The toxic effect of amyloid-β on these cells is prevented by blocking ERAB and is enhanced by overexpression of ERAB.  By interacting with intracellular amyloid-β, ERAB may therefore contribute to the neuronal dysfunction assocd. with Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4z15QNwg_QbVg90H21EOLACvtfcHk0lgnqhzuMTKucA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVSjtLc%253D&md5=b47b453a269f371e976486ee8c68cf6a</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2F39522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F39522%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DAl-Mohanna%26aufirst%3DF.%26aulast%3DCollison%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DA.%26aulast%3DStern%26aufirst%3DE.%26aulast%3DSaido%26aufirst%3DT.%26aulast%3DTohyama%26aufirst%3DM.%26aulast%3DOgawa%26aufirst%3DS.%26aulast%3DRoherk%26aufirst%3DA.%26aulast%3DStern%26aufirst%3DD.%26atitle%3DAn%2520intracellular%2520protein%2520that%2520binds%2520amyloid-%25CE%25B2%2520peptide%2520and%2520mediates%2520neurotoxicity%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D1997%26volume%3D389%26spage%3D689%26epage%3D695%26doi%3D10.1038%2F39522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial Aβ: a potential cause of metabolic dysfunction in Alzheimer’s disease</span>. <i>IUBMB Life</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">686</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1080/15216540601047767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1080%2F15216540601047767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17424907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=686-694&author=X.+Chenauthor=S.+D.+Yan&title=Mitochondrial+A%CE%B2%3A+a+potential+cause+of+metabolic+dysfunction+in+Alzheimer%E2%80%99s+disease&doi=10.1080%2F15216540601047767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Aβ: a potential cause of metabolic dysfunction in Alzheimer's disease</span></div><div class="casAuthors">Chen, Xi; Yan, Shi Du</div><div class="citationInfo"><span class="NLM_cas:title">IUBMB Life</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">686-694</span>CODEN:
                <span class="NLM_cas:coden">IULIF8</span>;
        ISSN:<span class="NLM_cas:issn">1521-6543</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Deficits in mitochondrial function are a characteristic finding in Alzheimer's disease (AD), though the mechanism remains to be clarified.  Recent studies revealed that amyloid β peptide (Aβ) gains access into mitochondrial matrix, which was much more pronounced in both AD brain and transgenic mutant APP mice than in normal controls.  Aβ progressively accumulates in mitochondria and mediates mitochondrial toxicity.  Interaction of mitochondrial Aβ with mitochondrial enzymes such as amyloid β binding alc. dehydrogenase (ABAD) exaggerates mitochondrial stress by inhibiting the enzyme activity, releasing reactive oxygen species (ROS), and affecting glycolytic, Krebs cycle and/or the respiratory chain pathways through the accumulation of deleterious intermediate metabolites.  The pathways proposed may play a key role in the pathogenesis of this devastating neurodegenerative disorder, Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_CF2SM-eg7bVg90H21EOLACvtfcHk0lgnqhzuMTKucA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWjtbg%253D&md5=6d59ff700fa63d14c2e871a0f8e6cbcf</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1080%2F15216540601047767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15216540601047767%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DS.%2BD.%26atitle%3DMitochondrial%2520A%25CE%25B2%253A%2520a%2520potential%2520cause%2520of%2520metabolic%2520dysfunction%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DIUBMB%2520Life%26date%3D2006%26volume%3D58%26spage%3D686%26epage%3D694%26doi%3D10.1080%2F15216540601047767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lustbader, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirilli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takuma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspersen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinchese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lue, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuppusamy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zewier, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">H, W.</span></span> <span> </span><span class="NLM_article-title">ABAD directly links Aβ to mitochondrial toxicity in Alzheimer’s disease</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>304</i></span>,  <span class="NLM_fpage">448</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1126/science.1091230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1126%2Fscience.1091230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15087549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVWksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=448-452&author=J.+W.+Lustbaderauthor=M.+Cirilliauthor=C.+Linauthor=H.+W.+Xuauthor=K.+Takumaauthor=N.+Wangauthor=C.+Caspersenauthor=X.+Chenauthor=S.+Pollakauthor=M.+Chaneyauthor=F.+Trincheseauthor=S.+Liuauthor=F.+J.+Gunn-Mooreauthor=L.+F.+Lueauthor=D.+G.+Walkerauthor=P.+Kuppusamyauthor=Z.+L.+Zewierauthor=O.+Arancioauthor=D.+Sternauthor=S.+S.+Yanauthor=W.+H&title=ABAD+directly+links+A%CE%B2+to+mitochondrial+toxicity+in+Alzheimer%E2%80%99s+disease&doi=10.1126%2Fscience.1091230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">ABAD Directly Links Aβ to Mitochondrial Toxicity in Alzheimer's Disease</span></div><div class="casAuthors">Lustbader, Joyce W.; Cirilli, Maurizio; Lin, Chang; Xu, Hong Wei; Takuma, Kazuhiro; Wang, Ning; Caspersen, Casper; Chen, Xi; Pollak, Susan; Chaney, Michael; Trinchese, Fabrizio; Liu, Shumin; Gunn-Moore, Frank; Lue, Lih-Fen; Walker, Douglas G.; Kuppusamy, Periannan; Zewier, Zay L.; Arancio, Ottavio; Stern, David; Yan, Shirley ShiDu; Wu, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">5669</span>),
    <span class="NLM_cas:pages">448-452</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mitochondrial dysfunction is a hallmark of β-amyloid (Aβ)-induced neuronal toxicity in Alzheimer's disease (AD).  Here, the authors demonstrate that Aβ-binding alc. dehydrogenase (ABAD) is a direct mol. link from Aβ to mitochondrial toxicity.  Aβ interacts with ABAD in the mitochondria of AD patients and transgenic mice.  The crystal structure of Aβ-bound ABAD shows substantial deformation of the active site that prevents NAD binding.  An ABAD peptide specifically inhibits ABAD-Aβ interaction and suppresses Aβ-induced apoptosis and free-radical generation in neurons.  Transgenic mice overexpressing ABAD in an Aβ-rich environment manifest exaggerated neuronal oxidative stress and impaired memory.  These data suggest that the ABAD-Aβ interaction may be a therapeutic target in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-Mj3nwaRF1bVg90H21EOLACvtfcHk0lgnqhzuMTKucA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVWksrg%253D&md5=45b6e63c36e6b9ffac3492319c7035e0</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1126%2Fscience.1091230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1091230%26sid%3Dliteratum%253Aachs%26aulast%3DLustbader%26aufirst%3DJ.%2BW.%26aulast%3DCirilli%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DH.%2BW.%26aulast%3DTakuma%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCaspersen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DPollak%26aufirst%3DS.%26aulast%3DChaney%26aufirst%3DM.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DGunn-Moore%26aufirst%3DF.%2BJ.%26aulast%3DLue%26aufirst%3DL.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BG.%26aulast%3DKuppusamy%26aufirst%3DP.%26aulast%3DZewier%26aufirst%3DZ.%2BL.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DStern%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DS.%2BS.%26aulast%3DH%26aufirst%3DW.%26atitle%3DABAD%2520directly%2520links%2520A%25CE%25B2%2520to%2520mitochondrial%2520toxicity%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D448%26epage%3D452%26doi%3D10.1126%2Fscience.1091230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinton, R. D.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial bioenergetic deficit precedes Alzheimer’s pathology in female mouse model of Alzheimer’s disease</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">14670</span>– <span class="NLM_lpage">14675</span>, <span class="refDoi"> DOI: 10.1073/pnas.0903563106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1073%2Fpnas.0903563106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=19667196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWrt7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=14670-14675&author=J.+Yaoauthor=R.+W.+Irwinauthor=L.+Zhaoauthor=J.+Nilsenauthor=R.+T.+Hamiltonauthor=R.+D.+Brinton&title=Mitochondrial+bioenergetic+deficit+precedes+Alzheimer%E2%80%99s+pathology+in+female+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1073%2Fpnas.0903563106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease</span></div><div class="casAuthors">Yao, Jia; Irwin, Ronald W.; Zhao, Liqin; Nilsen, Jon; Hamilton, Ryan T.; Brinton, Roberta Diaz</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">14670-14675, S14670/1-S14670/3</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mitochondrial dysfunction has been proposed to play a pivotal role in neurodegenerative diseases, including Alzheimer's disease (AD).  To address whether mitochondrial dysfunction precedes the development of AD pathol., we conducted mitochondrial functional analyses in female triple transgenic Alzheimer's mice (3xTg-AD) and age-matched nontransgenic (nonTg).  Mitochondrial dysfunction in the 3xTg-AD brain was evidenced by decreased mitochondrial respiration and decreased pyruvate dehydrogenase (PDH) protein level and activity as early as 3 mo of age.  3XTg-AD mice also exhibited increased oxidative stress as manifested by increased hydrogen peroxide prodn. and lipid peroxidn.  Mitochondrial amyloid beta (Aβ) level in the 3xTg-AD mice was significantly increased at 9 mo and temporally correlated with increased level of Aβ binding to alc. dehydrogenase (ABAD).  Embryonic neurons derived from 3xTg-AD mouse hippocampus exhibited significantly decreased mitochondrial respiration and increased glycolysis.  Results of these analyses indicate that compromised mitochondrial function is evident in embryonic hippocampal neurons, continues unabated in females throughout the reproductive period, and is exacerbated during reproductive senescence.  In nontransgenic control mice, oxidative stress was coincident with reproductive senescence and accompanied by a significant decline in mitochondrial function.  Reproductive senescence in the 3xTg-AD mouse brain markedly exacerbated mitochondrial dysfunction.  Collectively, the data indicate significant mitochondrial dysfunction occurs early in AD pathogenesis in a female AD mouse model.  Mitochondrial dysfunction provides a plausible mechanistic rationale for the hypometabolism in brain that precedes AD diagnosis and suggests therapeutic targets for prevention of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvpVG7kli_pbVg90H21EOLACvtfcHk0ljh4CVbH67oLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWrt7%252FM&md5=afa5516e1b8215b5ffdd072217336cac</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0903563106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0903563106%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DIrwin%26aufirst%3DR.%2BW.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DNilsen%26aufirst%3DJ.%26aulast%3DHamilton%26aufirst%3DR.%2BT.%26aulast%3DBrinton%26aufirst%3DR.%2BD.%26atitle%3DMitochondrial%2520bioenergetic%2520deficit%2520precedes%2520Alzheimer%25E2%2580%2599s%2520pathology%2520in%2520female%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D14670%26epage%3D14675%26doi%3D10.1073%2Fpnas.0903563106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Abundant type 10 17β-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer’s disease model</span>. <i>Mol. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">46</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1016/S0169-328X(02)00102-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS0169-328X%2802%2900102-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=11869808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsFalurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=46-53&author=X.+Y.+Heauthor=G.+Y.+Wenauthor=G.+Merzauthor=D.+Linauthor=Y.+Z.+Yangauthor=P.+Mehtaauthor=H.+Schulzauthor=S.+Y.+Yang&title=Abundant+type+10+17%CE%B2-hydroxysteroid+dehydrogenase+in+the+hippocampus+of+mouse+Alzheimer%E2%80%99s+disease+model&doi=10.1016%2FS0169-328X%2802%2900102-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Abundant type 10 17β-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model</span></div><div class="casAuthors">He, Xue-Ying; Wen, Guang-Yeong; Merz, George; Lin, Dawei; Yang, Ying-Zi; Mehta, Penkaj; Schulz, Horst; Yang, Song-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-53</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A full-length cDNA of mouse type 10 17β-hydroxysteroid dehydrogenase (17β-HSD10) was cloned from brain, representing the accurate nucleotide sequence information that rendered possible an accurate deduction of the amino acid sequence of the wild-type enzyme.  A comparison of sequences and three-dimensional models of this enzyme revealed that structures previously reported by other groups carry either a truncated or mutated amino-terminal sequence.  Fusion of the first 11 residues of the wild-type enzyme to the green fluorescent protein directed the reporter protein into mitochondria.  Thus, the N-terminus was identified as a mitochondrial targeting signal that accounts for the intracellular localization of the mouse enzyme.  This enzyme is normally assocd. with mitochondria, not with the endoplasmic reticulum as suggested by its trivial name 'endoplasmic reticulum-assocd. amyloid-β binding protein (ERAB)'.  After its C-terminal region was used to raise rabbit anti-17βHSD10 antibodies, immunogold electron microscopy showed that an abundance of this enzyme could be found in hippocampal synaptic mitochondria of βAPP transgenic mice, but not in normal controls.  High levels of this enzyme may disrupt steroid hormone homeostasis in synapses and contribute to synapse loss in the hippocampus of the mouse Alzheimer's disease model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA1NiJzDDAbLVg90H21EOLACvtfcHk0ljh4CVbH67oLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsFalurs%253D&md5=62c6bdfcfd70ce58744d4e7b9fca9c64</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2FS0169-328X%2802%2900102-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-328X%252802%252900102-X%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%2BY.%26aulast%3DWen%26aufirst%3DG.%2BY.%26aulast%3DMerz%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DY.%2BZ.%26aulast%3DMehta%26aufirst%3DP.%26aulast%3DSchulz%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DAbundant%2520type%252010%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520in%2520the%2520hippocampus%2520of%2520mouse%2520Alzheimer%25E2%2580%2599s%2520disease%2520model%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D2002%26volume%3D99%26spage%3D46%26epage%3D53%26doi%3D10.1016%2FS0169-328X%2802%2900102-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span> <span> </span><span class="NLM_article-title">3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">4874</span>– <span class="NLM_lpage">4883</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2005.04911.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1111%2Fj.1742-4658.2005.04911.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=2005&pages=4874-4883&author=S.+Y.+Yangauthor=X.+Y.+Heauthor=H.+Schulz&title=3-Hydroxyacyl-CoA+dehydrogenase+and+short+chain+3-hydroxyacyl-CoA+dehydrogenase+in+human+health+and+disease&doi=10.1111%2Fj.1742-4658.2005.04911.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2005.04911.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2005.04911.x%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DHe%26aufirst%3DX.%2BY.%26aulast%3DSchulz%26aufirst%3DH.%26atitle%3D3-Hydroxyacyl-CoA%2520dehydrogenase%2520and%2520short%2520chain%25203-hydroxyacyl-CoA%2520dehydrogenase%2520in%2520human%2520health%2520and%2520disease%26jtitle%3DFEBS%2520J.%26date%3D2005%26volume%3D272%26spage%3D4874%26epage%3D4883%26doi%3D10.1111%2Fj.1742-4658.2005.04911.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Powell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfield, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lustbader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, R. L.</span></span> <span> </span><span class="NLM_article-title">Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-β binding alcohol dehydrogenase (ABAD)</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">327</span>, <span class="refDoi"> DOI: 10.1006/jmbi.2000.4139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1006%2Fjmbi.2000.4139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=11023795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFWqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2000&pages=311-327&author=A.+J.+Powellauthor=J.+A.+Readauthor=M.+J.+Banfieldauthor=F.+Gunn-Mooreauthor=S.+D.+Yanauthor=J.+Lustbaderauthor=A.+R.+Sternauthor=D.+M.+Sternauthor=R.+L.+Brady&title=Recognition+of+structurally+diverse+substrates+by+type+II+3-hydroxyacyl-CoA+dehydrogenase+%28HADH+II%29%2Famyloid-%CE%B2+binding+alcohol+dehydrogenase+%28ABAD%29&doi=10.1006%2Fjmbi.2000.4139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Recognition of Structurally Diverse Substrates by Type II 3-Hydroxyacyl-CoA Dehydrogenase (HADH II)/Amyloid-β Binding Alcohol Dehydrogenase (ABAD)</span></div><div class="casAuthors">Powell, A. J.; Read, J. A.; Banfield, M. J.; Gunn-Moore, F.; Yan, S. D.; Lustbader, J.; Stern, A. R.; Stern, D. M.; Brady, R. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">311-327</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Human type II hydroxyacyl-CoA dehydrogenase/amyloid-β binding alc. dehydrogenase (HADH II/ABAD) is an oxidoreductase whose salient features include broad substrate specificity, encompassing 3-hydroxyacyl-CoA derivs., hydroxysteroids, alcs. and β-hydroxybutyrate, and the capacity to bind amyloid-β peptide, leading to propagation of amyloid-induced cell stress.  In this study, we examine the structure and enzymic activity of the homologous rat HADH II/ABAD enzyme.  We report the crystal structure of rat HADH II/ABAD as a binary complex with its NADH cofactor to 2.0 Å resoln., as a ternary complex with NAD+ and 3-ketobutyrate (acetoacetate) to 1.4 Å resoln., and as a ternary complex with NADH and 17β-estradiol to 1.7 Å resoln.  This first crystal structure of an HADH II confirms these enzymes are closely related to the short-chain hydroxysteroid dehydrogenases and differ substantially from the classic, type I 3-hydroxyacyl-CoA dehydrogenases.  Binding of the ketobutyrate substrate is accompanied by closure of the active site specificity loop, whereas the steroid substrate does not appear to require closure for binding.  Despite the different chem. nature of the two bound substrates, the presentation of chem. groups within the active site of each complex is remarkably similar, allowing a general mechanism for catalytic activity to be proposed.  There is a characteristic extension to the active site that is likely to accommodate the CoA moiety of 3-hydroxyacyl-CoA substrates.  Rat HADH II/ABAD also binds amyloid-β (1-40) peptide with a KD of 21 nM, which is similar to the interaction exhibited between this peptide and human HADH II/ABAD.  These studies provide the first structural insights into HADH II/ABAD interaction with its substrates, and indicate the relevance of the rodent enzyme and assocd. rodent models for anal. of HADH II/ABAD's physiol. and pathophysiol. properties.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7JHZthaDeDbVg90H21EOLACvtfcHk0ljh4CVbH67oLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFWqtLk%253D&md5=f9337b16dc06510b449dceb903973bd1</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.2000.4139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.2000.4139%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DA.%2BJ.%26aulast%3DRead%26aufirst%3DJ.%2BA.%26aulast%3DBanfield%26aufirst%3DM.%2BJ.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DLustbader%26aufirst%3DJ.%26aulast%3DStern%26aufirst%3DA.%2BR.%26aulast%3DStern%26aufirst%3DD.%2BM.%26aulast%3DBrady%26aufirst%3DR.%2BL.%26atitle%3DRecognition%2520of%2520structurally%2520diverse%2520substrates%2520by%2520type%2520II%25203-hydroxyacyl-CoA%2520dehydrogenase%2520%2528HADH%2520II%2529%252Famyloid-%25CE%25B2%2520binding%2520alcohol%2520dehydrogenase%2520%2528ABAD%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D303%26spage%3D311%26epage%3D327%26doi%3D10.1006%2Fjmbi.2000.4139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kissinger, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rejto, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abreo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agree, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margosiak, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aust, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderpool, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempczyk-Russell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villafranca, J. E.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer’s disease therapeutics</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">943</span>– <span class="NLM_lpage">952</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2004.07.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.jmb.2004.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15342248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntlOgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2004&pages=943-952&author=C.+R.+Kissingerauthor=P.+A.+Rejtoauthor=L.+A.+Pelletierauthor=J.+A.+Thomsonauthor=R.+E.+Showalterauthor=M.+A.+Abreoauthor=C.+S.+Agreeauthor=S.+Margosiakauthor=J.+J.+Mengauthor=R.+M.+Austauthor=D.+Vanderpoolauthor=B.+Liauthor=A.+Tempczyk-Russellauthor=J.+E.+Villafranca&title=Crystal+structure+of+human+ABAD%2FHSD10+with+a+bound+inhibitor%3A+implications+for+design+of+Alzheimer%E2%80%99s+disease+therapeutics&doi=10.1016%2Fj.jmb.2004.07.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of Human ABAD/HSD10 with a Bound Inhibitor: Implications for Design of Alzheimer's Disease Therapeutics</span></div><div class="casAuthors">Kissinger, Charles R.; Rejto, Paul A.; Pelletier, Laura A.; Thomson, James A.; Showalter, Richard E.; Abreo, Melwyn A.; Agree, Charles S.; Margosiak, Stephen; Meng, Jerry J.; Aust, Robert M.; Vanderpool, Darin; Li, Bin; Tempczyk-Russell, Anna; Villafranca, J. Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">943-952</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The enzyme 17β-hydroxysteroid dehydrogenase type 10 (HSD10), also known as amyloid β-peptide-binding alc. dehydrogenase (ABAD), has been implicated in the development of Alzheimer's disease.  This protein, a member of the short-chain dehydrogenase/reductase family of enzymes, has been shown to bind β-amyloid and to participate in β-amyloid neurotoxicity.  We have detd. the crystal structure of human ABAD/HSD10 complexed with NAD+ and an inhibitory small mol.  The inhibitor occupies the substrate-binding site and forms a covalent adduct with the NAD+ cofactor.  The crystal structure provides a basis for the design of potent, highly specific ABAD/HSD10 inhibitors with potential application in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9CoeEHvGNpbVg90H21EOLACvtfcHk0li3ufIat5bDeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntlOgsLw%253D&md5=42eda56430fb17232fa024879604d5bd</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2004.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2004.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DKissinger%26aufirst%3DC.%2BR.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DPelletier%26aufirst%3DL.%2BA.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DShowalter%26aufirst%3DR.%2BE.%26aulast%3DAbreo%26aufirst%3DM.%2BA.%26aulast%3DAgree%26aufirst%3DC.%2BS.%26aulast%3DMargosiak%26aufirst%3DS.%26aulast%3DMeng%26aufirst%3DJ.%2BJ.%26aulast%3DAust%26aufirst%3DR.%2BM.%26aulast%3DVanderpool%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DTempczyk-Russell%26aufirst%3DA.%26aulast%3DVillafranca%26aufirst%3DJ.%2BE.%26atitle%3DCrystal%2520structure%2520of%2520human%2520ABAD%252FHSD10%2520with%2520a%2520bound%2520inhibitor%253A%2520implications%2520for%2520design%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapeutics%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D342%26spage%3D943%26epage%3D952%26doi%3D10.1016%2Fj.jmb.2004.07.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ofman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiter, J. P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feenstra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poll-The, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zschocke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ensenauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehnert, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sass, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanders, R. J. A.</span></span> <span> </span><span class="NLM_article-title">2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene</span>. <i>Am. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1086/375116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1086%2F375116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12696021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslagu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2003&pages=1300-1307&author=R.+Ofmanauthor=J.+P.+N.+Ruiterauthor=M.+Feenstraauthor=M.+Duranauthor=B.+T.+Poll-Theauthor=J.+Zschockeauthor=R.+Ensenauerauthor=W.+Lehnertauthor=J.+O.+Sassauthor=W.+Sperlauthor=R.+J.+A.+Wanders&title=2-Methyl-3-hydroxybutyryl-CoA+dehydrogenase+deficiency+is+caused+by+mutations+in+the+HADH2+gene&doi=10.1086%2F375116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene</span></div><div class="casAuthors">Ofman, Rob; Ruiter, Jos P. N.; Feenstra, Marike; Duran, Marinus; Poll-The, Bwee Tien; Zschocke, Johannes; Ensenauer, Regina; Lehnert, Willy; Sass, Jorn Oliver; Sperl, Wolfgang; Wanders, Ronald J. A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1300-1307</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency is a novel inborn error of isoleucine degrdn.  In this article, we report the elucidation of the mol. basis of MHBD deficiency.  To this end, we purified the enzyme from bovine liver.  MALDI-TOF mass spectrometry anal. revealed that the purified protein was identical to bovine 3-hydroxyacyl-CoA dehydrogenase type II.  The human homolog of this bovine enzyme is a short-chain 3-hydroxyacyl-CoA dehydrogenase, also known as the "endoplasmic reticulum-assocd. amyloid-β binding protein" (ERAB).  This led to the identification of the X-chromosomal gene involved, which previously had been denoted "HADH2.".  Sequence anal. of the HADH2 gene from patients with MHBD deficiency revealed the presence of two missense mutations (R130C and L122V).  Heterologous expression of the mutant cDNAs in Escherichia coli showed that both mutations almost completely abolish enzyme activity.  This confirms that MHBD deficiency is caused by mutations in the HADH2 gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTeQLEzXyqJrVg90H21EOLACvtfcHk0li3ufIat5bDeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslagu7o%253D&md5=7fb6558c8a6db6c351cea92e5c3a91db</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1086%2F375116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F375116%26sid%3Dliteratum%253Aachs%26aulast%3DOfman%26aufirst%3DR.%26aulast%3DRuiter%26aufirst%3DJ.%2BP.%2BN.%26aulast%3DFeenstra%26aufirst%3DM.%26aulast%3DDuran%26aufirst%3DM.%26aulast%3DPoll-The%26aufirst%3DB.%2BT.%26aulast%3DZschocke%26aufirst%3DJ.%26aulast%3DEnsenauer%26aufirst%3DR.%26aulast%3DLehnert%26aufirst%3DW.%26aulast%3DSass%26aufirst%3DJ.%2BO.%26aulast%3DSperl%26aufirst%3DW.%26aulast%3DWanders%26aufirst%3DR.%2BJ.%2BA.%26atitle%3D2-Methyl-3-hydroxybutyryl-CoA%2520dehydrogenase%2520deficiency%2520is%2520caused%2520by%2520mutations%2520in%2520the%2520HADH2%2520gene%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2003%26volume%3D72%26spage%3D1300%26epage%3D1307%26doi%3D10.1086%2F375116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span> <span> </span><span class="NLM_article-title">Multiple functions of type 10 17β-hydroxysteroid dehydrogenase</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">175</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2005.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.tem.2005.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15860413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslKhu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=167-175&author=S.+Y.+Yangauthor=X.+Y.+Heauthor=H.+Schulz&title=Multiple+functions+of+type+10+17%CE%B2-hydroxysteroid+dehydrogenase&doi=10.1016%2Fj.tem.2005.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple functions of type 10 17β-hydroxysteroid dehydrogenase</span></div><div class="casAuthors">Yang, Song-Yu; He, Xue-Ying; Schulz, Horst</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">167-175</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Human 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10) is a mitochondrial enzyme encoded by the SCHAD gene, which escapes chromosome X inactivation.  17β-HSD10/SCHAD mutations cause a spectrum of clin. conditions, from mild mental retardation to progressive infantile neurodegeneration.  17β-HSD10/SCHAD is essential for the metab. of isoleucine and branched-chain fatty acids.  It can inactivate 17β-estradiol and steroid modulators of GABAA receptors, and convert 5α-androstanediol into 5α-dihydrotestosterone (DHT).  Certain malignant prostatic epithelial cells contain high levels of 17β-HSD10, generating 5α-DHT in the absence of testosterone.  17β-HSD10 has an affinity for amyloid-β peptide, and might be linked to the mitochondrial dysfunction seen in Alzheimer's disease.  This versatile enzyme might provide a new drug target for neuronal excitability control and for intervention in Alzheimer's disease and certain cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVGujFEvwPn7Vg90H21EOLACvtfcHk0li3ufIat5bDeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslKhu7Y%253D&md5=b081cbad136808fde8cdd1736377e656</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2005.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2005.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%2BY.%26aulast%3DHe%26aufirst%3DX.%2BY.%26aulast%3DSchulz%26aufirst%3DH.%26atitle%3DMultiple%2520functions%2520of%2520type%252010%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2005%26volume%3D16%26spage%3D167%26epage%3D175%26doi%3D10.1016%2Fj.tem.2005.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hroch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinklarova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisar, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musilek, K.</span></span> <span> </span><span class="NLM_article-title">1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">665</span>– <span class="NLM_lpage">670</span>, <span class="refDoi"> DOI: 10.1080/14756366.2018.1445736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1080%2F14756366.2018.1445736" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=29536773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks12mu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=665-670&author=O.+Benekauthor=L.+Hrochauthor=L.+Aitkenauthor=F.+Gunn-Mooreauthor=L.+Vinklarovaauthor=K.+Kucaauthor=D.+I.+Perezauthor=C.+Perezauthor=A.+Martinezauthor=Z.+Fisarauthor=K.+Musilek&title=1-%28Benzo%5Bd%5Dthiazol-2-yl%29-3-phenylureas+as+dual+inhibitors+of+casein+kinase+1+and+ABAD+enzymes+for+treatment+of+neurodegenerative+disorders&doi=10.1080%2F14756366.2018.1445736"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders</span></div><div class="casAuthors">Benek, Ondrej; Hroch, Lukas; Aitken, Laura; Gunn-Moore, Frank; Vinklarova, Lucie; Kuca, Kamil; Perez, Daniel I.; Perez, Concepcion; Martinez, Ana; Fisar, Zdenek; Musilek, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">665-670</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Several neurodegenerative disorders including Alzheimer's disease (AD) have been connected with deregulation of casein kinase 1 (CK1) activity.  Inhibition of CK1 therefore presents a potential therapeutic strategy against such pathologies.  Recently, novel class of CK1-specific inhibitors with N-(benzo[d]thiazol-2-yl)-2-phenylacetamide structural scaffold has been discovered. 1-(benzo[d]thiazol-2-yl)-3-phenylureas, on the other hand, are known inhibitors amyloid-beta binding alc. dehydrogenase (ABAD), an enzyme also involved in pathophysiol. of AD.  Based on their tight structural similarity, the authors decided to evaluate series of previously published benzothiazolylphenylureas, originally designed as ABAD inhibitors, for their inhibitory activity towards CK1.  Several compds. were found to be submicromolar CK1 inhibitors.  Moreover, two compds. were found to inhibit both, ABAD and CK1.  Such dual-activity could be of advantage for AD treatment, as it would simultaneously target two distinct pathol. processes involved in disease's progression.  Based on PAMPA testing both compds. were suggested to permeate the blood-brain barrier, which makes them, together with their unique dual activity, interesting lead compds. for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ZqR44ofgpLVg90H21EOLACvtfcHk0liHUecK9E3uSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks12mu7s%253D&md5=1230a25b26059d43bdbaad209f1d4495</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1080%2F14756366.2018.1445736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2018.1445736%26sid%3Dliteratum%253Aachs%26aulast%3DBenek%26aufirst%3DO.%26aulast%3DHroch%26aufirst%3DL.%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DVinklarova%26aufirst%3DL.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DFisar%26aufirst%3DZ.%26aulast%3DMusilek%26aufirst%3DK.%26atitle%3D1-%2528Benzo%255Bd%255Dthiazol-2-yl%2529-3-phenylureas%2520as%2520dual%2520inhibitors%2520of%2520casein%2520kinase%25201%2520and%2520ABAD%2520enzymes%2520for%2520treatment%2520of%2520neurodegenerative%2520disorders%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2018%26volume%3D33%26spage%3D665%26epage%3D670%26doi%3D10.1080%2F14756366.2018.1445736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balvers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paust, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, R.</span></span> <span> </span><span class="NLM_article-title">Differentiation-dependent expression of 17β-hydroxysteroid dehydrogenase, type 10, in the rodent testis: effect of aging in Leydig cells</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">3130</span>– <span class="NLM_lpage">3137</span>, <span class="refDoi"> DOI: 10.1210/en.2002-0082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1210%2Fen.2002-0082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12810569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvF2ktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2003&pages=3130-3137&author=R.+Ivellauthor=M.+Balversauthor=R.+J.+Anandauthor=H.+J.+Paustauthor=C.+McKinnellauthor=R.+Sharpe&title=Differentiation-dependent+expression+of+17%CE%B2-hydroxysteroid+dehydrogenase%2C+type+10%2C+in+the+rodent+testis%3A+effect+of+aging+in+Leydig+cells&doi=10.1210%2Fen.2002-0082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Differentiation-dependent expression of 17β-hydroxysteroid dehydrogenase, type 10, in the rodent testis: Effect of aging in Leydig cells</span></div><div class="casAuthors">Ivell, Richard; Balvers, Marga; Anand, Ravinder J. K.; Paust, Hans-Joachim; McKinnell, Chris; Sharpe, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3130-3137</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Expression of the new 17β-hydroxysteroid dehydrogenase (HSD), type 10 (17β-HSD-10), formerly known as endoplasmic reticulum-assocd. amyloid-binding protein, has been investigated in the testes of various mammals under normal and perturbed conditions.  Results show that 17β-HSD-10 is a major product of both fetal and adult-type Leydig cells.  In the former, protein persists until late in postnatal development; and in the short-day hamster model, it does not disappear when Leydig cells involute.  During puberty in the rat, immunohistochem. staining for 17β-HSD-10 in adult-type Leydig cells first becomes evident on d 20, increasing to maximal staining intensity by d 35.  In the rat, but not in the mouse or any other species examd., there is also staining in late spermatids.  Examn. of testes from rats subjected to perinatal treatment with either a GnRH antagonist or low and high doses of diethylstilbestrol revealed that expression of 17β-HSD-10 follows closely Leydig cell differentiation status, correlating with 3β-HSD expression in a previous study.  In aging (23 mo) rat testes, Leydig cell (but not germ cell) immunostaining for 17β-HSD-10 is markedly reduced.  17β-HSD-10 seems to preferentially convert 3α-androstanediol into dihydrotestosterone, and estradiol to estrone.  Thus, perinatal expression of this enzyme in fetal Leydig cells may contribute to protecting these cells from estrogens and encourage androgen formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnqAXJPlELArVg90H21EOLACvtfcHk0liHUecK9E3uSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvF2ktLg%253D&md5=77c3974ad3f0a2208eeeeda3cb267dce</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1210%2Fen.2002-0082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2002-0082%26sid%3Dliteratum%253Aachs%26aulast%3DIvell%26aufirst%3DR.%26aulast%3DBalvers%26aufirst%3DM.%26aulast%3DAnand%26aufirst%3DR.%2BJ.%26aulast%3DPaust%26aufirst%3DH.%2BJ.%26aulast%3DMcKinnell%26aufirst%3DC.%26aulast%3DSharpe%26aufirst%3DR.%26atitle%3DDifferentiation-dependent%2520expression%2520of%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%252C%2520type%252010%252C%2520in%2520the%2520rodent%2520testis%253A%2520effect%2520of%2520aging%2520in%2520Leydig%2520cells%26jtitle%3DEndocrinology%26date%3D2003%26volume%3D144%26spage%3D3130%26epage%3D3137%26doi%3D10.1210%2Fen.2002-0082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peehl, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauderdale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Oxidative 3α-hydroxysteroid dehydrogenase activity of human type 10 17β-hydroxysteroid dehydrogenase</span>. <i>J. Steroid Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1016/j.jsbmb.2003.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.jsbmb.2003.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=14672739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD3srpt1WrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2003&pages=191-198&author=X.+Heauthor=Y.+Yangauthor=D.+M.+Peehlauthor=A.+Lauderdaleauthor=H.+Schulzauthor=S.+Y.+Yang&title=Oxidative+3%CE%B1-hydroxysteroid+dehydrogenase+activity+of+human+type+10+17%CE%B2-hydroxysteroid+dehydrogenase&doi=10.1016%2Fj.jsbmb.2003.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative 3alpha-hydroxysteroid dehydrogenase activity of human type 10 17beta-hydroxysteroid dehydrogenase</span></div><div class="casAuthors">He Xue-Ying; Yang Ying-Zi; Peehl Donna M; Lauderdale Alexander; Schulz Horst; Yang Song-Yu</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of steroid biochemistry and molecular biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">191-8</span>
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">In vitro enzyme assays have demonstrated that human type 10 17beta-hydroxysteroid dehydrogenase (17beta-HSD10) catalyzes the oxidation of 5alpha-androstane-3alpha,17beta-diol (adiol), an almost inactive androgen, to dihydrotestosterone (DHT) rather than androsterone or androstanedione.  To further investigate the role of this steroid-metabolizing enzyme in intact cells, we produced stable transfectants expressing 17beta-HSD10 or its catalytically inactive Y168F mutant in human embryonic kidney (HEK) 293 cells.  It was found that DHT levels in HEK 293 cells expressing 17beta-HSD10, but not its catalytically inactive mutant, will dramatically increase if adiol is added to culture media.  Moreover, certain malignant prostatic epithelial cells have more 17beta-HSD10 than normal controls, and can generate DHT, the most potent androgen, from adiol.  This event might promote prostate cancer growth.  Analysis of the 17beta-HSD10 sequence shows that this enzyme does not have any ER retention signal or transmembrane segments and has not originated by divergence from a retinol dehydrogenase.  The data suggest that the unique mitochondrial location of this HSD [Eur.  J.  Biochem. 268 (2001) 4899] does not prevent it from oxidizing the 3alpha-hydroxyl group of a C19 sterol in living cells.  The experimental results lead to the conclusion that mitochondrial 17beta-HSD10 plays a significant part in a non-classical androgen synthesis pathway along with microsomal retinol dehydrogenases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1nDP7lyirxxe4jJGKT5N0fW6udTcc2eao4EnjzJn7SLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srpt1WrsQ%253D%253D&md5=012eacd22a911ae9bc7fce1141907772</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2003.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2003.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DPeehl%26aufirst%3DD.%2BM.%26aulast%3DLauderdale%26aufirst%3DA.%26aulast%3DSchulz%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DOxidative%25203%25CE%25B1-hydroxysteroid%2520dehydrogenase%2520activity%2520of%2520human%2520type%252010%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D87%26spage%3D191%26epage%3D198%26doi%3D10.1016%2Fj.jsbmb.2003.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Roles of mitochondrial 17β-hydroxysteroid dehydrogenase type 10 in Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">665</span>– <span class="NLM_lpage">673</span>, <span class="refDoi"> DOI: 10.3233/JAD-170974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-170974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=29480196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlWlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=665-673&author=X.+Y.+Heauthor=C.+Isaacsauthor=S.+Y.+Yang&title=Roles+of+mitochondrial+17%CE%B2-hydroxysteroid+dehydrogenase+type+10+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-170974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease</span></div><div class="casAuthors">He, Xue-Ying; Isaacs, Charles; Yang, Song-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">665-673</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">17β-Hydroxysteroid dehydrogenase type 10 is a multifunctional, homotetrameric, mitochondrial protein encoded by the HSD17B10 gene at Xp 11.2.  This protein, 17β-HSD10, is overexpressed in brain cells of Alzheimer's disease (AD) patients.  It was reported to be involved in AD pathogenesis as the endoplasmic reticulum-assocd. amyloid-β binding protein (ERAB) and as amyloid-β binding alc. dehydrogenase (ABAD).  However, the exaggerated catalytic efficiencies for ERAB/ABAD in these reports necessitated the re-characterization of the catalytic functions of this brain enzyme.  In addn. to isoleucine metab., 17β-HSD10 is also responsible for the mitochondrial metab. of neurosteroids such as 5α-androstane-3α,17β-diol and 17β-estradiol.  These neurosteroids are inactivated by the oxidn. catalyzed by 17β-HSD10.  Since neurosteroid homeostasis is presumably essential for cognitive function, anal. of the impact of 17β-HSD10 and its inhibitor, amyloid-β peptide (Aβ), on the metab. of neuroactive steroids offers a new approach to AD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg_TUu9Mmp17Vg90H21EOLACvtfcHk0lgHWa83KMcsTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlWlu78%253D&md5=78f6fb4d153bac39a2e2799d909acb29</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.3233%2FJAD-170974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-170974%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%2BY.%26aulast%3DIsaacs%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DRoles%2520of%2520mitochondrial%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%252010%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2018%26volume%3D62%26spage%3D665%26epage%3D673%26doi%3D10.3233%2FJAD-170974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siekevitz, P.</span></span> <span> </span><span class="NLM_article-title">The postsynaptic density: a possible role in long-lasting effects in the central nervous system</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">3494</span>– <span class="NLM_lpage">3498</span>, <span class="refDoi"> DOI: 10.1073/pnas.82.10.3494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1073%2Fpnas.82.10.3494" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1985&pages=3494-3498&author=P.+Siekevitz&title=The+postsynaptic+density%3A+a+possible+role+in+long-lasting+effects+in+the+central+nervous+system&doi=10.1073%2Fpnas.82.10.3494"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1073%2Fpnas.82.10.3494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.82.10.3494%26sid%3Dliteratum%253Aachs%26aulast%3DSiekevitz%26aufirst%3DP.%26atitle%3DThe%2520postsynaptic%2520density%253A%2520a%2520possible%2520role%2520in%2520long-lasting%2520effects%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1985%26volume%3D82%26spage%3D3494%26epage%3D3498%26doi%3D10.1073%2Fpnas.82.10.3494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laumonnier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuthbert, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, S. G. N.</span></span> <span> </span><span class="NLM_article-title">The role of neuronal complexes in human X-linked brain diseases</span>. <i>Am. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1086/511441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1086%2F511441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17236127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2007&pages=205-220&author=F.+Laumonnierauthor=P.+C.+Cuthbertauthor=S.+G.+N.+Grant&title=The+role+of+neuronal+complexes+in+human+X-linked+brain+diseases&doi=10.1086%2F511441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">The role of neuronal complexes in human X-linked brain diseases</span></div><div class="casAuthors">Laumonnier, Frederic; Cuthbert, Peter C.; Grant, Seth G. N.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-220</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">A review.  Beyond finding individual genes that are involved in medical disorders, an important challenge is the integration of sets of disease genes with the complexities of basic biol. processes.  We examine this issue by focusing on neuronal multiprotein complexes and their components encoded on the human X chromosome.  Multiprotein signaling complexes in the postsynaptic terminal of central nervous system synapses are essential for the induction of neuronal plasticity and cognitive processes in animals.  The prototype complex is the N-methyl-D-aspartate receptor complex/membrane-assocd. guanylate kinase-assocd. signaling complex (NRC/MASC) comprising 185 proteins and embedded within the postsynaptic d. (PSD), which is a set of complexes totaling ∼1,100 proteins.  It is striking that 86% (6 of 7) of X-linked NRC/MASC genes and 49% (19 of 39) of X-chromosomal PSD genes are already known to be involved in human psychiatric disorders.  Moreover, of the 69 known proteins mutated in X-linked mental retardation, 19 (28%) encode postsynaptic proteins.  The high incidence of involvement in cognitive disorders is also found in mouse mutants and indicates that the complexes are functioning as integrated entities or mol. machines and that disruption of different components impairs their overall role in cognitive processes.  We also noticed that NRC/MASC genes appear to be more strongly assocd. with mental retardation and autism spectrum disorders.  We propose that systematic studies of PSD and NRC/MASC genes in mice and humans will give a high yield of novel genes important for human disease and new mechanistic insights into higher cognitive functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYLYd31MKgAbVg90H21EOLACvtfcHk0lgHWa83KMcsTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOjurk%253D&md5=8be024c7338ddd81d34f18c69bb6c376</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1086%2F511441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F511441%26sid%3Dliteratum%253Aachs%26aulast%3DLaumonnier%26aufirst%3DF.%26aulast%3DCuthbert%26aufirst%3DP.%2BC.%26aulast%3DGrant%26aufirst%3DS.%2BG.%2BN.%26atitle%3DThe%2520role%2520of%2520neuronal%2520complexes%2520in%2520human%2520X-linked%2520brain%2520diseases%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2007%26volume%3D80%26spage%3D205%26epage%3D220%26doi%3D10.1086%2F511441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullarkat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of γ-aminobutyric acid type A receptors</span>. <i>Mol. Cell. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>229</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/j.mce.2004.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.mce.2004.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15607535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVyqs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=2005&pages=111-117&author=X.+Y.+Heauthor=J.+Wegielauthor=Y.+Z.+Yangauthor=R.+Pullarkatauthor=H.+Schulzauthor=S.+Y.+Yang&title=Type+10+17beta-hydroxysteroid+dehydrogenase+catalyzing+the+oxidation+of+steroid+modulators+of+%CE%B3-aminobutyric+acid+type+A+receptors&doi=10.1016%2Fj.mce.2004.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Type 10 17β-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of γ-aminobutyric acid type A receptors</span></div><div class="casAuthors">He, Xue-Ying; Wegiel, Jerzy; Yang, Ying-Zi; Pullarkat, Raju; Schulz, Horst; Yang, Song-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">111-117</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The steroids allopregnanolone and allotetrahydrodeoxycorticosterone (3α,5α-THDOC) are pos. allosteric modulators of GABAA receptors, generated by the redn. of 5α-dihydroprogesterone (5α-DHP) and 5α-DHDOC, resp., under the catalysis of human type 3 3α-hydroxysteroid dehydrogenase (HSD).  However, brain enzymes catalyzing the conversion of such tetrahydrosteroids back to the corresponding 5α-dihydrosteroids remain to be identified.  Characterization of human type 10 17β-HSD provides a new insight into its importance for the oxidn. of steroid modulators of GABAA receptors.  The apparent catalytic efficiency (kcat/Km) of this enzyme for the oxidn. of allopregnanolone and 3α,5α-THDOC are 432 and 1381 min-1 mM-1, resp.  This enzyme has negligible 3-ketosteroid reductase activity for 5α-DHP and 5α-DHDOC even in an acidic environment.  Immunoreactivity against 17β-HSD10 was found in a no. of neuronal populations.  Taken together, evidence suggests that 17β-HSD10 is the brain enzyme capable of catalyzing the oxidn. of steroid modulators of GABAA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr34wTAurbU37Vg90H21EOLACvtfcHk0lgHWa83KMcsTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVyqs7jL&md5=642e0e5be34b3853e8210b649622d895</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2004.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2004.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%2BY.%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%2BZ.%26aulast%3DPullarkat%26aufirst%3DR.%26aulast%3DSchulz%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DType%252010%252017beta-hydroxysteroid%2520dehydrogenase%2520catalyzing%2520the%2520oxidation%2520of%2520steroid%2520modulators%2520of%2520%25CE%25B3-aminobutyric%2520acid%2520type%2520A%2520receptors%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2005%26volume%3D229%26spage%3D111%26epage%3D117%26doi%3D10.1016%2Fj.mce.2004.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1040</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2005.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.brainres.2005.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15804423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1aitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1040&publication_year=2005&pages=29-35&author=X.+Y.+Heauthor=J.+Wegielauthor=S.+Y.+Yang&title=Intracellular+oxidation+of+allopregnanolone+by+human+brain+type+10+17beta-hydroxysteroid+dehydrogenase&doi=10.1016%2Fj.brainres.2005.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase</span></div><div class="casAuthors">He, Xue-Ying; Wegiel, Jerzy; Yang, Song-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1040</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">29-35</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Allopregnanolone is a pos. allosteric modulator of GABAA receptors, generated by the redn. of 5α-dihydroprogesterone (5α-DHP) in astrocytes.  This neuroactive steroid can be inactivated by its 3α-oxidn. to yield 5α-DHP.  It was found that 5α-DHP levels in HEK293 cells expressing type 10 17β-hydroxysteroid dehydrogenase (17β-HSD10), but not its catalytic inactive mutant, increased significantly as allopregnanolone was added to culture media.  The results demonstrate that mitochondrial 17β-HSD10 effectively catalyzes the intracellular oxidn. of allopregnanolone.  Moreover, brain astrocytes contain a moderate level of 17β-HSD10, which is elevated in activated astrocytes of brains with Alzheimer type pathol., including sporadic Alzheimer's disease (AD) and Down's syndrome with AD.  The distribution of 17β-HSD10 was found not to parallel that of 3α-HSD3.  Cerebral cortex has the lowest level of 17β-HSD10; whereas the hippocampus, hypothalamus, and amygdala possess relatively higher levels of this enzyme.  The catalysis of 17β-HSD10 appears to be essential for maintaining normal functions of GABAergic neurons.  The elevated level of 17β-HSD10 in activated astrocytes is a new feature found in brains of people with AD, and it may have important impact on AD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxMsnii75I3LVg90H21EOLACvtfcHk0lj83SGKjTR7pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1aitLc%253D&md5=b5fff69396d74c0ef6f45ee1e31fcf29</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2005.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2005.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.%2BY.%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DIntracellular%2520oxidation%2520of%2520allopregnanolone%2520by%2520human%2520brain%2520type%252010%252017beta-hydroxysteroid%2520dehydrogenase%26jtitle%3DBrain%2520Res.%26date%3D2005%26volume%3D1040%26spage%3D29%26epage%3D35%26doi%3D10.1016%2Fj.brainres.2005.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majewska, M. D.</span></span> <span> </span><span class="NLM_article-title">Neurosteroids: endogenous bimodal modulators of the GAB<sub>AA</sub> receptor. Mechanism of action and physiological significance</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1016/0301-0082(92)90025-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2F0301-0082%2892%2990025-A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1349441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK38XisVymsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1992&pages=379-395&author=M.+D.+Majewska&title=Neurosteroids%3A+endogenous+bimodal+modulators+of+the+GABAA+receptor.+Mechanism+of+action+and+physiological+significance&doi=10.1016%2F0301-0082%2892%2990025-A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Neurosteroids:  endogenous bimodal modulators of the GABAA receptor.  Mechanism of action and physiological significance</span></div><div class="casAuthors">Majewska, Maria Dorota</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-95</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    </div><div class="casAbstract">A review, with 118 refs., on neurosteroids, their formation and catabolism, and their modulatory effects on GABAergicA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOK0hISaV6UbVg90H21EOLACvtfcHk0lj83SGKjTR7pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XisVymsLw%253D&md5=a8dae7d53bc51af4733f7731793a2e23</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2F0301-0082%2892%2990025-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0301-0082%252892%252990025-A%26sid%3Dliteratum%253Aachs%26aulast%3DMajewska%26aufirst%3DM.%2BD.%26atitle%3DNeurosteroids%253A%2520endogenous%2520bimodal%2520modulators%2520of%2520the%2520GABAA%2520receptor.%2520Mechanism%2520of%2520action%2520and%2520physiological%2520significance%26jtitle%3DProg.%2520Neurobiol.%26date%3D1992%26volume%3D38%26spage%3D379%26epage%3D395%26doi%3D10.1016%2F0301-0082%2892%2990025-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tieu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vila, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspersen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teismann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson-Lewis, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przedborski, S.</span></span> <span> </span><span class="NLM_article-title"><sub>L</sub>-3-hydroxyacyl-CoA dehydrogenase II protects in a model of parkinson’s disease</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1002/ana.20133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1002%2Fana.20133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15236401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVSnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=51-60&author=K.+Tieuauthor=C.+Perierauthor=M.+Vilaauthor=C.+Caspersenauthor=H.+P.+Zhangauthor=P.+Teismannauthor=V.+Jackson-Lewisauthor=D.+M.+Sternauthor=S.+D.+Yanauthor=S.+Przedborski&title=L-3-hydroxyacyl-CoA+dehydrogenase+II+protects+in+a+model+of+parkinson%E2%80%99s+disease&doi=10.1002%2Fana.20133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">L-3-Hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease</span></div><div class="casAuthors">Tieu, Kim; Perier, Celine; Vila, Miquel; Caspersen, Casper; Zhang, Hui-Ping; Teismann, Peter; Jackson-Lewis, Vernice; Stern, David M.; Yan, Shi Du; Przedborski, Serge</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-60</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) impairs mitochondrial respiration and damages dopaminergic neurons as seen in Parkinson's disease (PD).  Here, the authors report that L-3-hydroxyacyl-CoA dehydrogenase type II/amyloid binding alc. dehydrogenase (HADH II/ABAD), a mitochondrial oxidoreductase enzyme involved in neuronal survival, is downregulated in PD patients and in MPTP-intoxicated mice.  The authors also show that transgenic mice with increased expression of human HADH II/ABAD are significantly more resistant to MPTP than their wild-type littermates.  This effect appears to be mediated by overexpression of HADH II/ABAD mitigating MPTP-induced impairment of oxidative phosphorylation and ATP prodn.  This study demonstrates that HADH II/ABAD modulates MPTP neurotoxicity and suggests that HADH II/ABAD mimetics may provide protective benefit in the treatment of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdiFF1YC82NLVg90H21EOLACvtfcHk0lj83SGKjTR7pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVSnsrY%253D&md5=475e43f621f1cf64dfb66e95e5261d06</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fana.20133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20133%26sid%3Dliteratum%253Aachs%26aulast%3DTieu%26aufirst%3DK.%26aulast%3DPerier%26aufirst%3DC.%26aulast%3DVila%26aufirst%3DM.%26aulast%3DCaspersen%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%2BP.%26aulast%3DTeismann%26aufirst%3DP.%26aulast%3DJackson-Lewis%26aufirst%3DV.%26aulast%3DStern%26aufirst%3DD.%2BM.%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DPrzedborski%26aufirst%3DS.%26atitle%3DL-3-hydroxyacyl-CoA%2520dehydrogenase%2520II%2520protects%2520in%2520a%2520model%2520of%2520parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2004%26volume%3D56%26spage%3D51%26epage%3D60%26doi%3D10.1002%2Fana.20133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frosch, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, E. S.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McTaggert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinsky, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramasamy, R.</span></span> <span> </span><span class="NLM_article-title">Amyloid beta-peptide binding alcohol dehydrogenase is a component of the cellular response to nutritional stress</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">27100</span>– <span class="NLM_lpage">27109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=27100-27109&author=S.+D.+Yanauthor=Y.+Zhuauthor=E.+D.+Sternauthor=Y.+C.+Hwangauthor=O.+Horiauthor=S.+Ogawaauthor=M.+P.+Froschauthor=E.+S.+Connollyauthor=R.+McTaggertauthor=D.+J.+Pinskyauthor=S.+G.+Clarkeauthor=D.+M.+Sternauthor=R.+Ramasamy&title=Amyloid+beta-peptide+binding+alcohol+dehydrogenase+is+a+component+of+the+cellular+response+to+nutritional+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DStern%26aufirst%3DE.%2BD.%26aulast%3DHwang%26aufirst%3DY.%2BC.%26aulast%3DHori%26aufirst%3DO.%26aulast%3DOgawa%26aufirst%3DS.%26aulast%3DFrosch%26aufirst%3DM.%2BP.%26aulast%3DConnolly%26aufirst%3DE.%2BS.%26aulast%3DMcTaggert%26aufirst%3DR.%26aulast%3DPinsky%26aufirst%3DD.%2BJ.%26aulast%3DClarke%26aufirst%3DS.%2BG.%26aulast%3DStern%26aufirst%3DD.%2BM.%26aulast%3DRamasamy%26aufirst%3DR.%26atitle%3DAmyloid%2520beta-peptide%2520binding%2520alcohol%2520dehydrogenase%2520is%2520a%2520component%2520of%2520the%2520cellular%2520response%2520to%2520nutritional%2520stress%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D27100%26epage%3D27109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Estrogen, β-amyloid metabolism/trafficking, and Alzheimer’s disease</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1089</i></span>,  <span class="NLM_fpage">324</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1196/annals.1386.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1196%2Fannals.1386.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1089&publication_year=2006&pages=324-342&author=H.+Xuauthor=R.+Wangauthor=Y.+W.+Zhangauthor=X.+Zhang&title=Estrogen%2C+%CE%B2-amyloid+metabolism%2Ftrafficking%2C+and+Alzheimer%E2%80%99s+disease&doi=10.1196%2Fannals.1386.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1196%2Fannals.1386.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1386.036%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%2BW.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DEstrogen%252C%2520%25CE%25B2-amyloid%2520metabolism%252Ftrafficking%252C%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2006%26volume%3D1089%26spage%3D324%26epage%3D342%26doi%3D10.1196%2Fannals.1386.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mensah-Nyagan, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, A.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease, oestrogen and mitochondria: an ambiguous relationship</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1007/s12035-012-8281-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1007%2Fs12035-012-8281-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=22678467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGmsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=151-160&author=A.+Grimmauthor=Y.+A.+Limauthor=A.+G.+Mensah-Nyaganauthor=J.+Gotzauthor=A.+Eckert&title=Alzheimer%E2%80%99s+disease%2C+oestrogen+and+mitochondria%3A+an+ambiguous+relationship&doi=10.1007%2Fs12035-012-8281-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's Disease, Oestrogen and Mitochondria: an Ambiguous Relationship</span></div><div class="casAuthors">Grimm, Amandine; Lim, Yun-An; Mensah-Nyagan, Ayikoe Guy; Goetz, Juergen; Eckert, Anne</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">151-160</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Hormonal deficit in post-menopausal women has been proposed to be one risk factor in Alzheimer's disease (AD) since two thirds of AD patients are women.  However, large treatment trials showed neg. effects of long-term treatment with estrogens in older women.  Thus, estrogen treatment after menopause is still under debate, and several hypotheses trying to explain the failure in outcome are under discussion.  Concurrently, it was shown that amyloid-beta (Aβ) peptide, the main constituent of senile plaques, as well as abnormally hyperphosphorylated tau protein, the main component of neurofibrillary tangles, can modulate the level of neurosteroids which notably represent neuroactive steroids synthesized within the nervous system, independently of peripheral endocrine glands.  In this review, we summarize the role of neurosteroids esp. that of estrogen in AD and discuss their potentially neuroprotective effects with specific regard to the role of estrogens on the maintenance and function of mitochondria, important organelles which are highly vulnerable to Aβ- and tau-induced toxicity.  We also discuss the role of Aβ-binding alc. dehydrogenase (ABAD), a mitochondrial enzyme able to bind Aβ peptide thereby modifying mitochondrial function as well as oestradiol levels suggesting possible modes of interaction between the three, and the potential therapeutic implication of inhibiting Aβ-ABAD interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGBhLwGqzGQrVg90H21EOLACvtfcHk0lgAVu3F0KuExA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGmsb7O&md5=87ccafc3c1043727516f54ddb7e7e2ce</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs12035-012-8281-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-012-8281-x%26sid%3Dliteratum%253Aachs%26aulast%3DGrimm%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DY.%2BA.%26aulast%3DMensah-Nyagan%26aufirst%3DA.%2BG.%26aulast%3DGotz%26aufirst%3DJ.%26aulast%3DEckert%26aufirst%3DA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%252C%2520oestrogen%2520and%2520mitochondria%253A%2520an%2520ambiguous%2520relationship%26jtitle%3DMol.%2520Neurobiol.%26date%3D2012%26volume%3D46%26spage%3D151%26epage%3D160%26doi%3D10.1007%2Fs12035-012-8281-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amtul, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westaway, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozmahel, R. F.</span></span> <span> </span><span class="NLM_article-title">Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer’s disease</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">781</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2010.05.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.neuroscience.2010.05.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=20493928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ymtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2010&pages=781-786&author=Z.+Amtulauthor=L.+Wangauthor=D.+Westawayauthor=R.+F.+Rozmahel&title=Neuroprotective+mechanism+conferred+by+17beta-estradiol+on+the+biochemical+basis+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neuroscience.2010.05.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease</span></div><div class="casAuthors">Amtul, Z.; Wang, L.; Westaway, D.; Rozmahel, R. F.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">781-786</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Estrogen (17β-estradiol) plays key regulatory roles in a variety of physiol. and biol. processes.  Several lines of evidence also support its role as a protective factor in Alzheimer's disease; however, the basis of this effect is unclear.  Here we show that an early-onset Alzheimer's disease transgenic mouse model expressing the double-mutant form of human amyloid precursor protein (APP); Swedish (K670N/M671L) and Indiana (V717F) undergoing treatment with 17β-estradiol show significantly lower levels of APP processing through beta-secretase and enhanced alpha-secretase processing resulting in marked redns. of APP-CTFbeta, Abeta42 and plaque burden, along with increased levels of the non-amyloidogenic sAPPalpha.  Moreover, 17β-estradiol resulted in elevated brain levels of transthyretin, which inhibits aggregation of Abeta into plaques; though the insulin-degrading enzyme, which breaks down Abeta, was significantly reduced.  These results illustrate a multifaceted effect of 17β-estradiol on the biochem. basis of Alzheimer's disease, through effects on APP processing, Abeta levels and factors that affect its clearance and aggregation.  Overall, these results support the need for further long-term longitudinal studies to elucidate consequences of menopause as well as hormone therapy on Alzheimer's disease, and explore its potential as a therapeutic avenue for the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSgvUbp_acjrVg90H21EOLACvtfcHk0lgAVu3F0KuExA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ymtLk%253D&md5=a14e582b0c2014e190e7b25d3c597594</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2010.05.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2010.05.031%26sid%3Dliteratum%253Aachs%26aulast%3DAmtul%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWestaway%26aufirst%3DD.%26aulast%3DRozmahel%26aufirst%3DR.%2BF.%26atitle%3DNeuroprotective%2520mechanism%2520conferred%2520by%252017beta-estradiol%2520on%2520the%2520biochemical%2520basis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuroscience%26date%3D2010%26volume%3D169%26spage%3D781%26epage%3D786%26doi%3D10.1016%2Fj.neuroscience.2010.05.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-de-la-Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Segura, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naftolin, F.</span></span> <span> </span><span class="NLM_article-title">Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer’s disease</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1052</i></span>,  <span class="NLM_fpage">210</span>– <span class="NLM_lpage">224</span>, <span class="refDoi"> DOI: 10.1196/annals.1347.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1196%2Fannals.1347.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=16024764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFaktbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1052&publication_year=2005&pages=210-224&author=M.+Alvarez-de-la-Rosaauthor=I.+Silvaauthor=J.+Nilsenauthor=M.+M.+Perezauthor=L.+M.+Garcia-Seguraauthor=J.+Avilaauthor=F.+Naftolin&title=Estradiol+prevents+neural+tau+hyperphosphorylation+characteristic+of+Alzheimer%E2%80%99s+disease&doi=10.1196%2Fannals.1347.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease</span></div><div class="casAuthors">Alvarez-de-la-Rosa, Margarita; Silva, Ivaldo; Nilsen, Jon; Perez, M. M.; Garcia-Segura, Luis Miguel; Avila, Jesus; Naftolin, Frederick</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1052</span>
        (<span class="NLM_cas:issue">Future of Hormone Therapy</span>),
    <span class="NLM_cas:pages">210-224</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is three times more prevalent in women than men, and epidemiol. studies have shown that estrogen replacement in aging women forestalls the onset of AD.  Hyperphosphorylation of the tau protein that forms the neurofibrillary tangles found in AD brains might be responsible for the breakdown of microtubules in affected neurons.  The mechanisms by which tau protein is phosphorylated in the AD brain are not fully understood.  Using a human neuroblastoma cell line (SH-SY5Y) and primary cultures of newborn male or female rat cerebral cortical neurons, we investigated the effect of 17β-estradiol on tau protein expression and phosphorylation.  We found that estradiol increased total tau and induced dephosphorylation at the proline-directed site of the-mol.  Further, estradiol prevented okadaic acid-induced hyperphosphorylation of tau in both proline- and non-proline-directed sites, and antiestrogens blocked this effect.  To our knowledge, this is the first report of an effect of estradiol on naturally occurring and induced tau phosphorylation.  This assumes special significance because the estrogen action was found to be sexually dimorphic in rat cortical neurons and differentiation-sensitive in human neuroblastoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3F6O-Hs1NQrVg90H21EOLACvtfcHk0lgAVu3F0KuExA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFaktbrJ&md5=1b1d83f77fad8c9a846361b3d745f5b2</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1196%2Fannals.1347.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1347.016%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez-de-la-Rosa%26aufirst%3DM.%26aulast%3DSilva%26aufirst%3DI.%26aulast%3DNilsen%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DM.%2BM.%26aulast%3DGarcia-Segura%26aufirst%3DL.%2BM.%26aulast%3DAvila%26aufirst%3DJ.%26aulast%3DNaftolin%26aufirst%3DF.%26atitle%3DEstradiol%2520prevents%2520neural%2520tau%2520hyperphosphorylation%2520characteristic%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2005%26volume%3D1052%26spage%3D210%26epage%3D224%26doi%3D10.1196%2Fannals.1347.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodenough, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleusner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrzik, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skutella, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behl, C.</span></span> <span> </span><span class="NLM_article-title">Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2004.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.neuroscience.2004.12.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15837120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlWrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2005&pages=581-589&author=S.+Goodenoughauthor=D.+Schleusnerauthor=C.+Pietrzikauthor=T.+Skutellaauthor=C.+Behl&title=Glycogen+synthase+kinase+3%CE%B2+links+neuroprotection+by+17%CE%B2-estradiol+to+key+Alzheimer+processes&doi=10.1016%2Fj.neuroscience.2004.12.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes</span></div><div class="casAuthors">Goodenough, S.; Schleusner, D.; Pietrzik, C.; Skutella, T.; Behl, C.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">581-589</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Estrogen exerts many of its receptor-mediated neuroprotective functions through the activation of various intracellular signal transduction pathways including the mitogen activating protein kinase (MAPK), phospho inositol-3 kinase and protein kinase C pathways.  Here we have used a hippocampal slice culture model of kainic acid-induced neurotoxic cell death to show that estrogen can protect against oxidative cell death.  We have previously shown that MAPK and glycogen synthase kinase-3β (GSK-3β) are involved in the cell death/cell survival induced by kainic acid.  In this model and other cellular and in vivo models we have shown that estrogen can also cause the phosphorylation and hence inactivation of GSK-3β, a known mediator of neuronal cell death.  The effect of estrogen on GSK-3β activity is estrogen receptor mediated.  Further, this estrogen/GSK-3β interaction may have functional consequences in cellular models of some key pathogenic pathways assocd. with Alzheimer's disease.  More specifically, estrogen affects the basal levels of tau phosphorylation at a site known to be phosphorylated by GSK-3β.  Taken together, these data indicate a novel mol. and functional link between estrogen and GSK-3β and may have implications for estrogen receptor modulation as a target for the prevention of neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGAu9tPhbiwLVg90H21EOLACvtfcHk0lgAk1S6ulweWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlWrtbY%253D&md5=952e48c75c7a96661cbb40ada6240e68</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2004.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2004.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DGoodenough%26aufirst%3DS.%26aulast%3DSchleusner%26aufirst%3DD.%26aulast%3DPietrzik%26aufirst%3DC.%26aulast%3DSkutella%26aufirst%3DT.%26aulast%3DBehl%26aufirst%3DC.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%25CE%25B2%2520links%2520neuroprotection%2520by%252017%25CE%25B2-estradiol%2520to%2520key%2520Alzheimer%2520processes%26jtitle%3DNeuroscience%26date%3D2005%26volume%3D132%26spage%3D581%26epage%3D589%26doi%3D10.1016%2Fj.neuroscience.2004.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pike, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosario, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barron, A. M.</span></span> <span> </span><span class="NLM_article-title">Protective actions of sex steroid hormones in Alzheimer’s disease</span>. <i>Front. Neuroendocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1016/j.yfrne.2009.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.yfrne.2009.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=19427328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsV2rsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=239-258&author=C.+J.+Pikeauthor=J.+C.+Carrollauthor=E.+R.+Rosarioauthor=A.+M.+Barron&title=Protective+actions+of+sex+steroid+hormones+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.yfrne.2009.04.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Protective actions of sex steroid hormones in Alzheimer's disease</span></div><div class="casAuthors">Pike, Christian J.; Carroll, Jenna C.; Rosario, Emily R.; Barron, Anna M.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Neuroendocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-258</span>CODEN:
                <span class="NLM_cas:coden">FNEDA7</span>;
        ISSN:<span class="NLM_cas:issn">0091-3022</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Risk for Alzheimer's disease (AD) is assocd. with age-related loss of sex steroid hormones in both women and men.  In post-menopausal women, the precipitous depletion of estrogens and progestogens is hypothesized to increase susceptibility to AD pathogenesis, a concept largely supported by epidemiol. evidence but refuted by some clin. findings.  Exptl. evidence suggests that estrogens have numerous neuroprotective actions relevant to prevention of AD, in particular promotion of neuron viability and redn. of β-amyloid accumulation, a crit. factor in the initiation and progression of AD.  Recent findings suggest neural responsiveness to estrogen can diminish with age, reducing neuroprotective actions of estrogen and, consequently, potentially limiting the utility of hormone therapies in aged women.  In addn., estrogen neuroprotective actions are also modulated by progestogens.  Specifically, continuous progestogen exposure is assocd. with inhibition of estrogen actions whereas cyclic delivery of progestogens may enhance neural benefits of estrogen.  In recent years, emerging literature has begun to elucidate a parallel relationship of sex steroid hormones and AD risk in men.  Normal age-related testosterone loss in men is assocd. with increased risk to several diseases including AD.  Like estrogen, testosterone has been established as an endogenous neuroprotective factor that not only increases neuronal resilience against AD-related insults, but also reduces β-amyloid accumulation.  Androgen neuroprotective effects are mediated both directly by activation of androgen pathways and indirectly by aromatization to estradiol and initiation of protective estrogen signaling mechanisms.  The successful use of hormone therapies in aging men and women to delay, prevent, and or treat AD will require addnl. research to optimize key parameters of hormone therapy and may benefit from the continuing development of selective estrogen and androgen receptor modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbdS4omTYJC7Vg90H21EOLACvtfcHk0lgAk1S6ulweWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsV2rsbw%253D&md5=72830b36e50e6132298ed4e8c9954125</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.yfrne.2009.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yfrne.2009.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DC.%2BJ.%26aulast%3DCarroll%26aufirst%3DJ.%2BC.%26aulast%3DRosario%26aufirst%3DE.%2BR.%26aulast%3DBarron%26aufirst%3DA.%2BM.%26atitle%3DProtective%2520actions%2520of%2520sex%2520steroid%2520hormones%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Neuroendocrinol.%26date%3D2009%26volume%3D30%26spage%3D239%26epage%3D258%26doi%3D10.1016%2Fj.yfrne.2009.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorke, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petroianu, G. A.</span></span> <span> </span><span class="NLM_article-title">Methylene blue and Alzheimer’s disease</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">927</span>– <span class="NLM_lpage">932</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2009.04.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.bcp.2009.04.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=19433072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFSns77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=927-932&author=M.+Ozauthor=D.+E.+Lorkeauthor=G.+A.+Petroianu&title=Methylene+blue+and+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bcp.2009.04.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Methylene blue and Alzheimer's disease</span></div><div class="casAuthors">Oz, Murat; Lorke, Dietrich E.; Petroianu, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">927-932</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The relationship between methylene blue (MB) and Alzheimer's disease (AD) has recently attracted increasing scientific attention since it has been suggested that MB may slow down the progression of this disease.  In fact, MB, in addn. to its well characterized inhibitory actions on the cGMP pathway, affects numerous cellular and mol. events closely related to the progression of AD.  Currently, MB has been shown to attenuate the formations of amyloid plaques and neurofibrillary tangles, and to partially repair impairments in mitochondrial function and cellular metab.  Furthermore, various neurotransmitter systems (cholinergic, serotonergic and glutamatergic), believed to play important roles in the pathogenesis of AD and other cognitive disorders, are also influenced by MB.  Recent studies suggest that the combination of diverse actions of MB on these cellular functions is likely to mediate potential beneficial effects of MB.  This has lead to attempts to develop novel MB-based treatment modalities for AD.  In this review article, actions of MB on neurotransmitter systems and multiple cellular and mol. targets are summarized with regard to their relevance to AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohIvSWd8UnA7Vg90H21EOLACvtfcHk0lgAk1S6ulweWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFSns77L&md5=f73feddb5c859463d4cd75b16c7d1a02</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DOz%26aufirst%3DM.%26aulast%3DLorke%26aufirst%3DD.%2BE.%26aulast%3DPetroianu%26aufirst%3DG.%2BA.%26atitle%3DMethylene%2520blue%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D78%26spage%3D927%26epage%3D932%26doi%3D10.1016%2Fj.bcp.2009.04.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wischik, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staff, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wischik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kook, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, C. R.</span></span> <span> </span><span class="NLM_article-title">Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">720</span>, <span class="refDoi"> DOI: 10.3233/JAD-142874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-142874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=25550228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslensbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=705-720&author=C.+M.+Wischikauthor=R.+T.+Staffauthor=D.+J.+Wischikauthor=P.+Benthamauthor=A.+D.+Murrayauthor=J.+M.+Storeyauthor=K.+A.+Kookauthor=C.+R.+Harrington&title=Tau+aggregation+inhibitor+therapy%3A+an+exploratory+phase+2+study+in+mild+or+moderate+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-142874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Tau Aggregation Inhibitor Therapy: An Exploratory Phase 2 Study in Mild or Moderate Alzheimer's Disease</span></div><div class="casAuthors">Wischik, Claude M.; Staff, Roger T.; Wischik, Damon J.; Bentham, Peter; Murray, Alison D.; Storey, John M. D.; Kook, Karin A.; Harrington, Charles R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">705-720</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Background: As tau aggregation pathol. correlates with clin. dementia in Alzheimer's disease (AD), a tau aggregation inhibitor (TAI) could have therapeutic utility.  Methylthioninium (MT) acts as a selective TAI in vitro and reduces tau pathol. in transgenic mouse models.  Objective: To det. the min. safe and ED of MT required to prevent disease progression on clin. and functional mol. imaging outcomes.  Methods: An exploratory double-blind, randomized, placebo-controlled, dose-finding trial of MT (69, 138, and 228 mg/day) was conducted in 321 mild/moderate AD subjects.  The primary outcome was change on the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) at 24 wk relative to baseline severity.  Effect of treatment on regional cerebral blood flow decline was detd. in a sub-study in 135 subjects.  After 24 wk, subjects were re-consented to enter sequential 6- and 12-mo blinded extension phases.  Registered with ClinicalTrials.gov (NCT00515333).  Results: At 24 wk, there were significant treatment benefits in two independent populations at the 138 mg/day dose: in moderate subjects on the ADAS-cog scale (treatment effect: -5.42 units, cor. p = 0.047) and two other clin. scales; in mild subjects on the more sensitive regional cerebral blood flow measure (treatment effect: 1.97%, cor. p < 0.001).  With continued treatment for 50 wk, benefit was seen on the ADAS-cog scale in both mild and moderate subjects.  The delivery of the highest dose was impaired due to dose-dependent dissoln. and absorption limitations.  Conclusion: The min. safe and effective daily MT dose is 138 mg and suggests that further study of MT is warranted in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ3bEMLyUxIrVg90H21EOLACvtfcHk0ljcHPhUNT1VPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslensbw%253D&md5=d478518b72d5a82ed3685a6312f2d51c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.3233%2FJAD-142874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-142874%26sid%3Dliteratum%253Aachs%26aulast%3DWischik%26aufirst%3DC.%2BM.%26aulast%3DStaff%26aufirst%3DR.%2BT.%26aulast%3DWischik%26aufirst%3DD.%2BJ.%26aulast%3DBentham%26aufirst%3DP.%26aulast%3DMurray%26aufirst%3DA.%2BD.%26aulast%3DStorey%26aufirst%3DJ.%2BM.%26aulast%3DKook%26aufirst%3DK.%2BA.%26aulast%3DHarrington%26aufirst%3DC.%2BR.%26atitle%3DTau%2520aggregation%2520inhibitor%2520therapy%253A%2520an%2520exploratory%2520phase%25202%2520study%2520in%2520mild%2520or%2520moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2015%26volume%3D44%26spage%3D705%26epage%3D720%26doi%3D10.3233%2FJAD-142874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zakaria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamdi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Kader, R. M.</span></span> <span> </span><span class="NLM_article-title">Methylene blue improves brain mitochondrial ABAD functions and decreases Aβ in a neuroinflammatory Alzheimer’s disease mouse model</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">1220</span>– <span class="NLM_lpage">1228</span>, <span class="refDoi"> DOI: 10.1007/s12035-014-9088-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1007%2Fs12035-014-9088-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=25601181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2016&pages=1220-1228&author=A.+Zakariaauthor=N.+Hamdiauthor=R.+M.+Abdel-Kader&title=Methylene+blue+improves+brain+mitochondrial+ABAD+functions+and+decreases+A%CE%B2+in+a+neuroinflammatory+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1007%2Fs12035-014-9088-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model</span></div><div class="casAuthors">Zakaria, Aya; Hamdi, Nabila; Abdel-Kader, Reham Mahmoud</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1220-1228</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Methylene blue (MB) phase II clin. trials reported improvements in cognitive functions of Alzheimer's disease (AD) patients.  Regarding MB mechanism of action, its antioxidant and mitochondrial protective effects have been previously described.  In relation to AD, it has been recently reported that MB reduced amyloid beta (Aβ) levels in AD models.  The mitochondrial enzyme amyloid-binding alc. dehydrogenase (ABAD) has been shown to bind Aβ inducing mitochondrial dysfunction, providing a direct relation between Aβ toxicity and mitochondrial dysfunction occurring in AD.  Since it has been reported that inhibiting ABAD protects mitochondrial functions and prevents Aβ-induced toxicity, the aim of the current study was to investigate if the protective effects of MB could be assocd. with an effect on ABAD levels and functions.  The current study shows that MB is able to enhance cell viability, reduce both reactive oxygen species levels and importantly Aβ oligomers in a lipopolysaccharide (LPS) mouse model.  Interestingly, ABAD levels were increased in the brains of the LPS mouse model and MB treatment was able to reduce its levels.  Given that regulation of the estradiol level is a well-established function of ABAD, brain estradiol level was compared in LPS mouse model and in MB-treated mice.  The results of the current study show that MB treatment is able to improve significantly the LPS-induced decrease of estradiol levels in mice brains, indicating its ability to modulate both levels and function of ABAD.  These results give a new insight to possible mechanisms of MB in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocECBFrT6UEbVg90H21EOLACvtfcHk0ljcHPhUNT1VPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOltb8%253D&md5=ab8ea34e98ac5878eba619a5e77bae5d</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1007%2Fs12035-014-9088-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-014-9088-8%26sid%3Dliteratum%253Aachs%26aulast%3DZakaria%26aufirst%3DA.%26aulast%3DHamdi%26aufirst%3DN.%26aulast%3DAbdel-Kader%26aufirst%3DR.%2BM.%26atitle%3DMethylene%2520blue%2520improves%2520brain%2520mitochondrial%2520ABAD%2520functions%2520and%2520decreases%2520A%25CE%25B2%2520in%2520a%2520neuroinflammatory%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DMol.%2520Neurobiol.%26date%3D2016%26volume%3D53%26spage%3D1220%26epage%3D1228%26doi%3D10.1007%2Fs12035-014-9088-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, D. W.</span></span> <span> </span><span class="NLM_article-title">Identification of small-molecule inhibitors of the Aβ-ABAD interaction</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">4657</span>– <span class="NLM_lpage">4660</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.05.099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.bmcl.2006.05.099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=16781151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFOlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4657-4660&author=Y.+Xieauthor=S.+Dengauthor=Z.+Chenauthor=S.+Yanauthor=D.+W.+Landry&title=Identification+of+small-molecule+inhibitors+of+the+A%CE%B2-ABAD+interaction&doi=10.1016%2Fj.bmcl.2006.05.099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of small-molecule inhibitors of the Aβ-ABAD interaction</span></div><div class="casAuthors">Xie, Yuli; Deng, Shixian; Chen, Zhenzhang; Yan, Shidu; Landry, Donald W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4657-4660</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The interaction of amyloid beta peptide (Aβ) and Aβ-binding alc. dehydrogenase (ABAD) was recently implicated in the pathogenesis of Alzheimer's disease (AD).  Using an ELISA-based screening assay, the authors identified frentizole, an FDA-approved immunosuppressive drug, as a novel inhibitor of the Aβ-ABAD interaction.  Anal. of the frentizole structure-activity relationship led to identification of a novel benzothiazole urea (I) with a 30-fold improvement in potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjbbBYe22v7bVg90H21EOLACvtfcHk0ljcHPhUNT1VPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFOlurY%253D&md5=edef30ddfd57348ffbe3d49fbca6400d</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.05.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.05.099%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26atitle%3DIdentification%2520of%2520small-molecule%2520inhibitors%2520of%2520the%2520A%25CE%25B2-ABAD%2520interaction%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4657%26epage%3D4660%26doi%3D10.1016%2Fj.bmcl.2006.05.099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfort, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lustbader, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">Surface plasmon resonance and nuclear magnetic resonance studies of ABAD–Aβ interaction</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1724</span>– <span class="NLM_lpage">1731</span>, <span class="refDoi"> DOI: 10.1021/bi061314n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi061314n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1Wqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=1724-1731&author=Y.+Yanauthor=Y.+Liuauthor=M.+Sorciauthor=G.+Belfortauthor=J.+W.+Lustbaderauthor=S.+S.+Yanauthor=C.+Wang&title=Surface+plasmon+resonance+and+nuclear+magnetic+resonance+studies+of+ABAD%E2%80%93A%CE%B2+interaction&doi=10.1021%2Fbi061314n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Surface Plasmon Resonance and Nuclear Magnetic Resonance Studies of ABAD-Aβ Interaction</span></div><div class="casAuthors">Yan, Yilin; Liu, Yangzhong; Sorci, Mirco; Belfort, Georges; Lustbader, Joyce W.; Yan, Shirley ShiDu; Wang, Chunyu</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1724-1731</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aβ binding alc. dehydrogenase (ABAD) is an NAD-dependent mitochondrial dehydrogenase.  The binding between ABAD and Aβ is likely a direct link between Aβ and mitochondrial toxicity in Alzheimer's disease.  In this study, surface plasmon resonance (SPR) was employed to det. the temp. dependence of the affinity of the ABAD-Aβ interaction.  A van't Hoff anal. revealed that the ABAD-Aβ assocn. is driven by a favorable entropic change (ΔS = 300 ± 30 J mol-1 K-1) which overcomes an unfavorable enthalpy change (ΔH = 49 ± 7 kJ/mol).  Therefore, hydrophobic interactions and changes in protein dynamics are the dominant driving forces of the ABAD-Aβ interaction.  This is the first dissection of the entropic and enthalpic contribution to the energetics of a protein-protein interaction involving Aβ.  SPR confirmed the conformational changes in the ABAD-Aβ complex after Aβ binding, consistent with differences seen in the crystal structures of free ABAD and the ABAD-Aβ complex.  Satn. transfer difference (STD) NMR expts. directly and unambiguously demonstrated the inhibitory effect of Aβ on the ABAD-NAD interaction.  Conversely, NAD inhibits the Aβ-ABAD interaction.  Binding of Aβ and binding of NAD to ABAD are likely mutually exclusive.  Thus, Aβ binding induces conformational and subsequently functional changes in ABAD, which may have a role in the mechanism of Aβ toxicity in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSbTtXw94QS7Vg90H21EOLACvtfcHk0lh7O7dHn36YQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1Wqsg%253D%253D&md5=94a2f50f08320939b83af9a2019a6dc5</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fbi061314n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi061314n%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSorci%26aufirst%3DM.%26aulast%3DBelfort%26aufirst%3DG.%26aulast%3DLustbader%26aufirst%3DJ.%2BW.%26aulast%3DYan%26aufirst%3DS.%2BS.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DSurface%2520plasmon%2520resonance%2520and%2520nuclear%2520magnetic%2520resonance%2520studies%2520of%2520ABAD%25E2%2580%2593A%25CE%25B2%2520interaction%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D1724%26epage%3D1731%26doi%3D10.1021%2Fbi061314n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marques, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, M. J.</span></span> <span> </span><span class="NLM_article-title">Molecular dynamics simulations of the amyloid-beta binding alcohol dehydrogenase (ABAD) enzyme</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">9511</span>– <span class="NLM_lpage">9518</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.09.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.bmc.2008.09.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=9511-9518&author=A.+T.+Marquesauthor=P.+A.+Fernandesauthor=M.+J.+Ramos&title=Molecular+dynamics+simulations+of+the+amyloid-beta+binding+alcohol+dehydrogenase+%28ABAD%29+enzyme&doi=10.1016%2Fj.bmc.2008.09.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.09.043%26sid%3Dliteratum%253Aachs%26aulast%3DMarques%26aufirst%3DA.%2BT.%26aulast%3DFernandes%26aufirst%3DP.%2BA.%26aulast%3DRamos%26aufirst%3DM.%2BJ.%26atitle%3DMolecular%2520dynamics%2520simulations%2520of%2520the%2520amyloid-beta%2520binding%2520alcohol%2520dehydrogenase%2520%2528ABAD%2529%2520enzyme%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D9511%26epage%3D9518%26doi%3D10.1016%2Fj.bmc.2008.09.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. Y.</span></span> <span> </span><span class="NLM_article-title">Human brain short chain <sub>L</sub>-3-hydroxyacyl coenzyme a dehydrogenase is a single-domain multifunctional enzyme</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">15014</span>– <span class="NLM_lpage">15019</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.21.15014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1074%2Fjbc.274.21.15014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=15014-15019&author=X.-Y.+Heauthor=G.+Merzauthor=P.+Mehtaauthor=H.+Schulzauthor=S.+Y.+Yang&title=Human+brain+short+chain+L-3-hydroxyacyl+coenzyme+a+dehydrogenase+is+a+single-domain+multifunctional+enzyme&doi=10.1074%2Fjbc.274.21.15014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.21.15014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.21.15014%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DX.-Y.%26aulast%3DMerz%26aufirst%3DG.%26aulast%3DMehta%26aufirst%3DP.%26aulast%3DSchulz%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DHuman%2520brain%2520short%2520chain%2520L-3-hydroxyacyl%2520coenzyme%2520a%2520dehydrogenase%2520is%2520a%2520single-domain%2520multifunctional%2520enzyme%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D15014%26epage%3D15019%26doi%3D10.1074%2Fjbc.274.21.15014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lue, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn Moore, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancio, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of amyloid-β (Aβ) peptide-binding alcohol dehydrogenase-Aβ interaction reduces Aβ accumulation and improves mitochondrial function in a mouse model of Alzheimer’s disease</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">2313</span>– <span class="NLM_lpage">2320</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4717-10.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1523%2FJNEUROSCI.4717-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=21307267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1antb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=2313-2320&author=J.+Yaoauthor=H.+Duauthor=S.+Yanauthor=F.+Fangauthor=C.+Wangauthor=L.+F.+Lueauthor=L.+Guoauthor=D.+Chenauthor=D.+M.+Sternauthor=F.+J.+Gunn+Mooreauthor=J.+Xi+Chenauthor=O.+Arancioauthor=S.+S.+Yan&title=Inhibition+of+amyloid-%CE%B2+%28A%CE%B2%29+peptide-binding+alcohol+dehydrogenase-A%CE%B2+interaction+reduces+A%CE%B2+accumulation+and+improves+mitochondrial+function+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1523%2FJNEUROSCI.4717-10.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of amyloid-β (Aβ) peptide-binding alcohol dehydrogenase-Aβ interaction reduces Aβ accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Yao, Jun; Du, Heng; Yan, Shiqiang; Fang, Fang; Wang, Chaodong; Lue, Lih-Fen; Guo, Lan; Chen, Doris; Stern, David M.; Gunn-Moore, Frank J.; Alikhani, Nyosha; Glaser, Elzbieta; Chen, John Xi; Arancio, Ottavio; Yan, Shirley Shi Du</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2313-2320</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ) peptide-binding alc. dehydrogenase (ABAD), an enzyme present in neuronal mitochondria, exacerbates Aβ-induced cell stress.  The interaction of ABAD with Aβ exacerbates Aβ-induced mitochondrial and neuronal dysfunction.  Here, we show that inhibition of the ABAD-Aβ interaction, using a decoy peptide (DP) in vitro and in vivo, protects against aberrant mitochondrial and neuronal function and improves spatial learning/memory.  I.p. administration of ABAD-DP [fused to the transduction of human immunodeficiency virus 1-transactivator (Tat) protein and linked to the mitochondrial targeting sequence (Mito) (TAT-mito-DP) to transgenic APP mice (Tg mAPP)] blocked formation of ABAD-Aβ complex in mitochondria, increased oxygen consumption and enzyme activity assocd. with the mitochondrial respiratory chain, attenuated mitochondrial oxidative stress, and improved spatial memory.  Similar protective effects were obsd. in Tg mAPP mice overexpressing neuronal ABAD decoy peptide (Tg mAPP/mito-ABAD).  Notably, inhibition of the ABAD-Aβ interaction significantly reduced mitochondrial Aβ accumulation.  In parallel, the activity of mitochondrial Aβ-degrading enzyme PreP (presequence peptidase) was enhanced in Tg mAPP mitochondria expressing the ABAD decoy peptide.  These data indicate that segregating ABAD from Aβ protects mitochondria/neurons from Aβ toxicity; thus, ABAD-Aβ interaction is an important mechanism underlying Aβ-mediated mitochondrial and neuronal perturbation.  Inhibitors of ABAD-Aβ interaction may hold promise as targets for the prevention and treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiiqnew5jVmLVg90H21EOLACvtfcHk0lh7O7dHn36YQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1antb4%253D&md5=aca1cd465a2dde082410d3d8a1116292</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4717-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4717-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DH.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLue%26aufirst%3DL.%2BF.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DStern%26aufirst%3DD.%2BM.%26aulast%3DGunn%2BMoore%26aufirst%3DF.%2BJ.%26aulast%3DXi%2BChen%26aufirst%3DJ.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DYan%26aufirst%3DS.%2BS.%26atitle%3DInhibition%2520of%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520peptide-binding%2520alcohol%2520dehydrogenase-A%25CE%25B2%2520interaction%2520reduces%2520A%25CE%25B2%2520accumulation%2520and%2520improves%2520mitochondrial%2520function%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D2313%26epage%3D2320%26doi%3D10.1523%2FJNEUROSCI.4717-10.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohsawa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, S.</span></span> <span> </span><span class="NLM_article-title">Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2007.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.neurobiolaging.2007.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17707551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFChtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=325-329&author=Y.+Murakamiauthor=I.+Ohsawaauthor=T.+Kasaharaauthor=S.+Ohta&title=Cytoprotective+role+of+mitochondrial+amyloid+beta+peptide-binding+alcohol+dehydrogenase+against+a+cytotoxic+aldehyde&doi=10.1016%2Fj.neurobiolaging.2007.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoprotective role of mitochondrial amyloid β peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde</span></div><div class="casAuthors">Murakami, Yayoi; Ohsawa, Ikuroh; Kasahara, Tadashi; Ohta, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">325-329</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Recent reports on amyloid β peptide (Aβ) binding-alc. dehydrogenase (ABAD) have revealed the link of Aβ with oxidative stress derived from mitochondria in the pathogenesis of Alzheimer's disease (AD).  As a novel function of ABAD, we speculate that ABAD may detoxify aldehydes, such as 4-hydroxy-2-nonenal (4-HNE).  To verify this speculation, we transfected cDNA encoding ABAD into cultured cells (HeLa and SH-SY5Y), where ABAD was localized to mitochondria.  ABAD-transfectants decreased the levels of externally added 4-HNE in cultured medium as detected by TLC and became resistant against external 4-HNE.  Moreover, ABAD suppressed the cytotoxic effects caused by cellular 4-HNE, which were produced through excess reactive oxygen species (ROS) by treatment with an inhibitor of mitochondrial respiration, antimycin A or by adding H2O2.  Catabolism of 4-HNE by ABAD was inhibited by Aβ, resulting in the abolishment of the cytoprotective function by ABAD against ROS.  These results propose an addnl. role of ABAD in neural cell death in AD: ABAD detoxifies aldehydes, such as 4-HNE derived from lipid peroxides in healthy brains, and inhibited by Aβ in the development of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd49E5QN4nzrVg90H21EOLACvtfcHk0lg2BZ1o8Pwklw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFChtL7E&md5=0905b0141ea0a46b33d0de4e91f4906b</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2007.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2007.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DY.%26aulast%3DOhsawa%26aufirst%3DI.%26aulast%3DKasahara%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DS.%26atitle%3DCytoprotective%2520role%2520of%2520mitochondrial%2520amyloid%2520beta%2520peptide-binding%2520alcohol%2520dehydrogenase%2520against%2520a%2520cytotoxic%2520aldehyde%26jtitle%3DNeurobiol.%2520Aging%26date%3D2009%26volume%3D30%26spage%3D325%26epage%3D329%26doi%3D10.1016%2Fj.neurobiolaging.2007.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simpkins, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykens, J. A.</span></span> <span> </span><span class="NLM_article-title">Mitochondrial mechanisms of estrogen neuroprotection</span>. <i>Brain Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1016/j.brainresrev.2007.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.brainresrev.2007.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17512984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Srtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&pages=421-430&author=J.+W.+Simpkinsauthor=J.+A.+Dykens&title=Mitochondrial+mechanisms+of+estrogen+neuroprotection&doi=10.1016%2Fj.brainresrev.2007.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial mechanisms of estrogen neuroprotection</span></div><div class="casAuthors">Simpkins, James W.; Dykens, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">421-430</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress, bioenergetic failure and mitochondrial dysfunction are all implicated in the etiol. of neurodegenerative diseases such as Alzheimer's disease (AD).  The mitochondrial involvement in neurodegenerative diseases reflects the regulatory role mitochondrial failure plays in both necrotic cell death and apoptosis.  The potent feminizing hormone, 17 β-estradiol (E2), is neuroprotective in a host of cell and animal models of stroke and neurodegenerative diseases.  The discovery that 17α-estradiol, an isomer of E2, is equally as neuroprotective as E2 yet is > 200-fold less active as a hormone, has permitted development of novel, more potent analogs where neuroprotection is independent of hormonal potency.  Studies of structure-activity relationships and mitochondrial function have led to a mechanistic model in which these steroidal phenols intercalate into cell membranes where they block lipid peroxidn. reactions, and are in turn recycled.  Indeed, the parental estrogens and novel analogs stabilize mitochondria under Ca2+ loading otherwise sufficient to collapse membrane potential.  The neuroprotective and mitoprotective potencies for a series of estrogen analogs are significantly correlated, suggesting that these compds. prevent cell death in large measure by maintaining functionally intact mitochondria.  This therapeutic strategy is germane not only to sudden mitochondrial failure in acute circumstances, such as during a stroke or myocardial infarction, but also to gradual mitochondrial dysfunction assocd. with chronic degenerative disorders such as AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWP8-NuNKvpLVg90H21EOLACvtfcHk0lg2BZ1o8Pwklw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Srtbc%253D&md5=c8de974d3a5c3230c04ef17b942cd068</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresrev.2007.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresrev.2007.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DSimpkins%26aufirst%3DJ.%2BW.%26aulast%3DDykens%26aufirst%3DJ.%2BA.%26atitle%3DMitochondrial%2520mechanisms%2520of%2520estrogen%2520neuroprotection%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2008%26volume%3D57%26spage%3D421%26epage%3D430%26doi%3D10.1016%2Fj.brainresrev.2007.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, J.</span></span> <span> </span><span class="NLM_article-title">Estradiol and neurodegenerative oxidative stress</span>. <i>Front. Neuroendocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1016/j.yfrne.2007.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.yfrne.2007.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=18275991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCktLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=463-475&author=J.+Nilsen&title=Estradiol+and+neurodegenerative+oxidative+stress&doi=10.1016%2Fj.yfrne.2007.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Estradiol and neurodegenerative oxidative stress</span></div><div class="casAuthors">Nilsen, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Neuroendocrinology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">463-475</span>CODEN:
                <span class="NLM_cas:coden">FNEDA7</span>;
        ISSN:<span class="NLM_cas:issn">0091-3022</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Estradiol is a potent preventative against neurodegenerative disease, in part, by activating antioxidant defense systems scavenging reactive oxygen species, limiting mitochondrial protein damage, improving electron transport chain activity and reducing mitochondrial DNA damage.  Estradiol also increases the activity of complex IV of the electron transport chain, improving mitochondrial respiration and ATP prodn. under normal and stressful conditions.  However, the high oxidative cellular environment present during neurodegeneration makes estradiol a poor agent for treatment of existing disease.  Oxidative stress stimulates the prodn. of the hydroperoxide-dependent hydroxylation of estradiol to the catecholestrogen metabolites, which can undergo reactive oxygen species producing redox cycling, setting up a self-generating toxic cascade offsetting any antioxidant/antiapoptotic effects generated by the parent estradiol.  Addnl. disease-induced factors can further perpetuate this cycle.  For example dysregulation of the catecholamine system could alter catechol-O-methyltransferase-catalyzed methylation, preventing removal of redox cycling catecholestrogens from the system enhancing pro-oxidant effects of estradiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT0O2NBTuNc7Vg90H21EOLACvtfcHk0lg2BZ1o8Pwklw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCktLzK&md5=99788befcd14217abe3f0c5d346232d8</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.yfrne.2007.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yfrne.2007.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DNilsen%26aufirst%3DJ.%26atitle%3DEstradiol%2520and%2520neurodegenerative%2520oxidative%2520stress%26jtitle%3DFront.%2520Neuroendocrinol.%26date%3D2008%26volume%3D29%26spage%3D463%26epage%3D475%26doi%3D10.1016%2Fj.yfrne.2007.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borras, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Grueso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallardo, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vina, J.</span></span> <span> </span><span class="NLM_article-title">Direct antioxidant and protective effect of estradiol on isolated mitochondria</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1802</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2009.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.bbadis.2009.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=19751829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFanurnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1802&publication_year=2010&pages=205-211&author=C.+Borrasauthor=J.+Gambiniauthor=R.+Lopez-Gruesoauthor=F.+V.+Pallardoauthor=J.+Vina&title=Direct+antioxidant+and+protective+effect+of+estradiol+on+isolated+mitochondria&doi=10.1016%2Fj.bbadis.2009.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Direct antioxidant and protective effect of estradiol on isolated mitochondria</span></div><div class="casAuthors">Borras, Consuelo; Gambini, Juan; Lopez-Grueso, Raul; Pallardo, Federico V.; Vina, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1802</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">205-211</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Estrogens have antioxidant properties which are due to their ability to bind to estrogen receptors and to up-regulate the expression of antioxidant enzymes via intracellular signaling pathways.  Mitochondria are key organelles in the development of age-assocd. cellular damage.  Recently, estrogen receptors were identified in mitochondria.  The aim of this paper was to test whether estradiol directly affects mitochondria by preventing oxidative stress and protecting frail mitochondria.  Incubation with estradiol at normal intracellular concns. prevents the formation of reactive oxygen species by mitochondria in a saturable manner.  Moreover, estradiol protects mitochondrial integrity as indicated by an increase in mitochondrial membrane potential.  It also prevents the apoptogenic leakage of cytochrome c from mitochondria and as a result the mitochondrial content of this cytochrome c is maintained high.  Thus, estradiol prevents the onset of the mitochondrial pathway of apoptosis by a direct effect on the organelle.  Genistein, a phytoestrogen present at high concn. in soy, mimics the protective effect of estradiol by both decreasing the rate of formation of reactive oxygen species and preventing the release of cytochrome c from mitochondria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouZCB-G8saELVg90H21EOLACvtfcHk0lg2BZ1o8Pwklw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFanurnI&md5=744959a648db8c39bd602e5cf6eab896</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2009.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2009.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DBorras%26aufirst%3DC.%26aulast%3DGambini%26aufirst%3DJ.%26aulast%3DLopez-Grueso%26aufirst%3DR.%26aulast%3DPallardo%26aufirst%3DF.%2BV.%26aulast%3DVina%26aufirst%3DJ.%26atitle%3DDirect%2520antioxidant%2520and%2520protective%2520effect%2520of%2520estradiol%2520on%2520isolated%2520mitochondria%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2010%26volume%3D1802%26spage%3D205%26epage%3D211%26doi%3D10.1016%2Fj.bbadis.2009.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hy, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, D. M.</span></span> <span> </span><span class="NLM_article-title">Prevalence of AD among whites: a summary by levels of severity</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1212/WNL.55.2.198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1212%2FWNL.55.2.198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10908890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD3czpvVaksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2000&pages=198-204&author=L.+X.+Hyauthor=D.+M.+Keller&title=Prevalence+of+AD+among+whites%3A+a+summary+by+levels+of+severity&doi=10.1212%2FWNL.55.2.198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of AD among whites: a summary by levels of severity</span></div><div class="casAuthors">Hy L X; Keller D M</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">198-204</span>
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    </div><div class="casAbstract">OBJECTIVE:  To determine age- and sex-specific AD prevalence rates for whites using each of four severity-based definitions of a case: a person diagnosed as having at least questionable AD, one diagnosed as having at least mild AD, one diagnosed as having moderate or severe AD, and one diagnosed as having severe AD.  METHODS:  Data from 21 studies of Europeans and North Americans were pooled.  RESULTS:  Empirically, one study, from East Boston, is an outlier.  Applied to the US population of 1996, the obtained estimates yield a prevalence of 1.7 to 1.9 million cases, depending on whether the outlier study is excluded or included.  CONCLUSIONS:  With disease severity taken into account, estimates of AD prevalence from white populations are more consistent than is usually acknowledged.  By including disease severity in the case definition, variations in reported rates are much reduced.  The outlier status of the East Boston study appears to result from the use of a definition of AD that differs from that used in the other 20 studies.  Alternative explanations of the discrepancy between these estimates and the common estimate of 4 million cases are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7AokzmMvbnEloaUqgkFHkfW6udTcc2ebzKdWtAHivzbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3czpvVaksw%253D%253D&md5=8c568009d12cc64cfd953d41d02cfa2d</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1212%2FWNL.55.2.198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.55.2.198%26sid%3Dliteratum%253Aachs%26aulast%3DHy%26aufirst%3DL.%2BX.%26aulast%3DKeller%26aufirst%3DD.%2BM.%26atitle%3DPrevalence%2520of%2520AD%2520among%2520whites%253A%2520a%2520summary%2520by%2520levels%2520of%2520severity%26jtitle%3DNeurology%26date%3D2000%26volume%3D55%26spage%3D198%26epage%3D204%26doi%3D10.1212%2FWNL.55.2.198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corder, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghebremedhin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thal, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohm, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braak, H.</span></span> <span> </span><span class="NLM_article-title">The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>1019</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1196/annals.1297.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1196%2Fannals.1297.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1019&publication_year=2004&pages=24-28&author=E.+H.+Corderauthor=E.+Ghebremedhinauthor=M.+G.+Taylorauthor=D.+R.+Thalauthor=T.+G.+Ohmauthor=H.+Braak&title=The+biphasic+relationship+between+regional+brain+senile+plaque+and+neurofibrillary+tangle+distributions%3A+modification+by+age%2C+sex%2C+and+APOE+polymorphism&doi=10.1196%2Fannals.1297.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1196%2Fannals.1297.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1297.005%26sid%3Dliteratum%253Aachs%26aulast%3DCorder%26aufirst%3DE.%2BH.%26aulast%3DGhebremedhin%26aufirst%3DE.%26aulast%3DTaylor%26aufirst%3DM.%2BG.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DOhm%26aufirst%3DT.%2BG.%26aulast%3DBraak%26aufirst%3DH.%26atitle%3DThe%2520biphasic%2520relationship%2520between%2520regional%2520brain%2520senile%2520plaque%2520and%2520neurofibrillary%2520tangle%2520distributions%253A%2520modification%2520by%2520age%252C%2520sex%252C%2520and%2520APOE%2520polymorphism%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D1019%26spage%3D24%26epage%3D28%26doi%3D10.1196%2Fannals.1297.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borrás, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Sala, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloret, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallardó, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viña, J.</span></span> <span> </span><span class="NLM_article-title">Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">546</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.1016/S0891-5849(02)01356-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS0891-5849%2802%2901356-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12614843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsVant7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=546-552&author=C.+Borr%C3%A1sauthor=J.+Sastreauthor=D.+Garc%C3%ADa-Salaauthor=A.+Lloretauthor=F.+V.+Pallard%C3%B3author=J.+Vi%C3%B1a&title=Mitochondria+from+females+exhibit+higher+antioxidant+gene+expression+and+lower+oxidative+damage+than+males&doi=10.1016%2FS0891-5849%2802%2901356-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males</span></div><div class="casAuthors">Borras, Consuelo; Sastre, Juan; Garcia-Sala, David; Lloret, Ana; Pallardo, Federico V.; Vina, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">546-552</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">We have investigated the differential mitochondrial oxidative stress between males and females to understand the mol. mechanisms enabling females to live longer than males.  Mitochondria are a major source of free radicals in cells.  Those from female rats generate half the amt. of peroxides than those of males.  This does not occur in ovariectomized animals.  Estrogen replacement therapy prevents the effect of ovariectomy.  Mitochondria from females have higher levels of reduced glutathione than those from males.  Those from ovariectomized rats have similar levels to males, and estrogen therapy prevents the fall in glutathione levels that occurs in ovariectomized animals.  Oxidative damage to mitochondrial DNA in males is 4-fold higher than that in females.  This is due to higher expression and activities of Mn-superoxide dismutase and of glutathione peroxidase in females, which behave as double transgenics overexpressing superoxide dismutase and glutathione peroxidase, conferring protection against free-radical-mediated damage in aging.  Moreover, 16S rRNA expression, which decreases significantly with aging, is four times higher in mitochondria from females than in those from males of the same chronol. age.  The facts reported here provide mol. evidence to explain the different life span in males and females.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnryDgHoXOcbVg90H21EOLACvtfcHk0lg2wd9LTnTgGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsVant7c%253D&md5=69135f8b531bc7036184ea60f50faedc</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2802%2901356-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252802%252901356-4%26sid%3Dliteratum%253Aachs%26aulast%3DBorr%25C3%25A1s%26aufirst%3DC.%26aulast%3DSastre%26aufirst%3DJ.%26aulast%3DGarc%25C3%25ADa-Sala%26aufirst%3DD.%26aulast%3DLloret%26aufirst%3DA.%26aulast%3DPallard%25C3%25B3%26aufirst%3DF.%2BV.%26aulast%3DVi%25C3%25B1a%26aufirst%3DJ.%26atitle%3DMitochondria%2520from%2520females%2520exhibit%2520higher%2520antioxidant%2520gene%2520expression%2520and%2520lower%2520oxidative%2520damage%2520than%2520males%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2003%26volume%3D34%26spage%3D546%26epage%3D552%26doi%3D10.1016%2FS0891-5849%2802%2901356-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coote, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F. J.</span></span> <span> </span><span class="NLM_article-title">Interaction of amyloid binding alcohol dehydrogenase/Aβ mediates up-regulation of peroxiredoxin II in the brains of Alzheimer’s disease patients and a transgenic Alzheimer’s disease mouse model</span>. <i>Mol. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1016/j.mcn.2007.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.mcn.2007.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17490890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVOksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=377-382&author=J.+Yaoauthor=M.+Taylorauthor=F.+Daveyauthor=Y.+Renauthor=J.+Aitonauthor=P.+Cooteauthor=F.+Fangauthor=J.+X.+Chenauthor=S.+D.+Yanauthor=F.+J.+Gunn-Moore&title=Interaction+of+amyloid+binding+alcohol+dehydrogenase%2FA%CE%B2+mediates+up-regulation+of+peroxiredoxin+II+in+the+brains+of+Alzheimer%E2%80%99s+disease+patients+and+a+transgenic+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1016%2Fj.mcn.2007.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of amyloid binding alcohol dehydrogenase/Aβ mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model</span></div><div class="casAuthors">Yao, Jun; Taylor, Margaret; Davey, Fleur; Ren, Yimin; Aiton, Jim; Coote, Peter; Fang, Fang; Chen, John Xi; Yan, Shi Du; Gunn-Moore, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">377-382</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alzheimer's patients have increased levels of both the 42 beta amyloid-β-peptide (Aβ) and amyloid binding alc. dehydrogenase (ABAD) which is an intracellular binding site for Aβ.  The over-expression of Aβ and ABAD in transgenic mice has shown that the binding of Aβ to ABAD results in exaggerating neuronal stress and impairment of learning and memory.  From a proteomic anal. of the brains from these animals the authors identified that peroxiredoxin II levels increase in Alzheimer's diseased brain.  This increase in peroxiredoxin II levels protects neurons against Aβ induced toxicity.  The authors also demonstrate, for the first time in living animals, that the expression level of peroxiredoxin II is an indicator for the interaction of ABAD and Aβ as its expression levels return to normal if this interaction is perturbed.  Therefore this indicates the possibility of reversing changes obsd. in Alzheimer's disease and that the Aβ-ABAD interaction is a suitable drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6lUam7lMLrrVg90H21EOLACvtfcHk0lg2wd9LTnTgGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVOksLg%253D&md5=6dd751b16e28568c8a3e31657e87a391</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2007.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2007.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DDavey%26aufirst%3DF.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DAiton%26aufirst%3DJ.%26aulast%3DCoote%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DJ.%2BX.%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DGunn-Moore%26aufirst%3DF.%2BJ.%26atitle%3DInteraction%2520of%2520amyloid%2520binding%2520alcohol%2520dehydrogenase%252FA%25CE%25B2%2520mediates%2520up-regulation%2520of%2520peroxiredoxin%2520II%2520in%2520the%2520brains%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%2520and%2520a%2520transgenic%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2007%26volume%3D35%26spage%3D377%26epage%3D382%26doi%3D10.1016%2Fj.mcn.2007.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pei, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundke-Iqbal, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdanovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winblad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowburn, R. F.</span></span> <span> </span><span class="NLM_article-title">Accumulation of cyclin-dependent kinase 5 (Cdk5) in neurons with early stages of Alzheimer’s disease neurofibrillary degeneration</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>797</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1016/S0006-8993(98)00296-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS0006-8993%2898%2900296-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=9666145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFOjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=797&publication_year=1998&pages=267-277&author=J.-J.+Peiauthor=I.+Grundke-Iqbalauthor=K.+Iqbalauthor=N.+Bogdanovicauthor=B.+Winbladauthor=R.+F.+Cowburn&title=Accumulation+of+cyclin-dependent+kinase+5+%28Cdk5%29+in+neurons+with+early+stages+of+Alzheimer%E2%80%99s+disease+neurofibrillary+degeneration&doi=10.1016%2FS0006-8993%2898%2900296-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration</span></div><div class="casAuthors">Pei, Jin-Jing; Grundke-Iqbal, Inge; Iqbal, Khalid; Bogdanovic, Nenad; Winblad, Bengt; Cowburn, Richard F.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">797</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-277</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Cyclin-dependent kinase 5 (cdk5) is one of the candidate kinases involved in the abnormal hyperphosphorylation of tau.  To have a direct effect on tau hyperphosphorylation, cdk5 protein levels and enzyme activity should be upregulated in esp. those neurons that develop neurofibrillary tangles (NFTs).  The authors studied the distribution of cdk5 immunoreactivity in neurons with or without early- and late-stage NFTs in hippocampal, entorhinal, transentorhinal, temporal and frontal cortices, and cerebellum of Alzheimer's disease (AD) and control brain.  The immunocytochem. localization of cdk5 was compared with that obtained using antibodies to PHF-tau (tau in paired helical filaments of NFTs, mAb AT8) and ubiquitin as markers of early and late stage NFTs, resp.  Immunoreactivities of cdk5 and PHF-tau were found in neuronal perikarya and processes of hippocampal, entorhinal, transentorhinal, temporal and frontal, and cerebellar cortices.  An apparent increase of cdk5 immunoreactivity was seen in pretangle neurons and in neurons bearing early stage NFTs.  These findings suggest that this kinase might be involved in the formation of NFTs at a relatively early stage in the neocortex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpVMpfGtv2I7Vg90H21EOLACvtfcHk0lgxHC6uhCmtpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFOjsb4%253D&md5=c74e8a03eadfd368ef6e70a25c311237</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2898%2900296-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252898%252900296-0%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DJ.-J.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DBogdanovic%26aufirst%3DN.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DCowburn%26aufirst%3DR.%2BF.%26atitle%3DAccumulation%2520of%2520cyclin-dependent%2520kinase%25205%2520%2528Cdk5%2529%2520in%2520neurons%2520with%2520early%2520stages%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520neurofibrillary%2520degeneration%26jtitle%3DBrain%2520Res.%26date%3D1998%26volume%3D797%26spage%3D267%26epage%3D277%26doi%3D10.1016%2FS0006-8993%2898%2900296-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swatton, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faull, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iritani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahn, S.</span></span> <span> </span><span class="NLM_article-title">Increased MAP kinase activity in Alzheimer’s and down syndrome but not in schizophrenia human brain</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2711</span>– <span class="NLM_lpage">2719</span>, <span class="refDoi"> DOI: 10.1111/j.0953-816X.2004.03365.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1111%2Fj.0953-816X.2004.03365.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=15147305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A280%3ADC%252BD2c3kvFygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=2711-2719&author=J.+E.+Swattonauthor=L.+A.+Sellersauthor=R.+L.+M.+Faullauthor=A.+Hollandauthor=S.+Iritaniauthor=S.+Bahn&title=Increased+MAP+kinase+activity+in+Alzheimer%E2%80%99s+and+down+syndrome+but+not+in+schizophrenia+human+brain&doi=10.1111%2Fj.0953-816X.2004.03365.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain</span></div><div class="casAuthors">Swatton Jane E; Sellers Lynda A; Faull Richard L M; Holland Anthony; Iritani Shuji; Bahn Sabine</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2711-9</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Abnormal phosphorylation of tau is a feature of Alzheimer's disease (AD), which develops prematurely in Down syndrome (DS) patients.  Cognitive impairment is also recognized as a clinical characteristic of schizophrenia, which does not appear to be associated with tau-aggregate formation.  Several kinases can phosphorylate tau in cell-free assays.  Here we show increased activity of mitogen-activated protein kinases (MAPKs) (including ERK1/2, SAPKs and p38) in post mortem AD and DS brains, which could not be accounted for by expression changes.  In contrast, glycogen synthase kinase-3 activity (GSK-3 alpha beta) was reduced significantly.  Examination of tau in AD and DS using antibodies selective for MAPK phosphorylation sites showed increased immunoreactivity.  In addition, phosphorylation of S(199), reportedly a selective substrate for cyclin-dependent kinase-5 (cdk5) or GSK-3 alpha beta was only observed in AD samples, which showed a concomitant increase in the expression of p25, the enhancing cofactor for cdk5 activity.  However, in schizophrenia brain, MAPK-phosphorylated tau was unchanged compared to matched controls, despite similar expression levels to those in AD.  The activities of the MAPKs and GSK-3 alpha beta were also unchanged.  These data demonstrate that in AD and DS, enhanced MAPK activity, which has an established role in regulating neuronal plasticity and survival, can account for irregular tau phosphorylation, and that the molecular processes involved in these neurodegenerative disorders are distinct from those in schizophrenia.  These data also question the significance of GSK-3 alpha beta, as much previous work carried out in vitro has placed this kinase as a favoured candidate for involvement in the pathological phosphorylation of tau.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRV8rechdy1IXELvajU9pjPfW6udTcc2eZaY-O-HcZNLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3kvFygtg%253D%253D&md5=8760fef23803bbc0ceac5597a85d6cb9</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1111%2Fj.0953-816X.2004.03365.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.0953-816X.2004.03365.x%26sid%3Dliteratum%253Aachs%26aulast%3DSwatton%26aufirst%3DJ.%2BE.%26aulast%3DSellers%26aufirst%3DL.%2BA.%26aulast%3DFaull%26aufirst%3DR.%2BL.%2BM.%26aulast%3DHolland%26aufirst%3DA.%26aulast%3DIritani%26aufirst%3DS.%26aulast%3DBahn%26aufirst%3DS.%26atitle%3DIncreased%2520MAP%2520kinase%2520activity%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520down%2520syndrome%2520but%2520not%2520in%2520schizophrenia%2520human%2520brain%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2004%26volume%3D19%26spage%3D2711%26epage%3D2719%26doi%3D10.1111%2Fj.0953-816X.2004.03365.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashidian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mount, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleyasin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsanejad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daigle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousseaux, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slack, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woulfe, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, D. S.</span></span> <span> </span><span class="NLM_article-title">Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and parkinson’s disease</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2007.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.neuron.2007.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=17610816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1eltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=37-52&author=D.+Quauthor=J.+Rashidianauthor=M.+P.+Mountauthor=H.+Aleyasinauthor=M.+Parsanejadauthor=A.+Liraauthor=E.+Haqueauthor=Y.+Zhangauthor=S.+Callaghanauthor=M.+Daigleauthor=M.+W.+Rousseauxauthor=R.+S.+Slackauthor=P.+R.+Albertauthor=I.+Vincentauthor=J.+M.+Woulfeauthor=D.+S.+Park&title=Role+of+Cdk5-mediated+phosphorylation+of+Prx2+in+MPTP+toxicity+and+parkinson%E2%80%99s+disease&doi=10.1016%2Fj.neuron.2007.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease</span></div><div class="casAuthors">Qu, Dianbo; Rashidian, Juliet; Mount, Matthew P.; Aleyasin, Hossein; Parsanejad, Mohammad; Lira, Arman; Haque, Emdadul; Zhang, Yi; Callaghan, Steve; Daigle, Mireille; Rousseaux, Maxime W. C.; Slack, Ruth S.; Albert, Paul R.; Vincent, Inez; Woulfe, John M.; Park, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-52</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We reported previously that calpain-mediated Cdk5 activation is crit. for mitochondrial toxin-induced dopaminergic death.  Here, we report a target that mediates this loss.  Prx2, an antioxidant enzyme, binds Cdk5/p35.  Prx2 is phosphorylated at T89 in neurons treated with MPP+ and/or MPTP in animals in a calpain/Cdk5/p35-dependent manner.  This phosphorylation reduces Prx2 peroxidase activity.  Consistent with this, p35-/- neurons show reduced oxidative stress upon MPP+ treatment.  Expression of Prx2 and Prx2T89A, but not the phosphorylation mimic Prx2T89E, protects cultured and adult neurons following mitochondrial insult.  Finally, downregulation of Prx2 increases oxidative stress and sensitivity to MPP+.  We propose a mechanistic model by which mitochondrial toxin leads to calpain-mediated Cdk5 activation, reduced Prx2 activity, and decreased capacity to eliminate ROS.  Importantly, increased Prx2 phosphorylation also occurs in nigral neurons from postmortem tissue from Parkinson's disease patients when compared to control, suggesting the relevance of this pathway in the human condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6qVdsMNGrP7Vg90H21EOLACvtfcHk0lgxHC6uhCmtpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1eltro%253D&md5=b7dd368d334fbbcdcae8d9ee573fbad0</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2007.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2007.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DD.%26aulast%3DRashidian%26aufirst%3DJ.%26aulast%3DMount%26aufirst%3DM.%2BP.%26aulast%3DAleyasin%26aufirst%3DH.%26aulast%3DParsanejad%26aufirst%3DM.%26aulast%3DLira%26aufirst%3DA.%26aulast%3DHaque%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCallaghan%26aufirst%3DS.%26aulast%3DDaigle%26aufirst%3DM.%26aulast%3DRousseaux%26aufirst%3DM.%2BW.%26aulast%3DSlack%26aufirst%3DR.%2BS.%26aulast%3DAlbert%26aufirst%3DP.%2BR.%26aulast%3DVincent%26aufirst%3DI.%26aulast%3DWoulfe%26aufirst%3DJ.%2BM.%26aulast%3DPark%26aufirst%3DD.%2BS.%26atitle%3DRole%2520of%2520Cdk5-mediated%2520phosphorylation%2520of%2520Prx2%2520in%2520MPTP%2520toxicity%2520and%2520parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2007%26volume%3D55%26spage%3D37%26epage%3D52%26doi%3D10.1016%2Fj.neuron.2007.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kjaerulff, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, A.</span></span> <span> </span><span class="NLM_article-title">The structure and function of endophilin proteins</span>. <i>Cell Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1007/s12013-010-9137-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1007%2Fs12013-010-9137-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=21184288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntlagtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=137-154&author=O.+Kjaerulffauthor=L.+Brodinauthor=A.+Jung&title=The+structure+and+function+of+endophilin+proteins&doi=10.1007%2Fs12013-010-9137-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">The structure and function of endophilin proteins</span></div><div class="casAuthors">Kjaerulff, Ole; Brodin, Lennart; Jung, Anita</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-154</span>CODEN:
                <span class="NLM_cas:coden">CBBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1085-9195</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Members of the BAR domain protein superfamily are essential elements of cellular traffic.  Endophilins are among the best studied BAR domain proteins.  They have a prominent function in synaptic vesicle endocytosis (SVE), receptor trafficking, and apoptosis, and in other processes that require remodeling of the membrane structure.  Here, the authors discuss the role of endophilins in these processes and summarize novel insights into the mol. aspects of endophilin function.  The authors also discuss the phosphorylation of endophilins and how this and other mechanisms may contribute to disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWGbvSQ1NdGbVg90H21EOLACvtfcHk0ljBOZfh3AvbnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntlagtLY%253D&md5=1b7bd3a1669b1e69d33df4f78cf12617</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1007%2Fs12013-010-9137-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12013-010-9137-5%26sid%3Dliteratum%253Aachs%26aulast%3DKjaerulff%26aufirst%3DO.%26aulast%3DBrodin%26aufirst%3DL.%26aulast%3DJung%26aufirst%3DA.%26atitle%3DThe%2520structure%2520and%2520function%2520of%2520endophilin%2520proteins%26jtitle%3DCell%2520Biochem.%2520Biophys.%26date%3D2011%26volume%3D60%26spage%3D137%26epage%3D154%26doi%3D10.1007%2Fs12013-010-9137-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reutens, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begley, C. G.</span></span> <span> </span><span class="NLM_article-title">Endophilin-1: a multifunctional protein</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1173</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi"> DOI: 10.1016/S1357-2725(02)00063-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2FS1357-2725%2802%2900063-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=12127567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVOmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=1173-1177&author=A.+T.+Reutensauthor=C.+G.+Begley&title=Endophilin-1%3A+a+multifunctional+protein&doi=10.1016%2FS1357-2725%2802%2900063-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Endophilin-1: a multifunctional protein</span></div><div class="casAuthors">Reutens, Anne T.; Glenn Begley, C.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1173-1177</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Endophilin-1, a cytoplasmic Src homol. 3 (SH3) domain-contg. protein, localizes in brain presynaptic nerve termini.  Endophilin dimerizes through its N-terminus, and participates at multiple stages in clathrin-coated endocytosis, from early membrane invagination to synaptic vesicle uncoating.  Both its C-terminal SH3 domain and N-terminus are required for endocytosis.  Through its SH3 domain, endophilin bound to proline-rich domains (PRDs) in other endocytic proteins, including synaptojanin and dynamin.  The N-terminal region possesses unique functions affecting lipid membrane curvature, through lysophosphatidic acid acyl transferase (LPAAT) activity and direct binding and tubulating activity.  In addn. to synaptic vesicle formation, endophilin-1 complexes with signaling mols., including cell surface receptors, metalloprotease disintegrins and germinal center kinase-like kinase (GLK).  Therefore, endophilin-1 may serve to couple vesicle biogenesis with intracellular signaling cascades.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUYzr1Fq4AFrVg90H21EOLACvtfcHk0ljBOZfh3AvbnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVOmsrw%253D&md5=d8e1191bc4a302a24a6b1427085a259f</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2FS1357-2725%2802%2900063-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-2725%252802%252900063-8%26sid%3Dliteratum%253Aachs%26aulast%3DReutens%26aufirst%3DA.%2BT.%26aulast%3DBegley%26aufirst%3DC.%2BG.%26atitle%3DEndophilin-1%253A%2520a%2520multifunctional%2520protein%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2002%26volume%3D34%26spage%3D1173%26epage%3D1177%26doi%3D10.1016%2FS1357-2725%2802%2900063-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davey, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coote, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F. J.</span></span> <span> </span><span class="NLM_article-title">Endophilin I expression is increased in the brains of Alzheimer disease patients</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">5685</span>– <span class="NLM_lpage">5691</span>, <span class="refDoi"> DOI: 10.1074/jbc.M707932200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1074%2Fjbc.M707932200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=5685-5691&author=Y.+Renauthor=H.+W.+Xuauthor=F.+Daveyauthor=M.+Taylorauthor=J.+Aitonauthor=P.+Cooteauthor=F.+Fangauthor=J.+Yaoauthor=D.+Chenauthor=J.+X.+Chenauthor=S.+D.+Yanauthor=F.+J.+Gunn-Moore&title=Endophilin+I+expression+is+increased+in+the+brains+of+Alzheimer+disease+patients&doi=10.1074%2Fjbc.M707932200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M707932200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M707932200%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DH.%2BW.%26aulast%3DDavey%26aufirst%3DF.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DAiton%26aufirst%3DJ.%26aulast%3DCoote%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DJ.%2BX.%26aulast%3DYan%26aufirst%3DS.%2BD.%26aulast%3DGunn-Moore%26aufirst%3DF.%2BJ.%26atitle%3DEndophilin%2520I%2520expression%2520is%2520increased%2520in%2520the%2520brains%2520of%2520Alzheimer%2520disease%2520patients%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D5685%26epage%3D5691%26doi%3D10.1074%2Fjbc.M707932200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramjaun, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legendre-Guillemin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPherson, P. S.</span></span> <span> </span><span class="NLM_article-title">Endophilin regulates JNK activation through its interaction with the germinal center kinase-like kinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">28913</span>– <span class="NLM_lpage">28919</span>, <span class="refDoi"> DOI: 10.1074/jbc.M103198200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1074%2Fjbc.M103198200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=28913-28919&author=A.+R.+Ramjaunauthor=A.+Angersauthor=V.+Legendre-Guilleminauthor=X.+K.+Tongauthor=P.+S.+McPherson&title=Endophilin+regulates+JNK+activation+through+its+interaction+with+the+germinal+center+kinase-like+kinase&doi=10.1074%2Fjbc.M103198200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M103198200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M103198200%26sid%3Dliteratum%253Aachs%26aulast%3DRamjaun%26aufirst%3DA.%2BR.%26aulast%3DAngers%26aufirst%3DA.%26aulast%3DLegendre-Guillemin%26aufirst%3DV.%26aulast%3DTong%26aufirst%3DX.%2BK.%26aulast%3DMcPherson%26aufirst%3DP.%2BS.%26atitle%3DEndophilin%2520regulates%2520JNK%2520activation%2520through%2520its%2520interaction%2520with%2520the%2520germinal%2520center%2520kinase-like%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D28913%26epage%3D28919%26doi%3D10.1074%2Fjbc.M103198200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diener, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keesler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Z.</span></span> <span> </span><span class="NLM_article-title">Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">9687</span>– <span class="NLM_lpage">9692</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.18.9687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1073%2Fpnas.94.18.9687" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=9687-9692&author=K.+Dienerauthor=X.+S.+Wangauthor=C.+Chenauthor=C.+F.+Meyerauthor=G.+Keeslerauthor=M.+Zukowskiauthor=T.+Tanauthor=Z.+Yao&title=Activation+of+the+c-Jun+N-terminal+kinase+pathway+by+a+novel+protein+kinase+related+to+human+germinal+center+kinase&doi=10.1073%2Fpnas.94.18.9687"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.18.9687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.18.9687%26sid%3Dliteratum%253Aachs%26aulast%3DDiener%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DX.%2BS.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DMeyer%26aufirst%3DC.%2BF.%26aulast%3DKeesler%26aufirst%3DG.%26aulast%3DZukowski%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DT.%26aulast%3DYao%26aufirst%3DZ.%26atitle%3DActivation%2520of%2520the%2520c-Jun%2520N-terminal%2520kinase%2520pathway%2520by%2520a%2520novel%2520protein%2520kinase%2520related%2520to%2520human%2520germinal%2520center%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D9687%26epage%3D9692%26doi%3D10.1073%2Fpnas.94.18.9687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mehan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meena, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankhla, R.</span></span> <span> </span><span class="NLM_article-title">JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer’s and various neurodegenerative abnormalities</span>. <i>J. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">376</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1007/s12031-010-9454-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1007%2Fs12031-010-9454-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=20878262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1KiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=376-390&author=S.+Mehanauthor=H.+Meenaauthor=D.+Sharmaauthor=R.+Sankhla&title=JNK%3A+a+stress-activated+protein+kinase+therapeutic+strategies+and+involvement+in+Alzheimer%E2%80%99s+and+various+neurodegenerative+abnormalities&doi=10.1007%2Fs12031-010-9454-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">JNK: A Stress-Activated Protein Kinase Therapeutic Strategies and Involvement in Alzheimer's and Various Neurodegenerative Abnormalities</span></div><div class="casAuthors">Mehan, Sidharth; Meena, Harikesh; Sharma, Deepak; Sankhla, Rameshwar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">376-390</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  The c-Jun N-terminal kinase (JNKs), also known as stress-activated protein kinase (SAPK), is one such family of multifunctional-signaling mols., activated in response to wide range of cellular stresses as well as in response to inflammatory mediators.  JNKs regulate various processes such as brain development, repair, and memory formation; but on the other hand, JNKs are potent effectors of neuroinflammation and neuronal death.  A large body of evidence indicates that JNK activity is crit. for normal immune and inflammatory response.  Indeed, aberrant activation of JNK was implicated in the pathogenesis of Alzheimer's disease.  Moreover, the JNK pathway is considered to be a key regulator of various inflammatory pathways which are activated during normal aging and Alzheimer's disease therapy as well as key regulator of pro-inflammatory cytokines biosynthesis at the transcriptional and translational levels, which makes different components of these pathway potential targets for the treatment of autoimmune and inflammatory diseases.  Pharmacol. inhibition of JNK was demonstrated to attenuate microglial activation and the release of neurotoxic chems. including pro-inflammatory cytokines.  In this review, we provide an overview on implications and therapeutic strategies of JNK in neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogA33KBGCnFbVg90H21EOLACvtfcHk0lgT1zSXixdqDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1KiurY%253D&md5=b78c940bd4df0a03a64493bcbe90af26</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1007%2Fs12031-010-9454-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12031-010-9454-6%26sid%3Dliteratum%253Aachs%26aulast%3DMehan%26aufirst%3DS.%26aulast%3DMeena%26aufirst%3DH.%26aulast%3DSharma%26aufirst%3DD.%26aulast%3DSankhla%26aufirst%3DR.%26atitle%3DJNK%253A%2520a%2520stress-activated%2520protein%2520kinase%2520therapeutic%2520strategies%2520and%2520involvement%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520various%2520neurodegenerative%2520abnormalities%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2011%26volume%3D43%26spage%3D376%26epage%3D390%26doi%3D10.1007%2Fs12031-010-9454-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klunk, W. E.</span></span> <span> </span><span class="NLM_article-title">Imaging β-amyloid plaques and neurofibrillary tangles in the aging human brain</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1469</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.2174/1381612043384772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F1381612043384772" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1469-1492&author=C.+A.+Mathisauthor=Y.+Wangauthor=W.+E.+Klunk&title=Imaging+%CE%B2-amyloid+plaques+and+neurofibrillary+tangles+in+the+aging+human+brain&doi=10.2174%2F1381612043384772"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.2174%2F1381612043384772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043384772%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DImaging%2520%25CE%25B2-amyloid%2520plaques%2520and%2520neurofibrillary%2520tangles%2520in%2520the%2520aging%2520human%2520brain%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D1469%26epage%3D1492%26doi%3D10.2174%2F1381612043384772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Froemming, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sames, D.</span></span> <span> </span><span class="NLM_article-title">Harnessing functional plasticity of enzymes: a fluorogenic probe for imaging 17β-HSD10 dehydrogenase, an enzyme involved in Alzheimer’s and parkinson’s diseases</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">14518</span>– <span class="NLM_lpage">14522</span>, <span class="refDoi"> DOI: 10.1021/ja072601x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja072601x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=14518-14522&author=M.+K.+Froemmingauthor=D.+Sames&title=Harnessing+functional+plasticity+of+enzymes%3A+a+fluorogenic+probe+for+imaging+17%CE%B2-HSD10+dehydrogenase%2C+an+enzyme+involved+in+Alzheimer%E2%80%99s+and+parkinson%E2%80%99s+diseases&doi=10.1021%2Fja072601x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fja072601x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja072601x%26sid%3Dliteratum%253Aachs%26aulast%3DFroemming%26aufirst%3DM.%2BK.%26aulast%3DSames%26aufirst%3DD.%26atitle%3DHarnessing%2520functional%2520plasticity%2520of%2520enzymes%253A%2520a%2520fluorogenic%2520probe%2520for%2520imaging%252017%25CE%25B2-HSD10%2520dehydrogenase%252C%2520an%2520enzyme%2520involved%2520in%2520Alzheimer%25E2%2580%2599s%2520and%2520parkinson%25E2%2580%2599s%2520diseases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D14518%26epage%3D14522%26doi%3D10.1021%2Fja072601x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muirhead, K. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froemming, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musilek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sames, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F. J.</span></span> <span> </span><span class="NLM_article-title">(−)-CHANA, a fluorogenic probe for detecting amyloid binding alcohol dehydrogenase HSD10 activity in living cells</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1105</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.1021/cb100199m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100199m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1105-1114&author=K.+E.+A.+Muirheadauthor=M.+Froemmingauthor=X.+Liauthor=K.+Musilekauthor=S.+J.+Conwayauthor=D.+Samesauthor=F.+J.+Gunn-Moore&title=%28%E2%88%92%29-CHANA%2C+a+fluorogenic+probe+for+detecting+amyloid+binding+alcohol+dehydrogenase+HSD10+activity+in+living+cells&doi=10.1021%2Fcb100199m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fcb100199m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100199m%26sid%3Dliteratum%253Aachs%26aulast%3DMuirhead%26aufirst%3DK.%2BE.%2BA.%26aulast%3DFroemming%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DMusilek%26aufirst%3DK.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DSames%26aufirst%3DD.%26aulast%3DGunn-Moore%26aufirst%3DF.%2BJ.%26atitle%3D%2528%25E2%2588%2592%2529-CHANA%252C%2520a%2520fluorogenic%2520probe%2520for%2520detecting%2520amyloid%2520binding%2520alcohol%2520dehydrogenase%2520HSD10%2520activity%2520in%2520living%2520cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D1105%26epage%3D1114%26doi%3D10.1021%2Fcb100199m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hroch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolezal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musilek, K.</span></span> <span> </span><span class="NLM_article-title">Benzothiazoles - scaffold of interest for CNS targeted drugs</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.2174/0929867322666141212120631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F0929867322666141212120631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=25515509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=730-747&author=L.+Hrochauthor=L.+Aitkenauthor=O.+Benekauthor=M.+Dolezalauthor=K.+Kucaauthor=F.+Gunn-Mooreauthor=K.+Musilek&title=Benzothiazoles+-+scaffold+of+interest+for+CNS+targeted+drugs&doi=10.2174%2F0929867322666141212120631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Benzothiazoles - Scaffold of Interest for CNS Targeted Drugs</span></div><div class="casAuthors">Hroch, Lukas; Aitken, Laura; Benek, Ondrej; Dolezal, Martin; Kuca, Kamil; Gunn-Moore, Frank; Musilek, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">730-747</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Benzothiazole compds. represent heterocyclic systems comprising a benzene ring fused with a thiazole ring contg. nitrogen and sulfur in its structure.  Besides the presence of a benzothiazole core in naturally occurring mols., synthesized compds. contg. a benzothiazole moiety in their structure proved to be a significant class of potential therapeutics, as they exhibit biol. effects such as antitumor, antibacterial, antitubercular, antiviral, anthelmintic, antidiabetic and many others.  Apart from the aforementioned peripheral or microbial active sites, benzothiazole analogs are also biol. active compds. in the central nervous system, where some approved drugs contg. a benzothiazole moiety have already been identified and are used in the treatment of various neurol. disorders.  New benzothiazole mols. are currently under development and are being evaluated for several uses including diagnostics and as therapeutic drug candidates for the treatment of epilepsy and neurodegenerative diseases such as Alzheimer's disease, Huntington's disease and amyotrophic lateral sclerosis amongst others.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL0PHaGhRsPrVg90H21EOLACvtfcHk0ljj6V_e7HzgjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKiu7c%253D&md5=bc4f88a2a6020eabbe4b67b54d26b155</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.2174%2F0929867322666141212120631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666141212120631%26sid%3Dliteratum%253Aachs%26aulast%3DHroch%26aufirst%3DL.%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DBenek%26aufirst%3DO.%26aulast%3DDolezal%26aufirst%3DM.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DMusilek%26aufirst%3DK.%26atitle%3DBenzothiazoles%2520-%2520scaffold%2520of%2520interest%2520for%2520CNS%2520targeted%2520drugs%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D730%26epage%3D747%26doi%3D10.2174%2F0929867322666141212120631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mensah-Nyagan, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villafranca, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ittner, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotz, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e28887</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0028887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1371%2Fjournal.pone.0028887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=22174920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslKj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e28887&author=Y.+A.+Limauthor=A.+Grimmauthor=M.+Gieseauthor=A.+G.+Mensah-Nyaganauthor=J.+E.+Villafrancaauthor=L.+M.+Ittnerauthor=A.+Eckertauthor=J.+Gotz&title=Inhibition+of+the+mitochondrial+enzyme+ABAD+restores+the+amyloid-%CE%B2-mediated+deregulation+of+estradiol&doi=10.1371%2Fjournal.pone.0028887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol</span></div><div class="casAuthors">Lim, Yun-An; Grimm, Amandine; Giese, Maria; Mensah-Nyagan, Ayikoe Guy; Villafranca, J. Ernest; Ittner, Lars M.; Eckert, Anne; Gotz, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e28887</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a conformational disease that is characterized by amyloid-β (Aβ) deposition in the brain.  Aβ exerts its toxicity in part by receptor-mediated interactions that cause down-stream protein misfolding and aggregation, as well as mitochondrial dysfunction.  Recent reports indicate that Aβ may also interact directly with intracellular proteins such as the mitochondrial enzyme ABAD (Aβ binding alc. dehydrogenase) in executing its toxic effects.  Mitochondrial dysfunction occurs early in AD, and Aβ's toxicity is in part mediated by inhibition of ABAD as shown previously with an ABAD decoy peptide.  Here, we employed AG18051, a novel small ABAD-specific compd. inhibitor, to investigate the role of ABAD in Aβ toxicity.  Using SH-SY5Y neuroblastoma cells, we found that AG18051 partially blocked the Aβ-ABAD interaction in a pull-down assay while it also prevented the Aβ42-induced down-regulation of ABAD activity, as measured by levels of estradiol, a known hormone and product of ABAD activity.  Furthermore, AG18051 is protective against Aβ42 toxicity, as measured by LDH release and MTT absorbance.  Specifically, AG18051 reduced Aβ42-induced impairment of mitochondrial respiration and oxidative stress as shown by reduced ROS (reactive oxygen species) levels.  Guided by our previous finding of shared aspects of the toxicity of Aβ and human amylin (HA), with the latter forming aggregates in Type 2 diabetes mellitus (T2DM) pancreas, we detd. whether AG18051 would also confer protection from HA toxicity.  We found that the inhibitor conferred only partial protection from HA toxicity indicating distinct pathomechanisms of the two amyloidogenic agents.  Taken together, our results present the inhibition of ABAD by compds. such as AG18051 as a promising therapeutic strategy for the prevention and treatment of AD, and suggest levels of estradiol as a suitable read-out.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc1Q22AuUmybVg90H21EOLACvtfcHk0ljj6V_e7HzgjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslKj&md5=c3689b882868341914b2c66878ef8f7b</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0028887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0028887%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DY.%2BA.%26aulast%3DGrimm%26aufirst%3DA.%26aulast%3DGiese%26aufirst%3DM.%26aulast%3DMensah-Nyagan%26aufirst%3DA.%2BG.%26aulast%3DVillafranca%26aufirst%3DJ.%2BE.%26aulast%3DIttner%26aufirst%3DL.%2BM.%26aulast%3DEckert%26aufirst%3DA.%26aulast%3DGotz%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520the%2520mitochondrial%2520enzyme%2520ABAD%2520restores%2520the%2520amyloid-%25CE%25B2-mediated%2520deregulation%2520of%2520estradiol%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De28887%26doi%3D10.1371%2Fjournal.pone.0028887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannifer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McElroy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F. J.</span></span> <span> </span><span class="NLM_article-title">In vitro assay development and HTS of small-molecule human ABAD/17β-HSD10 inhibitors as therapeutics in Alzheimer’s disease</span>. <i>SLAS Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">676</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1177/2472555217697964</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1177%2F2472555217697964" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=676-685&author=L.+Aitkenauthor=G.+Baillieauthor=A.+Panniferauthor=A.+Morrisonauthor=P.+S.+Jonesauthor=T.+K.+Smithauthor=S.+P.+McElroyauthor=F.+J.+Gunn-Moore&title=In+vitro+assay+development+and+HTS+of+small-molecule+human+ABAD%2F17%CE%B2-HSD10+inhibitors+as+therapeutics+in+Alzheimer%E2%80%99s+disease&doi=10.1177%2F2472555217697964"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1177%2F2472555217697964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2472555217697964%26sid%3Dliteratum%253Aachs%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DBaillie%26aufirst%3DG.%26aulast%3DPannifer%26aufirst%3DA.%26aulast%3DMorrison%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DP.%2BS.%26aulast%3DSmith%26aufirst%3DT.%2BK.%26aulast%3DMcElroy%26aufirst%3DS.%2BP.%26aulast%3DGunn-Moore%26aufirst%3DF.%2BJ.%26atitle%3DIn%2520vitro%2520assay%2520development%2520and%2520HTS%2520of%2520small-molecule%2520human%2520ABAD%252F17%25CE%25B2-HSD10%2520inhibitors%2520as%2520therapeutics%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DSLAS%2520Discovery%26date%3D2017%26volume%3D22%26spage%3D676%26epage%3D685%26doi%3D10.1177%2F2472555217697964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ayan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, D.</span></span> <span> </span><span class="NLM_article-title">Identification of a 17β-hydroxysteroid dehydrogenase type 10 steroidal inhibitor: a tool to investigate the role of type 10 in Alzheimer’s disease and prostate cancer</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1002%2Fcmdc.201200129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=22674910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVertbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1181-1184&author=D.+Ayanauthor=R.+Maltaisauthor=D.+Poirier&title=Identification+of+a+17%CE%B2-hydroxysteroid+dehydrogenase+type+10+steroidal+inhibitor%3A+a+tool+to+investigate+the+role+of+type+10+in+Alzheimer%E2%80%99s+disease+and+prostate+cancer&doi=10.1002%2Fcmdc.201200129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a 17β-Hydroxysteroid Dehydrogenase Type 10 Steroidal Inhibitor: A Tool to Investigate the Role of Type 10 in Alzheimer's Disease and Prostate Cancer</span></div><div class="casAuthors">Ayan, Diana; Maltais, Rene; Poirier, Donald</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1181-1184, S1181/1-S1181/18</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In continuation of our efforts to develop 17β-hydroxysteroid dehydrogenase type 10 steroidal inhibitors for the treatment of androgen- and estrogen-dependent diseases, we report initial results regarding the development of such inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNkwHFbnNs8LVg90H21EOLACvtfcHk0ljj6V_e7HzgjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVertbg%253D&md5=bc8f320e1fc910ddc7dcb0299c4c616a</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200129%26sid%3Dliteratum%253Aachs%26aulast%3DAyan%26aufirst%3DD.%26aulast%3DMaltais%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520a%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%252010%2520steroidal%2520inhibitor%253A%2520a%2520tool%2520to%2520investigate%2520the%2520role%2520of%2520type%252010%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520prostate%2520cancer%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1181%26epage%3D1184%26doi%3D10.1002%2Fcmdc.201200129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boutin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maltais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alata, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, D.</span></span> <span> </span><span class="NLM_article-title">Identification of steroidal derivatives inhibiting the transformations of allopregnanolone and estradiol by 17β-hydroxysteroid dehydrogenase type 10</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3554</span>– <span class="NLM_lpage">3559</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.09.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.bmcl.2018.09.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=3554-3559&author=S.+Boutinauthor=J.+Royauthor=R.+Maltaisauthor=W.+Alataauthor=F.+Calonauthor=D.+Poirier&title=Identification+of+steroidal+derivatives+inhibiting+the+transformations+of+allopregnanolone+and+estradiol+by+17%CE%B2-hydroxysteroid+dehydrogenase+type+10&doi=10.1016%2Fj.bmcl.2018.09.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.09.031%26sid%3Dliteratum%253Aachs%26aulast%3DBoutin%26aufirst%3DS.%26aulast%3DRoy%26aufirst%3DJ.%26aulast%3DMaltais%26aufirst%3DR.%26aulast%3DAlata%26aufirst%3DW.%26aulast%3DCalon%26aufirst%3DF.%26aulast%3DPoirier%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520steroidal%2520derivatives%2520inhibiting%2520the%2520transformations%2520of%2520allopregnanolone%2520and%2520estradiol%2520by%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%252010%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D3554%26epage%3D3559%26doi%3D10.1016%2Fj.bmcl.2018.09.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Craik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D.</span></span> <span> </span><span class="NLM_article-title">The future of peptide-based drugs</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">136</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1111%2Fcbdd.12055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=23253135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1yktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=136-147&author=D.+J.+Craikauthor=D.+P.+Fairlieauthor=S.+Lirasauthor=D.+Price&title=The+future+of+peptide-based+drugs&doi=10.1111%2Fcbdd.12055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">The future of peptide-based drugs</span></div><div class="casAuthors">Craik, David J.; Fairlie, David P.; Liras, Spiros; Price, David</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">136-147</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The suite of currently used drugs can be divided into two categories - traditional "small mol." drugs with typical mol. wts. of <500 Da but with oral bioavailability, and much larger "biologics" typically >5000 Da that are not orally bioavailable and need to be delivered via injection.  Due to their small size, conventional small mol. drugs may suffer from reduced target selectivity that often ultimately manifests in human side-effects, whereas protein therapeutics tend to be exquisitely specific for their targets due to many more interactions with them, but this comes at a cost of low bioavailability, poor membrane permeability, and metabolic instability.  The time has now come to reinvestigate new drug leads that fit between these two mol. wt. extremes, with the goal of combining advantages of small mols. (cost, conformational restriction, membrane permeability, metabolic stability, oral bioavailability) with those of proteins (natural components, target specificity, high potency).  This article uses selected examples of peptides to highlight the importance of peptide drugs, some potential new opportunities for their exploitation, and some difficult challenges ahead in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlaEZbrPXLPbVg90H21EOLACvtfcHk0lgG7HPTvXV7dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1yktA%253D%253D&md5=1e7e4b7e725541587fad855e6a28cadf</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12055%26sid%3Dliteratum%253Aachs%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DD.%26atitle%3DThe%2520future%2520of%2520peptide-based%2520drugs%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2013%26volume%3D81%26spage%3D136%26epage%3D147%26doi%3D10.1111%2Fcbdd.12055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abreo, M. A.</span>; <span class="NLM_string-name">Meng, J. J.</span>; <span class="NLM_string-name">Agree, C. S.</span></span> <span> </span><span class="NLM_article-title">Fused Pyrazole Compounds, Pharmaceutical Compositions, and Methods for Modulating or Inhibiting ERAB or HADH2 Activity</span>. U.S. Patent <span class="NLM_patent">US6,964,957 B2</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=M.+A.+Abreo&author=J.+J.+Meng&author=C.+S.+Agree&title=Fused+Pyrazole+Compounds%2C+Pharmaceutical+Compositions%2C+and+Methods+for+Modulating+or+Inhibiting+ERAB+or+HADH2+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAbreo%26aufirst%3DM.%2BA.%26atitle%3DFused%2520Pyrazole%2520Compounds%252C%2520Pharmaceutical%2520Compositions%252C%2520and%2520Methods%2520for%2520Modulating%2520or%2520Inhibiting%2520ERAB%2520or%2520HADH2%2520Activity%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marques, A.
T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antunes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, M. J.</span></span> <span> </span><span class="NLM_article-title">Computational optimization of AG18051 inhibitor for amyloid-β binding alcohol dehydrogenase enzyme</span>. <i>Int. J. Quantum Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1982</span>– <span class="NLM_lpage">1991</span>, <span class="refDoi"> DOI: 10.1002/qua.21716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1002%2Fqua.21716" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=1982-1991&author=A.%0AT.+Marquesauthor=A.+Antunesauthor=P.+A.+Fernandesauthor=M.+J.+Ramos&title=Computational+optimization+of+AG18051+inhibitor+for+amyloid-%CE%B2+binding+alcohol+dehydrogenase+enzyme&doi=10.1002%2Fqua.21716"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1002%2Fqua.21716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fqua.21716%26sid%3Dliteratum%253Aachs%26aulast%3DMarques%26aufirst%3DA.%2BT.%26aulast%3DAntunes%26aufirst%3DA.%26aulast%3DFernandes%26aufirst%3DP.%2BA.%26aulast%3DRamos%26aufirst%3DM.%2BJ.%26atitle%3DComputational%2520optimization%2520of%2520AG18051%2520inhibitor%2520for%2520amyloid-%25CE%25B2%2520binding%2520alcohol%2520dehydrogenase%2520enzyme%26jtitle%3DInt.%2520J.%2520Quantum%2520Chem.%26date%3D2008%26volume%3D108%26spage%3D1982%26epage%3D1991%26doi%3D10.1002%2Fqua.21716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, D.</span></span> <span> </span><span class="NLM_article-title">Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: key tools for studying and treating estrogen-dependent diseases</span>. <i>J. Steroid Biochem. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1016/j.jsbmb.2010.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.jsbmb.2010.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=21182944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvVeit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2011&pages=83-94&author=D.+Poirier&title=Contribution+to+the+development+of+inhibitors+of+17%CE%B2-hydroxysteroid+dehydrogenase+types+1+and+7%3A+key+tools+for+studying+and+treating+estrogen-dependent+diseases&doi=10.1016%2Fj.jsbmb.2010.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: Key tools for studying and treating estrogen-dependent diseases</span></div><div class="casAuthors">Poirier, Donald</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">83-94</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  17β-Hydroxysteroid dehydrogenases (17β-HSDs) belong to a group of key enzymes involved in the biosynthesis of steroidal hormones by catalyzing the redn. of 17-ketosteroids or the oxidn. of 17β-hydroxysteroids.  From three members known in the early nineties, the 17β-HSD functional family has grown to 15 members over the last 20 years.  This growing no. of 17β-HSD isoforms questioned the importance of each member, esp. in their implication in estrogen- and androgen-dependent diseases, such as breast and prostate cancers.  One of the strategies used to address the physiol. importance of 17β-HSDs is to use potent and selective inhibitors.  Furthermore, enzyme inhibitors could also be of therapeutic interest by reducing the level of estradiol (E2).  Focusing on estrogens, we targeted 17β-HSD types 1 and 7, 2 enzymes able to transform the weak estrogen estrone (E1) into the potent estrogen E2.  The present review article gives a description of different classes of inhibitors of 17β-HSD1 (C6-derivs. of E2, C16-derivs. of E2 as alkylating and dual action compds., E2-adenosine hybrids, E2-simplified adenosine hybrids, and C16-derivs. of E1 or E2) and of inhibitors of 17β-HSD7, all these inhibitors developed in our lab.  The chem. structures and inhibitory activity of these steroidal inhibitors, their potential as therapeutic agents, and their use as tools to elucidate the role of these enzymes in particular biol. systems will be discussed.  Article from the Special issue on Targeted Inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Dv30uPIxDLVg90H21EOLACvtfcHk0lgG7HPTvXV7dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvVeit74%253D&md5=c917967b0ec79fe76af40f1c1c942325</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2010.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2010.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DPoirier%26aufirst%3DD.%26atitle%3DContribution%2520to%2520the%2520development%2520of%2520inhibitors%2520of%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520types%25201%2520and%25207%253A%2520key%2520tools%2520for%2520studying%2520and%2520treating%2520estrogen-dependent%2520diseases%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D125%26spage%3D83%26epage%3D94%26doi%3D10.1016%2Fj.jsbmb.2010.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hroch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guest, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janockova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dohnal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolezal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musilek, K.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer’s disease treatment</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3675</span>– <span class="NLM_lpage">3678</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.05.087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.bmcl.2016.05.087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=27287370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC28Xps1yntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3675-3678&author=L.+Hrochauthor=O.+Benekauthor=P.+Guestauthor=L.+Aitkenauthor=O.+Soukupauthor=J.+Janockovaauthor=K.+Musilauthor=V.+Dohnalauthor=R.+Dolezalauthor=K.+Kucaauthor=T.+K.+Smithauthor=F.+Gunn-Mooreauthor=K.+Musilek&title=Design%2C+synthesis+and+in+vitro+evaluation+of+benzothiazole-based+ureas+as+potential+ABAD%2F17%CE%B2-HSD10+modulators+for+Alzheimer%E2%80%99s+disease+treatment&doi=10.1016%2Fj.bmcl.2016.05.087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment</span></div><div class="casAuthors">Hroch, Lukas; Benek, Ondrej; Guest, Patrick; Aitken, Laura; Soukup, Ondrej; Janockova, Jana; Musil, Karel; Dohnal, Vlastimil; Dolezal, Rafael; Kuca, Kamil; Smith, Terry K.; Gunn-Moore, Frank; Musilek, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3675-3678</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Amyloid-beta peptide (Aβ) was recognized to interact with numerous proteins, which may lead to pathol. changes in cell metab. of Alzheimer's disease (AD) patients.  One such known metabolic enzyme is mitochondrial amyloid-binding alc. dehydrogenase (ABAD), also known as 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10).  Altered enzyme function caused by the Aβ-ABAD interaction, was previously shown to cause mitochondrial distress and a consequent cytotoxic effect, therefore providing a feasible target in AD drug development.  Based on previous frentizole derivs. studies, the authors report two novel series of benzothiazolyl ureas along with novel insights into the structure and activity relations for inhibition of ABAD.  Two benzothiazolylureas were identified as potent ABAD inhibitors, where one compd. exhibited comparable cytotoxicity with the frentizole std.; however, 1-fold higher cytotoxicity than the parent riluzole std.  The calcd. and exptl. phys. chem. properties of the most potent compds. showed promising features for blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEMtwJbI1gEbVg90H21EOLACvtfcHk0lglrSkCcrBJ3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xps1yntrc%253D&md5=d293defe7d0bfa51dfc98de7a520cbc2</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.05.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.05.087%26sid%3Dliteratum%253Aachs%26aulast%3DHroch%26aufirst%3DL.%26aulast%3DBenek%26aufirst%3DO.%26aulast%3DGuest%26aufirst%3DP.%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DJanockova%26aufirst%3DJ.%26aulast%3DMusil%26aufirst%3DK.%26aulast%3DDohnal%26aufirst%3DV.%26aulast%3DDolezal%26aufirst%3DR.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DT.%2BK.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DMusilek%26aufirst%3DK.%26atitle%3DDesign%252C%2520synthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520benzothiazole-based%2520ureas%2520as%2520potential%2520ABAD%252F17%25CE%25B2-HSD10%2520modulators%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3675%26epage%3D3678%26doi%3D10.1016%2Fj.bmcl.2016.05.087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuret, J.</span></span> <span> </span><span class="NLM_article-title">Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">15938</span>– <span class="NLM_lpage">15945</span>, <span class="refDoi"> DOI: 10.1074/jbc.M314116200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1074%2Fjbc.M314116200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=14761950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivF2ru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15938-15945&author=G.+Liauthor=H.+Yinauthor=J.+Kuret&title=Casein+kinase+1+delta+phosphorylates+tau+and+disrupts+its+binding+to+microtubules&doi=10.1074%2Fjbc.M314116200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Casein Kinase 1 Delta Phosphorylates Tau and Disrupts Its Binding to Microtubules</span></div><div class="casAuthors">Li, Guibin; Yin, Haishan; Kuret, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">15938-15945</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tau hyperphosphorylation precedes neuritic lesion formation in Alzheimer's disease, suggesting it participates in the tau fibrillization reaction pathway.  Candidate tau protein kinases include members of the casein kinase 1 (CK1) family of phosphotransferases, which are highly overexpressed in Alzheimer's disease brain and colocalize with neuritic and granulovacuolar lesions.  Here we characterized the contribution of one CK1 isoform, Ckiδ, to the phosphorylation of tau at residues Ser202/Thr205 and Ser396/Ser404 in human embryonic kidney 293 cells using immunodetection and fluorescence microscopy.  Treatment of cells with membrane permeable CK1 inhibitor 3-[(2,3,6-trimethoxyphenyl)methylidenyl]-indolin-2-one (IC261) lowered occupancy of Ser396/Ser404 phosphorylation sites by >70% at satn., suggesting that endogenous CK1 was the major source of basal phosphorylation activity at these sites.  Overexpression of Ckiδ increased CK1 enzyme activity and further raised tau phosphorylation at residues Ser202/Thr205 and Ser396/Ser404 in situ.  Inhibitor IC261 reversed tau hyperphosphorylation induced by Ckiδ overexpression.  Co-immunopptn. assays showed direct assocn. of tau and Ckiδ in situ, consistent with tau being a Ckiδ substrate.  Ckiδ overexpression also produced a decrease in the fraction of bulk tau bound to detergent-insol. microtubules.  These results suggest that Ckiδ phosphorylates tau at sites that modulate tau/microtubule binding, and that the expression pattern of Ckiδ in Alzheimer's disease is consistent with it playing an important role in tau aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs-5xMF88DsbVg90H21EOLACvtfcHk0lglrSkCcrBJ3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivF2ru7c%253D&md5=04a7d8fd87778a68d4b8e941f9ec7abf</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M314116200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M314116200%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DCasein%2520kinase%25201%2520delta%2520phosphorylates%2520tau%2520and%2520disrupts%2520its%2520binding%2520to%2520microtubules%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15938%26epage%3D15945%26doi%3D10.1074%2Fjbc.M314116200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flajolet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nairn, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greengard, P.</span></span> <span> </span><span class="NLM_article-title">Regulation of Alzheimer’s disease amyloid-β formation by casein kinase I</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">4159</span>– <span class="NLM_lpage">4164</span>, <span class="refDoi"> DOI: 10.1073/pnas.0611236104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1073%2Fpnas.0611236104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=4159-4164&author=M.+Flajoletauthor=G.+Heauthor=M.+Heimanauthor=A.+Linauthor=A.+C.+Nairnauthor=P.+Greengard&title=Regulation+of+Alzheimer%E2%80%99s+disease+amyloid-%CE%B2+formation+by+casein+kinase+I&doi=10.1073%2Fpnas.0611236104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0611236104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0611236104%26sid%3Dliteratum%253Aachs%26aulast%3DFlajolet%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DG.%26aulast%3DHeiman%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DNairn%26aufirst%3DA.%2BC.%26aulast%3DGreengard%26aufirst%3DP.%26atitle%3DRegulation%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520amyloid-%25CE%25B2%2520formation%2520by%2520casein%2520kinase%2520I%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D4159%26epage%3D4164%26doi%3D10.1073%2Fpnas.0611236104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valasani, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaney, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer’s disease</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1111%2Fcbdd.12068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=23039767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=238-249&author=K.+R.+Valasaniauthor=G.+Huauthor=M.+O.+Chaneyauthor=S.+S.+Yan&title=Structure-based+design+and+synthesis+of+benzothiazole+phosphonate+analogues+with+inhibitors+of+human+ABAD-A%CE%B2+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fcbdd.12068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design and synthesis of benzothiazole phosphonate analogs with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease</span></div><div class="casAuthors">Valasani, Koteswara R.; Hu, Gang; Chaney, Michael O.; Yan, Shirley S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">238-249</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Amyloid binding alc. dehydrogenase, a mitochondrial protein, is a cofactor facilitating amyloid-β peptide (Aβ) induced cell stress.  Antagonizing Aβ-ABAD interaction protects against aberrant mitochondrial and neuronal function and improves learning memory in the Alzheimer's disease mouse model.  Therefore, it offers a potential target for Alzheimer's drug design, by identifying potential inhibitors of Aβ-ABAD interaction.  2D QSAR methods were applied to novel compds. with known IC50 values, which formed a training set.  A correlation anal. was carried out comparing the statistics of the measured IC50 with predicted values.  These selectivity-detg. descriptors were interpreted graphically in terms of principal component analyses, which are highly informative for the lead optimization process with respect to activity enhancement.  A 3D pharmacophore model also was created.  The 2D QSAR and 3D pharmacophore models will assist in high-throughput screening.  In addn., ADME descriptors were also detd. to study their pharmacokinetic properties.  Finally, amyloid binding alc. dehydrogenase mol. docking study of these novel mols. was undertaken to det. whether these compds. exhibit significant binding affinity with the binding site.  We have synthesized only the compds. that have shown the best drug-like properties as candidates for further studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5GFoI2vsRwLVg90H21EOLACvtfcHk0lglrSkCcrBJ3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKht78%253D&md5=d7d8f98616c5754cd82a7cd5d5b140da</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12068%26sid%3Dliteratum%253Aachs%26aulast%3DValasani%26aufirst%3DK.%2BR.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DChaney%26aufirst%3DM.%2BO.%26aulast%3DYan%26aufirst%3DS.%2BS.%26atitle%3DStructure-based%2520design%2520and%2520synthesis%2520of%2520benzothiazole%2520phosphonate%2520analogues%2520with%2520inhibitors%2520of%2520human%2520ABAD-A%25CE%25B2%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2013%26volume%3D81%26spage%3D238%26epage%3D249%26doi%3D10.1111%2Fcbdd.12068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valasani, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. S.</span></span> <span> </span><span class="NLM_article-title">Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.2174/1567205011666140130150108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F1567205011666140130150108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=24479630" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=128-136&author=K.+R.+Valasaniauthor=Q.+Sunauthor=G.+Huauthor=J.+Liauthor=F.+Duauthor=Y.+Guoauthor=E.+A.+Carlsonauthor=X.+Ganauthor=S.+S.+Yan&title=Identification+of+human+ABAD+inhibitors+for+rescuing+A%CE%B2-mediated+mitochondrial+dysfunction&doi=10.2174%2F1567205011666140130150108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.2174%2F1567205011666140130150108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205011666140130150108%26sid%3Dliteratum%253Aachs%26aulast%3DValasani%26aufirst%3DK.%2BR.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DCarlson%26aufirst%3DE.%2BA.%26aulast%3DGan%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DS.%2BS.%26atitle%3DIdentification%2520of%2520human%2520ABAD%2520inhibitors%2520for%2520rescuing%2520A%25CE%25B2-mediated%2520mitochondrial%2520dysfunction%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2014%26volume%3D11%26spage%3D128%26epage%3D136%26doi%3D10.2174%2F1567205011666140130150108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trippier, P. C.</span></span> <span> </span><span class="NLM_article-title">Selecting good ‘drug-like’ properties to optimize small molecule blood-brain barrier penetration</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1392</span>– <span class="NLM_lpage">1407</span>, <span class="refDoi"> DOI: 10.2174/0929867323666160405112353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F0929867323666160405112353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=27048339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVWlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1392-1407&author=P.+C.+Trippier&title=Selecting+good+%E2%80%98drug-like%E2%80%99+properties+to+optimize+small+molecule+blood-brain+barrier+penetration&doi=10.2174%2F0929867323666160405112353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Selecting Good 'Drug-Like' Properties to Optimize Small Molecule Blood-Brain Barrier Penetration</span></div><div class="casAuthors">Trippier, Paul C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1392-1407</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The success rate to achieve clin. approval of drugs developed to treat diseases of the central nervous system (CNS) is the lowest of all disease indications.  A large contributor to this poor success rate is failure of small mols. to pass through the blood-brain barrier (BBB), a barrier composed of capillary endothelial cells connected by tight junctions that functions to extrude xenobiotics from the brain.  Designing small mols. to be BBB penetrant has been the subject of intensive research and has resulted in a series of guidelines to attain the best possible chances of BBB penetration.  This review will analyze the current state of thinking in ranking the importance of various physicochem. properties required to select BBB penetrant mols., describe model systems to det. BBB penetration, summarize data anal. methods and provide an outlook on further developments in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozPwAxKg1WLrVg90H21EOLACvtfcHk0lgZCXeBkmHFZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVWlurw%253D&md5=8edfbeec9c34759a5ecc809b645794d5</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.2174%2F0929867323666160405112353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666160405112353%26sid%3Dliteratum%253Aachs%26aulast%3DTrippier%26aufirst%3DP.%2BC.%26atitle%3DSelecting%2520good%2520%25E2%2580%2598drug-like%25E2%2580%2599%2520properties%2520to%2520optimize%2520small%2520molecule%2520blood-brain%2520barrier%2520penetration%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2016%26volume%3D23%26spage%3D1392%26epage%3D1407%26doi%3D10.2174%2F0929867323666160405112353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vangavaragu, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valasani, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. S.</span></span> <span> </span><span class="NLM_article-title">Determination of small molecule ABAD inhibitors crossing blood-brain barrier and pharmacokinetics</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.3233/JAD-140252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.3233%2FJAD-140252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=24858403" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlaktL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=333-344&author=J.+R.+Vangavaraguauthor=K.+R.+Valasaniauthor=D.+Fangauthor=T.+D.+Williamsauthor=S.+S.+Yan&title=Determination+of+small+molecule+ABAD+inhibitors+crossing+blood-brain+barrier+and+pharmacokinetics&doi=10.3233%2FJAD-140252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of Small Molecule ABAD Inhibitors Crossing Blood-Brain Barrier and Pharmacokinetics</span></div><div class="casAuthors">Vangavaragu, Jhansi Rani; Valasani, Koteswara Rao; Fang, Du; Williams, Todd D.; Yan, Shirley ShiDu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">333-344</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A major obstacle to the development of effective treatment of Alzheimer's disease (AD) is successfully delivery of drugs to the brain.  We have previously identified a series of benzothiazole phosphonate compds. that block the interaction of amyloid-β peptide with amyloid-β binding alc. dehydrogenase (ABAD).  A selective and sensitive method for the presence of three new benzothiazole ABAD inhibitors in mouse plasma, brain, and artificial cerebrospinal fluid has been developed and validated based on high performance liq. chromatog. tandem mass spectrometry.  Mass spectra were generated using Micromass Quattro Ultima "triple" quadrupole mass spectrometer equipped with an Electrospray Ionization interface.  Good linearity was obtained over a concn. range of 0.05-2.5 μg/mL.  The lowest limit of quantification and detection was found to be 0.05 μg/mL.  All inter-day accuracies and precisions were within ± 15% of the nominal value and ± 20%, resp., at the lower limit of quantitation.  The tested compds. were stable at various conditions with recoveries >90.0% (RSD <10%).  The method used for pharmacokinetic studies of compds. in mouse cerebrospinal fluid, plasma, and brain is accurate, precise, and specific with no matrix effect.  Pharmacokinetic data showed that these compds. penetrate the blood-brain barrier (BBB) yielding 4-50 ng/mL peak brain concns. and 2 μg/mL peak plasma concns. from a 10 mg/kg dose.  These results indicate that our newly synthesized small mol. ABAD inhibitors have a good drug properties with the ability to cross the blood-brain barrier, which holds a great potential for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3525aF5LeNLVg90H21EOLACvtfcHk0lgZCXeBkmHFZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlaktL%252FK&md5=d7b9d02803840c674e5d59217ee10cd1</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.3233%2FJAD-140252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-140252%26sid%3Dliteratum%253Aachs%26aulast%3DVangavaragu%26aufirst%3DJ.%2BR.%26aulast%3DValasani%26aufirst%3DK.%2BR.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DT.%2BD.%26aulast%3DYan%26aufirst%3DS.%2BS.%26atitle%3DDetermination%2520of%2520small%2520molecule%2520ABAD%2520inhibitors%2520crossing%2520blood-brain%2520barrier%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2014%26volume%3D42%26spage%3D333%26epage%3D344%26doi%3D10.3233%2FJAD-140252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hroch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolezal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guest, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benkova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musilek, K.</span></span> <span> </span><span class="NLM_article-title">6-Benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17β-HSD10 and potential drugs for Alzheimer’s disease treatment: design, synthesis and in vitro evaluation</span>. <i>Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.2174/1573406413666170109142725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.2174%2F1573406413666170109142725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsl2htLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=345-358&author=O.+Benekauthor=L.+Hrochauthor=L.+Aitkenauthor=R.+Dolezalauthor=P.+Guestauthor=M.+Benkovaauthor=O.+Soukupauthor=K.+Musilauthor=K.+Kucaauthor=T.+K.+Smithauthor=F.+Gunn-Mooreauthor=K.+Musilek&title=6-Benzothiazolyl+ureas%2C+thioureas+and+guanidines+are+potent+inhibitors+of+ABAD%2F17%CE%B2-HSD10+and+potential+drugs+for+Alzheimer%E2%80%99s+disease+treatment%3A+design%2C+synthesis+and+in+vitro+evaluation&doi=10.2174%2F1573406413666170109142725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">6-Benzothiazolyl Ureas, Thioureas and Guanidines are Potent Inhibitors of ABAD/17β-HSD10 and Potential Drugs for Alzheimer"s Disease Treatment: Design, Synthesis and in vitro Evaluation</span></div><div class="casAuthors">Benek, Ondrej; Hroch, Lukas; Aitken, Laura; Dolezal, Rafael; Guest, Patrick; Benkova, Marketa; Soukup, Ondrej; Musil, Karel; Kuca, Kamil; Smith, Terry K.; Gunn-Moore, Frank; Musilek, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">345-358</span>CODEN:
                <span class="NLM_cas:coden">MCEHAJ</span>;
        ISSN:<span class="NLM_cas:issn">1573-4064</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: The mitochondrial enzyme amyloid beta-binding alc. dehydrogenase (ABAD) also known as 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10) has been connected with the pathogenesis of Alzheimer's disease (AD).  ABAD/17β-HSD10 is a binding site for the amyloid-beta peptide (Aβ) inside the mitochondrial matrix where it exacerbates Aβtoxicity.  Interaction between these two proteins triggers a series of events leading to mitochondrial dysfunction as seen in AD.  Methods: As ABAD's enzymic activity is required for mediating Aβ toxicity, its inhibition presents a promising strategy for AD treatment.  In this study, a series of new benzothiazolylurea analogs have been prepd. and evaluated in vitro for their potency to inhibit ABAD/17β-HSD10 enzymic activity.  The most potent compds. have also been tested for their cytotoxic properties and their ability to permeate through blood-brain barrier has been predicted.  To explain the structureactivity relationship QSAR and pharmacophore studies have been performed.  Results and Conclusion: Compd. 12 was identified being the most promising hit compd. with good inhibitory activity (IC50 = 3.06 ± 0.40 μ M) and acceptable cytotoxicity profile comparable to the parent compd. of frentizole.  The satisfactory phys.-chem. properties suggesting its capability to permeate through BBB make compd. 12 a novel lead structure for further development and biol. assessment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRkx9qgN5Jd7Vg90H21EOLACvtfcHk0lgTmvy5nTD3kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsl2htLg%253D&md5=c2c863ab2dd0df887736880fc9d5a3d9</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.2174%2F1573406413666170109142725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1573406413666170109142725%26sid%3Dliteratum%253Aachs%26aulast%3DBenek%26aufirst%3DO.%26aulast%3DHroch%26aufirst%3DL.%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DDolezal%26aufirst%3DR.%26aulast%3DGuest%26aufirst%3DP.%26aulast%3DBenkova%26aufirst%3DM.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DMusil%26aufirst%3DK.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DT.%2BK.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DMusilek%26aufirst%3DK.%26atitle%3D6-Benzothiazolyl%2520ureas%252C%2520thioureas%2520and%2520guanidines%2520are%2520potent%2520inhibitors%2520of%2520ABAD%252F17%25CE%25B2-HSD10%2520and%2520potential%2520drugs%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%253A%2520design%252C%2520synthesis%2520and%2520in%2520vitro%2520evaluation%26jtitle%3DMed.%2520Chem.%26date%3D2017%26volume%3D13%26spage%3D345%26epage%3D358%26doi%3D10.2174%2F1573406413666170109142725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hroch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guest, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benek, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janockova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolezal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn-Moore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zala, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musilek, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer’s disease treatment</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1152</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1016%2Fj.bmc.2016.12.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1143-1152&author=L.+Hrochauthor=P.+Guestauthor=O.+Benekauthor=O.+Soukupauthor=J.+Janockovaauthor=R.+Dolezalauthor=K.+Kucaauthor=L.+Aitkenauthor=T.+K.+Smithauthor=F.+Gunn-Mooreauthor=D.+Zalaauthor=R.+R.+Ramsayauthor=K.+Musilek&title=Synthesis+and+evaluation+of+frentizole-based+indolyl+thiourea+analogues+as+MAO%2FABAD+inhibitors+for+Alzheimer%E2%80%99s+disease+treatment&doi=10.1016%2Fj.bmc.2016.12.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DHroch%26aufirst%3DL.%26aulast%3DGuest%26aufirst%3DP.%26aulast%3DBenek%26aufirst%3DO.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DJanockova%26aufirst%3DJ.%26aulast%3DDolezal%26aufirst%3DR.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DAitken%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DT.%2BK.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DZala%26aufirst%3DD.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26aulast%3DMusilek%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520frentizole-based%2520indolyl%2520thiourea%2520analogues%2520as%2520MAO%252FABAD%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D1143%26epage%3D1152%26doi%3D10.1016%2Fj.bmc.2016.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Viswanath, A. N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span> <span> </span><span class="NLM_article-title">In silico-designed novel non-peptidic ABAD L<sub>D</sub> hot spot mimetics reverse Aβ-induced mitochondrial impairments in vitro</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">1041</span>– <span class="NLM_lpage">1055</span>, <span class="refDoi"> DOI: 10.1111/cbdd.13065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=10.1111%2Fcbdd.13065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=28660722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1arsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2017&pages=1041-1055&author=A.+N.+I.+Viswanathauthor=T.+Kimauthor=S.+Y.+Jungauthor=S.+M.+Limauthor=A.+N.+Pae&title=In+silico-designed+novel+non-peptidic+ABAD+LD+hot+spot+mimetics+reverse+A%CE%B2-induced+mitochondrial+impairments+in+vitro&doi=10.1111%2Fcbdd.13065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">In silico-designed novel non-peptidic ABAD LD hot spot mimetics reverse Aβ-induced mitochondrial impairments in vitro</span></div><div class="casAuthors">Viswanath, Ambily Nath Indu; Kim, Tae Hun; Jung, Seo Yun; Lim, Sang Min; Pae, Ae Nim</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1041-1055</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Present work aimed to introduce non-peptidic ABAD loop D (LD) hot spot mimetics as ABAD-Aβ inhibitors.  A full-length atomistic model of ABAD-Aβ complex was built as a scaffold to launch the lead design and its topol. later verified by cross-checking the computational mutagenesis results with that of in vitro data.  Thereafter, the interactions of prime Aβ-binding LD residues-Tyr101, Thr108, and Thr110-were translated into specific pharmacophore features and this hypothesis subsequently used as a virtual screen query.  ELISA-based screening of 20 hits identified two promising lead candidates, VC15 and VC19 with an IC50 of 4.4 ± 0.3 and 9.6 ± 0.1 μm, resp.  They productively reversed Aβ-induced mitochondrial dysfunctions such as mitochondrial membrane potential loss (JC-1 assay), toxicity (MTT assay), and ATP redn. (ATP assay) in addn. to increased cell viabilities.  This is the first reporting of LD hot spot-centric in silico scheme to discover novel compds. with promising ABAD-Aβ inhibitory potential.  These chemotypes are proposed for further structural optimization to derive novel Alzheimer's disease (AD) therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFfWyRk0Air7Vg90H21EOLACvtfcHk0lgTmvy5nTD3kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1arsr%252FO&md5=aef10ded69474131abc4b4c4b6515607</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.13065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.13065%26sid%3Dliteratum%253Aachs%26aulast%3DViswanath%26aufirst%3DA.%2BN.%2BI.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DS.%2BY.%26aulast%3DLim%26aufirst%3DS.%2BM.%26aulast%3DPae%26aufirst%3DA.%2BN.%26atitle%3DIn%2520silico-designed%2520novel%2520non-peptidic%2520ABAD%2520LD%2520hot%2520spot%2520mimetics%2520reverse%2520A%25CE%25B2-induced%2520mitochondrial%2520impairments%2520in%2520vitro%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2017%26volume%3D90%26spage%3D1041%26epage%3D1055%26doi%3D10.1111%2Fcbdd.13065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1U7T" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1U7T','PDB','1U7T'); return false;">PDB: 1U7T</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01530&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01530%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-9" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01530" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998bae5b563dc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
